Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Alzheimer's Disease

  Free Subscription


Articles published in J Alzheimers Dis

Retrieve available abstracts of 1859 articles:
HTML format



Single Articles


    July 2021
  1. CROSS DJ, Huber BR, Silverman MA, Cline MM, et al
    Intranasal Paclitaxel Alters Alzheimer's Disease Phenotypic Features in 3xTg-AD Mice.
    J Alzheimers Dis. 2021 Jul 23. pii: JAD210109. doi: 10.3233/JAD-210109.
    PubMed     Abstract available


  2. WANG F, Xu CS, Chen WH, Duan SW, et al
    Identification of Blood-Based Glycolysis Gene Associated with Alzheimer's Disease by Integrated Bioinformatics Analysis.
    J Alzheimers Dis. 2021 Jul 19. pii: JAD210540. doi: 10.3233/JAD-210540.
    PubMed     Abstract available


  3. NARA PL, Sindelar D, Penn MS, Potempa J, et al
    Porphyromonas gingivalis Outer Membrane Vesicles as the Major Driver of and Explanation for Neuropathogenesis, the Cholinergic Hypothesis, Iron Dyshomeostasis, and Salivary Lactoferrin in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jul 16. pii: JAD210448. doi: 10.3233/JAD-210448.
    PubMed     Abstract available


  4. ALEXOPOULOS P, Skondra M, Kontogianni E, Vratsista A, et al
    Validation of the Cognitive Telephone Screening Instruments COGTEL and COGTEL+ in Identifying Clinically Diagnosed Neurocognitive Disorder Due to Alzheimer's Disease in a Naturalistic Clinical Setting.
    J Alzheimers Dis. 2021 Jul 15. pii: JAD210477. doi: 10.3233/JAD-210477.
    PubMed     Abstract available


  5. DE LA TORRE JC, Gonzalez-Lima F
    The FDA Approves Aducanumab for Alzheimer's Disease, Raising Important Scientific Questions1.
    J Alzheimers Dis. 2021 Jul 9. pii: JAD210736. doi: 10.3233/JAD-210736.
    PubMed    


  6. CHEN S, Song Y, Xu W, Hu G, et al
    Impaired Memory Awareness and Loss Integration in Self-Referential Network Across the Progression of Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2021 Jul 9. pii: JAD210541. doi: 10.3233/JAD-210541.
    PubMed     Abstract available


  7. SIBLE IJ, Bangen KJ, Blanken AE, Ho JK, et al
    Antemortem Visit-To-Visit Blood Pressure Variability Predicts Cerebrovascular Lesion Burden in Autopsy-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jul 7. pii: JAD210435. doi: 10.3233/JAD-210435.
    PubMed     Abstract available


  8. JOSEPH S, Patterson R, Wang W, Blumberger DM, et al
    Quantitative Assessment of Cortical Excitability in Alzheimer's Dementia and Its Association with Clinical Symptoms: A Systematic Review and Meta-Analyses.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD210311. doi: 10.3233/JAD-210311.
    PubMed     Abstract available


  9. BEARDMORE R, Hou R, Darekar A, Holmes C, et al
    The Locus Coeruleus in Aging and Alzheimer's Disease: A Postmortem and Brain Imaging Review.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD210191. doi: 10.3233/JAD-210191.
    PubMed     Abstract available


  10. SQUITTI R, Faller P, Hureau C, Granzotto A, et al
    Copper Imbalance in Alzheimer's Disease and Its Link with the Amyloid Hypothesis: Towards a Combined Clinical, Chemical, and Genetic Etiology.
    J Alzheimers Dis. 2021 Jul 2. pii: JAD201556. doi: 10.3233/JAD-201556.
    PubMed     Abstract available


  11. HOJJATI SH, Feiz F, Ozoria S, Razlighi QR, et al
    Topographical Overlapping of the Amyloid-beta and Tau Pathologies in the Default Mode Network Predicts Alzheimer's Disease with Higher Specificity.
    J Alzheimers Dis. 2021 Jul 1. pii: JAD210419. doi: 10.3233/JAD-210419.
    PubMed     Abstract available


  12. KUWAR R, Rolfe A, Di L, Blevins H, et al
    A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.
    J Alzheimers Dis. 2021 Jul 1. pii: JAD210400. doi: 10.3233/JAD-210400.
    PubMed     Abstract available


    June 2021
  13. GABRIEL A, Lehner CT, Hohler C, Schneider T, et al
    Anticipatory and Reactive Grip Force Control in Patients with Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2021 Jun 30. pii: JAD210387. doi: 10.3233/JAD-210387.
    PubMed     Abstract available


  14. BAENA A, Bocanegra Y, Torres V, Vila-Castelar C, et al
    Neuroticism Is Associated with Tau Pathology in Cognitively Unimpaired Individuals with Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 30. pii: JAD210185. doi: 10.3233/JAD-210185.
    PubMed     Abstract available


  15. FRANK M, Hensel J, Baak L, Schramm S, et al
    Interaction of Alzheimer's Disease-Associated Genetic Risk with Indicators of Socioeconomic Position on Mild Cognitive Impairment in the Heinz Nixdorf Recall Study.
    J Alzheimers Dis. 2021 Jun 28. pii: JAD210244. doi: 10.3233/JAD-210244.
    PubMed     Abstract available


  16. MANCINI G, Dias C, Lourenco CF, Laranjinha J, et al
    A High Fat/Cholesterol Diet Recapitulates Some Alzheimer's Disease-Like Features in Mice: Focus on Hippocampal Mitochondrial Dysfunction.
    J Alzheimers Dis. 2021 Jun 28. pii: JAD210122. doi: 10.3233/JAD-210122.
    PubMed     Abstract available


  17. YAO W, Chen H, Sheng X, Zhao H, et al
    Core-Centered Connection Abnormalities Associated with Pathological Features Mediate the Progress of Cognitive Impairments in Alzheimer's Disease Spectrum Patients.
    J Alzheimers Dis. 2021 Jun 22. pii: JAD210481. doi: 10.3233/JAD-210481.
    PubMed     Abstract available


  18. CHAUDHARY S, Ashok A, McDonald D, Wise AS, et al
    Upregulation of Local Hepcidin Contributes to Iron Accumulation in Alzheimer's Disease Brains.
    J Alzheimers Dis. 2021 Jun 19. pii: JAD210221. doi: 10.3233/JAD-210221.
    PubMed     Abstract available


  19. KANG S, Gim J, Lee J, Gunasekaran TI, et al
    Potential Novel Genes for Late-Onset Alzheimer's Disease in East-Asian Descent Identified by APOE-Stratified Genome-Wide Association Study.
    J Alzheimers Dis. 2021 Jun 18. pii: JAD210145. doi: 10.3233/JAD-210145.
    PubMed     Abstract available


  20. XU LZ, Li FY, Li BQ, Cao SM, et al
    Decreased Levels of Insulin-Like Growth Factor-1 Are Associated with Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2021 Jun 17. pii: JAD210516. doi: 10.3233/JAD-210516.
    PubMed     Abstract available


  21. MITOLO M, Stanzani-Maserati M, Manners DN, Capellari S, et al
    The Combination of Metabolic Posterior Cingulate Cortical Abnormalities and Structural Asymmetries Improves the Differential Diagnosis Between Primary Progressive Aphasia and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 17. pii: JAD210211. doi: 10.3233/JAD-210211.
    PubMed     Abstract available


  22. TARGUM SD, Fosdick L, Drake KE, Rosenberg PB, et al
    Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 16. pii: JAD210530. doi: 10.3233/JAD-210530.
    PubMed     Abstract available


  23. BAHAR B, Kanagasingam S, Tambuwala MM, Aljabali AAA, et al
    Porphyromonas gingivalis (W83) Infection Induces Alzheimer's Disease-Like Pathophysiology in Obese and Diabetic Mice.
    J Alzheimers Dis. 2021 Jun 16. pii: JAD210465. doi: 10.3233/JAD-210465.
    PubMed     Abstract available


  24. FRANCOIS M, Karpe A, Liu JW, Beale D, et al
    Salivaomics as a Potential Tool for Predicting Alzheimer's Disease During the Early Stages of Neurodegeneration.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD210283. doi: 10.3233/JAD-210283.
    PubMed     Abstract available


  25. AKUSHEVICH I, Yashkin AP, Kravchenko J, Yashin AI, et al
    Analysis of Time Trends in Alzheimer's Disease and Related Dementias Using Partitioning Approach.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD210273. doi: 10.3233/JAD-210273.
    PubMed     Abstract available


  26. PAULO SL, Ribeiro-Rodrigues L, Rodrigues RS, Mateus JM, et al
    Sustained Hippocampal Neural Plasticity Questions the Reproducibility of an Amyloid-beta-Induced Alzheimer's Disease Model.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD201567. doi: 10.3233/JAD-201567.
    PubMed     Abstract available


  27. FERNANDEZ G, Parra MA
    Oculomotor Behaviors and Integrative Memory Functions in the Alzheimer's Clinical Syndrome.
    J Alzheimers Dis. 2021 Jun 15. pii: JAD201189. doi: 10.3233/JAD-201189.
    PubMed     Abstract available


  28. ESPAY AJ, Sturchio A, Schneider LS, Ezzat K, et al
    Soluble Amyloid-beta Consumption in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210415. doi: 10.3233/JAD-210415.
    PubMed     Abstract available


  29. QU M, Shi H, Wang K, Wang X, et al
    The Associations of Plasma/Serum Carotenoids with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210384. doi: 10.3233/JAD-210384.
    PubMed     Abstract available


  30. LOURENCO MV, Ribeiro FC, Santos LE, Beckman D, et al
    Cerebrospinal Fluid Neurotransmitters, Cytokines, and Chemokines in Alzheimer's and Lewy Body Diseases.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210147. doi: 10.3233/JAD-210147.
    PubMed     Abstract available


  31. WANG ZT, Li KY, Tan CC, Xu W, et al
    Associations of Alcohol Consumption with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD210140. doi: 10.3233/JAD-210140.
    PubMed     Abstract available


  32. BABILONI C, Ferri R, Noce G, Lizio R, et al
    Resting State Alpha Electroencephalographic Rhythms Are Differently Related to Aging in Cognitively Unimpaired Seniors and Patients with Alzheimer's Disease and Amnesic Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Jun 12. pii: JAD201271. doi: 10.3233/JAD-201271.
    PubMed     Abstract available


  33. CASTILLO-MENDIETA T, Arana-Lechuga Y, Campos-Pena V, Sosa AL, et al
    Plasma Levels of Amyloid-beta Peptides and Tau Protein in Mexican Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 11. pii: JAD200912. doi: 10.3233/JAD-200912.
    PubMed     Abstract available


  34. SERRA L, D'Amelio M, Esposito S, Domenico CD, et al
    Ventral Tegmental Area Disconnection Contributes Two Years Early to Correctly Classify Patients Converted to Alzheimer's Disease: Implications for Treatment.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210171. doi: 10.3233/JAD-210171.
    PubMed     Abstract available


  35. DARMANTHE N, Tabatabaei-Jafari H, Cherbuin N
    Combination of Plasma Neurofilament Light Chain and Mini-Mental State Examination Score Predicts Progression from Mild Cognitive Impairment to Alzheimer's Disease within 5 Years.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210092. doi: 10.3233/JAD-210092.
    PubMed     Abstract available


  36. KVELLO-ALME M, Brathen G, White LR, Sando SB, et al
    Time to Diagnosis in Young Onset Alzheimer's Disease: A Population-Based Study from Central Norway.
    J Alzheimers Dis. 2021 Jun 9. pii: JAD210090. doi: 10.3233/JAD-210090.
    PubMed     Abstract available


  37. SAMARA M, Levine SZ, Yoshida K, Goldberg Y, et al
    Linking the Clinical Dementia Rating Scale-Sum of Boxes, the Clinician's Interview-Based Impression Plus Caregiver Input, and the Clinical Global Impression Scale: Evidence based on Individual Participant Data from Five Randomized Clinical Trials of D
    J Alzheimers Dis. 2021 Jun 9. pii: JAD201541. doi: 10.3233/JAD-201541.
    PubMed     Abstract available


  38. RICHARD CHEN X, Shao Y, Sadowski MJ
    Segmented Linear Mixed Model Analysis Reveals Association of the APOEvarepsilon4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
    J Alzheimers Dis. 2021 Jun 7. pii: JAD210434. doi: 10.3233/JAD-210434.
    PubMed     Abstract available


  39. COVATTI MALCORRA BL, Mota NB, Weissheimer J, Schilling LP, et al
    Low Speech Connectedness in Alzheimer's Disease is Associated with Poorer Semantic Memory Performance.
    J Alzheimers Dis. 2021 Jun 7. pii: JAD210134. doi: 10.3233/JAD-210134.
    PubMed     Abstract available


  40. VECCHIO F, Miraglia F, Alu F, Orticoni A, et al
    Contribution of Graph Theory Applied to EEG Data Analysis for Alzheimer's Disease versus Vascular Dementia Diagnosis.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210394. doi: 10.3233/JAD-210394.
    PubMed     Abstract available


  41. SCHOEMAKER D, Velilla L, Zuluaga Y, Baena A, et al
    Global Cardiovascular Risk Profile and Cerebrovascular Abnormalities in Presymptomatic Individuals with CADASIL or Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210313. doi: 10.3233/JAD-210313.
    PubMed     Abstract available


  42. ZHAO X, Li C, Ding G, Heng Y, et al
    The Burden of Alzheimer's Disease Mortality in the United States, 1999-2018.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210225. doi: 10.3233/JAD-210225.
    PubMed     Abstract available


  43. SPERA V, Sitnikova T, Ward MJ, Farzam P, et al
    Pilot Study on Dose-Dependent Effects of Transcranial Photobiomodulation on Brain Electrical Oscillations: A Potential Therapeutic Target in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 3. pii: JAD210058. doi: 10.3233/JAD-210058.
    PubMed     Abstract available


  44. BEN AYED I, Castor-Guyonvarch N, Amimour S, Naija S, et al
    Acute Exercise and Cognitive Function in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jun 1. pii: JAD201317. doi: 10.3233/JAD-201317.
    PubMed     Abstract available


  45. GRECO FA, McKee AC, Kowall NW, Hanlon EB, et al
    Near-Infrared Optical Spectroscopy In Vivo Distinguishes Subjects with Alzheimer's Disease from Age-Matched Controls.
    J Alzheimers Dis. 2021 Jun 1. pii: JAD201021. doi: 10.3233/JAD-201021.
    PubMed     Abstract available


    May 2021
  46. JIN N, Babiloni C, Drinkenburg WH, Hajos M, et al
    Recommendations for Preclinical Testing of Treatments Against Alzheimer's Disease-Related Epileptiform Spikes in Transgenic Rodent Models.
    J Alzheimers Dis. 2021 May 29. pii: JAD210209. doi: 10.3233/JAD-210209.
    PubMed     Abstract available


  47. DELAZER M, Zamarian L, Djamshidian A
    Handwriting in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 28. pii: JAD210279. doi: 10.3233/JAD-210279.
    PubMed     Abstract available


  48. JEONG W, Joo JH, Kim H, Kim YK, et al
    Association Between the Use of Hypnotics and the Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 27. pii: JAD201319. doi: 10.3233/JAD-201319.
    PubMed     Abstract available


  49. BABIC LEKO M, Jurasovic J, Nikolac Perkovic M, Spanic E, et al
    The Association of Essential Metals with APOE Genotype in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 27. pii: JAD210158. doi: 10.3233/JAD-210158.
    PubMed     Abstract available


  50. WEI W, Liu Y, Dai C, Baazaoui N, et al
    Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction.
    J Alzheimers Dis. 2021 May 27. pii: JAD201599. doi: 10.3233/JAD-201599.
    PubMed     Abstract available


  51. THOMSEN BB, Madsen C, Krohn KT, Thygesen C, et al
    Mild Microglial Responses in the Cortex and Perivascular Macrophage Infiltration in Subcortical White Matter in Dogs with Age-Related Dementia Modelling Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 26. pii: JAD210040. doi: 10.3233/JAD-210040.
    PubMed     Abstract available


  52. KING-ROBSON J, Wilson H, Politis M
    Associations Between Amyloid and Tau Pathology, and Connectome Alterations, in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 May 22. pii: JAD201457. doi: 10.3233/JAD-201457.
    PubMed     Abstract available


  53. BARRIO JR, Whitehouse P, Alavi A, Hoilund-Carlsen PF, et al
    New IDEAS Amyloid Imaging 2021 Study: Running in Place with Ineffective Anti-Amyloid Treatments for Alzheimer's Disease Patients.
    J Alzheimers Dis. 2021 May 20. pii: JAD210383. doi: 10.3233/JAD-210383.
    PubMed    


  54. LI X, Tian Y, Yang YX, Ma YH, et al
    Life Course Adiposity and Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2021 May 20. pii: JAD210345. doi: 10.3233/JAD-210345.
    PubMed     Abstract available


  55. LAURIOLA M, D'Onofrio G, Ciccone F, Germano C, et al
    Relationship of Homocysteine Plasma Levels with Mild Cognitive Impairment, Alzheimer's Disease, Vascular Dementia, Psychobehavioral, and Functional Complications.
    J Alzheimers Dis. 2021 May 20. pii: JAD210166. doi: 10.3233/JAD-210166.
    PubMed     Abstract available


  56. YANG H, Luo Y, Hu Q, Tian X, et al
    Benefits in Alzheimer's Disease of Sensory and Multisensory Stimulation.
    J Alzheimers Dis. 2021 May 20. pii: JAD201554. doi: 10.3233/JAD-201554.
    PubMed     Abstract available


  57. BARTHELSON K, Dong Y, Newman M, Lardelli M, et al
    PRESENILIN 1 Mutations Causing Early-Onset Familial Alzheimer's Disease or Familial Acne Inversa Differ in Their Effects on Genes Facilitating Energy Metabolism and Signal Transduction.
    J Alzheimers Dis. 2021 May 19. pii: JAD210128. doi: 10.3233/JAD-210128.
    PubMed     Abstract available


  58. HAN H, Wang F, Chen J, Li X, et al
    Changes in Biothiol Levels Are Closely Associated with Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 19. pii: JAD210021. doi: 10.3233/JAD-210021.
    PubMed     Abstract available



  59. Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2021 May 18. pii: JAD219004. doi: 10.3233/JAD-219004.
    PubMed    


  60. FERNANDEZ-AGUILAR L, Lora Y, Satorres E, Ros L, et al
    Dimensional and Discrete Emotional Reactivity in Alzheimer's Disease: Film Clips as a Research Tool in Dementia.
    J Alzheimers Dis. 2021 May 18. pii: JAD210233. doi: 10.3233/JAD-210233.
    PubMed     Abstract available


  61. RODRIGO-HERRERO S, Luque-Tirado A, Mendez-Barrio C, Garcia-Solis D, et al
    TMA-93 Validation by Alzheimer's Disease Biomarkers: A Comparison with the Free and Cued Selective Reminding Test on a Biobank Sample.
    J Alzheimers Dis. 2021 May 18. pii: JAD210115. doi: 10.3233/JAD-210115.
    PubMed     Abstract available


  62. PISTONO A, Senoussi M, Guerrier L, Rafiq M, et al
    Language Network Connectivity Increases in Early Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 18. pii: JAD201584. doi: 10.3233/JAD-201584.
    PubMed     Abstract available


  63. BERNSTEIN AS, Rapcsak SZ, Hornberger M, Saranathan M, et al
    Structural Changes in Thalamic Nuclei Across Prodromal and Clinical Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 18. pii: JAD201583. doi: 10.3233/JAD-201583.
    PubMed     Abstract available


  64. MAO C, Sha L, Li J, Huang X, et al
    Relationship Between General Cognition, Visual Assessed Cortical Atrophy, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: A Cross-Sectional Study from a Chinese PUMCH Cohort.
    J Alzheimers Dis. 2021 May 16. pii: JAD210344. doi: 10.3233/JAD-210344.
    PubMed     Abstract available


  65. DUAN W, Zhou GD, Balachandrasekaran A, Bhumkar AB, et al
    Cerebral Blood Flow Predicts Conversion of Mild Cognitive Impairment into Alzheimer's Disease and Cognitive Decline: An Arterial Spin Labeling Follow-up Study.
    J Alzheimers Dis. 2021 May 16. pii: JAD210199. doi: 10.3233/JAD-210199.
    PubMed     Abstract available


  66. JIMENEZ EC, Sierra-Marcos A, Romeo A, Hashemi A, et al
    Altered Vergence Eye Movements and Pupil Response of Patients with Alzheimer's Disease and Mild Cognitive Impairment During an Oddball Task.
    J Alzheimers Dis. 2021 May 16. pii: JAD201301. doi: 10.3233/JAD-201301.
    PubMed     Abstract available


  67. ALVES SS, Silva-Junior RMPD, Servilha-Menezes G, Homolak J, et al
    Insulin Resistance as a Common Link Between Current Alzheimer's Disease Hypotheses.
    J Alzheimers Dis. 2021 May 15. pii: JAD210234. doi: 10.3233/JAD-210234.
    PubMed     Abstract available


  68. YIN X, Xie Q, Huang L, Liu L, et al
    Assessment of the Psychological Burden Among Family Caregivers of People Living with Alzheimer's Disease Using the Zarit Burden Interview.
    J Alzheimers Dis. 2021 May 15. pii: JAD210025. doi: 10.3233/JAD-210025.
    PubMed     Abstract available


  69. DU F, Yu Q, Yan SS
    PINK1 Activation Attenuates Impaired Neuronal-Like Differentiation and Synaptogenesis and Mitochondrial Dysfunction in Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    J Alzheimers Dis. 2021 May 14. pii: JAD210095. doi: 10.3233/JAD-210095.
    PubMed     Abstract available


  70. YE F, Wu A
    The Protective Mechanism of SIRT1 in the Regulation of Mitochondrial Biogenesis and Mitochondrial Autophagy in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 11. pii: JAD210132. doi: 10.3233/JAD-210132.
    PubMed     Abstract available


  71. MASSETT HA, Mitchell AK, Alley L, Simoneau E, et al
    Facilitators, Challenges, and Messaging Strategies for Hispanic/Latino Populations Participating in Alzheimer's Disease and Related Dementias Clinical Research: A Literature Review.
    J Alzheimers Dis. 2021 May 11. pii: JAD201463. doi: 10.3233/JAD-201463.
    PubMed     Abstract available


  72. OU GY, Lin WW, Zhao WJ
    Construction of Long Noncoding RNA-Associated ceRNA Networks Reveals Potential Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2021 May 11. pii: JAD210068. doi: 10.3233/JAD-210068.
    PubMed     Abstract available


  73. CAMARGO A, Wang Z
    Longitudinal Cerebral Blood Flow Changes in Normal Aging and the Alzheimer's Disease Continuum Identified by Arterial Spin Labeling MRI.
    J Alzheimers Dis. 2021 May 5. pii: JAD210116. doi: 10.3233/JAD-210116.
    PubMed     Abstract available


  74. DU Y, Dennis B, Liu J, Meyer K, et al
    A Conceptual Model to Improve Care for Individuals with Alzheimer's Disease and Related Dementias and Their Caregivers: Qualitative Findings in an Online Caregiver Forum.
    J Alzheimers Dis. 2021 May 3. pii: JAD210167. doi: 10.3233/JAD-210167.
    PubMed     Abstract available


  75. HANNESTAD J, Duclos T, Chao W, Koborsi K, et al
    Safety and Tolerability of GRF6019 Infusions in Severe Alzheimer's Disease: A Phase II Double-Blind Placebo-Controlled Trial.
    J Alzheimers Dis. 2021 May 3. pii: JAD210011. doi: 10.3233/JAD-210011.
    PubMed     Abstract available


    April 2021
  76. SERPENTE M, Fenoglio C, Arighi A, Fumagalli GG, et al
    Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease?
    J Alzheimers Dis. 2021 Apr 28. pii: JAD210249. doi: 10.3233/JAD-210249.
    PubMed     Abstract available


  77. SOMAA F
    A Review of the Application of Hyperbaric Oxygen Therapy in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 28. pii: JAD210157. doi: 10.3233/JAD-210157.
    PubMed     Abstract available


  78. SMIRNI D, Oliveri M, Misuraca E, Catania A, et al
    Verbal Fluency in Mild Alzheimer's Disease: Transcranial Direct Current Stimulation over the Dorsolateral Prefrontal Cortex.
    J Alzheimers Dis. 2021 Apr 28. pii: JAD210003. doi: 10.3233/JAD-210003.
    PubMed     Abstract available


  79. DE LA FUENTE M
    The Role of the Microbiota-Gut-Brain Axis in the Health and Illness Condition: A Focus on Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 28. pii: JAD201587. doi: 10.3233/JAD-201587.
    PubMed     Abstract available


  80. BERTRAND E, van Duinkerken E, Laks J, Dourado MCN, et al
    Structural Gray and White Matter Correlates of Awareness in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 28. pii: JAD201246. doi: 10.3233/JAD-201246.
    PubMed     Abstract available


  81. DE OLIVEIRA FF, Miraldo MC, de Castro-Neto EF, de Almeida SS, et al
    Associations of Neuropsychiatric Features with Cerebrospinal Fluid Biomarkers of Amyloidogenesis and Neurodegeneration in Dementia with Lewy Bodies Compared with Alzheimer's Disease and Cognitively Healthy People.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD210272. doi: 10.3233/JAD-210272.
    PubMed     Abstract available


  82. PLACIDO J, Ferreira JV, Araujo J, de Oliveira Silva F, et al
    Beyond the Mini-Mental State Examination: The Use of Physical and Spatial Navigation Tests to Help to Screen for Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD210106. doi: 10.3233/JAD-210106.
    PubMed     Abstract available


  83. GUZMAN-MARTINEZ L, Farias GA, Tapia JP, Sanchez MP, et al
    Interventional Study to Evaluate the Clinical Effects and Safety of the Nutraceutical Compound BrainUp-10(R) in a Cohort of Patients with Alzheimer's Disease: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD201501. doi: 10.3233/JAD-201501.
    PubMed     Abstract available


  84. ZUPANIC E, von Euler M, Winblad B, Xu H, et al
    Mortality After Ischemic Stroke in Patients with Alzheimer's Disease Dementia and Other Dementia Disorders.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD201459. doi: 10.3233/JAD-201459.
    PubMed     Abstract available


  85. LIN Y, Zeng Q, Hu M, Peng G, et al
    Temporal Dynamic Changes of Intrinsic Brain Activity Associated with Cognitive Reserve in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 27. pii: JAD201244. doi: 10.3233/JAD-201244.
    PubMed     Abstract available


  86. XU L, Li T, Xiong L, Wang X, et al
    Reliability and Validity of the Chinese Version of Mild Behavioral Impairment Checklist in Mild Cognitive Impairment and Mild Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 26. pii: JAD210098. doi: 10.3233/JAD-210098.
    PubMed     Abstract available


  87. REN D, Lopez OL, Lingler JH, Conley Y, et al
    Association Between the APOEvarepsilon2/varepsilon4 Genotype and Alzheimer's Disease and Mild Cognitive Impairment Among African Americans.
    J Alzheimers Dis. 2021 Apr 26. pii: JAD201613. doi: 10.3233/JAD-201613.
    PubMed     Abstract available


  88. HAJ ME, Moustafa AA, Gallouj K
    Higher Depression of Patients with Alzheimer's Disease During than Before the Lockdown.
    J Alzheimers Dis. 2021 Apr 21. pii: JAD210190. doi: 10.3233/JAD-210190.
    PubMed     Abstract available


  89. NERG O, Junkkari A, Hallikainen I, Rauramaa T, et al
    The CERAD Neuropsychological Battery in Patients with Idiopathic Normal Pressure Hydrocephalus Compared with Normal Population and Patients with Mild Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 21. pii: JAD201363. doi: 10.3233/JAD-201363.
    PubMed     Abstract available


  90. SZEGECZKI V, Perenyi H, Horvath G, Hinnah B, et al
    Physical Training Inhibits the Fibrosis Formation in Alzheimer's Disease Kidney Influencing the TGFbeta Signaling Pathways.
    J Alzheimers Dis. 2021 Apr 19. pii: JAD201206. doi: 10.3233/JAD-201206.
    PubMed     Abstract available


  91. GOTTESMAN RT, Kociolek A, Fernandez K, Cosentino S, et al
    Association Between Early Psychotic Symptoms and Alzheimer's Disease Prognosis in a Community-Based Cohort.
    J Alzheimers Dis. 2021 Apr 19. pii: JAD200729. doi: 10.3233/JAD-200729.
    PubMed     Abstract available



  92. Erratum Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD219318. doi: 10.3233/JAD-219318.
    PubMed    


  93. FELDMAN R
    Physicians Treating Alzheimer's Disease Patients Should Be Aware that Televised Direct-to-Consumer Advertising Links More Strongly to Drug Utilization in Older Patients.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210294. doi: 10.3233/JAD-210294.
    PubMed     Abstract available


  94. LI J, Bur AM, Villwock MR, Shankar S, et al
    Olfactory Phenotypes Differentiate Cognitively Unimpaired Seniors from Alzheimer's Disease and Mild Cognitive Impairment: A Combined Machine Learning and Traditional Statistical Approach.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210175. doi: 10.3233/JAD-210175.
    PubMed     Abstract available


  95. NORINS LC
    Repurposing Licensed Drugs for Use Against Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210080. doi: 10.3233/JAD-210080.
    PubMed     Abstract available


  96. SAKURAI K, Kaneda D, Inui S, Uchida Y, et al
    Simple Quantitative Indices for the Differentiation of Advanced-Stage Alzheimer's Disease and Other Limbic Tauopathies.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD210043. doi: 10.3233/JAD-210043.
    PubMed     Abstract available


  97. MULLER L, Kirschstein T, Kohling R, Kuhla A, et al
    Neuronal Hyperexcitability in APPSWE/PS1dE9 Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD201540. doi: 10.3233/JAD-201540.
    PubMed     Abstract available


  98. BEUCKMANN CT, Suzuki H, Musiek ES, Ueno T, et al
    Evaluation of SAMP8 Mice as a Model for Sleep-Wake and Rhythm Disturbances Associated with Alzheimer's Disease: Impact of Treatment with the Dual Orexin (Hypocretin) Receptor Antagonist Lemborexant.
    J Alzheimers Dis. 2021 Apr 5. pii: JAD201054. doi: 10.3233/JAD-201054.
    PubMed     Abstract available


  99. EEZA MNH, Singer R, Hofling C, Matysik J, et al
    Metabolic Profiling of Suprachiasmatic Nucleus Reveals Multifaceted Effects in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2021 Apr 3. pii: JAD201575. doi: 10.3233/JAD-201575.
    PubMed     Abstract available


  100. HALMINEN O, Vesikansa A, Mehtala J, Horhammer I, et al
    Early Start of Anti-Dementia Medication Delays Transition to 24-Hour Care in Alzheimer's Disease Patients: A Finnish Nationwide Cohort Study.
    J Alzheimers Dis. 2021 Apr 3. pii: JAD201502. doi: 10.3233/JAD-201502.
    PubMed     Abstract available


  101. TSAMOU M, Pistollato F, Roggen EL
    A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer's Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental Neurotoxicants.
    J Alzheimers Dis. 2021 Apr 3. pii: JAD201418. doi: 10.3233/JAD-201418.
    PubMed     Abstract available


  102. HASHIMOTO M, Ho G, Sugama S, Takenouchi T, et al
    Possible Role of Activin in the Adiponectin Paradox-Induced Progress of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 2. pii: JAD210206. doi: 10.3233/JAD-210206.
    PubMed     Abstract available


  103. MARRA C, Piccininni C, Iacobucci GM, Caprara A, et al
    Semantic Memory as an Early Cognitive Marker of Alzheimer's Disease: Role of Category and Phonological Verbal Fluency Tasks.
    J Alzheimers Dis. 2021 Apr 2. pii: JAD201452. doi: 10.3233/JAD-201452.
    PubMed     Abstract available


  104. O'BRYANT S, Zhang F, Petersen M, Johnson L, et al
    A Precision Medicine Approach to Treating Alzheimer's Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201610. doi: 10.3233/JAD-201610.
    PubMed     Abstract available


  105. BOSTROM G, Freyhult E, Virhammar J, Alcolea D, et al
    Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201565. doi: 10.3233/JAD-201565.
    PubMed     Abstract available


  106. ZHOU Y, Wang Y, Quan M, Zhao H, et al
    Gut Microbiota Changes and Their Correlation with Cognitive and Neuropsychiatric Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201497. doi: 10.3233/JAD-201497.
    PubMed     Abstract available


  107. ZHENG YM, Zhao YY, Zhang T, Hou XH, et al
    Left Ventricular Ejection Fraction and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Normal Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201222. doi: 10.3233/JAD-201222.
    PubMed     Abstract available


  108. AITKEN WW, Lombard J, Wang K, Toro M, et al
    Relationship of Neighborhood Greenness to Alzheimer's Disease and Non-Alzheimer's Dementia Among 249,405 U.S. Medicare Beneficiaries.
    J Alzheimers Dis. 2021 Apr 1. pii: JAD201179. doi: 10.3233/JAD-201179.
    PubMed     Abstract available


    March 2021
  109. QIU H, Zhao R, Fei G, Pan X, et al
    Dynamic Change of Intracellular Metabolism of Microglia Evaluated by Transcriptomics in an Alzheimer's Mouse Model.
    J Alzheimers Dis. 2021 Mar 30. pii: JAD210213. doi: 10.3233/JAD-210213.
    PubMed     Abstract available


  110. PILLAI JA, Bena J, Bekris LM, Foldvary-Schaefer N, et al
    Unique Sleep and Circadian Rhythm Dysfunction Neuroinflammatory and Immune Profiles in Alzheimer's Disease with Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Mar 30. pii: JAD201573. doi: 10.3233/JAD-201573.
    PubMed     Abstract available


  111. LI LL, Ma YH, Bi YL, Sun FR, et al
    Serum Uric Acid May Aggravate Alzheimer's Disease Risk by Affecting Amyloidosis in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Mar 30. pii: JAD201192. doi: 10.3233/JAD-201192.
    PubMed     Abstract available


  112. FENG LIU Q, Kanmani S, Lee J, Kim GW, et al
    Neoline Improves Memory Impairment and Reduces Amyloid-beta Level and Tau Phosphorylation Through AMPK Activation in the Mouse Alzheimer's Disease Model.
    J Alzheimers Dis. 2021 Mar 26. pii: JAD201614. doi: 10.3233/JAD-201614.
    PubMed     Abstract available


  113. TEITSDOTTIR UD, Halldorsson S, Rolfsson O, Lund SH, et al
    Cerebrospinal Fluid C18 Ceramide Associates with Markers of Alzheimer's Disease and Inflammation at the Pre- and Early Stages of Dementia.
    J Alzheimers Dis. 2021 Mar 25. pii: JAD200964. doi: 10.3233/JAD-200964.
    PubMed     Abstract available


  114. IKEDA S, Mimura M, Ikeda M, Wada-Isoe K, et al
    Economic Burden of Alzheimer's Disease Dementia in Japan.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD210075. doi: 10.3233/JAD-210075.
    PubMed     Abstract available


  115. MORRIS R, Luboff H, Jose RP, Eckhoff K, et al
    Bradycardia Due to Donepezil in Adults: Systematic Analysis of FDA Adverse Event Reporting System.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201551. doi: 10.3233/JAD-201551.
    PubMed     Abstract available


  116. DOUROS A, Santella C, Dell'Aniello S, Azoulay L, et al
    Infectious Disease Burden and the Risk of Alzheimer's Disease: A Population-Based Study.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201534. doi: 10.3233/JAD-201534.
    PubMed     Abstract available


  117. ASHIZAWA T, Igarashi A, Sakata Y, Azuma M, et al
    Impact of the Severity of Alzheimer's Disease on the Quality of Life, Activities of Daily Living, and Caregiving Costs for Institutionalized Patients on Anti-Alzheimer Medications in Japan.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201514. doi: 10.3233/JAD-201514.
    PubMed     Abstract available


  118. KLEIMAN MJ, Barenholtz E, Galvin JE
    Screening for Early-Stage Alzheimer's Disease Using Optimized Feature Sets and Machine Learning.
    J Alzheimers Dis. 2021 Mar 23. pii: JAD201377. doi: 10.3233/JAD-201377.
    PubMed     Abstract available


  119. WONG D, Broberg DN, Doad J, Umoh JU, et al
    Effect of Memantine Treatment and Combination with Vitamin D Supplementation on Body Composition in the APP/PS1 Mouse Model of Alzheimer's Disease Following Chronic Vitamin D Deficiency.
    J Alzheimers Dis. 2021 Mar 22. pii: JAD201137. doi: 10.3233/JAD-201137.
    PubMed     Abstract available


  120. ASTROM DO, Adolfsson R, Segersson D, Forsberg B, et al
    Local Contrasts in Concentration of Ambient Particulate Air Pollution (PM2.5) and Incidence of Alzheimer's Disease and Dementia: Results from the Betula Cohort in Northern Sweden.
    J Alzheimers Dis. 2021 Mar 18. pii: JAD201538. doi: 10.3233/JAD-201538.
    PubMed     Abstract available



  121. Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions.
    J Alzheimers Dis. 2021 Mar 16. pii: JAD219002. doi: 10.3233/JAD-219002.
    PubMed    


  122. NI R, Rojdner J, Voytenko L, Dyrks T, et al
    In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK1195 in Autopsy Alzheimer's Brain Tissue.
    J Alzheimers Dis. 2021 Mar 16. pii: JAD201344. doi: 10.3233/JAD-201344.
    PubMed     Abstract available


  123. FONSECA LM, Mattar GP, Haddad GG, Ekaterina B, et al
    Neuropsychiatric Symptoms of Alzheimer's Disease in Down Syndrome and Its Impact on Caregiver Distress.
    J Alzheimers Dis. 2021 Mar 16. pii: JAD201009. doi: 10.3233/JAD-201009.
    PubMed     Abstract available


  124. GAUDREAULT R, Herve V, van de Ven TGM, Mousseau N, et al
    Polyphenol-Peptide Interactions in Mitigation of Alzheimer's Disease: Role of Biosurface-Induced Aggregation.
    J Alzheimers Dis. 2021 Mar 15. pii: JAD201549. doi: 10.3233/JAD-201549.
    PubMed     Abstract available


  125. MA YH, Wang YY, Tan L, Xu W, et al
    Social Networks and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2021 Mar 15. pii: JAD201426. doi: 10.3233/JAD-201426.
    PubMed     Abstract available


  126. ARAYA J, Bello F, Shivashankar G, Neira D, et al
    Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer's Disease Are Linked with Neurotransmitter Alterations.
    J Alzheimers Dis. 2021 Mar 13. pii: JAD201195. doi: 10.3233/JAD-201195.
    PubMed     Abstract available


  127. YANG J, Jia L, Li Y, Qiu Q, et al
    Fluid Biomarkers in Clinical Trials for Alzheimer's Disease: Current and Future Application.
    J Alzheimers Dis. 2021 Mar 13. pii: JAD201068. doi: 10.3233/JAD-201068.
    PubMed     Abstract available


  128. MIRANDA A, Montiel E, Ulrich H, Paz C, et al
    Selective Secretase Targeting for Alzheimer's Disease Therapy.
    J Alzheimers Dis. 2021 Mar 13. pii: JAD201027. doi: 10.3233/JAD-201027.
    PubMed     Abstract available


  129. DIAS IHK, Griffiths HR
    Current and Future Directions for Targeting Lipoxin A4 in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Mar 11. pii: JAD210121. doi: 10.3233/JAD-210121.
    PubMed     Abstract available


  130. TONG Q, Chen L
    Associations of Alzheimer's Disease Neuropathologic Changes with Clinical Presentations of Parkinson's Disease.
    J Alzheimers Dis. 2021 Mar 11. pii: JAD210114. doi: 10.3233/JAD-210114.
    PubMed     Abstract available


  131. VALOTASSIOU V, Sifakis N, Tzavara C, Lykou E, et al
    Eating Disorders in Frontotemporal Dementia and Alzheimer's Disease: Evaluation of Brain Perfusion Correlates Using 99mTc-HMPAO SPECT with Brodmann Areas Analysis.
    J Alzheimers Dis. 2021 Mar 10. pii: JAD201434. doi: 10.3233/JAD-201434.
    PubMed     Abstract available


  132. DRAKE JD, Chambers AB, Ott BR, Daiello LA, et al
    Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Mar 10. pii: JAD200759. doi: 10.3233/JAD-200759.
    PubMed     Abstract available


  133. TASLIMA F, Jung CG, Zhou C, Abdelhamid M, et al
    Tooth Loss Induces Memory Impairment and Gliosis in App Knock-In Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Mar 9. pii: JAD201055. doi: 10.3233/JAD-201055.
    PubMed     Abstract available


  134. GUPTA HV, Beach TG, Mehta SH, Shill HA, et al
    Clinicopathological Correlation: Dopamine and Amyloid PET Imaging with Neuropathology in Three Subjects Clinically Diagnosed with Alzheimer's Disease or Dementia with Lewy Bodies.
    J Alzheimers Dis. 2021 Mar 9. pii: JAD200323. doi: 10.3233/JAD-200323.
    PubMed     Abstract available


  135. MOUSSAVI NIK SH, Porter T, Newman M, Bartlett B, et al
    Relevance of a Truncated PRESENILIN 2 Transcript to Alzheimer's Disease and Neurodegeneration.
    J Alzheimers Dis. 2021 Mar 7. pii: JAD201133. doi: 10.3233/JAD-201133.
    PubMed     Abstract available


  136. ELVERMAN KH, Paitel ER, Figueroa CM, McKindles RJ, et al
    Event-Related Potentials, Inhibition, and Risk for Alzheimer's Disease Among Cognitively Intact Elders.
    J Alzheimers Dis. 2021 Mar 5. pii: JAD201559. doi: 10.3233/JAD-201559.
    PubMed     Abstract available


  137. PEREZ-VALERO E, Lopez-Gordo MA, Morillas C, Pelayo F, et al
    A Review of Automated Techniques for Assisting the Early Detection of Alzheimer's Disease with a Focus on EEG.
    J Alzheimers Dis. 2021 Mar 5. pii: JAD201455. doi: 10.3233/JAD-201455.
    PubMed     Abstract available


  138. JOUINI N, Saied Z, Ben Sassi S, Nebli F, et al
    Impacts of Iron Metabolism Dysregulation on Alzheimer's Disease.
    J Alzheimers Dis. 2021 Mar 5. pii: JAD201250. doi: 10.3233/JAD-201250.
    PubMed     Abstract available


  139. WHITE B, Lyketsos CG, Rosenberg PB, Oh ES, et al
    Multiple Neurodegenerative Pathologies in an Alzheimer's Disease Patient Treated with Fornical Deep Brain Stimulation.
    J Alzheimers Dis. 2021 Mar 4. pii: JAD201415. doi: 10.3233/JAD-201415.
    PubMed     Abstract available


  140. VINUELA F, Barro A
    Assessment of a Potential Synergistic Effect of Souvenaid (R) in Mild Alzheimer's Disease Patients on Treatment with Acetylcholinesterase Inhibitors: An Observational, Non-Interventional Study.
    J Alzheimers Dis. 2021 Mar 4. pii: JAD201357. doi: 10.3233/JAD-201357.
    PubMed     Abstract available


  141. ZHANG B, Lin L, Wu S
    A Review of Brain Atrophy Subtypes Definition and Analysis for Alzheimer's Disease Heterogeneity Studies.
    J Alzheimers Dis. 2021 Mar 3. pii: JAD201274. doi: 10.3233/JAD-201274.
    PubMed     Abstract available


  142. DEVOUS MD, Fleisher AS, Pontecorvo MJ, Lu M, et al
    Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.
    J Alzheimers Dis. 2021 Mar 3. pii: JAD200808. doi: 10.3233/JAD-200808.
    PubMed     Abstract available


    February 2021
  143. AN N, Fu Y, Shi J, Guo HN, et al
    Synergistic Effects of APOE and CLU May Increase the Risk of Alzheimer's Disease: Acceleration of Atrophy in the Volumes and Shapes of the Hippocampus and Amygdala.
    J Alzheimers Dis. 2021 Feb 26. pii: JAD201162. doi: 10.3233/JAD-201162.
    PubMed     Abstract available


  144. HINTEREGGER B, Loeffler T, Flunkert S, Neddens J, et al
    Metabolic, Phenotypic, and Neuropathological Characterization of the Tg4-42 Mouse Model for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 25. pii: JAD201204. doi: 10.3233/JAD-201204.
    PubMed     Abstract available


  145. RYMAN SG, Yutsis M, Tian L, Henderson VW, et al
    Cognition at Each Stage of Lewy Body Disease with Co-occurring Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2021 Feb 25. pii: JAD201187. doi: 10.3233/JAD-201187.
    PubMed     Abstract available


  146. LOPIS D, Pape TL, Manetta C, Conty L, et al
    Sensory Cueing of Autobiographical Memories in Normal Aging and Alzheimer's Disease: A Comparison Between Visual, Auditory, and Olfactory Information.
    J Alzheimers Dis. 2021 Feb 25. pii: JAD200841. doi: 10.3233/JAD-200841.
    PubMed     Abstract available


  147. KIM S, Kim K, Nho K, Myung W, et al
    Shared Genetic Background Between Cerebrospinal Fluid Biomarkers and Risk for Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2021 Feb 25. pii: JAD200671. doi: 10.3233/JAD-200671.
    PubMed     Abstract available


  148. LIU X, Chen X, Zhou X, Shang Y, et al
    Validity of the MemTrax Memory Test Compared to the Montreal Cognitive Assessment in the Detection of Mild Cognitive Impairment and Dementia due to Alzheimer's Disease in a Chinese Cohort.
    J Alzheimers Dis. 2021 Feb 24. pii: JAD200936. doi: 10.3233/JAD-200936.
    PubMed     Abstract available


  149. MERIGHI S, Battistello E, Casetta I, Gragnaniello D, et al
    Upregulation of Cortical A2A Adenosine Receptors is Reflected in Platelets of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 23. pii: JAD201437. doi: 10.3233/JAD-201437.
    PubMed     Abstract available


  150. CUTTLER JM, Abdellah E, Goldberg Y, Al-Shamaa S, et al
    Low Doses of Ionizing Radiation as a Treatment for Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2021 Feb 23. pii: JAD200620. doi: 10.3233/JAD-200620.
    PubMed     Abstract available


  151. MONLLOR P, Giraldo E, Badia MC, de la Asuncion JG, et al
    Serum Levels of Clusterin, PKR, and RAGE Correlate with Amyloid Burden in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 20. pii: JAD201443. doi: 10.3233/JAD-201443.
    PubMed     Abstract available


  152. NAGARAJ S, Duong TQ
    Deep Learning and Risk Score Classification of Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 20. pii: JAD201438. doi: 10.3233/JAD-201438.
    PubMed     Abstract available


  153. KLEIN J, Yan X, Johnson A, Tomljanovic Z, et al
    Olfactory Impairment is Related to Tau Pathology and Neuroinflammation in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 20. pii: JAD201149. doi: 10.3233/JAD-201149.
    PubMed     Abstract available


  154. CHUNG M, Chung WK
    Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer's Disease Dementia Patients.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD210042. doi: 10.3233/JAD-210042.
    PubMed     Abstract available


  155. CIERI F, Yang Z, Cordes D, Jessica Caldwell ZK, et al
    Sex Differences of Brain Functional Topography Revealed in Normal Aging and Alzheimer's Disease Cohort.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD201596. doi: 10.3233/JAD-201596.
    PubMed     Abstract available


  156. JIN H, Wang R
    Alzheimer-Associated Neuronal Thread Protein: Research Course and Prospects for the Future.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD201273. doi: 10.3233/JAD-201273.
    PubMed     Abstract available


  157. LEYTON E, Matus D, Espinoza S, Benitez JM, et al
    DEF8 and Autophagy-Associated Genes are Altered in Mild Cognitive Impairment, Probable Alzheimer's Disease Patients and a Transgenic Model of the Disease.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD201264. doi: 10.3233/JAD-201264.
    PubMed     Abstract available


  158. ZHANG G, Zhang Y, Shen Y, Wang Y, et al
    The Potential Role of Ferroptosis in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 19. pii: JAD201369. doi: 10.3233/JAD-201369.
    PubMed     Abstract available


  159. KHODADADI H, Lopes Salles E, Jarrahi A, Costigliola V, et al
    Cannabidiol Ameliorates Cognitive Function via Regulation of IL-33 and TREM2 Upregulation in a Murine Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 17. pii: JAD210026. doi: 10.3233/JAD-210026.
    PubMed     Abstract available


  160. WANG YY, Huang ZT, Yuan MH, Jing F, et al
    Role of Hypoxia Inducible Factor-1alpha in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 17. pii: JAD201448. doi: 10.3233/JAD-201448.
    PubMed     Abstract available


  161. INDOREWALLA KK, O'Connor MK, Budson AE, Guess DiTerlizzi C, et al
    Modifiable Barriers for Recruitment and Retention of Oldeult Participants from Underrepresented Minorities in Alzheimer's Disease Research.
    J Alzheimers Dis. 2021 Feb 17. pii: JAD201081. doi: 10.3233/JAD-201081.
    PubMed     Abstract available


  162. SHOUP TM, Griciuc A, Normandin MD, Quinti L, et al
    Evaluation of Fluorinated Cromolyn Derivatives as Potential Therapeutics for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201419. doi: 10.3233/JAD-201419.
    PubMed     Abstract available


  163. WANG YZ, Meng L, Zhuang QS, Shen L, et al
    Screening Traditional Chinese Medicine Combination for Cotreatment of Alzheimer's Disease and Type 2 Diabetes Mellitus by Network Pharmacology.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201336. doi: 10.3233/JAD-201336.
    PubMed     Abstract available


  164. LLADO A, Froelich L, Khandker RK, Roset M, et al
    Assessing the Progression of Alzheimer's Disease in Real-World Settings in Three European Countries.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201172. doi: 10.3233/JAD-201172.
    PubMed     Abstract available


  165. SOOD A, Pavlik V, Darby E, Chan W, et al
    Different Cognitive Profiles Are Associated with Progression Rate and Age at Death in Probable Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201124. doi: 10.3233/JAD-201124.
    PubMed     Abstract available


  166. LIBARD S, Walter J, Alafuzoff I
    In vivo Characterization of Biochemical Variants of Amyloid-beta in Subjects with Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease Neuropathological Change.
    J Alzheimers Dis. 2021 Feb 12. pii: JAD201469. doi: 10.3233/JAD-201469.
    PubMed     Abstract available


  167. MA D, Yee E, Stocks JK, Jenkins LM, et al
    Blinded Clinical Evaluation for Dementia of Alzheimer's Type Classification Using FDG-PET: A Comparison Between Feature-Engineered and Non-Feature-Engineered Machine Learning Methods.
    J Alzheimers Dis. 2021 Feb 11. pii: JAD201591. doi: 10.3233/JAD-201591.
    PubMed     Abstract available


  168. DANIELE S, Baldacci F, Piccarducci R, Palermo G, et al
    alpha-Synuclein Heteromers in Red Blood Cells of Alzheimer's Disease and Lewy Body Dementia Patients.
    J Alzheimers Dis. 2021 Feb 11. pii: JAD201038. doi: 10.3233/JAD-201038.
    PubMed     Abstract available


  169. SHEN LX, Yang YX, Kuo K, Li HQ, et al
    Social Isolation, Social Interaction, and Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2021 Feb 9. pii: JAD201442. doi: 10.3233/JAD-201442.
    PubMed     Abstract available


  170. FUTAMURA A, Hieda S, Mori Y, Kasuga K, et al
    Toxic Amyloid-beta42 Conformer May Accelerate the Onset of Alzheimer's Disease in the Preclinical Stage.
    J Alzheimers Dis. 2021 Feb 9. pii: JAD201407. doi: 10.3233/JAD-201407.
    PubMed     Abstract available


  171. WANG J, Guo X, Lu W, Liu J, et al
    Donepezil Combined with DL-3-n-Butylphthalide Delays Cognitive Decline in Patients with Mild to Moderate Alzheimer's Disease: A Multicenter, Prospective Cohort Study.
    J Alzheimers Dis. 2021 Feb 9. pii: JAD201381. doi: 10.3233/JAD-201381.
    PubMed     Abstract available


  172. YAO W, Chen H, Luo C, Sheng X, et al
    Hyperconnectivity of Self-Referential Network as a Predictive Biomarker of the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 6. pii: JAD201376. doi: 10.3233/JAD-201376.
    PubMed     Abstract available


  173. YU E, Liao Z, Fan W, Hu W, et al
    The Economic Burden of Alzheimer's Disease in Zhejiang Province.
    J Alzheimers Dis. 2021 Feb 6. pii: JAD201285. doi: 10.3233/JAD-201285.
    PubMed     Abstract available


  174. ROSTAMZADEH A, Schwegler C, Gil-Navarro S, Rosende-Roca M, et al
    Biomarker-Based Risk Prediction of Alzheimer's Disease Dementia in Mild Cognitive Impairment: Psychosocial, Ethical, and Legal Aspects. Study Protocol of the PreDADQoL Project.
    J Alzheimers Dis. 2021 Feb 4. pii: JAD200484. doi: 10.3233/JAD-200484.
    PubMed     Abstract available


  175. CHALKIAS E, Topouzis F, Tegos T, Tsolaki M, et al
    The Contribution of Ocular Biomarkers in the Differential Diagnosis of Alzheimer's Disease versus Other Types of Dementia and Future Prospects.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201516. doi: 10.3233/JAD-201516.
    PubMed     Abstract available


  176. KHALSA DS, Newberg A
    Spiritual Fitness: A New Dimension in Alzheimer's Disease Prevention.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201433. doi: 10.3233/JAD-201433.
    PubMed     Abstract available


  177. RIPHAGEN JM, Van Egroo M, Jacobs HIL
    Elevated Norepinephrine Metabolism Gauges Alzheimer's Disease-Related Pathology and Memory Decline.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201411. doi: 10.3233/JAD-201411.
    PubMed     Abstract available


  178. KHATAMI SG, Domingo-Fernandez D, Mubeen S, Hoyt CT, et al
    A Systems Biology Approach for Hypothesizing the Effect of Genetic Variants on Neuroimaging Features in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201397. doi: 10.3233/JAD-201397.
    PubMed     Abstract available


  179. PIUBELLI L, Murtas G, Rabattoni V, Pollegioni L, et al
    The Role of D-Amino Acids in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Feb 1. pii: JAD201217. doi: 10.3233/JAD-201217.
    PubMed     Abstract available


    January 2021
  180. RIGBY T, Johnson DK, Taylor A, Galvin JE, et al
    Comparison of the Caregiving Experience of Grief, Burden, and Quality of Life in Dementia with Lewy Bodies, Alzheimer's Disease, and Parkinson's Disease Dementia.
    J Alzheimers Dis. 2021 Jan 30. pii: JAD201326. doi: 10.3233/JAD-201326.
    PubMed     Abstract available


  181. LI M, Li R, Lyu JH, Chen JH, et al
    Relationship Between Alzheimer's Disease and Retinal Choroidal Thickness: A Cross-Sectional Study.
    J Alzheimers Dis. 2021 Jan 30. pii: JAD201142. doi: 10.3233/JAD-201142.
    PubMed     Abstract available


  182. CHUANG YC, Chiu MJ, Chen TF, Chang YL, et al
    An Exploration of the Own-Age Effect on Facial Emotion Recognition in Normal Elderly People and Individuals with the Preclinical and Demented Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 27. pii: JAD200916. doi: 10.3233/JAD-200916.
    PubMed     Abstract available


  183. YU F, Vock DM, Zhang L, Salisbury D, et al
    Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial.
    J Alzheimers Dis. 2021 Jan 26. pii: JAD201100. doi: 10.3233/JAD-201100.
    PubMed     Abstract available


  184. GUO M, Peng J, Huang X, Xiao L, et al
    Gut Microbiome Features of Chinese Patients Newly Diagnosed with Alzheimer's Disease or Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Jan 26. pii: JAD201040. doi: 10.3233/JAD-201040.
    PubMed     Abstract available


  185. MACEDO A, Gomez C, Rebelo MA, Poza J, et al
    Risk Variants in Three Alzheimer's Disease Genes Show Association with EEG Endophenotypes.
    J Alzheimers Dis. 2021 Jan 26. pii: JAD200963. doi: 10.3233/JAD-200963.
    PubMed     Abstract available


  186. LLANO DA, Devanarayan V
    Serum Phosphatidylethanolamine and Lysophosphatidylethanolamine Levels Differentiate Alzheimer's Disease from Controls and Predict Progression from Mild Cognitive Impairment.
    J Alzheimers Dis. 2021 Jan 25. pii: JAD201420. doi: 10.3233/JAD-201420.
    PubMed     Abstract available


  187. ZHUANG QS, Meng L, Wang Z, Shen L, et al
    Associations Between Obesity and Alzheimer's Disease: Multiple Bioinformatic Analyses.
    J Alzheimers Dis. 2021 Jan 25. pii: JAD201235. doi: 10.3233/JAD-201235.
    PubMed     Abstract available


  188. JORGE L, Martins R, Canario N, Xavier C, et al
    Investigating the Spatial Associations Between Amyloid-beta Deposition, Grey Matter Volume, and Neuroinflammation in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 23. pii: JAD200840. doi: 10.3233/JAD-200840.
    PubMed     Abstract available


  189. CHEN F, Zhang Y, Wang L, Wang T, et al
    PLCG2 rs72824905 Variant Reduces the Risk of Alzheimer's Disease and Multiple Sclerosis.
    J Alzheimers Dis. 2021 Jan 23. pii: JAD201140. doi: 10.3233/JAD-201140.
    PubMed     Abstract available


  190. GUZMAN-MARTINEZ L, Calfio C, Farias GA, Vilches C, et al
    New Frontiers in the Prevention, Diagnosis, and Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 23. pii: JAD201059. doi: 10.3233/JAD-201059.
    PubMed     Abstract available


  191. CUERVO-ZANATTA D, Garcia-Mena J, Perez-Cruz C
    Gut Microbiota Alterations and Cognitive Impairment Are Sexually Dissociated in a Transgenic Mice Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 21. pii: JAD201367. doi: 10.3233/JAD-201367.
    PubMed     Abstract available


  192. GROBER E, Qi Q, Kuo L, Hassenstab J, et al
    Stages of Objective Memory Impairment Predict Alzheimer's Disease Neuropathology: Comparison with the Clinical Dementia Rating Scale-Sum of Boxes.
    J Alzheimers Dis. 2021 Jan 21. pii: JAD200946. doi: 10.3233/JAD-200946.
    PubMed     Abstract available


  193. ZHANG F, Petersen M, Johnson L, Hall J, et al
    Recursive Support Vector Machine Biomarker Selection for Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 18. pii: JAD201254. doi: 10.3233/JAD-201254.
    PubMed     Abstract available


  194. MEHDER RH, Bennett BM, Andrew RD
    Age-Related Neuronal Deterioration Specifically Within the Dorsal CA1 Region of the Hippocampus in a Mouse Model of Late Onset Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 15. pii: JAD201024. doi: 10.3233/JAD-201024.
    PubMed     Abstract available


  195. HAYASHI T, Shimonaka S, Elahi M, Matsumoto SE, et al
    Learning Deficits Accompanied by Microglial Proliferation After the Long-Term Post-Injection of Alzheimer's Disease Brain Extract in Mouse Brains.
    J Alzheimers Dis. 2021 Jan 15. pii: JAD201002. doi: 10.3233/JAD-201002.
    PubMed     Abstract available


  196. LEHINGUE E, Gueniat J, Jourdaa S, Hardouin JB, et al
    Improving the Diagnosis of the Frontal Variant of Alzheimer's Disease with the DAPHNE Scale.
    J Alzheimers Dis. 2021 Jan 15. pii: JAD201088. doi: 10.3233/JAD-201088.
    PubMed     Abstract available


  197. QIAN X, Zhang S, Duan L, Yang F, et al
    Periodontitis Deteriorates Cognitive Function and Impairs Neurons and Glia in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201007. doi: 10.3233/JAD-201007.
    PubMed     Abstract available


  198. SHAFFER RM, Li G, Adar SD, Dirk Keene C, et al
    Fine Particulate Matter and Markers of Alzheimer's Disease Neuropathology at Autopsy in a Community-Based Cohort.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201005. doi: 10.3233/JAD-201005.
    PubMed     Abstract available


  199. LAO K, Zhang R, Luan J, Zhang Y, et al
    Therapeutic Strategies Targeting Amyloid-beta Receptors and Transporters in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD200851. doi: 10.3233/JAD-200851.
    PubMed     Abstract available


  200. LY M, Raji CA, Yu GZ, Wang Q, et al
    Obesity and White Matter Neuroinflammation Related Edema in Alzheimer Disease Dementia Biomarker Negative Cognitively Normal Individuals.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201242. doi: 10.3233/JAD-201242.
    PubMed     Abstract available


  201. LOEFFLER DA
    Modifiable, Non-Modifiable, and Clinical Factors Associated with Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201182. doi: 10.3233/JAD-201182.
    PubMed     Abstract available


  202. MERCERON-MARTINEZ D, Ibaceta-Gonzalez C, Salazar C, Almaguer-Melian W, et al
    Alzheimer's Disease, Neural Plasticity, and Functional Recovery.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201178. doi: 10.3233/JAD-201178.
    PubMed     Abstract available


  203. FERINI-STRAMBI L, Hensley M, Salsone M
    Decoding Causal Links Between Sleep Apnea and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201066. doi: 10.3233/JAD-201066.
    PubMed     Abstract available


  204. CHEN YS, Shu K, Kang HC
    Deep Brain Stimulation in Alzheimer's Disease: Targeting the Nucleus Basalis of Meynert.
    J Alzheimers Dis. 2021 Jan 13. pii: JAD201141. doi: 10.3233/JAD-201141.
    PubMed     Abstract available


  205. PRAKASH M, Abdelaziz M, Zhang L, Strange BA, et al
    Quantitative Longitudinal Predictions of Alzheimer's Disease by Multi-Modal Predictive Learning.
    J Alzheimers Dis. 2021 Jan 12. pii: JAD200906. doi: 10.3233/JAD-200906.
    PubMed     Abstract available


  206. BARIL AA, Beiser AS, Redline S, McGrath ER, et al
    Interleukin-6 Interacts with Sleep Apnea Severity when Predicting Incident Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD200545. doi: 10.3233/JAD-200545.
    PubMed     Abstract available


  207. MAI Y, Yu Q, Zhu F, Luo Y, et al
    AD Resemblance Atrophy Index as a Diagnostic Biomarker for Alzheimer's Disease: A Retrospective Clinical and Biological Validation.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD201033. doi: 10.3233/JAD-201033.
    PubMed     Abstract available


  208. DELIC V, Ratliff WA, Citron BA
    Sleep Deprivation, a Link Between Post-Traumatic Stress Disorder and Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD201378. doi: 10.3233/JAD-201378.
    PubMed     Abstract available


  209. CASTAGNA A, Fabbo A, Manzo C, Lacava R, et al
    A Retrospective Study on the Benefits of Combined Citicoline, Memantine, and Acetylcholinesterase Inhibitor Treatments in Older Patients Affected with Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD201211. doi: 10.3233/JAD-201211.
    PubMed     Abstract available


  210. DE LA TORRE JC
    Deciphering Alzheimer's Disease Pathogenic Pathway: Role of Chronic Brain Hypoperfusion on p-Tau and mTOR.
    J Alzheimers Dis. 2021 Jan 11. pii: JAD201165. doi: 10.3233/JAD-201165.
    PubMed     Abstract available


  211. DARST BF, Huo Z, Jonaitis EM, Koscik RL, et al
    Metabolites Associated with Early Cognitive Changes Implicated in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 8. pii: JAD200176. doi: 10.3233/JAD-200176.
    PubMed    


  212. PARK JH, Ah Lee S
    The Fragility of Temporal Memory in Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 8. pii: JAD200892. doi: 10.3233/JAD-200892.
    PubMed     Abstract available


  213. WU R, Gu J, Zhou D, Tung YC, et al
    Seeding-Competent Tau in Gray Matter Versus White Matter of Alzheimer's Disease Brain.
    J Alzheimers Dis. 2021 Jan 8. pii: JAD201290. doi: 10.3233/JAD-201290.
    PubMed     Abstract available


  214. HYUN LEE Y, Jeon S, Soo Yoo H, Jong Chung S, et al
    Effect of Alzheimer's Disease and Lewy Body Disease on Metabolic Changes.
    J Alzheimers Dis. 2021 Jan 8. pii: JAD201094. doi: 10.3233/JAD-201094.
    PubMed     Abstract available


  215. JING J, Zhang F, Zhao L, Xie J, et al
    Correlation Between Brain 18F-AV45 and 18F-FDG PET Distribution Characteristics and Cognitive Function in Patients with Mild and Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 5. pii: JAD201335. doi: 10.3233/JAD-201335.
    PubMed     Abstract available


  216. KHAN MJ, Desaire H, Lopez OL, Kamboh MI, et al
    Why Inclusion Matters for Alzheimer's Disease Biomarker Discovery in Plasma.
    J Alzheimers Dis. 2021 Jan 5. pii: JAD201318. doi: 10.3233/JAD-201318.
    PubMed     Abstract available


  217. YAN Y, Wu X, Wang X, Geng Z, et al
    The Retinal Vessel Density Can Reflect Cognitive Function in Patients with Alzheimer's Disease: Evidence from Optical Coherence Tomography Angiography.
    J Alzheimers Dis. 2021 Jan 5. pii: JAD200971. doi: 10.3233/JAD-200971.
    PubMed     Abstract available


  218. SOHRABI M, Pecoraro HL, Combs CK
    Gut Inflammation Induced by Dextran Sulfate Sodium Exacerbates Amyloid-beta Plaque Deposition in the AppNL - G - F Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2021 Jan 3. pii: JAD201099. doi: 10.3233/JAD-201099.
    PubMed     Abstract available


  219. RADHAKRISHNAN NS, Mufti M, Ortiz D, Maye ST, et al
    Implementing Delirium Prevention in the Era of COVID-19.
    J Alzheimers Dis. 2021;79:31-36.
    PubMed     Abstract available


  220. CLARK IA, Vissel B
    Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches.
    J Alzheimers Dis. 2021;79:931-948.
    PubMed     Abstract available


  221. CARCAVILLA N, Pozo AS, Gonzalez B, Moral-Cuesta D, et al
    Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic.
    J Alzheimers Dis. 2021;80:533-537.
    PubMed     Abstract available


  222. TAM MT, Dosso JA, Robillard JM
    The Impact of a Global Pandemic on People Living with Dementia and Their Care Partners: Analysis of 417 Lived Experience Reports.
    J Alzheimers Dis. 2021;80:865-875.
    PubMed     Abstract available



  223. Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer's Disease Dementia Patients.
    J Alzheimers Dis. 2021;81:1343.
    PubMed    


  224. DAVOUDI A, Dion C, Amini S, Tighe PJ, et al
    Classifying Non-Dementia and Alzheimer's Disease/Vascular Dementia Patients Using Kinematic, Time-Based, and Visuospatial Parameters: The Digital Clock Drawing Test.
    J Alzheimers Dis. 2021;82:47-57.
    PubMed     Abstract available


    December 2020
  225. SOLDEVILA-DOMENECH N, Forcano L, Boronat A, Lorenzo T, et al
    Effects of COVID-19 Home Confinement on Mental Health in Individuals with Increased Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 31. pii: JAD201408. doi: 10.3233/JAD-201408.
    PubMed     Abstract available


  226. GONZALEZ C, Tommasi NS, Briggs D, Properzi MJ, et al
    Financial Capacity and Regional Cerebral Tau in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2020 Dec 29. pii: JAD201122. doi: 10.3233/JAD-201122.
    PubMed     Abstract available


  227. FU Z, Zhao M, Wang X, He Y, et al
    Altered Neuroanatomical Asymmetries of Subcortical Structures in Subjective Cognitive Decline, Amnestic Mild Cognitive Impairment, and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 29. pii: JAD201116. doi: 10.3233/JAD-201116.
    PubMed    


  228. BARTHELSON K, Pederson SM, Newman M, Lardelli M, et al
    Brain Transcriptome Analysis of a Protein-Truncating Mutation in Sortilin-Related Receptor 1 Associated With Early-Onset Familial Alzheimer's Disease Indicates Early Effects on Mitochondrial and Ribosome Function.
    J Alzheimers Dis. 2020 Dec 26. pii: JAD201383. doi: 10.3233/JAD-201383.
    PubMed     Abstract available


  229. TRUMBORE CN
    Shear-Induced Amyloid Aggregation in the Brain: V. Are Alzheimer's and Other Amyloid Diseases Initiated in the Lower Brain and Brainstem by Cerebrospinal Fluid Flow Stresses?
    J Alzheimers Dis. 2020 Dec 26. pii: JAD201025. doi: 10.3233/JAD-201025.
    PubMed     Abstract available


  230. RYAN M, Tan VTY, Thompson N, Guevremont D, et al
    Lentivirus-Mediated Expression of Human Secreted Amyloid Precursor Protein-Alpha Promotes Long-Term Induction of Neuroprotective Genes and Pathways in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 26. pii: JAD200757. doi: 10.3233/JAD-200757.
    PubMed     Abstract available


  231. BABULAL GM, Johnson A, Fagan AM, Morris JC, et al
    Identifying Preclinical Alzheimer's Disease Using Everyday Driving Behavior: Proof of Concept.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD201294. doi: 10.3233/JAD-201294.
    PubMed     Abstract available


  232. STREIT WJ, Khoshbouei H, Bechmann I
    The Role of Microglia in Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD201248. doi: 10.3233/JAD-201248.
    PubMed     Abstract available


  233. FUTAMURA A, Hieda S, Mori Y, Sugimoto A, et al
    Cingulate Island Sign in Single Photon Emission Computed Tomography: Clinical Biomarker Correlations in Lewy Body Disease and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD201145. doi: 10.3233/JAD-201145.
    PubMed     Abstract available


  234. HOANG MT, Kareholt I, von Euler M, von Koch L, et al
    Satisfaction with Stroke Care Among Patients with Alzheimer's and Other Dementias: A Swedish Register-Based Study.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD200976. doi: 10.3233/JAD-200976.
    PubMed     Abstract available


  235. BAO YW, Chau ACM, Chiu PK, Shea YF, et al
    Heterogeneity of Amyloid Binding in Cognitively Impaired Patients Consecutively Recruited from a Memory Clinic: Evaluating the Utility of Quantitative 18F-Flutemetamol PET-CT in Discrimination of Mild Cognitive Impairment from Alzheimer's Disease and
    J Alzheimers Dis. 2020 Dec 23. pii: JAD200890. doi: 10.3233/JAD-200890.
    PubMed     Abstract available


  236. TROMP K, Smedinga M, Richard E, Perry M, et al
    Views on Early Diagnosis of Alzheimer's Disease Among Dutch Physicians: A Qualitative Interview Study.
    J Alzheimers Dis. 2020 Dec 23. pii: JAD200884. doi: 10.3233/JAD-200884.
    PubMed     Abstract available


  237. YUAN J, Maserejian N, Liu Y, Devine S, et al
    Severity Distribution of Alzheimer's Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study.
    J Alzheimers Dis. 2020 Dec 20. pii: JAD200786. doi: 10.3233/JAD-200786.
    PubMed     Abstract available


  238. MINTA K, Brinkmalm G, Portelius E, Johansson P, et al
    Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 17. pii: JAD201039. doi: 10.3233/JAD-201039.
    PubMed     Abstract available


  239. WU W, Lee I, Spratt H, Fang X, et al
    tRNA-Derived Fragments in Alzheimer's Disease: Implications for New Disease Biomarkers and Neuropathological Mechanisms.
    J Alzheimers Dis. 2020 Dec 17. pii: JAD200917. doi: 10.3233/JAD-200917.
    PubMed     Abstract available


  240. PETERSEN ME, Rafii MS, Zhang F, Hall J, et al
    Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down Syndrome.
    J Alzheimers Dis. 2020 Dec 16. pii: JAD201167. doi: 10.3233/JAD-201167.
    PubMed     Abstract available


  241. ORJUELA A, Lakey-Beitia J, Mojica-Flores R, Hegde ML, et al
    Computational Evaluation of Interaction Between Curcumin Derivatives and Amyloid-beta Monomers and Fibrils: Relevance to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 16. pii: JAD200941. doi: 10.3233/JAD-200941.
    PubMed     Abstract available


  242. MOZERSKY J, Hartz S, Linnenbringer E, Levin L, et al
    Communicating 5-Year Risk of Alzheimer's Disease Dementia: Development and Evaluation of Materials that Incorporate Multiple Genetic and Biomarker Research Results.
    J Alzheimers Dis. 2020 Dec 15. pii: JAD200993. doi: 10.3233/JAD-200993.
    PubMed     Abstract available


  243. FANET H, Tournissac M, Leclerc M, Caron V, et al
    Tetrahydrobiopterin Improves Recognition Memory in the Triple-Transgenic Mouse Model of Alzheimer's Disease, Without Altering Amyloid-beta and Tau Pathologies.
    J Alzheimers Dis. 2020 Dec 15. pii: JAD200637. doi: 10.3233/JAD-200637.
    PubMed     Abstract available


  244. MURCHISON CF, Kennedy RE, McConathy JE, Roberson ED, et al
    Racial Differences in Alzheimer's Disease Specialist Encounters are Associated with Usage of Molecular Imaging and Dementia Medications: An Enterprise-Wide Analysis Using i2b2.
    J Alzheimers Dis. 2020 Dec 14. pii: JAD200796. doi: 10.3233/JAD-200796.
    PubMed     Abstract available


  245. ROMANO RR, Carter MA, Dietrich MS, Cowan RL, et al
    Could Altered Evoked Pain Responsiveness Be a Phenotypic Biomarker for Alzheimer's Disease Risk? A Cross-Sectional Analysis of Cognitively Healthy Individuals.
    J Alzheimers Dis. 2020 Dec 13. pii: JAD201293. doi: 10.3233/JAD-201293.
    PubMed     Abstract available


  246. TEIPEL SJ, Marie Temp AG, Levin F, Dyrba M, et al
    Association of TDP-43 Pathology with Global and Regional 18F-Florbetapir PET Signal in the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2020 Dec 13. pii: JAD201032. doi: 10.3233/JAD-201032.
    PubMed     Abstract available


  247. IBI D, Hirashima K, Kojima Y, Sumiya K, et al
    Preventive Effects of Continuous Betaine Intake on Cognitive Impairment and Aberrant Gene Expression in Hippocampus of 3xTg Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 13. pii: JAD200972. doi: 10.3233/JAD-200972.
    PubMed     Abstract available


  248. WANG Q, Chen B, Zhong X, Zhou H, et al
    Olfactory Dysfunction Is Already Present with Subjective Cognitive Decline and Deepens with Disease Severity in the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2020 Dec 13. pii: JAD201168. doi: 10.3233/JAD-201168.
    PubMed     Abstract available


  249. ETTCHETO M, Busquets O, Cano A, Sanchez-Lopez E, et al
    Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 2. pii: JAD201106. doi: 10.3233/JAD-201106.
    PubMed     Abstract available


  250. BEACH TG, Malek-Ahmadi M
    Alzheimer's Disease Neuropathological Comorbidities are Common in the Younger-Old.
    J Alzheimers Dis. 2020 Dec 1. pii: JAD201213. doi: 10.3233/JAD-201213.
    PubMed     Abstract available


  251. FLAX J, Wilkins HM, Miller R, Griffith S, et al
    OGA Inhibition Alters Energetics and Nutrient Sensing in Alzheimer's Disease Cytoplasmic Hybrids.
    J Alzheimers Dis. 2020 Dec 1. pii: JAD200996. doi: 10.3233/JAD-200996.
    PubMed     Abstract available


  252. BIRKENBIHL C, Westwood S, Shi L, Nevado-Holgado A, et al
    ANMerge: A Comprehensive and Accessible Alzheimer's Disease Patient-Level Dataset.
    J Alzheimers Dis. 2020 Dec 1. pii: JAD200948. doi: 10.3233/JAD-200948.
    PubMed     Abstract available


  253. JAYATUNGA DPW, Hone E, Bharadwaj P, Garg M, et al
    Targeting Mitophagy in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Dec 1. pii: JAD191258. doi: 10.3233/JAD-191258.
    PubMed     Abstract available


    November 2020
  254. DENIZ K, Ho CCG, Malphrus KG, Reddy JS, et al
    Plasma Biomarkers of Alzheimer's Disease in African Americans.
    J Alzheimers Dis. 2020 Nov 27. pii: JAD200828. doi: 10.3233/JAD-200828.
    PubMed     Abstract available


  255. BASTRUP J, Hansen KH, Poulsen TBG, Kastaniegaard K, et al
    Anti-Abeta Antibody Aducanumab Regulates the Proteome of Senile Plaques and Closely Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Nov 27. pii: JAD200715. doi: 10.3233/JAD-200715.
    PubMed     Abstract available


  256. KOYCHEV I, Jansen K, Dette A, Shi L, et al
    Blood-Based ATN Biomarkers of Alzheimer's Disease: A Meta-Analysis.
    J Alzheimers Dis. 2020 Nov 24. pii: JAD200900. doi: 10.3233/JAD-200900.
    PubMed     Abstract available


  257. SOTO-MERCADO V, Mendivil-Perez M, Jimenez-Del-Rio M, Velez-Pardo C, et al
    Multi-Target Effects of the Cannabinoid CP55940 on Familial Alzheimer's Disease PSEN1 E280A Cholinergic-Like Neurons: Role of CB1 Receptor.
    J Alzheimers Dis. 2020 Nov 23. pii: JAD201045. doi: 10.3233/JAD-201045.
    PubMed     Abstract available


  258. GIL R, Arroyo-Anllo EM
    Alzheimer's Disease and Face Masks in Times of COVID-19.
    J Alzheimers Dis. 2020 Nov 22. pii: JAD201233. doi: 10.3233/JAD-201233.
    PubMed     Abstract available


  259. YEE E, Ma D, Popuri K, Wang L, et al
    Construction of MRI-Based Alzheimer's Disease Score Based on Efficient 3D Convolutional Neural Network: Comprehensive Validation on 7,902 Images from a Multi-Center Dataset.
    J Alzheimers Dis. 2020 Nov 21. pii: JAD200830. doi: 10.3233/JAD-200830.
    PubMed     Abstract available


  260. SERGOTT RC, Raji A, Kost J, Sur C, et al
    Retinal Optical Coherence Tomography Metrics are Unchanged in Verubecestat Alzheimer's Disease Clinical Trial but Correlate with Baseline Regional Brain Atrophy.
    J Alzheimers Dis. 2020 Nov 21. pii: JAD200735. doi: 10.3233/JAD-200735.
    PubMed     Abstract available


  261. VAN WAALWIJK VAN DOORN LJC, Ghafoorian M, van Leijsen EMC, Claassen JAHR, et al
    White Matter Hyperintensities are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers.
    J Alzheimers Dis. 2020 Nov 21. pii: JAD200496. doi: 10.3233/JAD-200496.
    PubMed     Abstract available


  262. FLORES-CUADRA JA, Madrid A, Fernandez PL, Perez-Lao AR, et al
    Critical Review of the Alzheimer's Disease Non-Transgenic Models: Can They Contribute to Disease Treatment?
    J Alzheimers Dis. 2020 Nov 20. pii: JAD200870. doi: 10.3233/JAD-200870.
    PubMed     Abstract available


  263. BUSQUETS O, Parcerisas A, Verdaguer E, Ettcheto M, et al
    c-Jun N-Terminal Kinases in Alzheimer's Disease: A Possible Target for the Modulation of the Earliest Alterations.
    J Alzheimers Dis. 2020 Nov 18. pii: JAD201053. doi: 10.3233/JAD-201053.
    PubMed     Abstract available


  264. RADESTIG MA, Skoog J, Zetterberg H, Kern J, et al
    Cognitive Performance and Cerebrospinal Fluid Markers in Preclinical Alzheimer's Disease: Results from the Gothenburg H70 Birth Cohort Studies.
    J Alzheimers Dis. 2020 Nov 17. pii: JAD200751. doi: 10.3233/JAD-200751.
    PubMed     Abstract available


  265. YANG B, Yang S, Zhang Y, Liu W, et al
    Stressor-Oriented MUlticomponent Intervention and the WeLl-Being of Patients with Alzheimer's Disease: A Randomized Controlled Trial (SOUL-P).
    J Alzheimers Dis. 2020 Nov 17. pii: JAD200652. doi: 10.3233/JAD-200652.
    PubMed     Abstract available


  266. FEMMINELLA GD, Harold D, Scott J, Williams J, et al
    The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Nov 17. pii: JAD200578. doi: 10.3233/JAD-200578.
    PubMed     Abstract available


  267. BECKER S, Boettinger O, Sulzer P, Hobert MA, et al
    Everyday Function in Alzheimer's and Parkinson's Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2020 Nov 17. pii: JAD200256. doi: 10.3233/JAD-200256.
    PubMed     Abstract available


  268. MADERNA E, Visona S, Bolcato V, Redaelli V, et al
    Neuropathological Alzheimer's Disease Lesions in Nasu-Hakola Disease with TREM2 Mutation: Atypical Distribution of Neurofibrillary Changes.
    J Alzheimers Dis. 2020 Nov 13. pii: JAD201085. doi: 10.3233/JAD-201085.
    PubMed     Abstract available


  269. BARKER W, Quinonez C, Greig MT, Behar R, et al
    Utility of Plasma Neurofilament Light in the 1Florida Alzheimer's Disease Research Center (ADRC).
    J Alzheimers Dis. 2020 Nov 13. pii: JAD200901. doi: 10.3233/JAD-200901.
    PubMed     Abstract available


  270. GUARNIERI B, Maestri M, Cucchiara F, Lo Gerfo A, et al
    Multicenter Study on Sleep and Circadian Alterations as Objective Markers of Mild Cognitive Impairment and Alzheimer's Disease Reveals Sex Differences.
    J Alzheimers Dis. 2020 Nov 11. pii: JAD200632. doi: 10.3233/JAD-200632.
    PubMed     Abstract available


  271. SINGH A, Allen D, Fracassi A, Tumurbaatar B, et al
    Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology is Associated with Absence of Synaptic Tau Oligomers.
    J Alzheimers Dis. 2020 Nov 7. pii: JAD200716. doi: 10.3233/JAD-200716.
    PubMed     Abstract available


  272. WALKER JD, Spiro G, Loewen K, Jacklin K, et al
    Alzheimer's Disease and Related Dementia in Indigenous Populations: A Systematic Review of Risk Factors.
    J Alzheimers Dis. 2020 Nov 7. pii: JAD200704. doi: 10.3233/JAD-200704.
    PubMed     Abstract available


  273. HONG T, Hirano S, Sakurai T, Nakano Y, et al
    The Neuropsychological Correlates of Brain Perfusion and Gray Matter Volume in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Nov 7. pii: JAD200676. doi: 10.3233/JAD-200676.
    PubMed     Abstract available


  274. LI X, Xuan W, Chen D, Gao H, et al
    Research Progress of Alzheimer's Disease Therapeutic Drugs: Based on Renin-Angiotensin System Axis.
    J Alzheimers Dis. 2020 Nov 6. pii: JAD200770. doi: 10.3233/JAD-200770.
    PubMed     Abstract available


  275. DE LA FUENTE GARCIA S, Ritchie C, Luz S
    Artificial Intelligence, Speech, and Language Processing Approaches to Monitoring Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2020 Nov 6. pii: JAD200888. doi: 10.3233/JAD-200888.
    PubMed     Abstract available


  276. YANG YX, Ku K, Li HQ, Shen XN, et al
    Investigating Causal Relations Between Risk Tolerance, Risky Behaviors, and Alzheimer's Disease: A Bidirectional Two-Sample Mendelian Randomization Study.
    J Alzheimers Dis. 2020 Nov 6. pii: JAD200773. doi: 10.3233/JAD-200773.
    PubMed     Abstract available


  277. ARMSTRONG TD, Suwannasual U, Kennedy CL, Thasma A, et al
    Exposure to Traffic-Generated Pollutants Exacerbates the Expression of Factors Associated with the Pathophysiology of Alzheimer's Disease in Aged C57BL/6 Wild-Type Mice.
    J Alzheimers Dis. 2020 Nov 4. pii: JAD200929. doi: 10.3233/JAD-200929.
    PubMed     Abstract available


  278. RICHTER N, Bischof G, Dronse J, Nellessen N, et al
    Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Nov 4. pii: JAD200835. doi: 10.3233/JAD-200835.
    PubMed     Abstract available


    October 2020
  279. POPLE CB, Meng Y, Li DZ, Bigioni L, et al
    Neuromodulation in the Treatment of Alzheimer's Disease: Current and Emerging Approaches.
    J Alzheimers Dis. 2020 Oct 29. pii: JAD200913. doi: 10.3233/JAD-200913.
    PubMed     Abstract available


  280. YILMAZ A, Ustun I, Ugur Z, Akyol S, et al
    A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
    J Alzheimers Dis. 2020 Oct 29. pii: JAD200305. doi: 10.3233/JAD-200305.
    PubMed     Abstract available


  281. BARTELS C, Kogel A, Schweda M, Wiltfang J, et al
    Use of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Risk in Mild Cognitive Impairment and Subjective Cognitive Decline in Routine Clinical Care in Germany.
    J Alzheimers Dis. 2020 Oct 20. pii: JAD200794. doi: 10.3233/JAD-200794.
    PubMed     Abstract available


  282. LIU KY, Costello H, Reeves S, Howard R, et al
    The Relationship Between Anxiety and Incident Agitation in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 20. pii: JAD200516. doi: 10.3233/JAD-200516.
    PubMed     Abstract available


  283. FIELDS TN, Mueller KD, Koscik RL, Johnson SC, et al
    Self-Reported Hearing Loss and Longitudinal Cognitive Function in a Cohort Enriched with Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 17. pii: JAD200701. doi: 10.3233/JAD-200701.
    PubMed     Abstract available


  284. GIBSON GE, Luchsinger JA, Cirio R, Chen H, et al
    Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200896. doi: 10.3233/JAD-200896.
    PubMed     Abstract available


  285. RESCHKE-HERNANDEZ AE, Belfi AM, Guzman-Velez E, Tranel D, et al
    Hooked on a Feeling: Influence of Brief Exposure to Familiar Music on Feelings of Emotion in Individuals with Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200889. doi: 10.3233/JAD-200889.
    PubMed     Abstract available


  286. CROCCO E, Curiel-Cid RE, Kitaigorodsky M, Gonzalez-Jimenez CJ, et al
    A Brief Version of the LASSI-L Detects Prodromal Alzheimer's Disease States.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200790. doi: 10.3233/JAD-200790.
    PubMed     Abstract available


  287. MENNE F, Schipke CG, Klostermann A, Fuentes-Casan M, et al
    Value of Neuropsychological Tests to Identify Patients with Depressive Symptoms on the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200710. doi: 10.3233/JAD-200710.
    PubMed     Abstract available


  288. KRITIKOS M, Gandy S, Meliker JR, Luft BJ, et al
    Acute versus Chronic Exposures to Inhaled Particulate Matter and Neurocognitive Dysfunction: Pathways to Alzheimer's Disease or a Related Dementia.
    J Alzheimers Dis. 2020 Oct 16. pii: JAD200679. doi: 10.3233/JAD-200679.
    PubMed     Abstract available


  289. MARIZZONI M, Cattaneo A, Mirabelli P, Festari C, et al
    Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 14. pii: JAD200306. doi: 10.3233/JAD-200306.
    PubMed     Abstract available


  290. KHALSA DS
    The End of Alzheimer's Protocol: The First Protocol to Enhance Cognition and Reverse Decline at Any Age by Dale Bredesen, Avery, 2020, 352 pp.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD201157. doi: 10.3233/JAD-201157.
    PubMed    


  291. ITZHAKI RF
    Antivirals Against SARS-CoV2: Relevance to the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200986. doi: 10.3233/JAD-200986.
    PubMed     Abstract available


  292. MATIAS-GUIU JA, Pytel V, Matias-Guiu J
    Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200940. doi: 10.3233/JAD-200940.
    PubMed     Abstract available


  293. DUGGAN MR, Torkzaban B, Ahooyi TM, Khalili K, et al
    Potential Role for Herpesviruses in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200814. doi: 10.3233/JAD-200814.
    PubMed     Abstract available


  294. GABERE M, Thu Pham NT, Graff-Radford J, Machulda MM, et al
    Automated Hippocampal Subfield Volumetric Analyses in Atypical Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200625. doi: 10.3233/JAD-200625.
    PubMed     Abstract available


  295. LOUPY KM, Lee T, Zambrano CA, Elsayed AI, et al
    Alzheimer's Disease: Protective Effects of Mycobacterium vaccae, a Soil-Derived Mycobacterium with Anti-Inflammatory and Anti-Tubercular Properties, on the Proteomic Profiles of Plasma and Cerebrospinal Fluid in Rats.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200568. doi: 10.3233/JAD-200568.
    PubMed     Abstract available


  296. ZHANG T, Han X, Zhang X, Chen Z, et al
    Dietary Fatty Acid Factors in Alzheimer's Disease: A Mini-Review.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200558. doi: 10.3233/JAD-200558.
    PubMed     Abstract available


  297. RUITER M, Herstel LJ, Wierenga CJ
    Reduction of Dendritic Inhibition in CA1 Pyramidal Neurons in Amyloidosis Models of Early Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 13. pii: JAD200527. doi: 10.3233/JAD-200527.
    PubMed     Abstract available


  298. ROSIN ER, Blasco D, Pilozzi AR, Yang LH, et al
    A Narrative Review of Alzheimer's Disease Stigma.
    J Alzheimers Dis. 2020 Oct 9. pii: JAD200932. doi: 10.3233/JAD-200932.
    PubMed     Abstract available


  299. HUTTENRAUCH M, Lopez-Noguerola JS, Castro-Obregon S
    Connecting Mind-Body Therapy-Mediated Effects to Pathological Features of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Oct 9. pii: JAD200743. doi: 10.3233/JAD-200743.
    PubMed     Abstract available


  300. RAVONA-SPRINGER R, Sharvit-Ginon I, Ganmore I, Greenbaum L, et al
    The Israel Registry for Alzheimer's Prevention (IRAP) Study: Design and Baseline Characteristics.
    J Alzheimers Dis. 2020 Oct 2. pii: JAD200623. doi: 10.3233/JAD-200623.
    PubMed     Abstract available


  301. CHANG KH, Huang CC, Chen CM, Wu HC, et al
    Differences in Clinical Presentation of Behavioral and Psychological Symptoms of Dementia in Alzheimer's Disease According to Sex and Education Level.
    J Alzheimers Dis. 2020 Oct 2. pii: JAD200507. doi: 10.3233/JAD-200507.
    PubMed     Abstract available


  302. STONNINGTON CM, Velgos SN, Chen Y, Syed S, et al
    Interaction Between BDNF Val66Met and APOE4 on Biomarkers of Alzheimer's Disease and Cognitive Decline.
    J Alzheimers Dis. 2020 Oct 2. pii: JAD200132. doi: 10.3233/JAD-200132.
    PubMed     Abstract available


  303. LEE JH, Byun MS, Yi D, Ko K, et al
    Long-Term Exposure to PM10 and in vivo Alzheimer's Disease Pathologies.
    J Alzheimers Dis. 2020 Oct 1. pii: JAD200694. doi: 10.3233/JAD-200694.
    PubMed     Abstract available


  304. GAVRIEL Y, Rabinovich-Nikitin I, Ezra A, Barbiro B, et al
    Subcutaneous Administration of AMD3100 into Mice Models of Alzheimer's Disease Ameliorated Cognitive Impairment, Reduced Neuroinflammation, and Improved Pathophysiological Markers.
    J Alzheimers Dis. 2020 Oct 1. pii: JAD200506. doi: 10.3233/JAD-200506.
    PubMed     Abstract available


  305. GAO L, Wang J, Jiang Y, Wei S, et al
    Relationship Between Peripheral Transport Proteins and Plasma Amyloid-beta in Patients with Alzheimer's Disease were Different from Cognitively Normal Controls: A Propensity Score Matching Analysis.
    J Alzheimers Dis. 2020 Oct 1. pii: JAD191320. doi: 10.3233/JAD-191320.
    PubMed     Abstract available


    September 2020
  306. POSADA-DUQUE RA, Cardona-Gomez GP
    CDK5 Targeting as a Therapy for Recovering Neurovascular Unit Integrity in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 28. pii: JAD200730. doi: 10.3233/JAD-200730.
    PubMed     Abstract available


  307. SI Z, Wang X
    The Neuroprotective and Neurodegeneration Effects of Heme Oxygenase-1 in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 28. pii: JAD200720. doi: 10.3233/JAD-200720.
    PubMed     Abstract available


  308. GEERTS H, Spiros A
    Simulating the Effects of Common Comedications and Genotypes on Alzheimer's Cognitive Trajectory Using a Quantitative Systems Pharmacology Approach.
    J Alzheimers Dis. 2020 Sep 28. pii: JAD200688. doi: 10.3233/JAD-200688.
    PubMed     Abstract available


  309. DUARTE-GUTERMAN P, Albert AY, Inkster AM, Barha CK, et al
    Inflammation in Alzheimer's Disease: Do Sex and APOE Matter?
    J Alzheimers Dis. 2020 Sep 27. pii: JAD200982. doi: 10.3233/JAD-200982.
    PubMed     Abstract available


  310. TORRES-ACOSTA N, O'Keefe JH, O'Keefe EL, Isaacson R, et al
    Therapeutic Potential of TNF-alpha Inhibition for Alzheimer's Disease Prevention.
    J Alzheimers Dis. 2020 Sep 27. pii: JAD200711. doi: 10.3233/JAD-200711.
    PubMed     Abstract available


  311. TALAN J
    A Life Committed to Changing the Face of Alzheimer's.
    J Alzheimers Dis. 2020 Sep 25. pii: JAD201108. doi: 10.3233/JAD-201108.
    PubMed    


  312. LI D, Liu Y, Zeng X, Xiong Z, et al
    Quantitative Study of the Changes in Cerebral Blood Flow and Iron Deposition During Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 25. pii: JAD200843. doi: 10.3233/JAD-200843.
    PubMed     Abstract available


  313. YUAN X, Wang L, Tendon N, Sun H, et al
    Triheptanoin Mitigates Brain ATP Depletion and Mitochondrial Dysfunction in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 25. pii: JAD200594. doi: 10.3233/JAD-200594.
    PubMed     Abstract available


  314. CARDOSO R, Lemos C, Oliveiros B, Rosario Almeida M, et al
    APOEvarepsilon4-TOMM40L Haplotype Increases the Risk of Mild Cognitive Impairment Conversion to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 25. pii: JAD200556. doi: 10.3233/JAD-200556.
    PubMed     Abstract available


  315. ABDELNOUR C, Esteban de Antonio E, Perez-Cordon A, Lafuente A, et al
    Managing Clinical Trials for Alzheimer's Disease During the COVID-19 Crisis: Experience at Fundacio ACE in Barcelona, Spain.
    J Alzheimers Dis. 2020 Sep 23. pii: JAD200750. doi: 10.3233/JAD-200750.
    PubMed     Abstract available


  316. MOREIRA NCDS, Lima JEBF, Chierrito TPC, Carvalho I, et al
    Novel Hybrid Acetylcholinesterase Inhibitors Induce Differentiation and Neuritogenesis in Neuronal Cells in vitro Through Activation of the AKT Pathway.
    J Alzheimers Dis. 2020 Sep 23. pii: JAD200425. doi: 10.3233/JAD-200425.
    PubMed     Abstract available


  317. KATHERINE BLUJUS J, Elizabeth Korthauer L, Awe E, Frahmand M, et al
    Single Nucleotide Polymorphisms in Alzheimer's Disease Risk Genes Are Associated with Intrinsic Connectivity in Middle Age.
    J Alzheimers Dis. 2020 Sep 20. pii: JAD200444. doi: 10.3233/JAD-200444.
    PubMed     Abstract available


  318. XIA Y, Yassi N, Raniga P, Bourgeat P, et al
    Comorbidity of Cerebrovascular and Alzheimer's Disease in Aging.
    J Alzheimers Dis. 2020 Sep 19. pii: JAD200419. doi: 10.3233/JAD-200419.
    PubMed     Abstract available


  319. LI Y, Li S, Xu S, Yu H, et al
    Association of Androgens and Gonadotropins with Amnestic Mild Cognitive Impairment and Probable Alzheimer's Disease in Chinese Elderly Men.
    J Alzheimers Dis. 2020 Sep 19. pii: JAD200233. doi: 10.3233/JAD-200233.
    PubMed     Abstract available


  320. CALDERON-GARCIDUENAS L, Torres-Jardon R, Franco-Lira M, Kulesza R, et al
    Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.
    J Alzheimers Dis. 2020 Sep 18. pii: JAD200891. doi: 10.3233/JAD-200891.
    PubMed     Abstract available


  321. SANDAU US, Wiedrick JT, Smith SJ, McFarland TJ, et al
    Performance of Validated MicroRNA Biomarkers for Alzheimer's Disease in Mild Cognitive Impairment.
    J Alzheimers Dis. 2020 Sep 16. pii: JAD200396. doi: 10.3233/JAD-200396.
    PubMed     Abstract available


  322. WATERMEYER T, Marroig A, Ritchie CW, Ritchie K, et al
    Cognitive Dispersion is not Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Results from the European Prevention of Alzheimer's Dementia (EPAD) v500.0 Cohort.
    J Alzheimers Dis. 2020 Sep 11. pii: JAD200514. doi: 10.3233/JAD-200514.
    PubMed     Abstract available


  323. MOLD MJ, O'Farrell A, Morris B, Exley C, et al
    Aluminum and Neurofibrillary Tangle Co-Localization in Familial Alzheimer's Disease and Related Neurological Disorders.
    J Alzheimers Dis. 2020 Sep 8. pii: JAD200838. doi: 10.3233/JAD-200838.
    PubMed     Abstract available


  324. KARKI R, Madan S, Gadiya Y, Domingo-Fernandez D, et al
    Data-Driven Modeling of Knowledge Assemblies in Understanding Comorbidity Between Type 2 Diabetes Mellitus and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 8. pii: JAD200752. doi: 10.3233/JAD-200752.
    PubMed     Abstract available


  325. GU Y, Wu Z, Zeng F, Jiang M, et al
    Systemic Exposure to Lipopolysaccharide from Porphyromonas gingivalis Induces Bone Loss-Correlated Alzheimer's Disease-Like Pathologies in Middle-Aged Mice.
    J Alzheimers Dis. 2020 Sep 8. pii: JAD200689. doi: 10.3233/JAD-200689.
    PubMed     Abstract available


  326. BERGERON D, Beauregard JM, Soucy JP, Verret L, et al
    Posterior Cingulate Cortex Hypometabolism in Non-Amnestic Variants of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 8. pii: JAD200567. doi: 10.3233/JAD-200567.
    PubMed     Abstract available


  327. VILA-CASTELAR C, Guzman-Velez E, Pardilla-Delgado E, Buckley R, et al
    Examining Sex Differences in Markers of Cognition and Neurodegeneration in Autosomal Dominant Alzheimer's Disease: Preliminary Findings from the Colombian Alzheimer's Prevention Initiative Biomarker Study.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200723. doi: 10.3233/JAD-200723.
    PubMed     Abstract available


  328. PISANO F, Caltagirone C, Satriano F, Perri R, et al
    Can Alzheimer's Disease Be Prevented? First Evidence from Spinal Stimulation Efficacy on Executive Functions.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200695. doi: 10.3233/JAD-200695.
    PubMed     Abstract available


  329. HULME B, Didikoglu A, Bradburn S, Robinson A, et al
    Epigenetic Regulation of BMAL1 with Sleep Disturbances and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200634. doi: 10.3233/JAD-200634.
    PubMed     Abstract available


  330. GHOWERI AO, Gagolewicz P, Frazier HN, Gant JC, et al
    Neuronal Calcium Imaging, Excitability, and Plasticity Changes in the Aldh2-/- Mouse Model of Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200617. doi: 10.3233/JAD-200617.
    PubMed     Abstract available


  331. CHAE S, Park J, Soo Byun M, Yi D, et al
    Decreased Alpha Reactivity from Eyes-Closed to Eyes-Open in Non-Demented Older Adults with Alzheimer's Disease: A Combined EEG and [18F]florbetaben PET Study.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200442. doi: 10.3233/JAD-200442.
    PubMed     Abstract available


  332. BLAZEL MM, Lazar KK, Van Hulle CA, Ma Y, et al
    Factors Associated with Lumbar Puncture Participation in Alzheimer's Disease Research.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200394. doi: 10.3233/JAD-200394.
    PubMed     Abstract available


  333. SIBLE IJ, Nation DA
    Long-Term Blood Pressure Variability Across the Clinical and Biomarker Spectrum of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200221. doi: 10.3233/JAD-200221.
    PubMed     Abstract available


  334. DUTT S, Li Y, Mather M, Nation DA, et al
    Brainstem Volumetric Integrity in Preclinical and Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200187. doi: 10.3233/JAD-200187.
    PubMed     Abstract available


  335. XU H, Jia J
    Immune-Related Hub Genes and the Competitive Endogenous RNA Network in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Sep 5. pii: JAD200081. doi: 10.3233/JAD-200081.
    PubMed     Abstract available


    August 2020
  336. GELMAN S, Palma J, Ghavami A
    Axonal Conduction Velocity in CA1 Area of Hippocampus is Reduced in Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 30. pii: JAD200661. doi: 10.3233/JAD-200661.
    PubMed     Abstract available


  337. PADALA PR, Boozer EM, Lensing SY, Parkes CM, et al
    Neuromodulation for Apathy in Alzheimer's Disease: A Double-Blind, Randomized, Sham-Controlled Pilot Study.
    J Alzheimers Dis. 2020 Aug 30. pii: JAD200640. doi: 10.3233/JAD-200640.
    PubMed     Abstract available


  338. SANTANGELO R, Huang SC, Bernasconi MP, Falautano M, et al
    Neuro-Retina Might Reflect Alzheimer's Disease Stage.
    J Alzheimers Dis. 2020 Aug 30. pii: JAD200043. doi: 10.3233/JAD-200043.
    PubMed     Abstract available


  339. TSUGAWA A, Sakurai S, Inagawa Y, Hirose D, et al
    Awareness of the COVID-19 Outbreak and Resultant Depressive Tendencies in Patients with Severe Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 27. pii: JAD200832. doi: 10.3233/JAD-200832.
    PubMed     Abstract available


  340. GROSSMANN K
    Anticoagulants for Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 26. pii: JAD200610. doi: 10.3233/JAD-200610.
    PubMed     Abstract available


  341. RAI SP, Bascunana P, Brackhan M, Krohn M, et al
    Detection and Prediction of Mild Cognitive Impairment in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2020 Aug 20. pii: JAD200675. doi: 10.3233/JAD-200675.
    PubMed     Abstract available


  342. SHI L, Winchester LM, Liu BY, Killick R, et al
    Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2020 Aug 20. pii: JAD200208. doi: 10.3233/JAD-200208.
    PubMed     Abstract available


  343. CHU TH, Cummins K, Stys PK
    Traumatic Injury Reduces Amyloid Plaque Burden in the Transgenic 5xFAD Alzheimer's Mouse Spinal Cord.
    J Alzheimers Dis. 2020 Aug 19. pii: JAD200387. doi: 10.3233/JAD-200387.
    PubMed     Abstract available


  344. ENACHE D, Pereira JB, Jelic V, Winblad B, et al
    Increased Cerebrospinal Fluid Concentration of ZnT3 Is Associated with Cognitive Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 18. pii: JAD200498. doi: 10.3233/JAD-200498.
    PubMed     Abstract available


  345. VAN ENGELEN ME, Gossink FT, de Vijlder LS, Meursing JRA, et al
    End Stage Clinical Features and Cause of Death of Behavioral Variant Frontotemporal Dementia and Young-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 18. pii: JAD200337. doi: 10.3233/JAD-200337.
    PubMed     Abstract available


  346. LIM YY, Maruff P, Kaneko N, Doecke J, et al
    Plasma Amyloid-beta Biomarker Associated with Cognitive Decline in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 17. pii: JAD200475. doi: 10.3233/JAD-200475.
    PubMed     Abstract available


  347. BERGLAND AK, Proitsi P, Kirsebom BE, Soennesyn H, et al
    Exploration of Plasma Lipids in Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 14. pii: JAD200441. doi: 10.3233/JAD-200441.
    PubMed     Abstract available


  348. MA YH, Wu JH, Xu W, Shen XN, et al
    Associations of Green Tea Consumption and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2020 Aug 14. pii: JAD200410. doi: 10.3233/JAD-200410.
    PubMed     Abstract available


  349. SUTOVSKY S, Petrovic R, Fischerova M, Haverlikova V, et al
    Allelic Distribution of Genes for Apolipoprotein E and MTHFR in Patients with Alzheimer's Disease and Their Epistatic Interaction.
    J Alzheimers Dis. 2020 Aug 14. pii: JAD200321. doi: 10.3233/JAD-200321.
    PubMed     Abstract available


  350. PARKER AF, Smart CM, Scarapicchia V, Gawryluk JR, et al
    Identification of Earlier Biomarkers for Alzheimer's Disease: A Multimodal Neuroimaging Study of Individuals with Subjective Cognitive Decline.
    J Alzheimers Dis. 2020 Aug 14. pii: JAD200299. doi: 10.3233/JAD-200299.
    PubMed     Abstract available


  351. HUANG J, Beach P, Bozoki A, Zhu DC, et al
    Alzheimer's Disease Progressively Alters the Face-Evoked Visual-Processing Network.
    J Alzheimers Dis. 2020 Aug 14. pii: JAD200173. doi: 10.3233/JAD-200173.
    PubMed     Abstract available


  352. TOURNIER BB, Tsartsalis S, Ceyzeriat K, Fraser BH, et al
    Astrocytic TSPO Upregulation Appears Before Microglial TSPO in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 14. pii: JAD200136. doi: 10.3233/JAD-200136.
    PubMed     Abstract available


  353. LI J, Long X, Huang H, Tang J, et al
    Resilience of Alzheimer's Disease to COVID-19.
    J Alzheimers Dis. 2020 Aug 14. pii: JAD200649. doi: 10.3233/JAD-200649.
    PubMed     Abstract available


  354. SHI JQ, Wang BR, Jiang T, Gao L, et al
    NLRP3 Inflammasome: A Potential Therapeutic Target in Fine Particulate Matter-Induced Neuroinflammation in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 11. pii: JAD200359. doi: 10.3233/JAD-200359.
    PubMed     Abstract available


  355. REJC L, Gomez-Vallejo V, Rios X, Cossio U, et al
    Oral Treatment with Iododiflunisal Delays Hippocampal Amyloid-beta Formation in a Transgenic Mouse Model of Alzheimer's Disease: A Longitudinal in vivo Molecular Imaging Study.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200570. doi: 10.3233/JAD-200570.
    PubMed     Abstract available


  356. HELLER A, Coffman SS, Jarvis K
    Potentially Pathogenic Calcium Oxalate Dihydrate and Titanium Dioxide Crystals in the Alzheimer's Disease Entorhinal Cortex.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200535. doi: 10.3233/JAD-200535.
    PubMed     Abstract available


  357. ROCCARO I, Smirni D
    Fiat Lux: The Light Became Therapy. An Overview on the Bright Light Therapy in Alzheimer's Disease Sleep Disorders.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200478. doi: 10.3233/JAD-200478.
    PubMed     Abstract available


  358. CIMINELLI BM, Menduti G, Benussi L, Ghidoni R, et al
    Polymorphic Genetic Markers of the GABA Catabolism Pathway in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200429. doi: 10.3233/JAD-200429.
    PubMed     Abstract available


  359. WANG RZ, Yang YX, Li HQ, Shen XN, et al
    Genome-Wide Association Study of Brain Alzheimer's Disease-Related Metabolic Decline as Measured by [18F] FDG-PET Imaging.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200415. doi: 10.3233/JAD-200415.
    PubMed     Abstract available


  360. ZHANG M, Zhong X, Shi H, Vanmechelen E, et al
    BACE1 and Other Alzheimer's-Related Biomarkers in Cerebrospinal Fluid and Plasma Distinguish Alzheimer's Disease Patients from Cognitively-Impaired Neurosyphilis Patients.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200362. doi: 10.3233/JAD-200362.
    PubMed     Abstract available


  361. BEGIC E, Hadzidedic S, Obradovic S, Begic Z, et al
    Increased Levels of Coagulation Factor XI in Plasma Are Related to Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200358. doi: 10.3233/JAD-200358.
    PubMed     Abstract available


  362. ZHANG LN, Li MJ, Shang YH, Zhao FF, et al
    Independent and Correlated Role of Apolipoprotein E varepsilon4 Genotype and Herpes Simplex Virus Type 1 in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200607. doi: 10.3233/JAD-200607.
    PubMed     Abstract available


  363. DENNER J, Tanzi R, Jacobson S
    Animal Models of Alzheimer's Disease Should Be Controlled for Roseolovirus.
    J Alzheimers Dis. 2020 Aug 10. pii: JAD200591. doi: 10.3233/JAD-200591.
    PubMed     Abstract available


  364. RAJI CA, Torosyan N, Silverman DHS
    Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders.
    J Alzheimers Dis. 2020 Aug 6. pii: JAD200487. doi: 10.3233/JAD-200487.
    PubMed     Abstract available


  365. QUACH TT, Moutal A, Khanna R, Deems NP, et al
    Collapsin Response Mediator Proteins: Novel Targets for Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 6. pii: JAD200721. doi: 10.3233/JAD-200721.
    PubMed     Abstract available


  366. DEATON CA, Johnson GVW
    Presenilin 1 Regulates Membrane Homeostatic Pathways that are Dysregulated in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Aug 6. pii: JAD200598. doi: 10.3233/JAD-200598.
    PubMed     Abstract available


    July 2020
  367. WANG YJ, Gong WG, Ren QG, Zhang ZJ, et al
    Escitalopram Alleviates Alzheimer's Disease-Type Tau Pathologies in the Aged P301L Tau Transgenic Mice.
    J Alzheimers Dis. 2020 Jul 29. pii: JAD200401. doi: 10.3233/JAD-200401.
    PubMed     Abstract available


  368. GONZLEZ A, Guzmn-Martinez L, Maccioni RB
    Plasma Tau Variants Detected by a Novel Anti-Tau Monoclonal Antibody: A Potential Biomarker for Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 29. pii: JAD200386. doi: 10.3233/JAD-200386.
    PubMed     Abstract available


  369. FURTADO A, Astaburuaga R, Costa A, Duarte AC, et al
    The Rhythmicity of Clock Genes is Disrupted in the Choroid Plexus of the APP/PS1 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 29. pii: JAD200331. doi: 10.3233/JAD-200331.
    PubMed     Abstract available


  370. AKSNES M, Muller EG, Tiiman A, Edwin TH, et al
    Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer's Disease in a Memory Clinic Cohort.
    J Alzheimers Dis. 2020 Jul 29. pii: JAD200237. doi: 10.3233/JAD-200237.
    PubMed     Abstract available


  371. CALIGIORE D, Silvetti M, D'Amelio M, Puglisi-Allegra S, et al
    Computational Modeling of Catecholamines Dysfunction in Alzheimer's Disease at Pre-Plaque Stage.
    J Alzheimers Dis. 2020 Jul 27. pii: JAD200276. doi: 10.3233/JAD-200276.
    PubMed     Abstract available


  372. XU A, Tang Y, Zeng Q, Wang X, et al
    Electroacupuncture Enhances Cognition by Promoting Brain Glucose Metabolism and Inhibiting Inflammation in the APP/PS1 Mouse Model of Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2020 Jul 27. pii: JAD200242. doi: 10.3233/JAD-200242.
    PubMed     Abstract available


  373. KIM J, Lee Y, Lee S, Kim K, et al
    Mesenchymal Stem Cell Therapy and Alzheimer's Disease: Current Status and Future Perspectives.
    J Alzheimers Dis. 2020 Jul 27. pii: JAD200219. doi: 10.3233/JAD-200219.
    PubMed     Abstract available


  374. KELEMAN A, Wisch JK, Bollinger RM, Grant EA, et al
    Falls Associate with Neurodegenerative Changes in ATN Framework of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 25. pii: JAD200192. doi: 10.3233/JAD-200192.
    PubMed     Abstract available


  375. CARUSO G, Perri R, Fadda L, Caltagirone C, et al
    Recall and Recognition in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2020 Jul 25. pii: JAD200126. doi: 10.3233/JAD-200126.
    PubMed     Abstract available


  376. TRAMMELL AR, McDaniel DJ, Obideen M, Okafor M, et al
    Perceived Stress is Associated with Alzheimer's Disease Cerebrospinal Fluid Biomarkers in African Americans with Mild Cognitive Impairment.
    J Alzheimers Dis. 2020 Jul 25. pii: JAD200089. doi: 10.3233/JAD-200089.
    PubMed     Abstract available


  377. BADJI A, de la Colina AN, Boshkovski T, Sabra D, et al
    A Cross-Sectional Study on the Impact of Arterial Stiffness on the Corpus Callosum, a Key White Matter Tract Implicated in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 24. pii: JAD200668. doi: 10.3233/JAD-200668.
    PubMed     Abstract available


  378. FUNG S, Smith CL, Prater KE, Case A, et al
    Early-Onset Familial Alzheimer's Disease Variant PSEN2 N141I Heterozygosity is Associated with Altered Microglia Phenotype.
    J Alzheimers Dis. 2020 Jul 24. pii: JAD200492. doi: 10.3233/JAD-200492.
    PubMed     Abstract available


  379. FU P, Yung KKL
    Air Pollution and Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2020 Jul 24. pii: JAD200483. doi: 10.3233/JAD-200483.
    PubMed     Abstract available


  380. PEDRINI S, Hone E, Gupta VB, James I, et al
    Plasma High Density Lipoprotein Small Subclass is Reduced in Alzheimer's Disease Patients and Correlates with Cognitive Performance.
    J Alzheimers Dis. 2020 Jul 24. pii: JAD200291. doi: 10.3233/JAD-200291.
    PubMed     Abstract available


  381. MCKEOWN A, Turner A, Angehrn Z, Gove D, et al
    Health Outcome Prioritization in Alzheimer's Disease: Understanding the Ethical Landscape.
    J Alzheimers Dis. 2020 Jul 21. pii: JAD191300. doi: 10.3233/JAD-191300.
    PubMed     Abstract available


  382. BREUZA L, Arighi CN, Argoud-Puy G, Casals-Casas C, et al
    A Coordinated Approach by Public Domain Bioinformatics Resources to Aid the Fight Against Alzheimer's Disease Through Expert Curation of Key Protein Targets.
    J Alzheimers Dis. 2020 Jul 20. pii: JAD200206. doi: 10.3233/JAD-200206.
    PubMed     Abstract available


  383. LUIU AL, Favez N, Betrancourt M, Szilas N, et al
    Family Relationships and Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2020 Jul 20. pii: JAD200125. doi: 10.3233/JAD-200125.
    PubMed     Abstract available


  384. VIDONI ED, Kamat A, Gahan WP, Ourso V, et al
    Baseline Prevalence of Polypharmacy in Older Hypertensive Study Subjects with Elevated Dementia Risk: Findings from the Risk Reduction for Alzheimer's Disease Study (rrAD).
    J Alzheimers Dis. 2020 Jul 20. pii: JAD200122. doi: 10.3233/JAD-200122.
    PubMed     Abstract available


  385. LOMBARDI G, Pupi A, Bessi V, Polito C, et al
    Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences.
    J Alzheimers Dis. 2020 Jul 20. pii: JAD200119. doi: 10.3233/JAD-200119.
    PubMed     Abstract available


  386. GAO Y, Zhang N, Lv C, Li N, et al
    lncRNA SNHG1 Knockdown Alleviates Amyloid-beta-Induced Neuronal Injury by Regulating ZNF217 via Sponging miR-361-3p in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 18. pii: JAD191303. doi: 10.3233/JAD-191303.
    PubMed     Abstract available


  387. ARROYO-ANLLO EM, Sanchez JC, Gil R
    Could Self-Consciousness Be Enhanced in Alzheimer's Disease? An Approach from Emotional Sensorial Stimulation.
    J Alzheimers Dis. 2020 Jul 16. pii: JAD200408. doi: 10.3233/JAD-200408.
    PubMed     Abstract available


  388. LIM S, Mohaimin S, Min D, Roberts T, et al
    Alzheimer's Disease and its Related Dementias among Asian Americans, Native Hawaiians, and Pacific Islanders: A Scoping Review.
    J Alzheimers Dis. 2020 Jul 15. pii: JAD200509. doi: 10.3233/JAD-200509.
    PubMed     Abstract available


  389. MELGAREJO JD, Aguirre-Acevedo DC, Gaona C, Chavez CA, et al
    Nighttime Blood Pressure Interacts with APOE Genotype to Increase the Risk of Incident Dementia of the Alzheimer's Type in Hispanics.
    J Alzheimers Dis. 2020 Jul 15. pii: JAD200430. doi: 10.3233/JAD-200430.
    PubMed     Abstract available


  390. STYPA V, Haussermann P, Fleiner T, Neumann S, et al
    Validity and Reliability of the German Quality of Life-Alzheimer's Disease (QoL-AD) Self-Report Scale.
    J Alzheimers Dis. 2020 Jul 15. pii: JAD200400. doi: 10.3233/JAD-200400.
    PubMed     Abstract available


  391. FERGUSON AC, Tank R, Lyall LM, Ward J, et al
    Alzheimer's Disease Susceptibility Gene Apolipoprotein E (APOE) and Blood Biomarkers in UK Biobank (N = 395,769).
    J Alzheimers Dis. 2020 Jul 9. pii: JAD200338. doi: 10.3233/JAD-200338.
    PubMed     Abstract available


  392. GOTO T, Kuramoto E, Dhar A, Wang RP, et al
    Neurodegeneration of Trigeminal Mesencephalic Neurons by the Tooth Loss Triggers the Progression of Alzheimer's Disease in 3xTg-AD Model Mice.
    J Alzheimers Dis. 2020 Jul 9. pii: JAD200257. doi: 10.3233/JAD-200257.
    PubMed     Abstract available


  393. FAN KH, Feingold E, Rosenthal SL, Demirci FY, et al
    Whole-Exome Sequencing Analysis of Alzheimer's Disease in Non-APOE*4 Carriers.
    J Alzheimers Dis. 2020 Jul 8. pii: JAD200037. doi: 10.3233/JAD-200037.
    PubMed     Abstract available


  394. CALFIO C, Gonzalez A, Singh SK, Rojo LE, et al
    The Emerging Role of Nutraceuticals and Phytochemicals in the Prevention and Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 7. pii: JAD200443. doi: 10.3233/JAD-200443.
    PubMed     Abstract available


  395. BAKULSKI KM, Seo YA, Hickman RC, Brandt D, et al
    Heavy Metals Exposure and Alzheimer's Disease and Related Dementias.
    J Alzheimers Dis. 2020 Jul 7. pii: JAD200282. doi: 10.3233/JAD-200282.
    PubMed     Abstract available


  396. HAKIM MA, Behringer EJ
    Development of Alzheimer's Disease Progressively Alters Sex-Dependent KCa and Sex-Independent KIR Channel Function in Cerebrovascular Endothelium.
    J Alzheimers Dis. 2020 Jul 7. pii: JAD200085. doi: 10.3233/JAD-200085.
    PubMed     Abstract available


  397. SUN Z, Sun L, Tu L
    GABAB Receptor-Mediated PI3K/Akt Signaling Pathway Alleviates Oxidative Stress and Neuronal Cell Injury in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 7. pii: JAD191032. doi: 10.3233/JAD-191032.
    PubMed     Abstract available


  398. COPPALLE R, Mauger C, Quernet S, Dewald A, et al
    New Long-Term Encoding in Severely Amnesic Alzheimer's Disease Patients Revealed Through Repeated Exposure to Artistic Items.
    J Alzheimers Dis. 2020 Jul 7. pii: JAD191318. doi: 10.3233/JAD-191318.
    PubMed     Abstract available


  399. SCHWAB S, Afyouni S, Chen Y, Han Z, et al
    Functional Connectivity Alterations of the Temporal Lobe and Hippocampus in Semantic Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 4. pii: JAD191113. doi: 10.3233/JAD-191113.
    PubMed     Abstract available


  400. WARAGAI M, Ho G, Takamatsu Y, Wada R, et al
    Adiponectin Paradox as a Therapeutic Target in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jul 2. pii: JAD200416. doi: 10.3233/JAD-200416.
    PubMed     Abstract available


    June 2020
  401. KAUR H, Golovko S, Golovko MY, Singh S, et al
    Effects of Probiotic Supplementation on Short Chain Fatty Acids in the AppNL-G-F Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 29. pii: JAD200436. doi: 10.3233/JAD-200436.
    PubMed     Abstract available


  402. HAYASHI K, Gonzales TK, Kapoor A, Ziegler TE, et al
    Development of Classification Models for the Prediction of Alzheimer's Disease Utilizing Circulating Sex Hormone Ratios.
    J Alzheimers Dis. 2020 Jun 29. pii: JAD200418. doi: 10.3233/JAD-200418.
    PubMed     Abstract available


  403. LI T, Martin E, Abada YS, Boucher C, et al
    Effects of Chronic Masitinib Treatment in APPPS1dE9 Transgenic Mice Modeling Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 27. pii: JAD200466. doi: 10.3233/JAD-200466.
    PubMed     Abstract available


  404. SHI Y, Zhang L, Gao X, Zhang J, et al
    Intranasal Dantrolene as a Disease-Modifying Drug in Alzheimer 5XFAD Mice.
    J Alzheimers Dis. 2020 Jun 27. pii: JAD200227. doi: 10.3233/JAD-200227.
    PubMed     Abstract available


  405. KIM DY, Choi SH, Lee JS, Kim HJ, et al
    Feasibility and Efficacy of Intra-Arterial Administration of Embryonic Stem Cell Derived-Mesenchymal Stem Cells in Animal Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 25. pii: JAD200026. doi: 10.3233/JAD-200026.
    PubMed     Abstract available


  406. FUENTES M, Klostermann A, Kleineidam L, Bauer C, et al
    Identification of a Cascade of Changes in Activities of Daily Living Preceding Short-Term Clinical Deterioration in Mild Alzheimer's Disease via Lead-Lag Analysis.
    J Alzheimers Dis. 2020 Jun 24. pii: JAD200230. doi: 10.3233/JAD-200230.
    PubMed     Abstract available


  407. LIANG Y, Raven F, Ward JF, Zhen S, et al
    Upregulation of Alzheimer's Disease Amyloid-beta Protein Precursor in Astrocytes Both in vitro and in vivo.
    J Alzheimers Dis. 2020 Jun 24. pii: JAD200128. doi: 10.3233/JAD-200128.
    PubMed     Abstract available


  408. DUAN W, Sehrawat P, Balachandrasekaran A, Bhumkar AB, et al
    Cerebral Blood Flow Is Associated with Diagnostic Class and Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 24. pii: JAD200034. doi: 10.3233/JAD-200034.
    PubMed     Abstract available


  409. SOLIS E, Hascup KN, Hascup ER
    Alzheimer's Disease: The Link Between Amyloid-beta and Neurovascular Dysfunction.
    J Alzheimers Dis. 2020 Jun 23. pii: JAD200473. doi: 10.3233/JAD-200473.
    PubMed     Abstract available


  410. HABIBA U, Merlin S, Lim JKH, Wong VHY, et al
    Age-Specific Retinal and Cerebral Immunodetection of Amyloid-beta Plaques and Oligomers in a Rodent Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 23. pii: JAD191346. doi: 10.3233/JAD-191346.
    PubMed     Abstract available


  411. ANGEHRN Z, Sostar J, Nordon C, Turner A, et al
    Ethical and Social Implications of Using Predictive Modeling for Alzheimer's Disease Prevention: A Systematic Literature Review.
    J Alzheimers Dis. 2020 Jun 23. pii: JAD191159. doi: 10.3233/JAD-191159.
    PubMed     Abstract available


  412. MACCIONI RB, Navarrete LP, Gonzalez A, Gonzalez-Canacer A, et al
    Inflammation: A Major Target for Compounds to Control Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 23. pii: JAD191014. doi: 10.3233/JAD-191014.
    PubMed     Abstract available


  413. WING JJ, Levine DA, Ramamurthy A, Reider C, et al
    Alzheimer's Disease and Related Disorders Prevalence Differs by Appalachian Residence in Ohio.
    J Alzheimers Dis. 2020 Jun 22. pii: JAD200491. doi: 10.3233/JAD-200491.
    PubMed     Abstract available


  414. RESENDE R, Ferreira-Marques M, Moreira P, Coimbra JRM, et al
    New BACE1 Chimeric Peptide Inhibitors Selectively Prevent AbetaPPbeta Cleavage Decreasing Amyloid-beta Production and Accumulation in Alzheimer's Disease Models.
    J Alzheimers Dis. 2020 Jun 22. pii: JAD200381. doi: 10.3233/JAD-200381.
    PubMed     Abstract available


  415. GRISWOLD AJ, Sivasankaran SK, Van Booven D, Gardner OK, et al
    Immune and Inflammatory Pathways Implicated by Whole Blood Transcriptomic Analysis in a Diverse Ancestry Alzheimer's Disease Cohort.
    J Alzheimers Dis. 2020 Jun 22. pii: JAD190855. doi: 10.3233/JAD-190855.
    PubMed     Abstract available


  416. SCHINDLER SE, Jicha GA, Nelson PT, Keene CD, et al
    Maximizing Safety in the Conduct of Alzheimer's Disease Fluid Biomarker Research in the Era of COVID-19.
    J Alzheimers Dis. 2020 Jun 19. pii: JAD200684. doi: 10.3233/JAD-200684.
    PubMed     Abstract available


  417. BOUTOLEAU-BRETONNIERE C, Pouclet-Courtemanche H, Gillet A, Bernard A, et al
    The Effects of Confinement on Neuropsychiatric Symptoms in Alzheimer's Disease During the COVID-19 Crisis.
    J Alzheimers Dis. 2020 Jun 17. pii: JAD200604. doi: 10.3233/JAD-200604.
    PubMed     Abstract available


  418. NARUKAWA M, Takahashi S, Saito T, Saido TC, et al
    Analysis of Taste Sensitivities in App Knock-In Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 17. pii: JAD200284. doi: 10.3233/JAD-200284.
    PubMed     Abstract available


  419. GUTHRIE H, Honig LS, Lin H, Sink KM, et al
    xSafety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-To-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133 Weeks.
    J Alzheimers Dis. 2020 Jun 17. pii: JAD200134. doi: 10.3233/JAD-200134.
    PubMed     Abstract available


  420. THORDARDOTTIR S, Almkvist O, Johansson C, Zetterberg H, et al
    Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2020 Jun 17. pii: JAD191261. doi: 10.3233/JAD-191261.
    PubMed     Abstract available


  421. WANG SY, Gong PY, Yan E, Zhang YD, et al
    The Role of TREML2 in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 16. pii: JAD200406. doi: 10.3233/JAD-200406.
    PubMed     Abstract available


  422. LIU RM, Chong Z, Chen JC
    Ozone and Particulate Matter Exposure and Alzheimer's Disease: A Review of Human and Animal Studies.
    J Alzheimers Dis. 2020 Jun 15. pii: JAD200435. doi: 10.3233/JAD-200435.
    PubMed     Abstract available


  423. ATTADEMO L, Bernardini F
    Air Pollution as Risk Factor for Mental Disorders: In Search for a Possible Link with Alzheimer's Disease and Schizophrenia.
    J Alzheimers Dis. 2020 Jun 15. pii: JAD200289. doi: 10.3233/JAD-200289.
    PubMed     Abstract available


  424. TAKEMOTO M, Ohta Y, Hishikawa N, Yamashita T, et al
    The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP).
    J Alzheimers Dis. 2020 Jun 15. pii: JAD200247. doi: 10.3233/JAD-200247.
    PubMed     Abstract available


  425. CUTTLER K, Bignoux MJ, Otgaar TC, Chigumba S, et al
    LRP::FLAG Reduces Phosphorylated Tau Levels in Alzheimer's Disease Cell Culture Models.
    J Alzheimers Dis. 2020 Jun 15. pii: JAD200244. doi: 10.3233/JAD-200244.
    PubMed     Abstract available


  426. ROY M, Rheault F, Croteau E, Castellano CA, et al
    Fascicle- and Glucose-Specific Deterioration in White Matter Energy Supply in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 15. pii: JAD200213. doi: 10.3233/JAD-200213.
    PubMed     Abstract available


  427. LAKEY-BEITIA J, Burillo AM, La Penna G, Hegde ML, et al
    Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 15. pii: JAD200185. doi: 10.3233/JAD-200185.
    PubMed     Abstract available


  428. RAJJI TK, Bowie CR, Herrmann N, Pollock BG, et al
    Design and Rationale of the PACt-MD Randomized Clinical Trial: Prevention of Alzheimer's dementia with Cognitive remediation plus transcranial direct current stimulation in Mild cognitive impairment and Depression.
    J Alzheimers Dis. 2020 Jun 15. pii: JAD200141. doi: 10.3233/JAD-200141.
    PubMed     Abstract available


  429. NAUGHTON SX, Raval U, Pasinetti GM
    Potential Novel Role of COVID-19 in Alzheimer's Disease and Preventative Mitigation Strategies.
    J Alzheimers Dis. 2020 Jun 12. pii: JAD200537. doi: 10.3233/JAD-200537.
    PubMed     Abstract available


  430. MOTTA C, Finardi A, Toniolo S, Di Lorenzo F, et al
    Protective Role of Cerebrospinal Fluid Inflammatory Cytokines in Patients with Amnestic Mild Cognitive Impairment and Early Alzheimer's Disease Carrying Apolipoprotein E4 Genotype.
    J Alzheimers Dis. 2020 Jun 8. pii: JAD191250. doi: 10.3233/JAD-191250.
    PubMed     Abstract available


  431. HE Y, Zhang H, Wang T, Han Z, et al
    Impact of Serum Calcium Levels on Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2020 Jun 8. pii: JAD191249. doi: 10.3233/JAD-191249.
    PubMed     Abstract available


  432. PIAMONTE BLC, Espiritu AI, Anlacan VMM
    Effects of Citicoline as an Adjunct Treatment for Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2020 Jun 6. pii: JAD200378. doi: 10.3233/JAD-200378.
    PubMed     Abstract available


  433. HERNANDES-ALEJANDRO M, Montano S, Harrington CR, Wischik CM, et al
    Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jun 6. pii: JAD200146. doi: 10.3233/JAD-200146.
    PubMed     Abstract available


  434. BARTHOLD D, Joyce G, Ferido P, Drabo EF, et al
    Pharmaceutical Treatment for Alzheimer's Disease and Related Dementias: Utilization and Disparities.
    J Alzheimers Dis. 2020 Jun 6. pii: JAD200133. doi: 10.3233/JAD-200133.
    PubMed     Abstract available


  435. FOWLER ME, Triebel KL, Cutter GR, Schneider LS, et al
    Progression of Alzheimer's Disease by Self-Reported Cancer History in the Alzheimer's Disease Neuroimaging Initiative.
    J Alzheimers Dis. 2020 Jun 6. pii: JAD200108. doi: 10.3233/JAD-200108.
    PubMed     Abstract available


  436. STRICKER NH, Lundt ES, Albertson SM, Machulda MM, et al
    Diagnostic and Prognostic Accuracy of the Cogstate Brief Battery and Auditory Verbal Learning Test in Preclinical Alzheimer's Disease and Incident Mild Cognitive Impairment: Implications for Defining Subtle Objective Cognitive Impairment.
    J Alzheimers Dis. 2020 Jun 6. pii: JAD200087. doi: 10.3233/JAD-200087.
    PubMed     Abstract available


  437. PRIETO S, Valerio KE, Moody JN, Hayes SM, et al
    Genetic Risk for Alzheimer's Disease Moderates the Association Between Medial Temporal Lobe Volume and Episodic Memory Performance Among Older Adults.
    J Alzheimers Dis. 2020 Jun 6. pii: JAD191312. doi: 10.3233/JAD-191312.
    PubMed     Abstract available


  438. BEAM CR, Kaneshiro C, Jang JY, Reynolds CA, et al
    A Twin Study of Sex Differences in Genetic Risk for All Dementia, Alzheimer's Disease (AD), and Non-AD Dementia.
    J Alzheimers Dis. 2020 Jun 6. pii: JAD191192. doi: 10.3233/JAD-191192.
    PubMed     Abstract available


  439. PANZARELLA V, Mauceri R, Baschi R, Maniscalco L, et al
    Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabut Aging Project.
    J Alzheimers Dis. 2020 Jun 4. pii: JAD200385. doi: 10.3233/JAD-200385.
    PubMed     Abstract available


  440. RAJI CA, Meysami S, Merrill DA, Porter VR, et al
    Brain Structure in Bilingual Compared to Monolingual Individuals with Alzheimer's Disease: Proof of Concept.
    J Alzheimers Dis. 2020 Jun 1. pii: JAD200200. doi: 10.3233/JAD-200200.
    PubMed     Abstract available


    May 2020
  441. TRAINI E, Carotenuto A, Fasanaro AM, Amenta F, et al
    Volume Analysis of Brain Cognitive Areas in Alzheimer's Disease: Interim 3-Year Results from the ASCOMALVA Trial.
    J Alzheimers Dis. 2020 May 30. pii: JAD190623. doi: 10.3233/JAD-190623.
    PubMed     Abstract available


  442. CHEN M, Xia W
    Proteomic Profiling of Plasma and Brain Tissue from Alzheimer's Disease Patients Reveals Candidate Network of Plasma Biomarkers.
    J Alzheimers Dis. 2020 May 26. pii: JAD200110. doi: 10.3233/JAD-200110.
    PubMed     Abstract available


  443. LIM WLF, Huynh K, Chatterjee P, Martins I, et al
    Relationships Between Plasma Lipids Species, Gender, Risk Factors, and Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 26. pii: JAD191304. doi: 10.3233/JAD-191304.
    PubMed     Abstract available


  444. RABIPOUR S, Rajagopal S, Yu E, Pasvanis S, et al
    APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset.
    J Alzheimers Dis. 2020 May 26. pii: JAD191292. doi: 10.3233/JAD-191292.
    PubMed     Abstract available


  445. BENHAMRON S, Nitzan K, Valitsky M, Lax N, et al
    Cerebrospinal Fluid (CSF) Exchange Therapy with Artificial CSF Enriched with Mesenchymal Stem Cell Secretions Ameliorates Cognitive Deficits and Brain Pathology in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2020 May 26. pii: JAD191219. doi: 10.3233/JAD-191219.
    PubMed     Abstract available


  446. NICASTRO N, Malpetti M, Cope TE, Bevan-Jones WR, et al
    Cortical Complexity Analyses and Their Cognitive Correlate in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2020 May 22. pii: JAD200246. doi: 10.3233/JAD-200246.
    PubMed     Abstract available


  447. PARIZKOVA M, Lerch O, Andel R, Kalinova J, et al
    Spatial Pattern Separation in Early Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 20. pii: JAD200093. doi: 10.3233/JAD-200093.
    PubMed     Abstract available


  448. SHI Y, Gao F, Yang X, Liu D, et al
    Increase of BACE1, Brain-Renal Risk Factor, Contributes to Kidney Damage in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2020 May 19. pii: JAD200204. doi: 10.3233/JAD-200204.
    PubMed     Abstract available


  449. SCHWABER EJ, Thompson AC, Smilnak G, Stinnett SS, et al
    Co-Prevalence of Alzheimer's Disease and Age-Related Macular Degeneration Established by Histopathologic Diagnosis.
    J Alzheimers Dis. 2020 May 19. pii: JAD200111. doi: 10.3233/JAD-200111.
    PubMed     Abstract available


  450. WANG X, Zimmermann HR, Lockhart SN, Craft S, et al
    Decreased Levels of Blood AMPKalpha1 but not AMPKalpha2 Isoform in Patients with Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2020 May 19. pii: JAD191189. doi: 10.3233/JAD-191189.
    PubMed     Abstract available


  451. GUEIB C, Pop A, Bannay A, Nassau E, et al
    Impact of a Healing Garden on Self-Consciousness in Patients with Advanced Alzheimer's Disease: An Exploratory Study1.
    J Alzheimers Dis. 2020 May 19. pii: JAD190748. doi: 10.3233/JAD-190748.
    PubMed     Abstract available


  452. JACUS JP, Mayelle A, Voltzenlogel V, Cuervo-Lombard CV, et al
    Modeling Awareness in Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 14. pii: JAD200017. doi: 10.3233/JAD-200017.
    PubMed     Abstract available


  453. PEI YA, Davies J, Zhang M, Zhang HT, et al
    The Role of Synaptic Dysfunction in Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 14. pii: JAD191334. doi: 10.3233/JAD-191334.
    PubMed     Abstract available


  454. KRAMARZ B, Huntley RP, Rodriguez-Lopez M, Roncaglia P, et al
    Gene Ontology Curation of Neuroinflammation Biology Improves the Interpretation of Alzheimer's Disease Gene Expression Data.
    J Alzheimers Dis. 2020 May 13. pii: JAD200207. doi: 10.3233/JAD-200207.
    PubMed     Abstract available


  455. VECCHIO F, Miraglia F, Alu F, Menna M, et al
    Classification of Alzheimer's Disease with Respect to Physiological Aging with Innovative EEG Biomarkers in a Machine Learning Implementation.
    J Alzheimers Dis. 2020 May 11. pii: JAD200171. doi: 10.3233/JAD-200171.
    PubMed     Abstract available


  456. RAI SP, Krohn M, Pahnke J
    Early Cognitive Training Rescues Remote Spatial Memory but Reduces Cognitive Flexibility in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2020 May 11. pii: JAD200161. doi: 10.3233/JAD-200161.
    PubMed     Abstract available


  457. KAWASAKI A, Ouanes S, Crippa SV, Popp J, et al
    Early-Stage Alzheimer's Disease Does Not Alter Pupil Responses to Colored Light Stimuli.
    J Alzheimers Dis. 2020 May 11. pii: JAD200120. doi: 10.3233/JAD-200120.
    PubMed     Abstract available


  458. COURAULT P, Emery S, Bouvard S, Liger F, et al
    Change in Expression of 5-HT6 Receptor at Different Stages of Alzheimer's Disease: A Postmortem Study with the PET Radiopharmaceutical [18F]2FNQ1P.
    J Alzheimers Dis. 2020 May 11. pii: JAD191278. doi: 10.3233/JAD-191278.
    PubMed     Abstract available


  459. WILLIAMS OA, An Y, Armstrong NM, Kitner-Triolo M, et al
    Profiles of Cognitive Change in Preclinical and Prodromal Alzheimer's Disease Using Change-Point Analysis.
    J Alzheimers Dis. 2020 May 8. pii: JAD191268. doi: 10.3233/JAD-191268.
    PubMed     Abstract available


  460. ZIBRANDTSEN IC, Agger M, Kjaer TW
    Gamma Entrainment in a Large Retrospective Cohort: Implications for Photic Stimulation Therapy for Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 7. pii: JAD200083. doi: 10.3233/JAD-200083.
    PubMed     Abstract available


  461. ANDRADE V, Cortes N, Pastor G, Gonzalez A, et al
    N-Acetyl Cysteine and Catechin-Derived Polyphenols: A Path Toward Multi-Target Compounds Against Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 7. pii: JAD200067. doi: 10.3233/JAD-200067.
    PubMed     Abstract available


  462. ENENGL J, Hamblin MR, Dungel P
    Photobiomodulation for Alzheimer's Disease: Translating Basic Research to Clinical Application.
    J Alzheimers Dis. 2020 May 7. pii: JAD191210. doi: 10.3233/JAD-191210.
    PubMed     Abstract available


  463. ROBERT C, Wilson CS, Lipton RB, Arreto CD, et al
    Evolution of the Research Literature and the Scientific Community of Alzheimer's Disease from 1983-2017: A 35-Year Survey.
    J Alzheimers Dis. 2020 May 6. pii: JAD191281. doi: 10.3233/JAD-191281.
    PubMed     Abstract available


  464. HADITSCH U, Roth T, Rodriguez L, Hancock S, et al
    Alzheimer's Disease-Like Neurodegeneration in Porphyromonas gingivalis Infected Neurons with Persistent Expression of Active Gingipains.
    J Alzheimers Dis. 2020 May 5. pii: JAD200393. doi: 10.3233/JAD-200393.
    PubMed     Abstract available


  465. FIALA M, Lau YCC, Aghajani A, Bhargava S, et al
    Omega-3 Fatty Acids Increase Amyloid-beta Immunity, Energy, and Circadian Rhythm for Cognitive Protection of Alzheimer's Disease Patients Beyond Cholinesterase Inhibitors.
    J Alzheimers Dis. 2020 May 4. pii: JAD200252. doi: 10.3233/JAD-200252.
    PubMed     Abstract available


  466. PYUN JM, Kang MJ, Ryoo N, Suh J, et al
    Amyloid Metabolism and Amyloid-Targeting Blood-Based Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 4. pii: JAD200104. doi: 10.3233/JAD-200104.
    PubMed     Abstract available


  467. WANG P, Zhou B, Yao H, Xie S, et al
    Aberrant Hippocampal Functional Connectivity Is Associated with Fornix White Matter Integrity in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2020 May 4. pii: JAD200066. doi: 10.3233/JAD-200066.
    PubMed     Abstract available


  468. BABIC LEKO M, Nikolac Perkovic M, Klepac N, Strac DS, et al
    IL-1beta, IL-6, IL-10, and TNFalpha Single Nucleotide Polymorphisms in Human Influence the Susceptibility to Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2020 May 4. pii: JAD200056. doi: 10.3233/JAD-200056.
    PubMed     Abstract available


  469. WROOLIE T, Roat-Shumway S, Watson K, Reiman E, et al
    Effects of LDL Cholesterol and Statin Use on Verbal Learning and Memory in Older Adults at Genetic Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 4. pii: JAD191090. doi: 10.3233/JAD-191090.
    PubMed     Abstract available


  470. WIMO A, Handels R, Winblad B, Black CM, et al
    Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions.
    J Alzheimers Dis. 2020 May 4. pii: JAD191055. doi: 10.3233/JAD-191055.
    PubMed     Abstract available


  471. IACCARINO L, Sala A, Caminiti SP, Presotto L, et al
    In vivo MRI Structural and PET Metabolic Connectivity Study of Dopamine Pathways in Alzheimer's Disease.
    J Alzheimers Dis. 2020 May 4. pii: JAD190954. doi: 10.3233/JAD-190954.
    PubMed     Abstract available


  472. LIM HJ, Park JE, Kim BC, Choi SM, et al
    Comparison of Two Analytical Platforms in Cerebrospinal Fluid Biomarkers for the Classification of Alzheimer's Disease Spectrum with Amyloid PET Imaging.
    J Alzheimers Dis. 2020 May 2. pii: JAD191331. doi: 10.3233/JAD-191331.
    PubMed     Abstract available


    April 2020
  473. DEVANAND DP, Liu X, Chunga RE, Cohen H, et al
    Odor Identification Impairment and Change with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment.
    J Alzheimers Dis. 2020 Apr 24. pii: JAD200021. doi: 10.3233/JAD-200021.
    PubMed     Abstract available


  474. INNES KE, Sambamoorthi U
    The Association of Osteoarthritis and Related Pain Burden to Incident Alzheimer's Disease and Related Dementias: A Retrospective Cohort Study of U.S. Medicare Beneficiaries.
    J Alzheimers Dis. 2020 Apr 24. pii: JAD191311. doi: 10.3233/JAD-191311.
    PubMed     Abstract available


  475. KAUR G, Poljak A, Braidy N, Crawford JD, et al
    Fluid Biomarkers and APOE Status of Early Onset Alzheimer's Disease Variants: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2020 Apr 23. pii: JAD200052. doi: 10.3233/JAD-200052.
    PubMed     Abstract available


  476. LEE SH, Byun MS, Lee JH, Yi D, et al
    Sex-Specific Association of Lifetime Body Mass Index with Alzheimer's Disease Neuroimaging Biomarkers.
    J Alzheimers Dis. 2020 Apr 18. pii: JAD191216. doi: 10.3233/JAD-191216.
    PubMed     Abstract available


  477. CAI HB, Fan ZZ, Tian T, Li ZC, et al
    Diabetes-Induced H3K9 Hyperacetylation Promotes Development of Alzheimer's Disease Through CDK5.
    J Alzheimers Dis. 2020 Apr 13. pii: JAD200163. doi: 10.3233/JAD-200163.
    PubMed     Abstract available


  478. LIU B, Liu J, Shi JS
    SAMP8 Mice as a Model of Age-Related Cognition Decline with Underlying Mechanisms in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Apr 13. pii: JAD200063. doi: 10.3233/JAD-200063.
    PubMed     Abstract available


  479. HUANG SY, Zhu JX, Shen XN, Xu W, et al
    Prevalence of the Preclinical Stages of Alzheimer's Disease in Cognitively Intact Older Adults: The CABLE Study.
    J Alzheimers Dis. 2020 Apr 13. pii: JAD200059. doi: 10.3233/JAD-200059.
    PubMed     Abstract available


  480. WESTFALL S, Dinh DM, Pasinetti GM
    Investigation of Potential Brain Microbiome in Alzheimer's Disease: Implications of Study Bias.
    J Alzheimers Dis. 2020 Apr 13. pii: JAD191328. doi: 10.3233/JAD-191328.
    PubMed     Abstract available


  481. HENDERSON ST, Morimoto BH, Cummings JL, Farlow MR, et al
    A Placebo-Controlled, Parallel Group, Randomized Clinical Trial of AC-1204 in Mild-to-Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2020 Apr 13. pii: JAD191302. doi: 10.3233/JAD-191302.
    PubMed     Abstract available


  482. YOUN YC, Lee BS, Kim GJ, Ryu JS, et al
    Blood Amyloid-beta Oligomerization as a Biomarker of Alzheimer's Disease: A Blinded Validation Study.
    J Alzheimers Dis. 2020 Apr 9. pii: JAD200061. doi: 10.3233/JAD-200061.
    PubMed     Abstract available


  483. KIM BH, Choi YH, Yang JJ, Kim S, et al
    Identification of Novel Genes Associated with Cortical Thickness in Alzheimer's Disease: Systems Biology Approach to Neuroimaging Endophenotype.
    J Alzheimers Dis. 2020 Apr 9. pii: JAD191175. doi: 10.3233/JAD-191175.
    PubMed     Abstract available


  484. CLAY F, Howett D, FitzGerald J, Fletcher P, et al
    Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2020 Apr 8. pii: JAD191218. doi: 10.3233/JAD-191218.
    PubMed     Abstract available


  485. JIN J, Guo J, Cai H, Zhao C, et al
    M2-Like Microglia Polarization Attenuates Neuropathic Pain Associated with Alzheimer's Disease.
    J Alzheimers Dis. 2020 Apr 6. pii: JAD200099. doi: 10.3233/JAD-200099.
    PubMed     Abstract available


  486. LI N, Wang G, Lu H
    Development of Alzheimer's Disease after Myocardial Infarction.
    J Alzheimers Dis. 2020 Apr 6. pii: JAD200068. doi: 10.3233/JAD-200068.
    PubMed     Abstract available


  487. BEYDOUN MA, Beydoun HA, Hossain S, El-Hajj ZW, et al
    Clinical and Bacterial Markers of Periodontitis and Their Association with Incident All-Cause and Alzheimer's Disease Dementia in a Large National Survey.
    J Alzheimers Dis. 2020 Apr 6. pii: JAD200064. doi: 10.3233/JAD-200064.
    PubMed     Abstract available


  488. SCHEDIN-WEISS S, Nilsson P, Sandebring-Matton A, Axenhus M, et al
    Proteomics Time-Course Study of App Knock-In Mice Reveals Novel Presymptomatic Abeta42-Induced Pathways to Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2020 Apr 6. pii: JAD200028. doi: 10.3233/JAD-200028.
    PubMed     Abstract available


  489. LU MH, Zhao XY, Xu DE, Chen JB, et al
    Transplantation of GABAergic Interneuron Progenitor Attenuates Cognitive Deficits of Alzheimer's Disease Model Mice.
    J Alzheimers Dis. 2020 Apr 6. pii: JAD200010. doi: 10.3233/JAD-200010.
    PubMed     Abstract available


  490. OU YN, Zhu JX, Hou XH, Shen XN, et al
    Associations of Infectious Agents with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2020 Apr 6. pii: JAD191337. doi: 10.3233/JAD-191337.
    PubMed     Abstract available


  491. CHENG Y, Ahmed A, Zamrini E, Tsuang DW, et al
    Alzheimer's Disease and Alzheimer's Disease-Related Dementias in Older African American and White Veterans.
    J Alzheimers Dis. 2020 Apr 3. pii: JAD191188. doi: 10.3233/JAD-191188.
    PubMed     Abstract available


  492. KUMAR VV, Huang H, Zhao L, Verble DD, et al
    Baseline Results: The Association between Cardiovascular Risk and Preclinical Alzheimer's Disease Pathology (ASCEND) Study.
    J Alzheimers Dis. 2020 Apr 3. pii: JAD191103. doi: 10.3233/JAD-191103.
    PubMed     Abstract available


  493. QIAO Y, Xie XY, Lin GZ, Zou Y, et al
    Computer-Assisted Speech Analysis in Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study from Shanghai, China.
    J Alzheimers Dis. 2020 Apr 2. pii: JAD191056. doi: 10.3233/JAD-191056.
    PubMed     Abstract available


  494. HORVATH A, Salman Z, Quinlan P, Wallin A, et al
    Patients with Alzheimer's Disease Have Increased Levels of Insulin-like Growth Factor-I in Serum but not in Cerebrospinal Fluid.
    J Alzheimers Dis. 2020 Apr 2. pii: JAD190921. doi: 10.3233/JAD-190921.
    PubMed     Abstract available


  495. BASSENDINE MF, Taylor-Robinson SD, Fertleman M, Khan M, et al
    Is Alzheimer's Disease a Liver Disease of the Brain?
    J Alzheimers Dis. 2020 Apr 2. pii: JAD190848. doi: 10.3233/JAD-190848.
    PubMed     Abstract available


  496. YAMOAH A, Tripathi P, Sechi A, Kohler C, et al
    Aggregates of RNA Binding Proteins and ER Chaperones Linked to Exosomes in Granulovacuolar Degeneration of the Alzheimer's Disease Brain.
    J Alzheimers Dis. 2020 Apr 2. pii: JAD190722. doi: 10.3233/JAD-190722.
    PubMed     Abstract available


  497. DALY T, Houot M, Barberousse A, Agid Y, et al
    Amyloid-beta in Alzheimer's Disease: A Study of Citation Practices of the Amyloid Cascade Hypothesis Between 1992 and 2019.
    J Alzheimers Dis. 2020 Apr 1. pii: JAD191321. doi: 10.3233/JAD-191321.
    PubMed     Abstract available


  498. RACINE AM, Touroutoglou A, Abrantes T, Wong B, et al
    Older Patients with Alzheimer's Disease-Related Cortical Atrophy Who Develop Post-Operative Delirium May Be at Increased Risk of Long-Term Cognitive Decline After Surgery.
    J Alzheimers Dis. 2020 Apr 1. pii: JAD190380. doi: 10.3233/JAD-190380.
    PubMed     Abstract available


    March 2020
  499. CHUANG YF, Varma V, An Y, Tanaka T, et al
    Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
    J Alzheimers Dis. 2020 Mar 31. pii: JAD191335. doi: 10.3233/JAD-191335.
    PubMed     Abstract available


  500. ROBINSON RL, Rentz DM, Andrews JS, Zagar A, et al
    Costs of Early Stage Alzheimer's Disease in the United States: Cross-Sectional Analysis of a Prospective Cohort Study (GERAS-US)1.
    J Alzheimers Dis. 2020 Mar 31. pii: JAD191212. doi: 10.3233/JAD-191212.
    PubMed     Abstract available


  501. PEREIRA MLGF, Camargo MVZA, Bellan AFR, Tahira AC, et al
    Visual Search Efficiency in Mild Cognitive Impairment and Alzheimer's Disease: An Eye Movement Study.
    J Alzheimers Dis. 2020 Mar 31. pii: JAD190690. doi: 10.3233/JAD-190690.
    PubMed     Abstract available


  502. HARRISON JR, Mistry S, Muskett N, Escott-Price V, et al
    From Polygenic Scores to Precision Medicine in Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2020 Mar 30. pii: JAD191233. doi: 10.3233/JAD-191233.
    PubMed     Abstract available


  503. LUCHSINGER JA, Palta P, Rippon B, Soto L, et al
    Sex Differences in in vivo Alzheimer's Disease Neuropathology in Late Middle-Aged Hispanics.
    J Alzheimers Dis. 2020 Mar 30. pii: JAD191183. doi: 10.3233/JAD-191183.
    PubMed     Abstract available


  504. FEINKOHL I, Schipke CG, Kruppa J, Menne F, et al
    Plasma Amyloid Concentration in Alzheimer's Disease: Performance of a High-Throughput Amyloid Assay in Distinguishing Alzheimer's Disease Cases from Controls.
    J Alzheimers Dis. 2020 Mar 11. pii: JAD200046. doi: 10.3233/JAD-200046.
    PubMed     Abstract available


  505. COUNIL H, Krantic S
    Synaptic Activity and (Neuro)Inflammation in Alzheimer's Disease: Could Exosomes be an Additional Link?
    J Alzheimers Dis. 2020 Mar 11. pii: JAD191237. doi: 10.3233/JAD-191237.
    PubMed     Abstract available


  506. YANG HJ, Kang NR, Jung YE, Kim MD, et al
    "Choosing Wisely": Apolipoprotein E Genetic Testing for the Diagnosis of Alzheimer's Disease in Dementia Clinics.
    J Alzheimers Dis. 2020 Mar 11. pii: JAD190983. doi: 10.3233/JAD-190983.
    PubMed     Abstract available


  507. OESTERHUS R, Dalen I, Bergland AK, Aarsland D, et al
    Risk of Hospitalization in Patients with Alzheimer's Disease and Lewy Body Dementia: Time to and Length of Stay.
    J Alzheimers Dis. 2020 Mar 5. pii: JAD191141. doi: 10.3233/JAD-191141.
    PubMed     Abstract available


  508. TERRERA GM, Harrison JE, Ritchie CW, Ritchie K, et al
    Cognitive Functions as Predictors of Alzheimer's Disease Biomarker Status in the European Prevention of Alzheimer's Dementia Cohort.
    J Alzheimers Dis. 2020 Mar 5. pii: JAD191108. doi: 10.3233/JAD-191108.
    PubMed     Abstract available


  509. IHARA M, Saito S
    Drug Repositioning for Alzheimer's Disease: Finding Hidden Clues in Old Drugs.
    J Alzheimers Dis. 2020 Mar 3. pii: JAD200049. doi: 10.3233/JAD-200049.
    PubMed     Abstract available


  510. ASCHENBRENNER AJ, Gordon BA, Fagan AM, Schindler SE, et al
    Neurofilament Light Predicts Decline in Attention but Not Episodic Memory in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2020 Mar 2. pii: JAD200018. doi: 10.3233/JAD-200018.
    PubMed     Abstract available


  511. MEHDER RH, Bennett BM, Andrew RD
    Morphometric Analysis of Hippocampal and Neocortical Pyramidal Neurons in a Mouse Model of Late Onset Alzheimer's Disease.
    J Alzheimers Dis. 2020 Mar 2. pii: JAD191067. doi: 10.3233/JAD-191067.
    PubMed     Abstract available


  512. WISCH JK, Roe CM, Babulal GM, Schindler SE, et al
    Resting State Functional Connectivity Signature Differentiates Cognitively Normal from Individuals Who Convert to Symptomatic Alzheimer's Disease.
    J Alzheimers Dis. 2020 Mar 2. pii: JAD191039. doi: 10.3233/JAD-191039.
    PubMed     Abstract available


    February 2020
  513. ZHANG H, Wang T, Han Z, Wang L, et al
    Impact of Vitamin D Binding Protein Levels on Alzheimer's Disease: A Mendelian Randomization Study.
    J Alzheimers Dis. 2020 Feb 27. pii: JAD191051. doi: 10.3233/JAD-191051.
    PubMed     Abstract available


  514. TOMASZEWSKI N, He X, Solomon V, Lee M, et al
    Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial.
    J Alzheimers Dis. 2020 Feb 27. pii: JAD191017. doi: 10.3233/JAD-191017.
    PubMed     Abstract available


  515. MARIANO LI, Caramelli P, Guimaraes HC, Gambogi LB, et al
    Can Social Cognition Measurements Differentiate Behavioral Variant Frontotemporal Dementia from Alzheimer's Disease Regardless of Apathy?
    J Alzheimers Dis. 2020 Feb 27. pii: JAD190861. doi: 10.3233/JAD-190861.
    PubMed     Abstract available


  516. POPOVAC A, Mladenovic I, Krunic J, Trifkovic B, et al
    Apolipoprotein E4 Allele and Dental Occlusion Deficiency as Risk Factors for Alzheimer's Disease.
    J Alzheimers Dis. 2020 Feb 25. pii: JAD191283. doi: 10.3233/JAD-191283.
    PubMed     Abstract available


  517. ARNALDI D, Donniaquio A, Mattioli P, Massa F, et al
    Epilepsy in Neurodegenerative Dementias: A Clinical, Epidemiological, and EEG Study.
    J Alzheimers Dis. 2020 Feb 25. pii: JAD191315. doi: 10.3233/JAD-191315.
    PubMed     Abstract available


  518. KAPOOR A, Bartha R, Black SE, Borrie M, et al
    Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 Ye
    J Alzheimers Dis. 2020 Feb 24. pii: JAD191097. doi: 10.3233/JAD-191097.
    PubMed     Abstract available


  519. ATAYDE AL, Fischer CE, Schweizer TA, Munoz DG, et al
    Neuropsychiatric Inventory-Assessed Nighttime Behavior Accompanies, but Does Not Precede, Progressive Cognitive Decline Independent of Alzheimer's Disease Histopathology.
    J Alzheimers Dis. 2020 Feb 22. pii: JAD190907. doi: 10.3233/JAD-190907.
    PubMed     Abstract available


  520. SILVA D, Cardoso S, Guerreiro M, Maroco J, et al
    Neuropsychological Contribution to Predict Conversion to Dementia in Patients with Mild Cognitive Impairment Due to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Feb 20. pii: JAD191133. doi: 10.3233/JAD-191133.
    PubMed     Abstract available


  521. TEIMOURI E, Rainey-Smith SR, Bharadwaj P, Verdile G, et al
    Amla Therapy as a Potential Modulator of Alzheimer's Disease Risk Factors and Physiological Change.
    J Alzheimers Dis. 2020 Feb 17. pii: JAD191033. doi: 10.3233/JAD-191033.
    PubMed     Abstract available


  522. OKAFOR M, Nye JA, Shokouhi M, Shaw L, et al
    18F-Flortaucipir PET Associations with Cerebrospinal Fluid, Cognition, and Neuroimaging in Mild Cognitive Impairment due to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Feb 12. pii: JAD191330. doi: 10.3233/JAD-191330.
    PubMed     Abstract available


  523. CIPOLLARI E, Szapary HJ, Picataggi A, Billheimer JT, et al
    Correlates and Predictors of Cerebrospinal Fluid Cholesterol Efflux Capacity from Neural Cells, a Family of Biomarkers for Cholesterol Epidemiology in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Feb 11. pii: JAD191246. doi: 10.3233/JAD-191246.
    PubMed     Abstract available


  524. PATEL H, Iniesta R, Stahl D, Dobson RJB, et al
    Working Towards a Blood-Derived Gene Expression Biomarker Specific for Alzheimer's Disease.
    J Alzheimers Dis. 2020 Feb 11. pii: JAD191163. doi: 10.3233/JAD-191163.
    PubMed     Abstract available


  525. TONIOLO S, Serra L, Olivito G, Caltagirone C, et al
    Cerebellar White Matter Disruption in Alzheimer's Disease Patients: A Diffusion Tensor Imaging Study.
    J Alzheimers Dis. 2020 Feb 10. pii: JAD191125. doi: 10.3233/JAD-191125.
    PubMed     Abstract available


  526. LIGUORI C, Spanetta M, Izzi F, Franchini F, et al
    Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation.
    J Alzheimers Dis. 2020 Feb 10. pii: JAD191124. doi: 10.3233/JAD-191124.
    PubMed     Abstract available


  527. JAMES HJ, Van Houtven CH, Lippmann S, Burke JR, et al
    How Accurately Do Patients and Their Care Partners Report Results of Amyloid-beta PET Scans for Alzheimer's Disease Assessment?
    J Alzheimers Dis. 2020 Feb 10. pii: JAD190922. doi: 10.3233/JAD-190922.
    PubMed     Abstract available


  528. BHARADWAJ P, Martins RN
    PRKAG2 Gene Expression Is Elevated and its Protein Levels Are Associated with Increased Amyloid-beta Accumulation in the Alzheimer's Disease Brain.
    J Alzheimers Dis. 2020 Feb 6. pii: JAD190948. doi: 10.3233/JAD-190948.
    PubMed     Abstract available


  529. TOBEY H, Lucas T, Paul S, Berr SS, et al
    Mechanoceutics Alters Alzheimer's Disease Phenotypes in Transgenic Rats: A Pilot Study.
    J Alzheimers Dis. 2020 Feb 5. pii: JAD191071. doi: 10.3233/JAD-191071.
    PubMed     Abstract available


  530. CEYZERIAT K, Tournier BB, Millet P, Frisoni GB, et al
    Low-Dose Radiation Therapy: A New Treatment Strategy for Alzheimer's Disease?
    J Alzheimers Dis. 2020 Feb 5. pii: JAD190984. doi: 10.3233/JAD-190984.
    PubMed     Abstract available


  531. GOLDWASER EL, Acharya NK, Wu H, Godsey GA, et al
    Evidence that Brain-Reactive Autoantibodies Contribute to Chronic Neuronal Internalization of Exogenous Amyloid-beta1-42 and Key Cell Surface Proteins During Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2020 Feb 5. pii: JAD190962. doi: 10.3233/JAD-190962.
    PubMed     Abstract available


  532. WHITWELL JL, Tosakulwong N, Weigand SD, Graff-Radford J, et al
    Longitudinal Amyloid-beta PET in Atypical Alzheimer's Disease and Frontotemporal Lobar Degeneration.
    J Alzheimers Dis. 2020 Feb 5. pii: JAD190699. doi: 10.3233/JAD-190699.
    PubMed     Abstract available


  533. MARTINS TS, Magalhaes S, Rosa IM, Vogelgsang J, et al
    Potential of FTIR Spectroscopy Applied to Exosomes for Alzheimer's Disease Discrimination: A Pilot Study.
    J Alzheimers Dis. 2020 Feb 3. pii: JAD191034. doi: 10.3233/JAD-191034.
    PubMed     Abstract available


    January 2020
  534. JAASKELAINEN O, Hall A, Tiainen M, van Gils M, et al
    Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 28. pii: JAD191226. doi: 10.3233/JAD-191226.
    PubMed     Abstract available


  535. YANG H, Wang W, Jia L, Qin W, et al
    The Effect of Chronic Cerebral Hypoperfusion on Blood-Brain Barrier Permeability in a Transgenic Alzheimer's Disease Mouse Model (PS1V97L).
    J Alzheimers Dis. 2020 Jan 28. pii: JAD191045. doi: 10.3233/JAD-191045.
    PubMed     Abstract available


  536. MALEK-AHMADI M, Perez SE, Chen K, Mufson EJ, et al
    Braak Stage, Cerebral Amyloid Angiopathy, and Cognitive Decline in Early Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 24. pii: JAD191151. doi: 10.3233/JAD-191151.
    PubMed     Abstract available


  537. MENDES FR, Leclerc JL, Liu L, Kamat PK, et al
    Effect of Experimental Ischemic Stroke and PGE2 EP1 Selective Antagonism in Alzheimer's Disease Mouse Models.
    J Alzheimers Dis. 2020 Jan 24. pii: JAD191069. doi: 10.3233/JAD-191069.
    PubMed     Abstract available


  538. WESTWOOD S, Baird AL, Anand SN, Nevado-Holgado AJ, et al
    Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
    J Alzheimers Dis. 2020 Jan 22. pii: JAD190434. doi: 10.3233/JAD-190434.
    PubMed     Abstract available


  539. JIA J, Wei C, Chen W, Jia L, et al
    Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 21. pii: JAD190940. doi: 10.3233/JAD-190940.
    PubMed     Abstract available


  540. DOREY JM, Rouch I, Padovan C, Boublay N, et al
    Neuroticism-Withdrawal and Neuroticism-Volatility Differently Influence the Risk of Neuropsychiatric Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 20. pii: JAD190884. doi: 10.3233/JAD-190884.
    PubMed     Abstract available


  541. EZZATI A, Lipton RB
    Machine Learning Predictive Models Can Improve Efficacy of Clinical Trials for Alzheimer's Disease1,2.
    J Alzheimers Dis. 2020 Jan 20. pii: JAD190822. doi: 10.3233/JAD-190822.
    PubMed     Abstract available


  542. BEYER L, Brendel M, Scheiwein F, Sauerbeck J, et al
    Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-beta Positron Emission Tomography.
    J Alzheimers Dis. 2020 Jan 20. pii: JAD190818. doi: 10.3233/JAD-190818.
    PubMed     Abstract available


  543. NAKANISHI M, Igarashi A, Ueda K, Brnabic AJM, et al
    Costs and Resource Use Associated with Community-Dwelling Patients with Alzheimer's Disease in Japan: Baseline Results from the Prospective Observational GERAS-J Study.
    J Alzheimers Dis. 2020 Jan 19. pii: JAD190811. doi: 10.3233/JAD-190811.
    PubMed     Abstract available


  544. RAUCHMANN BS, Sadlon A, Perneczky R
    Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal Fluid.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD191120. doi: 10.3233/JAD-191120.
    PubMed     Abstract available


  545. WONG D, Atiya S, Fogarty J, Montero-Odasso M, et al
    Reduced Hippocampal Glutamate and Posterior Cingulate N-Acetyl Aspartate in Mild Cognitive Impairment and Alzheimer's Disease Is Associated with Episodic Memory Performance and White Matter Integrity in the Cingulum: A Pilot Study.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190773. doi: 10.3233/JAD-190773.
    PubMed     Abstract available


  546. COEBERGH JAF, McDowell S, van Woerkom TCAM, Koopman JP, et al
    Auditory Agnosia for Environmental Sounds in Alzheimer's Disease: Not Hearing and Not Listening?
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190431. doi: 10.3233/JAD-190431.
    PubMed     Abstract available


  547. FERNANDO WMADB, Martins IJ, Morici M, Bharadwaj P, et al
    Sodium Butyrate Reduces Brain Amyloid-beta Levels and Improves Cognitive Memory Performance in an Alzheimer's Disease Transgenic Mouse Model at an Early Disease Stage.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190120. doi: 10.3233/JAD-190120.
    PubMed     Abstract available


  548. MOLD M, Linhart C, Gomez-Ramirez J, Villegas-Lanau A, et al
    Aluminum and Amyloid-beta in Familial Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD191140. doi: 10.3233/JAD-191140.
    PubMed     Abstract available


  549. FAURA J, Bustamante A, Penalba A, Giralt D, et al
    CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190753. doi: 10.3233/JAD-190753.
    PubMed     Abstract available


  550. HASHIGUCHI D, Campos HC, Wuo-Silva R, Faber J, et al
    Resistance Exercise Decreases Amyloid Load and Modulates Inflammatory Responses in the APP/PS1 Mouse Model for Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190729. doi: 10.3233/JAD-190729.
    PubMed     Abstract available


  551. PLANTON M, Saint-Aubert L, Raposo N, Payoux P, et al
    Florbetapir Regional Distribution in Cerebral Amyloid Angiopathy and Alzheimer's Disease: A PET Study.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190625. doi: 10.3233/JAD-190625.
    PubMed     Abstract available


  552. ONO K, Zhao D, Wu Q, Simon J, et al
    Pine Bark Polyphenolic Extract Attenuates Amyloid-beta and Tau Misfolding in a Model System of Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190543. doi: 10.3233/JAD-190543.
    PubMed     Abstract available


  553. PRIKHODKO O, Rynearson KD, Sekhon T, Mante MM, et al
    The GSM BPN-15606 as a Potential Candidate for Preventative Therapy in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190442. doi: 10.3233/JAD-190442.
    PubMed     Abstract available


  554. TUZZI E, Balla DZ, Loureiro JRA, Neumann M, et al
    Ultra-High Field MRI in Alzheimer's Disease: Effective Transverse Relaxation Rate and Quantitative Susceptibility Mapping of Human Brain In Vivo and Ex Vivo Compared to Histology.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD190424. doi: 10.3233/JAD-190424.
    PubMed     Abstract available


  555. FALGAS N, Balasa M, Bargallo N, Borrego-Ecija S, et al
    Diagnostic Accuracy of MRI Visual Rating Scales in the Diagnosis of Early Onset Cognitive Impairment.
    J Alzheimers Dis. 2020 Jan 13. pii: JAD191167. doi: 10.3233/JAD-191167.
    PubMed     Abstract available


  556. BUCIUC M, Wennberg AM, Weigand SD, Murray ME, et al
    Effect Modifiers of TDP-43 Associated Hippocampal Atrophy Rates in Patients with Alzheimer's Disease Neuropathological Changes.
    J Alzheimers Dis. 2020 Jan 9. pii: JAD191040. doi: 10.3233/JAD-191040.
    PubMed     Abstract available


  557. CHINTAPALUDI SR, Uyar A, Jackson HM, Acklin CJ, et al
    Staging Alzheimer's Disease in the Brain and Retina of B6.APP/PS1 Mice by Transcriptional Profiling.
    J Alzheimers Dis. 2020 Jan 9. pii: JAD190793. doi: 10.3233/JAD-190793.
    PubMed     Abstract available


  558. ZHAO T, Quan M, Jia J
    Functional Connectivity of Default Mode Network Subsystems in the Presymptomatic Stage of Autosomal Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 6. pii: JAD191065. doi: 10.3233/JAD-191065.
    PubMed     Abstract available


  559. XU C, Apostolova LG, Oblak AL, Gao S, et al
    Association of Hypercholesterolemia with Alzheimer's Disease Pathology and Cerebral Amyloid Angiopathy.
    J Alzheimers Dis. 2020 Jan 6. pii: JAD191023. doi: 10.3233/JAD-191023.
    PubMed     Abstract available


  560. ANO Y, Ohya R, Takaichi Y, Washinuma T, et al
    beta-Lactolin, a Whey-Derived Lacto-Tetrapeptide, Prevents Alzheimer's Disease Pathologies and Cognitive Decline.
    J Alzheimers Dis. 2020 Jan 6. pii: JAD190997. doi: 10.3233/JAD-190997.
    PubMed     Abstract available


  561. MELENDEZ JC, Satorres E, Oliva I
    Comparing the Effect of Interference on an Emotional Stroop Task in Older Adults with and without Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 6. pii: JAD190989. doi: 10.3233/JAD-190989.
    PubMed     Abstract available


  562. DEVYATKIN VA, Redina OE, Kolosova NG, Muraleva NA, et al
    Single-Nucleotide Polymorphisms Associated with the Senescence-Accelerated Phenotype of OXYS Rats: A Focus on Alzheimer's Disease-Like and Age-Related-Macular-Degeneration-Like Pathologies.
    J Alzheimers Dis. 2020 Jan 6. pii: JAD190956. doi: 10.3233/JAD-190956.
    PubMed     Abstract available


  563. ALZUBAIDI H, Saidawi W, Hussein A, Hasan S, et al
    Critical Role of Pharmacists in Caring for Alzheimer's Disease Patients.
    J Alzheimers Dis. 2020 Jan 2. pii: JAD190804. doi: 10.3233/JAD-190804.
    PubMed     Abstract available


  564. GIIL LM, Aarsland D
    Greater Variability in Cognitive Decline in Lewy Body Dementia Compared to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 2. pii: JAD190731. doi: 10.3233/JAD-190731.
    PubMed     Abstract available


  565. PALMER JC, Tayler HM, Dyer L, Kehoe PG, et al
    Zibotentan, an Endothelin Alzheimer's Disease Receptor Antagonist, Prevents Amyloid-beta-Induced Hypertension and Maintains Cerebral Perfusion.
    J Alzheimers Dis. 2020 Jan 2. pii: JAD190630. doi: 10.3233/JAD-190630.
    PubMed     Abstract available


  566. BOUBLAY N, Bouet R, Dorey JM, Padovan C, et al
    Brain Volume Predicts Behavioral and Psychological Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 2. pii: JAD190612. doi: 10.3233/JAD-190612.
    PubMed     Abstract available


  567. TURCHETTA CS, De Simone MS, Perri R, Fadda L, et al
    Forgetting Rates on the Recency Portion of a Word List Predict Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 2. pii: JAD190509. doi: 10.3233/JAD-190509.
    PubMed     Abstract available


  568. LAMPELA P, Tolppanen AM, Koponen M, Tanskanen A, et al
    Asthma and Chronic Obstructive Pulmonary Disease as a Comorbidity and Association with the Choice of Antidementia Medication Among Persons with Alzheimer's Disease.
    J Alzheimers Dis. 2020 Jan 2. pii: JAD190850. doi: 10.3233/JAD-190850.
    PubMed     Abstract available



  569. Post-Transcriptional Regulation of Soluble Guanylate Cyclase that Governs Neuropathic Pain in Alzheimer's Disease.
    J Alzheimers Dis. 2020;74:407.
    PubMed    


  570. KUHN AJ, Raskatov J
    Is the p3 Peptide (Abeta17-40, Abeta17-42) Relevant to the Pathology of Alzheimer's Disease?1.
    J Alzheimers Dis. 2020;74:43-53.
    PubMed     Abstract available



  571. The Impact of Antiplatelet Use on the Risk of Intracerebral Hemorrhage in Patients with Alzheimer's Disease: A Nationwide Cohort Study.
    J Alzheimers Dis. 2020;74:1011.
    PubMed    



  572. Post-Transcriptional Regulation of Soluble Guanylate Cyclase that Governs Neuropathic Pain in Alzheimer's Disease.
    J Alzheimers Dis. 2020;74:407.
    PubMed    


  573. HATADA Y, Hashimoto M, Shiraishi S, Ishikawa T, et al
    Cerebral Microbleeds Are Associated with Cerebral Hypoperfusion in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2020;75:361.
    PubMed    



  574. Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2020;75:683.
    PubMed    


  575. PERRY G
    Alzheimer's Disease Patients in the Crosshairs of COVID-19.
    J Alzheimers Dis. 2020;76:1.
    PubMed    



  576. Christin Nance, B.A, and Sarah Banks, Ph.D., recipients of the 2019 Alzheimer Award.
    J Alzheimers Dis. 2020;76:443-444.
    PubMed    


  577. ONO K, Zhao D, Wu Q, Simon J, et al
    Pine Bark Polyphenolic Extract Attenuates Amyloid-beta and Tau Misfolding in a Model System of Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2020;77:457.
    PubMed    



  578. The Impact of Antiplatelet Use on the Risk of Intracerebral Hemorrhage in Patients with Alzheimer's Disease: A Nationwide Cohort Study.
    J Alzheimers Dis. 2020;74:1011.
    PubMed    


  579. HAMILTON RKB, Phelan CH, Chin NA, Wyman MF, et al
    The U-ARE Protocol: A Pragmatic Approach to Decisional Capacity Assessment for Clinical Research.
    J Alzheimers Dis. 2020;73:431-442.
    PubMed     Abstract available


  580. WANG YL, Chen W, Cai WJ, Hu H, et al
    Associations of White Matter Hyperintensities with Cognitive Decline: A Longitudinal Study.
    J Alzheimers Dis. 2020;73:759-768.
    PubMed     Abstract available


  581. ECKERSTROM C, Eckerstrom M, Gothlin M, Molinder A, et al
    Characteristic Biomarker and Cognitive Profile in Incipient Mixed Dementia.
    J Alzheimers Dis. 2020;73:597-607.
    PubMed     Abstract available


  582. REIMAND J, Groot C, Teunissen CE, Windhorst AD, et al
    Why Is Amyloid-beta PET Requested After Performing CSF Biomarkers?
    J Alzheimers Dis. 2020;73:559-569.
    PubMed     Abstract available


  583. ROBINSON AC, Chew-Graham S, Davidson YS, Horan MA, et al
    A Comparative Study of Pathological Outcomes in The University of Manchester Longitudinal Study of Cognition in Normal Healthy Old Age and Brains for Dementia Research Cohorts.
    J Alzheimers Dis. 2020;73:619-632.
    PubMed     Abstract available


  584. KLINEDINST BS, Le ST, Larsen B, Pappas C, et al
    Genetic Factors of Alzheimer's Disease Modulate How Diet is Associated with Long-Term Cognitive Trajectories: A UK Biobank Study.
    J Alzheimers Dis. 2020;78:1245-1257.
    PubMed     Abstract available


  585. ZHANG Y, Hao Y, Li L, Xia K, et al
    A Novel Computational Proxy for Characterizing Cognitive Reserve in Alzheimer's Disease.
    J Alzheimers Dis. 2020;78:1217-1228.
    PubMed     Abstract available


  586. SRIVASTAVA A, Das B, Yao AY, Yan R, et al
    Metabotropic Glutamate Receptors in Alzheimer's Disease Synaptic Dysfunction: Therapeutic Opportunities and Hope for the Future.
    J Alzheimers Dis. 2020;78:1345-1361.
    PubMed     Abstract available


  587. LIU N, Sun J, Wang X, Zhao M, et al
    The Impact of Dementia on the Clinical Outcome of COVID-19: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2020;78:1775-1782.
    PubMed     Abstract available


  588. KRESGE HA, Liu D, Gupta DK, Moore EE, et al
    Lower Left Ventricular Ejection Fraction Relates to Cerebrospinal Fluid Biomarker Evidence of Neurodegeneration in Older Adults.
    J Alzheimers Dis. 2020;74:965-974.
    PubMed     Abstract available


  589. WATT G, Shang K, Zieba J, Olaya J, et al
    Chronic Treatment with 50 mg/kg Cannabidiol Improves Cognition and Moderately Reduces Abeta40 Levels in 12-Month-Old Male AbetaPPswe/PS1DeltaE9 Transgenic Mice.
    J Alzheimers Dis. 2020;74:937-950.
    PubMed     Abstract available


  590. GRONTVEDT GR, Lauridsen C, Berge G, White LR, et al
    The Amyloid, Tau, and Neurodegeneration (A/T/N) Classification Applied to a Clinical Research Cohort with Long-Term Follow-Up.
    J Alzheimers Dis. 2020;74:829-837.
    PubMed     Abstract available


  591. RICHARDSON K, Wharton SB, Grossi CM, Matthews FE, et al
    Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug Use.
    J Alzheimers Dis. 2020;74:999-1009.
    PubMed     Abstract available


  592. ZHANG J, Hua XF, Gu J, Chen F, et al
    High Mobility Group Box 1 Ameliorates Cognitive Impairment in the 3xTg-AD Mouse Model.
    J Alzheimers Dis. 2020;74:851-864.
    PubMed     Abstract available


  593. SUNDSTROM A, Sorman DE, Hansson P, Ljungberg JK, et al
    Mental Demands at Work and Risk of Dementia.
    J Alzheimers Dis. 2020;74:735-740.
    PubMed     Abstract available


  594. BREWER GJ, Herrera RA, Philipp S, Sosna J, et al
    Age-Related Intraneuronal Aggregation of Amyloid-beta in Endosomes, Mitochondria, Autophagosomes, and Lysosomes.
    J Alzheimers Dis. 2020;73:229-246.
    PubMed     Abstract available


  595. VERGOUW LJM, Bosman B, van de Beek M, Salome M, et al
    Family History is Associated with Phenotype in Dementia with Lewy Bodies.
    J Alzheimers Dis. 2020;73:269-275.
    PubMed     Abstract available


  596. ARFANAKIS K, Evia AM, Leurgans SE, Cardoso LFC, et al
    Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.
    J Alzheimers Dis. 2020;73:333-345.
    PubMed     Abstract available


  597. TSUNODA K, Yamashita T, Osakada Y, Sasaki R, et al
    Early Emergence of Neuropsychiatric Symptoms in Cognitively Normal Subjects and Mild Cognitive Impairment.
    J Alzheimers Dis. 2020;73:209-215.
    PubMed     Abstract available


  598. DAVIDOWITZ EJ, Krishnamurthy PK, Lopez P, Jimenez H, et al
    In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice.
    J Alzheimers Dis. 2020;73:147-161.
    PubMed     Abstract available


  599. PARVAND M, Rankin CH
    Is There a Shared Etiology of Olfactory Impairments in Normal Aging and Neurodegenerative Disease?
    J Alzheimers Dis. 2020;73:1-21.
    PubMed     Abstract available


    December 2019
  600. LIU H, Reynolds GP, Wei X
    Uric Acid and High-Density Lipoprotein Cholesterol Are Differently Associated with Alzheimer's Disease and Vascular Dementia.
    J Alzheimers Dis. 2019 Dec 26. pii: JAD191111. doi: 10.3233/JAD-191111.
    PubMed     Abstract available


  601. ZUPANIC E, Kramberger MG, von Euler M, Norrving B, et al
    Secondary Stroke Prevention After Ischemic Stroke in Patients with Alzheimer's Disease and Other Dementia Disorders.
    J Alzheimers Dis. 2019 Dec 26. pii: JAD191011. doi: 10.3233/JAD-191011.
    PubMed     Abstract available


  602. MUSA G, Slachevsky A, Munoz-Neira C, Mendez C, et al
    Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia? Review of Key Points Toward an Accurate Clinical and Neuropsychological Diagnosis.
    J Alzheimers Dis. 2019 Dec 26. pii: JAD190924. doi: 10.3233/JAD-190924.
    PubMed     Abstract available


  603. SUN M, Ma K, Wen J, Wang G, et al
    A Review of the Brain-Gut-Microbiome Axis and the Potential Role of Microbiota in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Dec 26. pii: JAD190872. doi: 10.3233/JAD-190872.
    PubMed     Abstract available


  604. CHAMBERLAIN S, Gabriel H, Strittmatter W, Didsbury J, et al
    An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2019 Dec 26. pii: JAD190864. doi: 10.3233/JAD-190864.
    PubMed     Abstract available


  605. COGLIATI S, Clementi V, Francisco M, Crespo C, et al
    Bacillus Subtilis Delays Neurodegeneration and Behavioral Impairment in the Alzheimer's Disease Model Caenorhabditis Elegans.
    J Alzheimers Dis. 2019 Dec 26. pii: JAD190837. doi: 10.3233/JAD-190837.
    PubMed     Abstract available


  606. FISCHER CE, Ismail Z, Youakim JM, Creese B, et al
    Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research.
    J Alzheimers Dis. 2019 Dec 26. pii: JAD190828. doi: 10.3233/JAD-190828.
    PubMed     Abstract available



  607. The Italian INTERCEPTOR Project: From the Early Identification of Patients Eligible for Prescription of Antidementia Drugs to a Nationwide Organizational Model for Early Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2019 Dec 23. pii: JAD199670. doi: 10.3233/JAD-199670.
    PubMed    


  608. YASSI N, Hilal S, Xia Y, Lim YY, et al
    Influence of Comorbidity of Cerebrovascular Disease and Amyloid-beta on Alzheimer's Disease.
    J Alzheimers Dis. 2019 Dec 23. pii: JAD191028. doi: 10.3233/JAD-191028.
    PubMed     Abstract available


  609. KHATIB T, Chisholm DR, Whiting A, Platt B, et al
    Decay in Retinoic Acid Signaling in Varied Models of Alzheimer's Disease and In-Vitro Test of Novel Receptor Acid Receptor Ligands (RAR-Ms) to Regulate Protective Genes.
    J Alzheimers Dis. 2019 Dec 23. pii: JAD190931. doi: 10.3233/JAD-190931.
    PubMed     Abstract available


  610. LIU Y, Wang H
    Modeling Sporadic Alzheimer's Disease by Efficient Direct Reprogramming of the Elderly Derived Disease Dermal Fibroblasts into Neural Stem Cells.
    J Alzheimers Dis. 2019 Dec 23. pii: JAD190614. doi: 10.3233/JAD-190614.
    PubMed     Abstract available


  611. SUN R, Wang H, Shi Y, Sun Z, et al
    Changes in the Morphology, Number, and Pathological Protein Levels of Plasma Exosomes May Help Diagnose Alzheimer's Disease.
    J Alzheimers Dis. 2019 Dec 23. pii: JAD190497. doi: 10.3233/JAD-190497.
    PubMed     Abstract available


  612. GOTHLIN M, Eckerstrom M, Lindwall M, Rolstad S, et al
    Latent Cognitive Profiles Differ Between Incipient Alzheimer's Disease and Dementia with Subcortical Vascular Lesions in a Memory Clinic Population.
    J Alzheimers Dis. 2019 Dec 17. pii: JAD190515. doi: 10.3233/JAD-190515.
    PubMed     Abstract available


  613. VAN HAVRE Z, Maruff P, Villemagne V, Mengersen K, et al
    Identification of Pre-Clinical Alzheimer's Disease in a Population of Elderly Cognitively Normal Participants.
    J Alzheimers Dis. 2019 Dec 16. pii: JAD191095. doi: 10.3233/JAD-191095.
    PubMed     Abstract available


  614. CHEN Y, Lin C, Guo Z, Zhao S, et al
    Altered Expression Profile of Phosphatidylinositols in Erythrocytes of Alzheimer's Disease and Amnestic Mild Cognitive Impairment Patients.
    J Alzheimers Dis. 2019 Dec 16. pii: JAD190926. doi: 10.3233/JAD-190926.
    PubMed     Abstract available


  615. KOULOUSAKIS P, van den Hove D, Visser-Vandewalle V, Sesia T, et al
    Cognitive Improvements After Intermittent Deep Brain Stimulation of the Nucleus Basalis of Meynert in a Transgenic Rat Model for Alzheimer's Disease: A Preliminary Approach.
    J Alzheimers Dis. 2019 Dec 16. pii: JAD190919. doi: 10.3233/JAD-190919.
    PubMed     Abstract available


  616. WILSON EN, Do Carmo S, Welikovitch LA, Hall H, et al
    NP03, a Microdose Lithium Formulation, Blunts Early Amyloid Post-Plaque Neuropathology in McGill-R-Thy1-APP Alzheimer-Like Transgenic Rats.
    J Alzheimers Dis. 2019 Dec 16. pii: JAD190862. doi: 10.3233/JAD-190862.
    PubMed     Abstract available


  617. CHUNG SJ, Jeon S, Yoo HS, Lee YH, et al
    Neural Correlates of Cognitive Performance in Alzheimer's Disease- and Lewy Bodies-Related Cognitive Impairment.
    J Alzheimers Dis. 2019 Dec 16. pii: JAD190814. doi: 10.3233/JAD-190814.
    PubMed     Abstract available


  618. WANG X, Sun Y, Li T, Cai Y, et al
    Amyloid-beta as a Blood Biomarker for Alzheimer's Disease: A Review of Recent Literature.
    J Alzheimers Dis. 2019 Dec 16. pii: JAD190714. doi: 10.3233/JAD-190714.
    PubMed     Abstract available


  619. ALBARET G, Sifre E, Floch P, Laye S, et al
    Alzheimer's Disease and Helicobacter pylori Infection: Inflammation from Stomach to Brain?
    J Alzheimers Dis. 2019 Dec 16. pii: JAD190496. doi: 10.3233/JAD-190496.
    PubMed     Abstract available


  620. ROGERS NK, Romero C, SanMartin CD, Ponce DP, et al
    Inverse Relationship Between Alzheimer's Disease and Cancer: How Immune Checkpoints Might Explain the Mechanisms Underlying Age-Related Diseases.
    J Alzheimers Dis. 2019 Dec 9. pii: JAD190839. doi: 10.3233/JAD-190839.
    PubMed     Abstract available


  621. FANI L, Hilal S, Sedaghat S, Broer L, et al
    Telomere Length and the Risk of Alzheimer's Disease: The Rotterdam Study.
    J Alzheimers Dis. 2019 Dec 9. pii: JAD190759. doi: 10.3233/JAD-190759.
    PubMed     Abstract available


  622. ITZHAKI RF
    A Turning Point in Alzheimer's Disease: Microbes Matter.
    J Alzheimers Dis. 2019 Dec 2. pii: JAD191171. doi: 10.3233/JAD-191171.
    PubMed    


  623. HE JT, Zhao X, Xu L, Mao CY, et al
    Vascular Risk Factors and Alzheimer's Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links.
    J Alzheimers Dis. 2019 Dec 2. pii: JAD190764. doi: 10.3233/JAD-190764.
    PubMed     Abstract available


  624. WANG L, Qiao Y, Zhang H, Zhang Y, et al
    Circulating Vitamin D Levels and Alzheimer's Disease: A Mendelian Randomization Study in the IGAP and UK Biobank.
    J Alzheimers Dis. 2019 Dec 2. pii: JAD190713. doi: 10.3233/JAD-190713.
    PubMed     Abstract available


  625. EMRANI S, Lamar M, Price CC, Wasserman V, et al
    Alzheimer's/Vascular Spectrum Dementia: Classification in Addition to Diagnosis.
    J Alzheimers Dis. 2019 Dec 2. pii: JAD190654. doi: 10.3233/JAD-190654.
    PubMed     Abstract available


  626. YOON B, Choi SH, Jeong JH, Park KW, et al
    Balance and Mobility Performance Along the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2019 Dec 2. pii: JAD190601. doi: 10.3233/JAD-190601.
    PubMed     Abstract available


    November 2019
  627. FRANCIS N, Robison LS, Popescu DL, Michaelos M, et al
    Voluntary Wheel Running Reduces Amyloid-beta42 and Rescues Behavior in Aged Tg2576 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 25. pii: JAD190810. doi: 10.3233/JAD-190810.
    PubMed     Abstract available


  628. SCHNAIDER L, Arnon Z, Gazit E
    Reevaluating the Microbial Infection Link to Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 25. pii: JAD190765. doi: 10.3233/JAD-190765.
    PubMed     Abstract available


  629. BOUJI M, Lecomte A, Gamez C, Blazy K, et al
    Impact of Cerebral Radiofrequency Exposures on Oxidative Stress and Corticosterone in a Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 25. pii: JAD190593. doi: 10.3233/JAD-190593.
    PubMed     Abstract available


  630. CHEN H, Liang L, Xu H, Xu J, et al
    Short Term Exposure to Bilirubin Induces Encephalopathy Similar to Alzheimer's Disease in Late Life.
    J Alzheimers Dis. 2019 Nov 23. pii: JAD190945. doi: 10.3233/JAD-190945.
    PubMed     Abstract available


  631. AGCA C, Klakotskaia D, Stopa EG, Schachtman TR, et al
    Ovariectomy Influences Cognition and Markers of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 23. pii: JAD190935. doi: 10.3233/JAD-190935.
    PubMed     Abstract available


  632. BASTRUP J, Kastaniegaard K, Asuni AA, Volbracht C, et al
    Proteomic and Unbiased Post-Translational Modification Profiling of Amyloid Plaques and Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 21. pii: JAD190652. doi: 10.3233/JAD-190652.
    PubMed     Abstract available


  633. AGARWAL P, Brockman JD, Wang Y, Schneider JA, et al
    Brain Bromine Levels Associated with Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2019 Nov 21. pii: JAD190646. doi: 10.3233/JAD-190646.
    PubMed     Abstract available


  634. SONG S, Chen J, Xiao P, Duan H, et al
    Role of Macrophages in Status Epilepticus Predisposing to Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 20. pii: JAD190994. doi: 10.3233/JAD-190994.
    PubMed     Abstract available


  635. KURODA E, Takata K, Nishimura K, Oka H, et al
    Peripheral Blood-Derived Microglia-Like Cells Decrease Amyloid-beta Burden and Ameliorate Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 20. pii: JAD190974. doi: 10.3233/JAD-190974.
    PubMed     Abstract available


  636. WADA-ISOE K, Kikuchi T, Umeda-Kameyama Y, Mori T, et al
    ABC Dementia Scale Classifies Alzheimer's Disease Patients into Subgroups Characterized by Activities of Daily Living, Behavioral and Psychological Symptoms of Dementia, and Cognitive Function.
    J Alzheimers Dis. 2019 Nov 19. pii: JAD190767. doi: 10.3233/JAD-190767.
    PubMed     Abstract available


  637. YEH TS, Wang JD, Ku LJ
    Estimating Life Expectancy and Lifetime Healthcare Costs for Alzheimer's Disease in Taiwan: Does the Age of Disease Onset Matter?
    J Alzheimers Dis. 2019 Nov 19. pii: JAD181060. doi: 10.3233/JAD-181060.
    PubMed     Abstract available


  638. ABE K, Shang J, Shi X, Yamashita T, et al
    A New Serum Biomarker Set to Detect Mild Cognitive Impairment and Alzheimer's Disease by Peptidome Technology.
    J Alzheimers Dis. 2019 Nov 18. pii: JAD191016. doi: 10.3233/JAD-191016.
    PubMed     Abstract available


  639. IMAI M, Tanaka M, Sakata M, Wagatsuma K, et al
    Metabolic Network Topology of Alzheimer's Disease and Dementia with Lewy Bodies Generated Using Fluorodeoxyglucose Positron Emission Tomography.
    J Alzheimers Dis. 2019 Nov 18. pii: JAD190843. doi: 10.3233/JAD-190843.
    PubMed     Abstract available


  640. LEE TL, Liu CH, Chang YM, Lin TY, et al
    The Impact of Antiplatelet Use on the Risk of Intracerebral Hemorrhage in Patients with Alzheimer's Disease: A Nationwide Cohort Study.
    J Alzheimers Dis. 2019 Nov 18. pii: JAD190762. doi: 10.3233/JAD-190762.
    PubMed     Abstract available


  641. BABIC LEKO M, Nikolac Perkovic M, Klepac N, Svob Strac D, et al
    Relationships of Cerebrospinal Fluid Alzheimer's Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms.
    J Alzheimers Dis. 2019 Nov 16. pii: JAD190991. doi: 10.3233/JAD-190991.
    PubMed     Abstract available


  642. SHIMIZU S, Takenoshita N, Inagawa Y, Tsugawa A, et al
    Positive Association Between Cognitive Function and Cerebrospinal Fluid Orexin A Levels in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190958. doi: 10.3233/JAD-190958.
    PubMed     Abstract available


  643. YARE K, Woodward M
    Hormone Therapy and Effects on Sporadic Alzheimer's Disease in Postmenopausal Women: Importance of Nomenclature.
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190896. doi: 10.3233/JAD-190896.
    PubMed     Abstract available


  644. CIOFFI F, Adam RHI, Broersen K
    Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190863. doi: 10.3233/JAD-190863.
    PubMed     Abstract available


  645. HEGDE V, Dhurandhar NV, Reddy PH
    Hyperinsulinemia or Insulin Resistance: What Impacts the Progression of Alzheimer's Disease?
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190808. doi: 10.3233/JAD-190808.
    PubMed     Abstract available


  646. JIA J, Ji Y, Feng T, Ye Q, et al
    Sixteen-Week Interventional Study to Evaluate the Clinical Effects and Safety of Rivastigmine Capsules in Chinese Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190791. doi: 10.3233/JAD-190791.
    PubMed     Abstract available


  647. DEFRANCESCO M, Marksteiner J, Kemmler G, Dal-Bianco P, et al
    Specific Neuropsychiatric Symptoms Are Associated with Faster Progression in Alzheimer's Disease: Results of the Prospective Dementia Registry (PRODEM-Austria).
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190662. doi: 10.3233/JAD-190662.
    PubMed     Abstract available


  648. GARCIA-SEGURA ME, Fischer CE, Schweizer TA, Munoz DG, et al
    APOE varepsilon4/varepsilon4 Is Associated with Aberrant Motor Behavior Through Both Lewy Body and Cerebral Amyloid Angiopathy Pathology in High Alzheimer's Disease Pathological Load.
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190643. doi: 10.3233/JAD-190643.
    PubMed     Abstract available


  649. NEWKIRK LA, Dao VL, Jordan JT, Alving LI, et al
    Factors Associated with Supportive Care Service Use Among California Alzheimer's Disease Patients and Their Caregivers.
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190438. doi: 10.3233/JAD-190438.
    PubMed     Abstract available


  650. LIECHTI C, Caviezel MP, Muller S, Reichert CF, et al
    Correlation Between Hippocampal Volume and Autobiographical Memory Depending on Retrieval Frequency in Healthy Individuals and Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2019 Nov 11. pii: JAD190047. doi: 10.3233/JAD-190047.
    PubMed     Abstract available


  651. ALI F, Baringer SL, Neal A, Choi EY, et al
    Parvalbumin-Positive Neuron Loss and Amyloid-beta Deposits in the Frontal Cortex of Alzheimer's Disease-Related Mice.
    J Alzheimers Dis. 2019 Nov 11. pii: JAD181190. doi: 10.3233/JAD-181190.
    PubMed     Abstract available


  652. ULAMEK-KOZIOL M, Czuczwar SJ, Kocki J, Januszewski S, et al
    Dysregulation of Autophagy, Mitophagy, and Apoptosis Genes in the CA3 Region of the Hippocampus in the Ischemic Model of Alzheimer's Disease in the Rat.
    J Alzheimers Dis. 2019 Nov 7. pii: JAD190966. doi: 10.3233/JAD-190966.
    PubMed     Abstract available


  653. ORDING AG, Veres K, Horvath-Puho E, Glymour MM, et al
    Alzheimer's and Parkinson's Diseases and the Risk of Cancer: A Cohort Study.
    J Alzheimers Dis. 2019 Nov 7. pii: JAD190867. doi: 10.3233/JAD-190867.
    PubMed     Abstract available


    October 2019
  654. ABDULLAH M, Kimura N, Akatsu H, Hashizume Y, et al
    Flotillin is a Novel Diagnostic Blood Marker of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190908. doi: 10.3233/JAD-190908.
    PubMed     Abstract available


  655. POZUETA A, Lage C, Garcia-Martinez M, Kazimierczak M, et al
    Cognitive and Behavioral Profiles of Left and Right Semantic Dementia: Differential Diagnosis with Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190877. doi: 10.3233/JAD-190877.
    PubMed     Abstract available


  656. AL RIHANI SB, Lan RS, Kaddoumi A
    Granisetron Alleviates Alzheimer's Disease Pathology in TgSwDI Mice Through Calmodulin-Dependent Protein Kinase II/cAMP-Response Element Binding Protein Pathway.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190849. doi: 10.3233/JAD-190849.
    PubMed     Abstract available


  657. GATT A, Whitfield DR, Ballard C, Doherty P, et al
    Alzheimer's Disease Progression in the 5xFAD Mouse Captured with a Multiplex Gene Expression Array.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190805. doi: 10.3233/JAD-190805.
    PubMed     Abstract available


  658. WANG ZJ, Zhao F, Wang CF, Zhang XM, et al
    Xestospongin C, a Reversible IP3 Receptor Antagonist, Alleviates the Cognitive and Pathological Impairments in APP/PS1 Mice of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190796. doi: 10.3233/JAD-190796.
    PubMed     Abstract available


  659. CHRISTL J, Verhulsdonk S, Pessanha F, Menge T, et al
    Association of Cerebrospinal Fluid S100B Protein with Core Biomarkers and Cognitive Deficits in Prodromal and Mild Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190550. doi: 10.3233/JAD-190550.
    PubMed     Abstract available


  660. MASSA F, Farotti L, Eusebi P, Capello E, et al
    Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190539. doi: 10.3233/JAD-190539.
    PubMed     Abstract available


  661. DOWJAT K, Adayev T, Wojda U, Brzozowska K, et al
    Abnormalities of DYRK1A-Cytoskeleton Complexes in the Blood Cells as Potential Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 29. pii: JAD190475. doi: 10.3233/JAD-190475.
    PubMed     Abstract available



  662. Abeta42/Abeta40 and Abeta42/Abeta38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2019 Oct 21. pii: JAD199010. doi: 10.3233/JAD-199010.
    PubMed    



  663. Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study.
    J Alzheimers Dis. 2019 Oct 21. pii: JAD199009. doi: 10.3233/JAD-199009.
    PubMed    


  664. SCHELTER BO, Shiells H, Baddeley TC, Rubino CM, et al
    Concentration-Dependent Activity of Hydromethylthionine on Cognitive Decline and Brain Atrophy in Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 21. pii: JAD190772. doi: 10.3233/JAD-190772.
    PubMed     Abstract available


  665. CLARK LR, Norton D, Berman SE, Johnson SC, et al
    Association of Cardiovascular and Alzheimer's Disease Risk Factors with Intracranial Arterial Blood Flow in Whites and African Americans.
    J Alzheimers Dis. 2019 Oct 21. pii: JAD190645. doi: 10.3233/JAD-190645.
    PubMed     Abstract available


  666. BOCCARDI V, Paolacci L, Remondini D, Giampieri E, et al
    Cognitive Decline and Alzheimer's Disease in Old Age: A Sex-Specific "Cytokinome Signature".
    J Alzheimers Dis. 2019 Oct 21. pii: JAD190480. doi: 10.3233/JAD-190480.
    PubMed     Abstract available


  667. FUCHSBERGER T, Yuste R, Martinez-Bellver S, Blanco-Gandia MC, et al
    Oral Monosodium Glutamate Administration Causes Early Onset of Alzheimer's Disease-Like Pathophysiology in APP/PS1 Mice.
    J Alzheimers Dis. 2019 Oct 21. pii: JAD190274. doi: 10.3233/JAD-190274.
    PubMed     Abstract available


  668. POPTSI E, Tsardoulias E, Moraitou D, Symeonidis AL, et al
    REMEDES for Alzheimer-R4Alz Battery: Design and Development of a New Tool of Cognitive Control Assessment for the Diagnosis of Minor and Major Neurocognitive Disorders.
    J Alzheimers Dis. 2019 Oct 18. pii: JAD190798. doi: 10.3233/JAD-190798.
    PubMed     Abstract available


  669. PATHAK GA, Silzer TK, Sun J, Zhou Z, et al
    Genome-Wide Methylation of Mild Cognitive Impairment in Mexican Americans Highlights Genes Involved in Synaptic Transport, Alzheimer's Disease-Precursor Phenotypes, and Metabolic Morbidities.
    J Alzheimers Dis. 2019 Oct 18. pii: JAD190634. doi: 10.3233/JAD-190634.
    PubMed     Abstract available


  670. WAN Y, Liang Y, Liang F, Shen N, et al
    A Curcumin Analog Reduces Levels of the Alzheimer's Disease-Associated Amyloid-beta Protein by Modulating AbetaPP Processing and Autophagy.
    J Alzheimers Dis. 2019 Oct 17. pii: JAD190562. doi: 10.3233/JAD-190562.
    PubMed     Abstract available


  671. NITZAN K, Benhamron S, Valitsky M, Kesner E, et al
    Mitochondrial Transfer Ameliorates Cognitive Deficits, Neuronal Loss, and Gliosis in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2019 Oct 14. pii: JAD190853. doi: 10.3233/JAD-190853.
    PubMed     Abstract available


  672. ELSHATOURY H, Avots E, Anbarjafari G
    Volumetric Histogram-Based Alzheimer's Disease Detection Using Support Vector Machine.
    J Alzheimers Dis. 2019 Oct 9. pii: JAD190704. doi: 10.3233/JAD-190704.
    PubMed     Abstract available


  673. TURRIZIANI P, Smirni D, Mangano GR, Zappala G, et al
    Low-Frequency Repetitive Transcranial Magnetic Stimulation of the Right Dorsolateral Prefrontal Cortex Enhances Recognition Memory in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 8. pii: JAD190888. doi: 10.3233/JAD-190888.
    PubMed     Abstract available


  674. TIAN J, Wang T, Wang Q, Guo L, et al
    MK0677, a Ghrelin Mimetic Improves Neurogenesis but Fails to Prevent Hippocampal Lesions in a Mouse Model of Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190779. doi: 10.3233/JAD-190779.
    PubMed     Abstract available


  675. KEHOE PG, Al Mulhim N, Zetterberg H, Blennow K, et al
    Cerebrospinal Fluid Changes in the Renin-Angiotensin System in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190721. doi: 10.3233/JAD-190721.
    PubMed     Abstract available


  676. ROSSINI PM, Cappa SF, Lattanzio F, Perani D, et al
    The Italian INTERCEPTOR Project: From the Early Identification of Patients Eligible for Prescription of Antidementia Drugs to a Nationwide Organizational Model for Early Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190670. doi: 10.3233/JAD-190670.
    PubMed     Abstract available


  677. AULSTON B, Liu Q, Mante M, Florio J, et al
    Extracellular Vesicles Isolated from Familial Alzheimer's Disease Neuronal Cultures Induce Aberrant Tau Phosphorylation in the Wild-Type Mouse Brain.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190656. doi: 10.3233/JAD-190656.
    PubMed     Abstract available


  678. LIU XX, Jiao B, Liao XX, Guo LN, et al
    Analysis of Salivary Microbiome in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190587. doi: 10.3233/JAD-190587.
    PubMed     Abstract available


  679. ZHOU G, Zhao X, Lou Z, Zhou S, et al
    Impaired Cerebral Autoregulation in Alzheimer's Disease: A Transcranial Doppler Study.
    J Alzheimers Dis. 2019 Oct 3. pii: JAD190296. doi: 10.3233/JAD-190296.
    PubMed     Abstract available


  680. GOLDSTEIN FC, Loring DW, Thomas T, Saleh S, et al
    Recognition Memory Performance as a Cognitive Marker of Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2019 Oct 1. pii: JAD190468. doi: 10.3233/JAD-190468.
    PubMed     Abstract available


  681. TEIPEL SJ, Kuper-Smith JO, Bartels C, Brosseron F, et al
    Multicenter Tract-Based Analysis of Microstructural Lesions within the Alzheimer's Disease Spectrum: Association with Amyloid Pathology and Diagnostic Usefulness.
    J Alzheimers Dis. 2019 Oct 1. pii: JAD190446. doi: 10.3233/JAD-190446.
    PubMed     Abstract available


    September 2019
  682. LIU X, Hebron ML, Mulki S, Wang C, et al
    Ubiquitin Specific Protease 13 Regulates Tau Accumulation and Clearance in Models of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 28. pii: JAD190635. doi: 10.3233/JAD-190635.
    PubMed     Abstract available


  683. KANG DE, Woo JA
    Cofilin, a Master Node Regulating Cytoskeletal Pathogenesis in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 25. pii: JAD190585. doi: 10.3233/JAD-190585.
    PubMed     Abstract available


  684. PALEY EL
    Discovery of Gut Bacteria Specific to Alzheimer's Associated Diseases is a Clue to Understanding Disease Etiology: Meta-Analysis of Population-Based Data on Human Gut Metagenomics and Metabolomics.
    J Alzheimers Dis. 2019 Sep 24. pii: JAD190873. doi: 10.3233/JAD-190873.
    PubMed     Abstract available


  685. MORSY A, Trippier PC
    Current and Emerging Pharmacological Targets for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 24. pii: JAD190744. doi: 10.3233/JAD-190744.
    PubMed     Abstract available


  686. WANG Q, Jiang H, Wang L, Yi H, et al
    Vitegnoside Mitigates Neuronal Injury, Mitochondrial Apoptosis, and Inflammation in an Alzheimer's Disease Cell Model via the p38 MAPK/JNK Pathway.
    J Alzheimers Dis. 2019 Sep 23. pii: JAD190640. doi: 10.3233/JAD-190640.
    PubMed     Abstract available


  687. JINGAMI N, Uemura K, Asada M, Kuzuya A, et al
    Two-Point Dynamic Observation of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2019 Sep 20. pii: JAD190775. doi: 10.3233/JAD-190775.
    PubMed     Abstract available


  688. CHOU PS, Wu MN, Yang CC, Shen CT, et al
    Effect of Advanced Glycation End Products on the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 20. pii: JAD190639. doi: 10.3233/JAD-190639.
    PubMed     Abstract available


  689. ZYSK M, Clausen F, Aguilar X, Sehlin D, et al
    Long-Term Effects of Traumatic Brain Injury in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 20. pii: JAD190572. doi: 10.3233/JAD-190572.
    PubMed     Abstract available


  690. AMLIE-WOLF A, Tang M, Way J, Dombroski B, et al
    Inferring the Molecular Mechanisms of Noncoding Alzheimer's Disease-Associated Genetic Variants.
    J Alzheimers Dis. 2019 Sep 20. pii: JAD190568. doi: 10.3233/JAD-190568.
    PubMed     Abstract available


  691. ROBINSON RL, Rentz DM, Bruemmer V, Andrews JS, et al
    Observation of Patient and Caregiver Burden Associated with Early Alzheimer's Disease in the United States: Design and Baseline Findings of the GERAS-US Cohort Study1.
    J Alzheimers Dis. 2019 Sep 20. pii: JAD190430. doi: 10.3233/JAD-190430.
    PubMed     Abstract available


  692. CASTORA FJ, Conyers BL, Gershon BS, Kerns KA, et al
    The T9861C Mutation in the mtDNA-Encoded Cytochrome C Oxidase Subunit III Gene Occurs in High Frequency but with Unequal Distribution in the Alzheimer's Disease Brain.
    J Alzheimers Dis. 2019 Sep 20. pii: JAD190176. doi: 10.3233/JAD-190176.
    PubMed     Abstract available


  693. SNOWDEN SG, Ebshiana AA, Hye A, Pletnikova O, et al
    Neurotransmitter Imbalance in the Brain and Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2019 Sep 19. pii: JAD190577. doi: 10.3233/JAD-190577.
    PubMed     Abstract available


  694. PANG RQ, Wang XF, Pei FF, Zhang W, et al
    Regular Exercise Enhances Cognitive Function and Intracephalic GLUT Expression in Alzheimer's Disease Model Mice.
    J Alzheimers Dis. 2019 Sep 18. pii: JAD190328. doi: 10.3233/JAD-190328.
    PubMed     Abstract available


  695. THUNELL J, Ferido P, Zissimopoulos J
    Measuring Alzheimer's Disease and Other Dementias in Diverse Populations Using Medicare Claims Data.
    J Alzheimers Dis. 2019 Sep 12. pii: JAD190310. doi: 10.3233/JAD-190310.
    PubMed     Abstract available


  696. RALBOVSKY NM, Halamkova L, Wall K, Anderson-Hanley C, et al
    Screening for Alzheimer's Disease Using Saliva: A New Approach Based on Machine Learning and Raman Hyperspectroscopy.
    J Alzheimers Dis. 2019 Sep 11. pii: JAD190675. doi: 10.3233/JAD-190675.
    PubMed     Abstract available


  697. XU H, Yue C, Chen L
    Post-Transcriptional Regulation of Soluble Guanylate Cyclase that Governs Neuropathic Pain in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 10. pii: JAD190743. doi: 10.3233/JAD-190743.
    PubMed     Abstract available


  698. HASHIMOTO M, Yamazaki A, Ohno A, Kimura T, et al
    A Fragment of S38AA is a Novel Plasma Biomarker of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 10. pii: JAD190700. doi: 10.3233/JAD-190700.
    PubMed     Abstract available


  699. KUMAR S, Reddy PH
    A New Discovery of MicroRNA-455-3p in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 10. pii: JAD190583. doi: 10.3233/JAD-190583.
    PubMed     Abstract available


  700. ROUCH I, Padovan C, Pongan E, Boublay N, et al
    Personality Traits are Related to Selective Cognitive Impairment in Early Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 9. pii: JAD190459. doi: 10.3233/JAD-190459.
    PubMed     Abstract available


  701. LI Y, Kang M, Wang H, Jin H, et al
    Urinary Alzheimer-Associated Neuronal Thread Protein is not Elevated in Patients with Subjective Cognitive Decline and Patients with Depressive State.
    J Alzheimers Dis. 2019 Sep 9. pii: JAD190401. doi: 10.3233/JAD-190401.
    PubMed     Abstract available


  702. LINNA M, Vuoti S, Silander K, Horhammer I, et al
    Impact of Anti-Dementia Medication on the Risk of Death and Causes of Death in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 6. pii: JAD190288. doi: 10.3233/JAD-190288.
    PubMed     Abstract available


  703. GUO Z, Peng X, Li HY, Wang Y, et al
    Evaluation of Peripheral Immune Dysregulation in Alzheimer's Disease and Vascular Dementia.
    J Alzheimers Dis. 2019 Sep 5. pii: JAD190666. doi: 10.3233/JAD-190666.
    PubMed     Abstract available


  704. LUIKKU AJ, Hall A, Nerg O, Koivisto AM, et al
    Predicting Development of Alzheimer's Disease in Patients with Shunted Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2019 Sep 5. pii: JAD190334. doi: 10.3233/JAD-190334.
    PubMed     Abstract available


  705. PATRA K, Giannisis A, Edlund AK, Sando SB, et al
    Plasma Apolipoprotein E Monomer and Dimer Profile and Relevance to Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 3. pii: JAD190175. doi: 10.3233/JAD-190175.
    PubMed     Abstract available


  706. CHANTELOUP G, Cordonnier M, Moreno-Ramos T, Pytel V, et al
    Exosomal HSP70 for Monitoring of Frontotemporal Dementia and Alzheimer's Disease: Clinical and FDG-PET Correlation.
    J Alzheimers Dis. 2019 Sep 3. pii: JAD190545. doi: 10.3233/JAD-190545.
    PubMed     Abstract available


  707. YOKOYAMA S, Yoshinaga T, Matsuzaki J, Suzuki H, et al
    A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Teprenone in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2019 Sep 3. pii: JAD190305. doi: 10.3233/JAD-190305.
    PubMed     Abstract available


    August 2019
  708. MOSS DE
    Is Combining an Anticholinergic with a Cholinesterase Inhibitor a Good Strategy for High-Level CNS Cholinesterase Inhibition?
    J Alzheimers Dis. 2019 Aug 27. pii: JAD190626. doi: 10.3233/JAD-190626.
    PubMed     Abstract available


  709. ELMALEH DR, Farlow MR, Conti PS, Tompkins RG, et al
    Developing Effective Alzheimer's Disease Therapies: Clinical Experience and Future Directions.
    J Alzheimers Dis. 2019 Aug 27. pii: JAD190507. doi: 10.3233/JAD-190507.
    PubMed     Abstract available


  710. EZZATI A, Zammit AR, Harvey DJ, Habeck C, et al
    Optimizing Machine Learning Methods to Improve Predictive Models of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Aug 27. pii: JAD190262. doi: 10.3233/JAD-190262.
    PubMed     Abstract available


  711. SCHLEGEL P, Novotny M, Klimova B, Valis M, et al
    "Muscle-Gut-Brain Axis": Can Physical Activity Help Patients with Alzheimer's Disease Due to Microbiome Modulation?
    J Alzheimers Dis. 2019 Aug 24. pii: JAD190460. doi: 10.3233/JAD-190460.
    PubMed     Abstract available


  712. CHARIL A, Shcherbinin S, Southekal S, Devous MD, et al
    Tau Subtypes of Alzheimer's Disease Determined in vivo Using Flortaucipir PET Imaging.
    J Alzheimers Dis. 2019 Aug 24. pii: JAD190264. doi: 10.3233/JAD-190264.
    PubMed     Abstract available


  713. WIEST I, Wiemers T, Kraus MJ, Neeb H, et al
    Multivariate Platelet Analysis Differentiates Between Patients with Alzheimer's Disease and Healthy Controls at First Clinical Diagnosis.
    J Alzheimers Dis. 2019 Aug 23. pii: JAD190574. doi: 10.3233/JAD-190574.
    PubMed     Abstract available


  714. ANDRE P, Samieri C, Buisson C, Dartigues JF, et al
    Lipopolysaccharide-Binding Protein, Soluble CD14, and the Long-Term Risk of Alzheimer's Disease: A Nested Case-Control Pilot Study of Older Community Dwellers from the Three-City Cohort.
    J Alzheimers Dis. 2019 Aug 23. pii: JAD190295. doi: 10.3233/JAD-190295.
    PubMed     Abstract available


  715. MONTERO-ODASSO M, Perry G
    Gait Disorders in Alzheimer's Disease and Other Dementias: There is Something in the Way You Walk.
    J Alzheimers Dis. 2019 Aug 23. pii: JAD190790. doi: 10.3233/JAD-190790.
    PubMed    


  716. HUSEBY CJ, Hoffman CN, Cooper GL, Cocuron JC, et al
    Quantification of Tau Protein Lysine Methylation in Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2019 Aug 22. pii: JAD190604. doi: 10.3233/JAD-190604.
    PubMed     Abstract available


  717. MAYELLE A, El Haj M, Antoine P
    Awareness of Self and Disease Assessment: Development and Validation of a Subjective Measure in People with Alzheimer's Disease.
    J Alzheimers Dis. 2019 Aug 20. pii: JAD190371. doi: 10.3233/JAD-190371.
    PubMed     Abstract available


  718. RAMASUBRAMANIAN B, Reddy PH
    Are TallyHo Mice A True Mouse Model for Type 2 Diabetes and Alzheimer's Disease?
    J Alzheimers Dis. 2019 Aug 16. pii: JAD190613. doi: 10.3233/JAD-190613.
    PubMed     Abstract available


  719. CHATTERJEE P, Elmi M, Goozee K, Shah T, et al
    Ultrasensitive Detection of Plasma Amyloid-beta as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Aug 16. pii: JAD190533. doi: 10.3233/JAD-190533.
    PubMed     Abstract available


  720. PEDRINOLLA A, Tamburin S, Brasioli A, Sollima A, et al
    An Indoor Therapeutic Garden for Behavioral Symptoms in Alzheimer's Disease: A Randomized Controlled Trial.
    J Alzheimers Dis. 2019 Aug 16. pii: JAD190394. doi: 10.3233/JAD-190394.
    PubMed     Abstract available


  721. STIRLAND LE, Russ TC, Ritchie CW, Muniz-Terrera G, et al
    Associations Between Multimorbidity and Cerebrospinal Fluid Amyloid: A Cross-Sectional Analysis of the European Prevention of Alzheimer's Dementia (EPAD) V500.0 Cohort.
    J Alzheimers Dis. 2019 Aug 16. pii: JAD190222. doi: 10.3233/JAD-190222.
    PubMed     Abstract available


  722. PAVLIK VN, Chan W, Darby E
    Cohort Effects in Progression Rate on Cognitive and Functional Measures in an Alzheimer's Disease Clinical Cohort.
    J Alzheimers Dis. 2019 Aug 14. pii: JAD190661. doi: 10.3233/JAD-190661.
    PubMed     Abstract available


  723. SHOWRAKI A, Murari G, Ismail Z, Barfett JJ, et al
    Cerebrospinal Fluid Correlates of Neuropsychiatric Symptoms in Patients with Alzheimer's Disease/Mild Cognitive Impairment: A Systematic Review.
    J Alzheimers Dis. 2019 Aug 14. pii: JAD190365. doi: 10.3233/JAD-190365.
    PubMed     Abstract available


  724. SUPASITTHUMRONG T, Tunvirachaisakul C, Aniwattanapong D, Tangwongchai S, et al
    Peripheral Blood Biomarkers Coupled with the Apolipoprotein E4 Genotype Are Strongly Associated with Semantic and Episodic Memory Impairments in Elderly Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2019 Aug 14. pii: JAD190114. doi: 10.3233/JAD-190114.
    PubMed     Abstract available


  725. HOBEL Z, Isenberg AL, Raghupathy D, Mack W, et al
    APOE varepsilon4 Gene Dose and Sex Effects on Alzheimer's Disease MRI Biomarkers in Older Adults with Mild Cognitive Impairment.
    J Alzheimers Dis. 2019 Aug 14. pii: JAD180859. doi: 10.3233/JAD-180859.
    PubMed     Abstract available


  726. PIRKER-KEES A, Dal-Bianco P, Schmidt R
    Effects of Psychotropic Medication on Cognition, Caregiver Burden, and Neuropsychiatric Symptoms in Alzheimer's Disease over 12 Months: Results from a Prospective Registry of Dementia in Austria (PRODEM).
    J Alzheimers Dis. 2019 Aug 13. pii: JAD181102. doi: 10.3233/JAD-181102.
    PubMed     Abstract available


  727. LAURENS B, Planche V, Cubizolle S, Declerck L, et al
    A Spatial Decision Eye-Tracking Task in Patients with Prodromal and Mild Alzheimer's Disease.
    J Alzheimers Dis. 2019;-1:1.
    PubMed     Abstract available


  728. MATSUNAGA S, Fujishiro H, Takechi H
    Efficacy and Safety of Cholinesterase Inhibitors for Mild Cognitive Impairment:A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2019;-1:1.
    PubMed     Abstract available


  729. FENG T, Yamashita T, Shang J, Shi X, et al
    Clinical and Pathological Benefits of Edaravone for Alzheimer's Disease with Chronic Cerebral Hypoperfusion in a Novel Mouse Model.
    J Alzheimers Dis. 2019 Aug 6. pii: JAD190369. doi: 10.3233/JAD-190369.
    PubMed     Abstract available


  730. ARENDASH G, Cao C, Abulaban H, Baranowski R, et al
    A Clinical Trial of Transcranial Electromagnetic Treatment in Alzheimer's Disease: Cognitive Enhancement and Associated Changes in Cerebrospinal Fluid, Blood, and Brain Imaging.
    J Alzheimers Dis. 2019 Aug 6. pii: JAD190367. doi: 10.3233/JAD-190367.
    PubMed     Abstract available


    July 2019
  731. ABBATE C, Trimarchi PD, Inglese S, Damanti S, et al
    Does the Right Focal Variant of Alzheimer's Disease Really Exist? A Literature Analysis.
    J Alzheimers Dis. 2019 Jul 31. pii: JAD190338. doi: 10.3233/JAD-190338.
    PubMed     Abstract available


  732. ATTIER-ZMUDKA J, Serot JM
    A Particularly Tragic Case of Possible Alzheimer's Disease, that of Marshal Petain.
    J Alzheimers Dis. 2019 Jul 31. pii: JAD190225. doi: 10.3233/JAD-190225.
    PubMed     Abstract available


  733. MAHER BA
    Airborne Magnetite- and Iron-Rich Pollution Nanoparticles: Potential Neurotoxicants and Environmental Risk Factors for Neurodegenerative Disease, Including Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jul 31. pii: JAD190204. doi: 10.3233/JAD-190204.
    PubMed     Abstract available


  734. LENNON MJ, Makkar SR, Crawford JD, Sachdev PS, et al
    Midlife Hypertension and Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2019 Jul 29. pii: JAD190474. doi: 10.3233/JAD-190474.
    PubMed     Abstract available


  735. OSBORN KE, Alverio JM, Dumitrescu L, Pechman KR, et al
    Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2019 Jul 26. pii: JAD190077. doi: 10.3233/JAD-190077.
    PubMed     Abstract available


  736. VILLALBA AC, Garcia J, Ramos C, Cuastumal AR, et al
    Mental Disorders in Young Adults from Families with the Presenilin-1 Gene Mutation E280A in the Preclinical Stage of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jul 26. pii: JAD181013. doi: 10.3233/JAD-181013.
    PubMed     Abstract available


  737. LACOUR M, Quenez O, Rovelet-Lecrux A, Salomon B, et al
    Causative Mutations and Genetic Risk Factors in Sporadic Early Onset Alzheimer's Disease Before 51 Years.
    J Alzheimers Dis. 2019 Jul 25. pii: JAD190193. doi: 10.3233/JAD-190193.
    PubMed     Abstract available


  738. TAKENOSHITA N, Shimizu S, Kanetaka H, Sakurai H, et al
    Classification of Clinically Diagnosed Alzheimer's Disease Associated with Diabetes Based on Amyloid and Tau PET Results.
    J Alzheimers Dis. 2019 Jul 23. pii: JAD190620. doi: 10.3233/JAD-190620.
    PubMed     Abstract available


  739. HATADA Y, Hashimoto M, Shiraishi S, Ishikawa T, et al
    Cerebral Microbleeds Are Associated with Cerebral Hypoperfusion in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jul 23. pii: JAD190272. doi: 10.3233/JAD-190272.
    PubMed     Abstract available


  740. DONG Y, Brewer GJ
    Global Metabolic Shifts in Age and Alzheimer's Disease Mouse Brains Pivot at NAD +/NADH Redox Sites.
    J Alzheimers Dis. 2019 Jul 22. pii: JAD190408. doi: 10.3233/JAD-190408.
    PubMed     Abstract available


  741. TUSTISON NJ, Holbrook AJ, Avants BB, Roberts JM, et al
    Longitudinal Mapping of Cortical Thickness Measurements: An Alzheimer's Disease Neuroimaging Initiative-Based Evaluation Study.
    J Alzheimers Dis. 2019 Jul 22. pii: JAD190283. doi: 10.3233/JAD-190283.
    PubMed     Abstract available


  742. MARTINEZ DE TODA I, Miguelez L, Vida C, Carro E, et al
    Altered Redox State in Whole Blood Cells from Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jul 22. pii: JAD190198. doi: 10.3233/JAD-190198.
    PubMed     Abstract available


  743. DEIBEL SH, Young B, Mohajerani MH, McDonald RJ, et al
    Activity Rhythms Are Largely Intact in APPNL-G-F Alzheimer's Disease Mice.
    J Alzheimers Dis. 2019 Jul 22. pii: JAD190102. doi: 10.3233/JAD-190102.
    PubMed     Abstract available


  744. JO H, Kim M, Park S, Park JE, et al
    Dopa Responsive Parkinsonism in an Early Onset Alzheimer's Disease Patient with a Presenilin 1 Mutation (A434T).
    J Alzheimers Dis. 2019 Jul 18. pii: JAD190469. doi: 10.3233/JAD-190469.
    PubMed     Abstract available


  745. NUDELMAN KNH, Lin J, Lane KA, Nho K, et al
    Telomere Shortening in the Alzheimer's Disease Neuroimaging Initiative Cohort.
    J Alzheimers Dis. 2019 Jul 18. pii: JAD190010. doi: 10.3233/JAD-190010.
    PubMed     Abstract available


  746. CALDERON-GARCIDUENAS L, Kulesza RJ, Mansour Y, Aiello-Mora M, et al
    Increased Gain in the Auditory Pathway, Alzheimer's Disease Continuum, and Air Pollution: Peripheral and Central Auditory System Dysfunction Evolves Across Pediatric and Adult Urbanites.
    J Alzheimers Dis. 2019 Jul 17. pii: JAD190405. doi: 10.3233/JAD-190405.
    PubMed     Abstract available


  747. RUTHIRAKUHAN M, Herrmann N, C Andreazza A, Verhoeff NPLG, et al
    24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer's Disease: Analyses from a Clinical Trial with Nabilone.
    J Alzheimers Dis. 2019 Jul 16. pii: JAD190202. doi: 10.3233/JAD-190202.
    PubMed     Abstract available


  748. MANJI Z, Rojas A, Wang W, Dingledine R, et al
    5xFAD Mice Display Sex-Dependent Inflammatory Gene Induction During the Prodromal Stage of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jul 15. pii: JAD180678. doi: 10.3233/JAD-180678.
    PubMed     Abstract available


  749. GUO Z, Ling Z, Li Y
    Detecting Alzheimer's Disease from Continuous Speech Using Language Models.
    J Alzheimers Dis. 2019 Jul 12. pii: JAD190452. doi: 10.3233/JAD-190452.
    PubMed     Abstract available


  750. EL HAJ M, Boudoukha A, Antoine P, Moustafa AA, et al
    Memories Supporting Myself: Autobiographical Memory Supports Self-Continuity in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jul 12. pii: JAD190440. doi: 10.3233/JAD-190440.
    PubMed     Abstract available


  751. KHOSRAVI M, Peter J, Wintering NA, Serruya M, et al
    18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis.
    J Alzheimers Dis. 2019 Jul 12. pii: JAD190220. doi: 10.3233/JAD-190220.
    PubMed     Abstract available


  752. LV X, Zhou D, Ge B, Chen H, et al
    Association of Folate Metabolites and Mitochondrial Function in Peripheral Blood Cells in Alzheimer's Disease: A Matched Case-Control Study.
    J Alzheimers Dis. 2019 Jul 11. pii: JAD190477. doi: 10.3233/JAD-190477.
    PubMed     Abstract available


  753. MENZEL LC, Kramer PW, A Groneberg D, Bendels MHK, et al
    Gender Disparities in Authorships of Alzheimer's Disease and Dementia Research Articles.
    J Alzheimers Dis. 2019 Jul 11. pii: JAD190216. doi: 10.3233/JAD-190216.
    PubMed     Abstract available


  754. PILLAI JA, Bonner-Jackson A, Bekris LM, Safar J, et al
    Highly Elevated Cerebrospinal Fluid Total Tau Level Reflects Higher Likelihood of Non-Amnestic Subtype of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jul 8. pii: JAD190519. doi: 10.3233/JAD-190519.
    PubMed     Abstract available


  755. PARODI-RULLAN R, Sone JY, Fossati S
    Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jul 8. pii: JAD190357. doi: 10.3233/JAD-190357.
    PubMed     Abstract available


  756. NANCE C, Ritter A, Miller JB, Lapin B, et al
    The Pathology of Rapid Cognitive Decline in Clinically Diagnosed Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jul 8. pii: JAD190302. doi: 10.3233/JAD-190302.
    PubMed     Abstract available


  757. CAUNCA MR, Simonetto M, Alperin N, Elkind MSV, et al
    Measures of Adiposity and Alzheimer's Disease-Related MRI Markers: The Northern Manhattan Study.
    J Alzheimers Dis. 2019 Jul 8. pii: JAD190092. doi: 10.3233/JAD-190092.
    PubMed     Abstract available


  758. KOSTEV K, Kurylo P, Kosik J, Jacob L, et al
    One-Year Persistence with Donepezil, Memantine, and Rivastigmine in More than 66,000 Elderly Patients Followed in Poland.
    J Alzheimers Dis. 2019 Jul 6. pii: JAD190508. doi: 10.3233/JAD-190508.
    PubMed     Abstract available


  759. PANDEY JP, Kothera RT, Liu S, Costa AS, et al
    Immunoglobulin Genes and Immunity to HSV1 in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jul 6. pii: JAD190265. doi: 10.3233/JAD-190265.
    PubMed     Abstract available


  760. ALM KH, Bakker A
    Relationships Between Diffusion Tensor Imaging and Cerebrospinal Fluid Metrics in Early Stages of the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2019 Jul 6. pii: JAD181210. doi: 10.3233/JAD-181210.
    PubMed     Abstract available


  761. TERRY N, Masliah A, Overk C, Masliah E, et al
    Remembering Robert D. Terry at a Time of Change in the World of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jul 5. pii: JAD190518. doi: 10.3233/JAD-190518.
    PubMed    


  762. NAZARIAN A, Kulminski AM
    Evaluation of the Genetic Variance of Alzheimer's Disease Explained by the Disease-Associated Chromosomal Regions.
    J Alzheimers Dis. 2019 Jul 5. pii: JAD190168. doi: 10.3233/JAD-190168.
    PubMed     Abstract available


  763. LOPEZ-GARCIA S, Jimenez-Bonilla J, Lopez Delgado A, Orizaola Balaguer P, et al
    A Rare PSEN1 (Leu85Pro) Mutation Causing Alzheimer's Disease in a 29-Year-Old Woman Presenting as Corticobasal Syndrome.
    J Alzheimers Dis. 2019 Jul 5. pii: JAD190107. doi: 10.3233/JAD-190107.
    PubMed     Abstract available


  764. GAGLIARDI G, Epelbaum S, Houot M, Bakardjian H, et al
    Which Episodic Memory Performance is Associated with Alzheimer's Disease Biomarkers in Elderly Cognitive Complainers? Evidence from a Longitudinal Observational Study with Four Episodic Memory Tests (Insight-PreAD).
    J Alzheimers Dis. 2019 Jul 5. pii: JAD180966. doi: 10.3233/JAD-180966.
    PubMed     Abstract available


  765. SCHAEFFER MJ, Callahan BL
    Investigating the Association Between Verbal Forgetting and Pathological Markers of Alzheimer's and Lewy Body Diseases.
    J Alzheimers Dis. 2019 Jul 5. pii: JAD180962. doi: 10.3233/JAD-180962.
    PubMed     Abstract available


  766. ZHU Y, Gong L, He C, Wang Q, et al
    Default Mode Network Connectivity Moderates the Relationship Between the APOE Genotype and Cognition and Individualizes Identification Across the Alzheimer's Disease Spectrum.
    J Alzheimers Dis. 2019 Jul 3. pii: JAD190254. doi: 10.3233/JAD-190254.
    PubMed     Abstract available


  767. ALVES C, Jorge L, Canario N, Santiago B, et al
    Interplay Between Macular Retinal Changes and White Matter Integrity in Early Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jul 3. pii: JAD190152. doi: 10.3233/JAD-190152.
    PubMed     Abstract available


    June 2019
  768. SAKAE N, Heckman MG, Vargas ER, Carrasquillo MM, et al
    Evaluation of Associations of Alzheimer's Disease Risk Variants that Are Highly Expressed in Microglia with Neuropathological Outcome Measures.
    J Alzheimers Dis. 2019 Jun 24. pii: JAD190451. doi: 10.3233/JAD-190451.
    PubMed     Abstract available


  769. EL-HAYEK YH, Wiley RE, Khoury CP, Daya RP, et al
    Tip of the Iceberg: Assessing the Global Socioeconomic Costs of Alzheimer's Disease and Related Dementias and Strategic Implications for Stakeholders.
    J Alzheimers Dis. 2019 Jun 24. pii: JAD190426. doi: 10.3233/JAD-190426.
    PubMed     Abstract available


  770. CALDERON-GARCIDUENAS L, Gonzalez-Maciel A, Kulesza RJ, Gonzalez-Gonzalez LO, et al
    Air Pollution, Combustion and Friction Derived Nanoparticles, and Alzheimer's Disease in Urban Children and Young Adults.
    J Alzheimers Dis. 2019 Jun 24. pii: JAD190331. doi: 10.3233/JAD-190331.
    PubMed     Abstract available


  771. BOMBA M, Granzotto A, Castelli V, Onofrj M, et al
    Exenatide Reverts the High-Fat-Diet-Induced Impairment of BDNF Signaling and Inflammatory Response in an Animal Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jun 24. pii: JAD190237. doi: 10.3233/JAD-190237.
    PubMed     Abstract available


  772. CUI Y, Dai S, Miao Z, Zhong Y, et al
    Reliability and Validity of the Chinese Version of the Mild Behavioral Impairment Checklist for Screening for Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jun 24. pii: JAD190113. doi: 10.3233/JAD-190113.
    PubMed     Abstract available


  773. ILOMAKI J, Fanning L, Keen C, Sluggett JK, et al
    Trends and Predictors of Oral Anticoagulant Use in People with Alzheimer's Disease and the General Population in Australia.
    J Alzheimers Dis. 2019 Jun 24. pii: JAD190094. doi: 10.3233/JAD-190094.
    PubMed     Abstract available


  774. MARTIN-MAESTRO P, Gargini R, Garcia E, Simon D, et al
    Mitophagy Failure in APP and Tau Overexpression Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jun 24. pii: JAD190086. doi: 10.3233/JAD-190086.
    PubMed     Abstract available


  775. JUN S, Kim H, Kim BS, Yoo BG, et al
    Quantitative Brain Amyloid Measures Predict Time-to-Progression from Amnestic Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jun 24. pii: JAD190070. doi: 10.3233/JAD-190070.
    PubMed     Abstract available


  776. BAUMAN J, Gibbons LE, Moore M, Mukherjee S, et al
    Associations Between Depression, Traumatic Brain Injury, and Cognitively-Defined Late-Onset Alzheimer's Disease Subgroups.
    J Alzheimers Dis. 2019 Jun 24. pii: JAD181212. doi: 10.3233/JAD-181212.
    PubMed     Abstract available


  777. TSUTSUMIMOTO K, Doi T, Nakakubo S, Kim M, et al
    Impact of Social Frailty on Alzheimer's Disease Onset: A 53-Month Longitudinal Cohort Study.
    J Alzheimers Dis. 2019 Jun 24. pii: JAD181178. doi: 10.3233/JAD-181178.
    PubMed     Abstract available


  778. DANI M, Wood M, Mizoguchi R, Fan Z, et al
    Tau Aggregation Correlates with Amyloid Deposition in Both Mild Cognitive Impairment and Alzheimer's Disease Subjects.
    J Alzheimers Dis. 2019 Jun 24. pii: JAD181168. doi: 10.3233/JAD-181168.
    PubMed     Abstract available


  779. PIRAS IS, Krate J, Delvaux E, Nolz J, et al
    Transcriptome Changes in the Alzheimer's Disease Middle Temporal Gyrus: Importance of RNA Metabolism and Mitochondria-Associated Membrane Genes.
    J Alzheimers Dis. 2019 Jun 24. pii: JAD181113. doi: 10.3233/JAD-181113.
    PubMed     Abstract available


  780. UDEH-MOMOH CT, Su B, Evans S, Zheng B, et al
    Cortisol, Amyloid-beta, and Reserve Predicts Alzheimer's Disease Progression for Cognitively Normal Older Adults.
    J Alzheimers Dis. 2019 Jun 24. pii: JAD181030. doi: 10.3233/JAD-181030.
    PubMed     Abstract available


  781. TANIGUCHI K, Yamamoto F, Arai T, Yang J, et al
    Tyrosol Reduces Amyloid-beta Oligomer Neurotoxicity and Alleviates Synaptic, Oxidative, and Cognitive Disturbances in Alzheimer's Disease Model Mice.
    J Alzheimers Dis. 2019 Jun 21. pii: JAD190098. doi: 10.3233/JAD-190098.
    PubMed     Abstract available


  782. MONACELLI F, Martella L, Parodi MN, Odetti P, et al
    Frontal Variant of Alzheimer's Disease: A Report of a Novel PSEN1 Mutation.
    J Alzheimers Dis. 2019 Jun 6. pii: JAD190363. doi: 10.3233/JAD-190363.
    PubMed     Abstract available


  783. ZAKIROVA EY, Chastukhina IB, Valeeva LR, Vorobev VV, et al
    Stable Co-Cultivation of the Moss Physcomitrella Patens with Human Cells in vitro as a New Approach to Support Metabolism of Diseased Alzheimer Cells.
    J Alzheimers Dis. 2019 Jun 6. pii: JAD190333. doi: 10.3233/JAD-190333.
    PubMed     Abstract available


  784. BLANKEN AE, Dutt S, Li Y, Nation DA, et al
    Disentangling Heterogeneity in Alzheimer's Disease: Two Empirically-Derived Subtypes.
    J Alzheimers Dis. 2019 Jun 6. pii: JAD190230. doi: 10.3233/JAD-190230.
    PubMed     Abstract available


  785. KELLY SC, McKay EC, Beck JS, Collier TJ, et al
    Locus Coeruleus Degeneration Induces Forebrain Vascular Pathology in a Transgenic Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jun 6. pii: JAD190090. doi: 10.3233/JAD-190090.
    PubMed     Abstract available


  786. TORT-MERINO A, Olives J, Leon M, Penaloza C, et al
    Tau Protein is Associated with Longitudinal Memory Decline in Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
    J Alzheimers Dis. 2019 Jun 6. pii: JAD190046. doi: 10.3233/JAD-190046.
    PubMed     Abstract available


  787. VAN DE BEEK M, van Steenoven I, Ramakers IHGB, Aalten P, et al
    Trajectories and Determinants of Quality of Life in Dementia with Lewy Bodies and Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jun 6. pii: JAD190041. doi: 10.3233/JAD-190041.
    PubMed     Abstract available


  788. VOROBYOV V, Bakharev B, Medvinskaya N, Nesterova I, et al
    Loss of Midbrain Dopamine Neurons and Altered Apomorphine EEG Effects in the 5xFAD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jun 6. pii: JAD181246. doi: 10.3233/JAD-181246.
    PubMed     Abstract available


  789. LIAN TH, Zhu WL, Li SW, Liu YO, et al
    Clinical, Structural, and Neuropathological Features of Olfactory Dysfunction in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jun 4. pii: JAD181217. doi: 10.3233/JAD-181217.
    PubMed     Abstract available


    May 2019
  790. ANDREWS SJ, McFall GP, Booth A, Dixon RA, et al
    Association of Alzheimer's Disease Genetic Risk Loci with Cognitive Performance and Decline: A Systematic Review.
    J Alzheimers Dis. 2019 May 27. pii: JAD190342. doi: 10.3233/JAD-190342.
    PubMed     Abstract available


  791. RAFII MS, Donohue MC, Matthews DC, Muranevici G, et al
    Plasma Neurofilament Light and Alzheimer's Disease Biomarkers in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).
    J Alzheimers Dis. 2019 May 27. pii: JAD190322. doi: 10.3233/JAD-190322.
    PubMed     Abstract available


  792. JONES M, McDermott B, Oliveira BL, O'Brien A, et al
    Gamma Band Light Stimulation in Human Case Studies: Groundwork for Potential Alzheimer's Disease Treatment.
    J Alzheimers Dis. 2019 May 27. pii: JAD190299. doi: 10.3233/JAD-190299.
    PubMed     Abstract available


  793. MATSUNAGA S, Fujishiro H, Takechi H
    Efficacy and Safety of Glycogen Synthase Kinase 3 Inhibitors for Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2019 May 27. pii: JAD190256. doi: 10.3233/JAD-190256.
    PubMed     Abstract available


  794. ZEGARRA-VALDIVIA JA, Santi A, Fernandez de Sevilla ME, Nunez A, et al
    Serum Insulin-Like Growth Factor I Deficiency Associates to Alzheimer's Disease Co-Morbidities.
    J Alzheimers Dis. 2019 May 27. pii: JAD190241. doi: 10.3233/JAD-190241.
    PubMed     Abstract available


  795. CAI HB, Fan ZZ, Tian T, Zhao CC, et al
    Epigenetic Control of CDK5 Promoter Regulates Diabetes-Associated Development of Alzheimer's Disease.
    J Alzheimers Dis. 2019 May 27. pii: JAD190227. doi: 10.3233/JAD-190227.
    PubMed     Abstract available


  796. HAMPEL H, Lista S, Mango D, Nistico R, et al
    Lithium as a Treatment for Alzheimer's Disease: The Systems Pharmacology Perspective.
    J Alzheimers Dis. 2019 May 27. pii: JAD190197. doi: 10.3233/JAD-190197.
    PubMed     Abstract available


  797. MINTA K, Portelius E, Janelidze S, Hansson O, et al
    Cerebrospinal Fluid Concentrations of Extracellular Matrix Proteins in Alzheimer's Disease.
    J Alzheimers Dis. 2019 May 27. pii: JAD190187. doi: 10.3233/JAD-190187.
    PubMed     Abstract available


  798. YAN X, Li F, Chen S, Jia J, et al
    Associated Factors of Total Costs of Alzheimer's Disease: A Cluster-Randomized Observational Study in China.
    J Alzheimers Dis. 2019 May 25. pii: JAD190166. doi: 10.3233/JAD-190166.
    PubMed     Abstract available


  799. CLEMENT C, Selman LE, Kehoe PG, Howden B, et al
    Challenges to and Facilitators of Recruitment to an Alzheimer's Disease Clinical Trial: A Qualitative Interview Study.
    J Alzheimers Dis. 2019 May 25. pii: JAD190146. doi: 10.3233/JAD-190146.
    PubMed     Abstract available


  800. GUO Y, Yu H
    Leukocyte Telomere Length Shortening and Alzheimer's Disease Etiology.
    J Alzheimers Dis. 2019 May 25. pii: JAD190134. doi: 10.3233/JAD-190134.
    PubMed     Abstract available


  801. SAMUDRA N, Motes M, Lu H, Sheng M, et al
    A Pilot Study of Changes in Medial Temporal Lobe Fractional Amplitude of Low Frequency Fluctuations after Sildenafil Administration in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2019 May 25. pii: JAD190128. doi: 10.3233/JAD-190128.
    PubMed     Abstract available


  802. MENDEZ MF, Monserratt LH, Liang LJ, Chavez D, et al
    Neuropsychological Similarities and Differences Between Amnestic Alzheimer's Disease and its Non-Amnestic Variants.
    J Alzheimers Dis. 2019 May 25. pii: JAD190124. doi: 10.3233/JAD-190124.
    PubMed     Abstract available


  803. KITAGUCHI N, Tatebe H, Sakai K, Kawaguchi K, et al
    Influx of Tau and Amyloid-beta Proteins into the Blood During Hemodialysis as a Therapeutic Extracorporeal Blood Amyloid-beta Removal System for Alzheimer's Disease.
    J Alzheimers Dis. 2019 May 24. pii: JAD190087. doi: 10.3233/JAD-190087.
    PubMed     Abstract available


  804. SADEGH MALVAJERD S, Izadi Z, Azadi A, Kurd M, et al
    Neuroprotective Potential of Curcumin-Loaded Nanostructured Lipid Carrier in an Animal Model of Alzheimer's Disease: Behavioral and Biochemical Evidence.
    J Alzheimers Dis. 2019 May 24. pii: JAD190083. doi: 10.3233/JAD-190083.
    PubMed     Abstract available


  805. WU Y, Zhao Y, Xu T, You L, et al
    Alzheimer's Disease Affects Severity of Asthma Through Methylation Control of Foxp3 Promoter.
    J Alzheimers Dis. 2019 May 20. pii: JAD190315. doi: 10.3233/JAD-190315.
    PubMed     Abstract available


  806. AARONS T, Bradburn S, Robinson A, Payton A, et al
    Dysregulation of BDNF in Prefrontal Cortex in Alzheimer's Disease.
    J Alzheimers Dis. 2019 May 20. pii: JAD190049. doi: 10.3233/JAD-190049.
    PubMed     Abstract available


  807. DIETLIN S, Soto M, Kiyasova V, Pueyo M, et al
    Neuropsychiatric Symptoms and Risk of Progression to Alzheimer's Disease Among Mild Cognitive Impairment Subjects.
    J Alzheimers Dis. 2019 May 20. pii: JAD190025. doi: 10.3233/JAD-190025.
    PubMed     Abstract available


  808. HAMINA A, Taipale H, Karttunen N, Tanskanen A, et al
    Hospital-Treated Pneumonia Associated with Opioid Use Among Community Dwellers with Alzheimer's Disease.
    J Alzheimers Dis. 2019 May 20. pii: JAD181295. doi: 10.3233/JAD-181295.
    PubMed     Abstract available


  809. BAYRAM E, Shan G, Cummings JL
    Associations between Comorbid TDP-43, Lewy Body Pathology, and Neuropsychiatric Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2019 May 20. pii: JAD181285. doi: 10.3233/JAD-181285.
    PubMed     Abstract available


  810. HADDAD M, Perrotte M, Landri S, Lepage A, et al
    Circulating and Extracellular Vesicles Levels of N-(1-Carboxymethyl)-L-Lysine (CML) Differentiate Early to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2019 May 20. pii: JAD181272. doi: 10.3233/JAD-181272.
    PubMed     Abstract available


  811. LUUKKAINEN L, Helisalmi S, Kytovuori L, Ahmasalo R, et al
    Mutation Analysis of the Genes Linked to Early Onset Alzheimer's Disease and Frontotemporal Lobar Degeneration.
    J Alzheimers Dis. 2019 May 20. pii: JAD181256. doi: 10.3233/JAD-181256.
    PubMed     Abstract available


  812. VEGH C, Stokes K, Ma D, Wear D, et al
    A Bird's-Eye View of the Multiple Biochemical Mechanisms that Propel Pathology of Alzheimer's Disease: Recent Advances and Mechanistic Perspectives on How to Halt the Disease Progression Targeting Multiple Pathways.
    J Alzheimers Dis. 2019 May 20. pii: JAD181230. doi: 10.3233/JAD-181230.
    PubMed     Abstract available


  813. HUNTER SW, Divine A, Omana H, Wittich W, et al
    Effect of Learning to Use a Mobility Aid on Gait and Cognitive Demands in People with Mild to Moderate Alzheimer's Disease: Part II - 4-Wheeled Walker.
    J Alzheimers Dis. 2019 May 20. pii: JAD181170. doi: 10.3233/JAD-181170.
    PubMed     Abstract available


  814. HUNTER SW, Divine A, Omana H, Wittich W, et al
    Effect of Learning to Use a Mobility Aid on Gait and Cognitive Demands in People with Mild to Moderate Alzheimer's Disease: Part I - Cane.
    J Alzheimers Dis. 2019 May 20. pii: JAD181169. doi: 10.3233/JAD-181169.
    PubMed     Abstract available


  815. STANLEY K, Whitfield T, Kuchenbaecker K, Sanders O, et al
    Rate of Cognitive Decline in Alzheimer's Disease Stratified by Age.
    J Alzheimers Dis. 2019 May 20. pii: JAD181047. doi: 10.3233/JAD-181047.
    PubMed     Abstract available


  816. AHMAN HB, Giedraitis V, Cedervall Y, Lennhed B, et al
    Dual-Task Performance and Neurodegeneration: Correlations Between Timed Up-and-Go Dual-Task Test Outcomes and Alzheimer's Disease Cerebrospinal Fluid Biomarkers.
    J Alzheimers Dis. 2019 May 16. pii: JAD181265. doi: 10.3233/JAD-181265.
    PubMed     Abstract available


  817. TAN RH, Yang Y, McCann H, Shepherd C, et al
    Von Economo Neurons in Behavioral Variant Frontotemporal Dementia with Underlying Alzheimer's Disease.
    J Alzheimers Dis. 2019 May 16. pii: JAD180900. doi: 10.3233/JAD-180900.
    PubMed     Abstract available


  818. ELSWORTHY RJ, Aldred S
    Depression in Alzheimer's Disease: An Alternative Role for Selective Serotonin Reuptake Inhibitors?
    J Alzheimers Dis. 2019 May 16. pii: JAD180780. doi: 10.3233/JAD-180780.
    PubMed     Abstract available


  819. SKILLBACK T, Kornhuber J, Blennow K, Zetterberg H, et al
    Erlangen Score Predicts Cognitive and Neuroimaging Progression in Mild Cognitive Impairment Stage of Alzheimer's Disease.
    J Alzheimers Dis. 2019 May 13. pii: JAD190067. doi: 10.3233/JAD-190067.
    PubMed     Abstract available


  820. KWON S, Moreno-Gonzalez I, Taylor-Presse K, Edwards Iii G, et al
    Impaired Peripheral Lymphatic Function and Cerebrospinal Fluid Outflow in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 May 13. pii: JAD190013. doi: 10.3233/JAD-190013.
    PubMed     Abstract available


  821. BUNAI T, Kakimoto A, Yoshikawa E, Terada T, et al
    Biopathological Significance of Early-Phase Amyloid Imaging in the Spectrum of Alzheimer's Disease.
    J Alzheimers Dis. 2019 May 13. pii: JAD181188. doi: 10.3233/JAD-181188.
    PubMed     Abstract available


  822. DOURADO MCN, Torres Mendonca de Melo Fdel B, Simoes Neto J, Alves G, et al
    Facial Expression Recognition Patterns in Mild and Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2019 May 13. pii: JAD181101. doi: 10.3233/JAD-181101.
    PubMed     Abstract available


  823. MCGURRAN H, Glenn JM, Madero EN, Bott NT, et al
    Prevention and Treatment of Alzheimer's Disease: Biological Mechanisms of Exercise.
    J Alzheimers Dis. 2019 May 13. pii: JAD180958. doi: 10.3233/JAD-180958.
    PubMed     Abstract available


  824. FISCHER A, Landeira-Fernandez J, Sollero de Campos F, Mograbi DC, et al
    Empathy in Alzheimer's Disease: Review of Findings and Proposed Model.
    J Alzheimers Dis. 2019 May 13. pii: JAD180730. doi: 10.3233/JAD-180730.
    PubMed     Abstract available


  825. NATION DA, Ho JK, Dutt S, Han SD, et al
    Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
    J Alzheimers Dis. 2019 May 13. pii: JAD180525. doi: 10.3233/JAD-180525.
    PubMed     Abstract available


    April 2019
  826. FUERMAIER ABM, Piersma D, de Waard D, Davidse RJ, et al
    Driving Difficulties Among Patients with Alzheimer's Disease and Other Neurodegenerative Disorders.
    J Alzheimers Dis. 2019 Apr 30. pii: JAD181095. doi: 10.3233/JAD-181095.
    PubMed     Abstract available


  827. KARRAN M, Guerrero-Berroa E, Schmeidler J, Lee PG, et al
    Recruitment of Older Veterans with Diabetes Risk for Alzheimer's Disease for a Randomized Clinical Trial of Computerized Cognitive Training.
    J Alzheimers Dis. 2019 Apr 15. pii: JAD180952. doi: 10.3233/JAD-180952.
    PubMed     Abstract available


  828. SPENCER BE, Jennings RG, Brewer JB
    Combined Biomarker Prognosis of Mild Cognitive Impairment: An 11-Year Follow-Up Study in the Alzheimer's Disease Neuroimaging Initiative.
    J Alzheimers Dis. 2019 Apr 3. pii: JAD181243. doi: 10.3233/JAD-181243.
    PubMed     Abstract available


  829. ROE CM, Stout SH, Rajasekar G, Ances BM, et al
    A 2.5-Year Longitudinal Assessment of Naturalistic Driving in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 3. pii: JAD181242. doi: 10.3233/JAD-181242.
    PubMed     Abstract available


  830. FARR SA, Roesler E, Niehoff ML, Roby DA, et al
    Metformin Improves Learning and Memory in the SAMP8 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 3. pii: JAD181240. doi: 10.3233/JAD-181240.
    PubMed     Abstract available


  831. SHI X, Ohta Y, Liu X, Shang J, et al
    Acute Anti-Inflammatory Markers ITIH4 and AHSG in Mice Brain of a Novel Alzheimer's Disease Model.
    J Alzheimers Dis. 2019 Apr 3. pii: JAD181218. doi: 10.3233/JAD-181218.
    PubMed     Abstract available


  832. GUO H, Zhao Z, Zhang R, Chen P, et al
    Monocytes in the Peripheral Clearance of Amyloid-beta and Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 3. pii: JAD181177. doi: 10.3233/JAD-181177.
    PubMed     Abstract available


  833. FRISONI GB, Blin O, Bordet R
    One Step Forward Toward a Surrogate Endpoint for Clinical Trials of Alzheimer's Disease Drugs: The Results of PharmaCog WP5 (European ADNI).
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190267. doi: 10.3233/JAD-190267.
    PubMed    


  834. MIAO Y, Guo D, Li W, Zhong Y, et al
    Diabetes Promotes Development of Alzheimer's Disease Through Suppression of Autophagy.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190156. doi: 10.3233/JAD-190156.
    PubMed     Abstract available


  835. PETUKHOVA EO, Mukhamedshina YO, Salafutdinov II, Garanina EE, et al
    Effects of Transplanted Umbilical Cord Blood Mononuclear Cells Overexpressing GDNF on Spatial Memory and Hippocampal Synaptic Proteins in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190150. doi: 10.3233/JAD-190150.
    PubMed     Abstract available


  836. COSTA AS, Guerini FR, Arosio B, Galimberti D, et al
    SNARE Complex Polymorphisms Associate with Alterations of Visual Selective Attention in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190147. doi: 10.3233/JAD-190147.
    PubMed     Abstract available


  837. LI WW, Shen YY, Tian DY, Bu XL, et al
    Brain Amyloid-beta Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190056. doi: 10.3233/JAD-190056.
    PubMed     Abstract available


  838. ROY U, Heredia-Munoz MT, Stute L, Hofling C, et al
    Degeneration of the Suprachiasmatic Nucleus in an Alzheimer's Disease Mouse Model Monitored by in vivo Magnetic Resonance Relaxation Measurements and Immunohistochemistry.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190037. doi: 10.3233/JAD-190037.
    PubMed     Abstract available


  839. PYUN JM, Kang MJ, Yun Y, Park YH, et al
    APOE varepsilon4 and REM Sleep Behavior Disorder as Risk Factors for Sundown Syndrome in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD190032. doi: 10.3233/JAD-190032.
    PubMed     Abstract available


  840. QIU Q, Shen L, Jia L, Wang Q, et al
    A Novel PSEN1 M139L Mutation Found in a Chinese Pedigree with Early-Onset Alzheimer's Disease Increases Abeta42/Abeta40 ratio.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181291. doi: 10.3233/JAD-181291.
    PubMed     Abstract available


  841. KUMAR S, Srivastav S, Fatima M, Giri RS, et al
    A Synthetic Pro-Drug Peptide Reverses Amyloid-beta-Induced Toxicity in the Rat Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181273. doi: 10.3233/JAD-181273.
    PubMed     Abstract available


  842. REGALADO-REYES M, Furcila D, Hernandez F, Avila J, et al
    Phospho-Tau Changes in the Human CA1 During Alzheimer's Disease Progression.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181263. doi: 10.3233/JAD-181263.
    PubMed     Abstract available


  843. BARDACH SH, Jicha GA, Karanth S, Zhang X, et al
    Genetic Sample Provision Among National Alzheimer's Coordinating Center Participants.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181159. doi: 10.3233/JAD-181159.
    PubMed     Abstract available


  844. MARTINEZ JF, Trujillo C, Arevalo A, Ibanez A, et al
    Assessment of Conjunctive Binding in Aging: A Promising Approach for Alzheimer's Disease Detection.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181154. doi: 10.3233/JAD-181154.
    PubMed     Abstract available


  845. JERNEREN F, Cederholm T, Refsum H, Smith AD, et al
    Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181148. doi: 10.3233/JAD-181148.
    PubMed     Abstract available


  846. LI C, Li Y, Zheng L, Zhu X, et al
    Abnormal Brain Network Connectivity in a Triple-Network Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181097. doi: 10.3233/JAD-181097.
    PubMed     Abstract available


  847. GOETGHEBEUR PJD, Wesnes KA, Targum SD
    D-Cycloserine Improves Difficult Discriminations in a Pattern Separation Task in Alzheimer's Disease Patients with Dementia.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181094. doi: 10.3233/JAD-181094.
    PubMed     Abstract available


  848. YAN T, Wang Y, Weng Z, Du W, et al
    Early-Stage Identification and Pathological Development of Alzheimer's Disease Using Multimodal MRI.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181049. doi: 10.3233/JAD-181049.
    PubMed     Abstract available


  849. MARIZZONI M, Ferrari C, Macis A, Jovicich J, et al
    Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181016. doi: 10.3233/JAD-181016.
    PubMed     Abstract available


  850. CAO C, Hasegawa Y, Hayashi K, Takemoto Y, et al
    Chronic Angiotensin 1-7 Infusion Prevents Angiotensin-II-Induced Cognitive Dysfunction and Skeletal Muscle Injury in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD181000. doi: 10.3233/JAD-181000.
    PubMed     Abstract available


  851. MUSTAPIC M, Tran J, Craft S, Kapogiannis D, et al
    Extracellular Vesicle Biomarkers Track Cognitive Changes Following Intranasal Insulin in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD180578. doi: 10.3233/JAD-180578.
    PubMed     Abstract available


  852. PATRICK S, Corrigan R, Grizzani J, Mey M, et al
    Neuroprotective Effects of the Amylin Analog, Pramlintide, on Alzheimer's Disease Are Associated with Oxidative Stress Regulation Mechanisms.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD180421. doi: 10.3233/JAD-180421.
    PubMed     Abstract available


  853. LI C, Duara R, Loewenstein DA, Izquierdo W, et al
    Greater Regional Cortical Thickness is Associated with Selective Vulnerability to Atrophy in Alzheimer's Disease, Independent of Amyloid Load and APOE Genotype.
    J Alzheimers Dis. 2019 Apr 1. pii: JAD180231. doi: 10.3233/JAD-180231.
    PubMed     Abstract available


    March 2019
  854. OLIVER DMA, Reddy PH
    Molecular Basis of Alzheimer's Disease: Focus on Mitochondria.
    J Alzheimers Dis. 2019 Mar 22. pii: JAD190048. doi: 10.3233/JAD-190048.
    PubMed     Abstract available


  855. WATT AD, Jenkins NL, McColl G, Collins S, et al
    "To Treat or not To Treat": Informing the Decision for Disease-Modifying Therapy in Late-Stage Alzheimer's Disease.
    J Alzheimers Dis. 2019 Mar 22. pii: JAD190033. doi: 10.3233/JAD-190033.
    PubMed     Abstract available


  856. YUAN J, Meloni BP, Shi T, Bonser A, et al
    The Potential Influence of Bone-Derived Modulators on the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Mar 22. pii: JAD181249. doi: 10.3233/JAD-181249.
    PubMed     Abstract available


  857. ZHU L, Gong L, Yang T, Xiao X, et al
    Calpastatin Mediates Development of Alzheimer's Disease in Diabetes.
    J Alzheimers Dis. 2019 Mar 19. pii: JAD190004. doi: 10.3233/JAD-190004.
    PubMed     Abstract available


  858. GOODMAN MS, Zomorrodi R, Kumar S, Barr MS, et al
    Changes in Theta but not Alpha Modulation Are Associated with Impairment in Working Memory in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2019 Mar 19. pii: JAD181195. doi: 10.3233/JAD-181195.
    PubMed     Abstract available


  859. LIM YY, Yassi N, Bransby L, Properzi M, et al
    The Healthy Brain Project: An Online Platform for the Recruitment, Assessment, and Monitoring of Middle-Aged Adults at Risk of Developing Alzheimer's Disease.
    J Alzheimers Dis. 2019 Mar 19. pii: JAD181139. doi: 10.3233/JAD-181139.
    PubMed     Abstract available


  860. RAHA-CHOWDHURY R, Henderson JW, Raha AA, Vuono R, et al
    Choroid Plexus Acts as Gatekeeper for TREM2, Abnormal Accumulation of ApoE, and Fibrillary Tau in Alzheimer's Disease and in Down Syndrome Dementia.
    J Alzheimers Dis. 2019 Mar 18. pii: JAD181179. doi: 10.3233/JAD-181179.
    PubMed     Abstract available


  861. BELBIN O, Morgan K, Medway C, Warden D, et al
    The Epistasis Project: A Multi-Cohort Study of the Effects of BDNF, DBH, and SORT1 Epistasis on Alzheimer's Disease Risk.
    J Alzheimers Dis. 2019 Mar 18. pii: JAD181116. doi: 10.3233/JAD-181116.
    PubMed     Abstract available


  862. ALEXOPOULOS P, Thierjung N, Economou P, Werle L, et al
    Plasma Levels of Soluble AbetaPPbeta as a Biomarker for Alzheimer's Disease with Dementia.
    J Alzheimers Dis. 2019 Mar 18. pii: JAD181088. doi: 10.3233/JAD-181088.
    PubMed     Abstract available


  863. PATEL H, Dobson RJB, Newhouse SJ
    A Meta-Analysis of Alzheimer's Disease Brain Transcriptomic Data.
    J Alzheimers Dis. 2019 Mar 18. pii: JAD181085. doi: 10.3233/JAD-181085.
    PubMed     Abstract available


  864. ROBENS S, Heymann P, Gienger R, Hett A, et al
    The Digital Tree Drawing Test for Screening of Early Dementia: An Explorative Study Comparing Healthy Controls, Patients with Mild Cognitive Impairment, and Patients with Early Dementia of the Alzheimer Type.
    J Alzheimers Dis. 2019 Mar 18. pii: JAD181029. doi: 10.3233/JAD-181029.
    PubMed     Abstract available


  865. SOEDA Y, Saito M, Maeda S, Ishida K, et al
    Methylene Blue Inhibits Formation of Tau Fibrils but not of Granular Tau Oligomers: A Plausible Key to Understanding Failure of a Clinical Trial for Alzheimer's Disease.
    J Alzheimers Dis. 2019 Mar 18. pii: JAD181001. doi: 10.3233/JAD-181001.
    PubMed     Abstract available


  866. BLACK C, Lipton RB, Thiel E, Brouillette M, et al
    Relationship Between Treatment Initiation and Healthcare Costs in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Mar 18. pii: JAD180983. doi: 10.3233/JAD-180983.
    PubMed     Abstract available


  867. AIELLO BOWLES EJ, Crane PK, Walker RL, Chubak J, et al
    Cognitive Resilience to Alzheimer's Disease Pathology in the Human Brain.
    J Alzheimers Dis. 2019 Mar 18. pii: JAD180942. doi: 10.3233/JAD-180942.
    PubMed     Abstract available


  868. BOSCHER E, Husson T, Quenez O, Laquerriere A, et al
    Copy Number Variants in miR-138 as a Potential Risk Factor for Early-Onset Alzheimer's Disease.
    J Alzheimers Dis. 2019 Mar 18. pii: JAD180940. doi: 10.3233/JAD-180940.
    PubMed     Abstract available


  869. O'CAOIMH R, Gao Y, Svendrovski A, Illario M, et al
    Effect of Visit-to-Visit Blood Pressure Variability on Cognitive and Functional Decline in Mild to Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2019 Mar 18. pii: JAD180774. doi: 10.3233/JAD-180774.
    PubMed     Abstract available


  870. LIEDES H, Lotjonen J, Kortelainen JM, Novak G, et al
    Multivariate Prediction of Hippocampal Atrophy in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Mar 18. pii: JAD180484. doi: 10.3233/JAD-180484.
    PubMed     Abstract available


  871. SHEIKH-BAHAEI N, Manavaki R, Sajjadi SA, Priest AN, et al
    Correlation of Lobar Cerebral Microbleeds with Amyloid, Perfusion, and Metabolism in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Mar 18. pii: JAD180443. doi: 10.3233/JAD-180443.
    PubMed     Abstract available


  872. HOLLINGER KR, Alt J, Rais R, Kaplin AI, et al
    The NAAG'ing Concerns of Modeling Human Alzheimer's Disease in Mice.
    J Alzheimers Dis. 2019 Mar 11. pii: JAD181251. doi: 10.3233/JAD-181251.
    PubMed     Abstract available


  873. MANCA C, Hopes L, Kearney-Schwartz A, Roch V, et al
    Assessment of 18F-Florbetaben Amyloid PET Imaging in Patients with Suspected Alzheimer's Disease and Isolated Increase in Cerebrospinal Fluid Tau Proteins.
    J Alzheimers Dis. 2019 Mar 11. pii: JAD181146. doi: 10.3233/JAD-181146.
    PubMed     Abstract available


  874. HACKNEY ME, McCullough LE, Bay AA, Silverstein HA, et al
    Rationale and Design of a Clinical Trial of Adapted Tango to Improve Negative Health Impacts in Middle Aged African-American Female Caregivers of Persons with Alzheimer's Disease (ACT Trial).
    J Alzheimers Dis. 2019 Mar 11. pii: JAD181130. doi: 10.3233/JAD-181130.
    PubMed     Abstract available


  875. STRUNZ M, Jarrell JT, Cohen DS, Rosin ER, et al
    Modulation of SPARC/Hevin Proteins in Alzheimer's Disease Brain Injury.
    J Alzheimers Dis. 2019 Mar 11. pii: JAD181032. doi: 10.3233/JAD-181032.
    PubMed     Abstract available


  876. NGABIRANO L, Samieri C, Feart C, Gabelle A, et al
    Intake of Meat, Fish, Fruits, and Vegetables and Long-Term Risk of Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2019 Mar 11. pii: JAD180919. doi: 10.3233/JAD-180919.
    PubMed     Abstract available


  877. PARONI G, Bisceglia P, Seripa D
    Understanding the Amyloid Hypothesis in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Mar 11. pii: JAD180802. doi: 10.3233/JAD-180802.
    PubMed     Abstract available


  878. GROUSSARD M, Chan TG, Coppalle R, Platel H, et al
    Preservation of Musical Memory Throughout the Progression of Alzheimer's Disease? Toward a Reconciliation of Theoretical, Clinical, and Neuroimaging Evidence.
    J Alzheimers Dis. 2019 Mar 11. pii: JAD180474. doi: 10.3233/JAD-180474.
    PubMed     Abstract available


  879. BRANDT J, Buchholz A, Henry-Barron B, Vizthum D, et al
    Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer's Disease.
    J Alzheimers Dis. 2019 Mar 2. pii: JAD180995. doi: 10.3233/JAD-180995.
    PubMed     Abstract available


    February 2019
  880. SATO K, Mano T, Ihara R, Suzuki K, et al
    Lower Serum Calcium as a Potentially Associated Factor for Conversion of Mild Cognitive Impairment to Early Alzheimer's Disease in the Japanese Alzheimer's Disease Neuroimaging Initiative.
    J Alzheimers Dis. 2019 Feb 22. pii: JAD181115. doi: 10.3233/JAD-181115.
    PubMed     Abstract available


  881. MEDORO A, Bartollino S, Mignogna D, Marziliano N, et al
    Proteases Upregulation in Sporadic Alzheimer's Disease Brain.
    J Alzheimers Dis. 2019 Feb 21. pii: JAD181284. doi: 10.3233/JAD-181284.
    PubMed     Abstract available


  882. MARKSTEINER J, Oberacher H, Humpel C
    Acyl-Alkyl-Phosphatidlycholines are Decreased in Saliva of Patients with Alzheimer's Disease as Identified by Targeted Metabolomics.
    J Alzheimers Dis. 2019 Feb 21. pii: JAD181278. doi: 10.3233/JAD-181278.
    PubMed     Abstract available


  883. TIIMAN A, Jelic V, Jarvet J, Jaremo P, et al
    Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer's Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis.
    J Alzheimers Dis. 2019 Feb 21. pii: JAD181144. doi: 10.3233/JAD-181144.
    PubMed     Abstract available


  884. LIU J, Wang Q, Jing D, Gao R, et al
    Diagnostic Approach of Early-Onset Dementia with Negative Family History: Implications from Two Cases of Early-Onset Alzheimer's Disease with De Novo PSEN1 Mutation.
    J Alzheimers Dis. 2019 Feb 21. pii: JAD181108. doi: 10.3233/JAD-181108.
    PubMed     Abstract available


  885. REGLAND B, McCaddon A
    Alzheimer's Amyloidopathy: An Alternative Aspect.
    J Alzheimers Dis. 2019 Feb 20. pii: JAD181007. doi: 10.3233/JAD-181007.
    PubMed     Abstract available


  886. AMEEN-ALI KE, Simpson JE, Wharton SB, Heath PR, et al
    The Time Course of Recognition Memory Impairment and Glial Pathology in the hAPP-J20 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Feb 19. pii: JAD181238. doi: 10.3233/JAD-181238.
    PubMed     Abstract available


  887. ASHFORD JW
    The Dichotomy of Alzheimer's Disease Pathology: Amyloid-beta and Tau.
    J Alzheimers Dis. 2019 Feb 19. pii: JAD181198. doi: 10.3233/JAD-181198.
    PubMed     Abstract available


  888. SHEN L, Ji HF
    Associations Between Gut Microbiota and Alzheimer's Disease: Current Evidences and Future Therapeutic and Diagnostic Perspectives.
    J Alzheimers Dis. 2019 Feb 19. pii: JAD181143. doi: 10.3233/JAD-181143.
    PubMed     Abstract available


  889. HAMPEL H, Vergallo A, Perry G, Lista S, et al
    The Alzheimer Precision Medicine Initiative.
    J Alzheimers Dis. 2019 Feb 19. pii: JAD181121. doi: 10.3233/JAD-181121.
    PubMed     Abstract available


  890. MANDAL PK, Shukla D, Tripathi M, Ersland L, et al
    Cognitive Improvement with Glutathione Supplement in Alzheimer's Disease: A Way Forward.
    J Alzheimers Dis. 2019 Feb 13. pii: JAD181054. doi: 10.3233/JAD-181054.
    PubMed     Abstract available


  891. HAN Z, Xue W, Tao L, Zhu F, et al
    Identification of Key Long Non-Coding RNAs in the Pathology of Alzheimer's Disease and their Functions Based on Genome-Wide Associations Study, Microarray, and RNA-seq Data.
    J Alzheimers Dis. 2019 Feb 13. pii: JAD181051. doi: 10.3233/JAD-181051.
    PubMed     Abstract available


  892. WANG X, Zimmermann HR, Ma T
    Therapeutic Potential of AMP-Activated Protein Kinase in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Feb 13. pii: JAD181043. doi: 10.3233/JAD-181043.
    PubMed     Abstract available


  893. BRUGNOLO A, De Carli F, Pagani M, Morbelli S, et al
    Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2019 Feb 13. pii: JAD181022. doi: 10.3233/JAD-181022.
    PubMed     Abstract available


  894. DEPCIUCH J, Zawlik I, Skrzypa M, Pajak J, et al
    FTIR Spectroscopy of Cerebrospinal Fluid Reveals Variations in the Lipid: Protein Ratio at Different Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD181008. doi: 10.3233/JAD-181008.
    PubMed     Abstract available


  895. FILSHTEIN TJ, Dugger BN, Jin LW, Olichney JM, et al
    Neuropathological Diagnoses of Demented Hispanic, Black, and Non-Hispanic White Decedents Seen at an Alzheimer's Disease Center.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180992. doi: 10.3233/JAD-180992.
    PubMed     Abstract available


  896. DAMULINA A, Pirpamer L, Seiler S, Benke T, et al
    White Matter Hyperintensities in Alzheimer's Disease: A Lesion Probability Mapping Study.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180982. doi: 10.3233/JAD-180982.
    PubMed     Abstract available


  897. CONNER SC, Benayoun L, Himali JJ, Adams SL, et al
    Methionine Sulfoxide Reductase-B3 Risk Allele Implicated in Alzheimer's Disease Associates with Increased Odds for Brain Infarcts.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180977. doi: 10.3233/JAD-180977.
    PubMed     Abstract available


  898. DECARLI C, Villeneuve S, Maillard P, Harvey D, et al
    Vascular Burden Score Impacts Cognition Independent of Amyloid PET and MRI Measures of Alzheimer's Disease and Vascular Brain Injury.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180965. doi: 10.3233/JAD-180965.
    PubMed     Abstract available


  899. KASAHARA H, Ikeda M, Nagashima K, Fujita Y, et al
    Deep White Matter Lesions Are Associated with Early Recognition of Dementia in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180939. doi: 10.3233/JAD-180939.
    PubMed     Abstract available


  900. TAIPALE H, Lampela P, Koponen M, Tanskanen A, et al
    Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180912. doi: 10.3233/JAD-180912.
    PubMed     Abstract available


  901. DE LA MONTE SM, Tong M, Daiello LA, Ott BR, et al
    Early-Stage Alzheimer's Disease Is Associated with Simultaneous Systemic and Central Nervous System Dysregulation of Insulin-Linked Metabolic Pathways.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180906. doi: 10.3233/JAD-180906.
    PubMed     Abstract available


  902. DEVANARAYAN P, Devanarayan V, Llano DA
    Identification of a Simple and Novel Cut-Point Based Cerebrospinal Fluid and MRI Signature for Predicting Alzheimer's Disease Progression that Reinforces the 2018 NIA-AA Research Framework.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180905. doi: 10.3233/JAD-180905.
    PubMed     Abstract available


  903. MARJANSKA M, McCarten JR, Hodges JS, Hemmy LS, et al
    Distinctive Neurochemistry in Alzheimer's Disease via 7 T In Vivo Magnetic Resonance Spectroscopy.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180861. doi: 10.3233/JAD-180861.
    PubMed     Abstract available


  904. RODA AR, Montoliu-Gaya L, Villegas S
    The Role of Apolipoprotein E Isoforms in Alzheimer's Disease.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180740. doi: 10.3233/JAD-180740.
    PubMed     Abstract available


  905. GUZMAN-MARTINEZ L, Tapia JP, Farias GA, Gonzalez A, et al
    The Alz-tau Biomarker for Alzheimer's Disease: Study in a Caucasian Population.
    J Alzheimers Dis. 2019 Feb 11. pii: JAD180637. doi: 10.3233/JAD-180637.
    PubMed     Abstract available


  906. ONOJIGHOFIA TOBORE T
    On the Etiopathogenesis and Pathophysiology of Alzheimer's Disease: A Comprehensive Theoretical Review.
    J Alzheimers Dis. 2019 Feb 8. pii: JAD181052. doi: 10.3233/JAD-181052.
    PubMed     Abstract available


  907. GROSSBERG GT, Tong G, Burke AD, Tariot PN, et al
    Present Algorithms and Future Treatments for Alzheimer's Disease.
    J Alzheimers Dis. 2019 Feb 7. pii: JAD180903. doi: 10.3233/JAD-180903.
    PubMed     Abstract available


  908. MANNICHE CS, Hejl AM, Hasselbalch SG, Simonsen AH, et al
    Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review.
    J Alzheimers Dis. 2019 Feb 7. pii: JAD180816. doi: 10.3233/JAD-180816.
    PubMed     Abstract available


  909. TAKAMATSU Y, Ho G, Waragai M, Wada R, et al
    Transgenerational Interaction of Alzheimer's Disease with Schizophrenia through Amyloid Evolvability.
    J Alzheimers Dis. 2019 Feb 6. pii: JAD180986. doi: 10.3233/JAD-180986.
    PubMed     Abstract available


  910. LI L, Ismael S, Nasoohi S, Sakata K, et al
    Thioredoxin-Interacting Protein (TXNIP) Associated NLRP3 Inflammasome Activation in Human Alzheimer's Disease Brain.
    J Alzheimers Dis. 2019 Feb 6. pii: JAD180814. doi: 10.3233/JAD-180814.
    PubMed     Abstract available


  911. MANSOUR Y, Blackburn K, Gonzalez-Gonzalez LO, Calderon-Garciduenas L, et al
    Auditory Brainstem Dysfunction, Non-Invasive Biomarkers for Early Diagnosis and Monitoring of Alzheimer's Disease in Young Urban Residents Exposed to Air Pollution.
    J Alzheimers Dis. 2019 Feb 2. pii: JAD181186. doi: 10.3233/JAD-181186.
    PubMed     Abstract available


  912. ZHANG X, Lao K, Qiu Z, Rahman MS, et al
    Potential Astrocytic Receptors and Transporters in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Feb 1. pii: JAD181084. doi: 10.3233/JAD-181084.
    PubMed     Abstract available


    January 2019
  913. PATEL AA, Ganepola GAP, Rutledge JR, Chang DH, et al
    The Potential Role of Dysregulated miRNAs in Alzheimer's Disease Pathogenesis and Progression.
    J Alzheimers Dis. 2019 Jan 28. pii: JAD181078. doi: 10.3233/JAD-181078.
    PubMed     Abstract available


  914. EVGEN'EV M, Bobkova N, Krasnov G, Garbuz D, et al
    The Effect of Human HSP70 Administration on a Mouse Model of Alzheimer's Disease Strongly Depends on Transgenicity and Age.
    J Alzheimers Dis. 2019 Jan 28. pii: JAD180987. doi: 10.3233/JAD-180987.
    PubMed     Abstract available


  915. MANABE T, Matsumura A, Yokokawa K, Saito T, et al
    Evaluation of Mitochondrial Oxidative Stress in the Brain of a Transgenic Mouse Model of Alzheimer's Disease by in vitro Electron Paramagnetic Resonance Spectroscopy.
    J Alzheimers Dis. 2019 Jan 28. pii: JAD180985. doi: 10.3233/JAD-180985.
    PubMed     Abstract available


  916. ALUGANTI NARASIMHULU C, Mitra C, Bhardwaj D, Burge KY, et al
    Alzheimer's Disease Markers in Aged ApoE-PON1 Deficient Mice.
    J Alzheimers Dis. 2019 Jan 28. pii: JAD180883. doi: 10.3233/JAD-180883.
    PubMed     Abstract available


  917. MARWARHA G, Claycombe-Larson K, Lund J, Schommer J, et al
    A Diet Enriched in Palmitate and Deficient in Linoleate Exacerbates Oxidative Stress and Amyloid-beta Burden in the Hippocampus of 3xTg-AD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jan 28. pii: JAD180835. doi: 10.3233/JAD-180835.
    PubMed     Abstract available


  918. JI Y, Wang X, Kalicki C, Menta BW, et al
    Effects of Microglial Cytokines on Alzheimer's Disease-Related Phenomena.
    J Alzheimers Dis. 2019 Jan 28. pii: JAD180820. doi: 10.3233/JAD-180820.
    PubMed     Abstract available


  919. GALLUCCI M, Dell'Acqua C, Bergamelli C, Fenoglio C, et al
    A Case with Early Onset Alzheimer's Disease, Frontotemporal Hypometabolism, ApoE Genotype varepsilon4/varepsilon4 and C9ORF72 Intermediate Expansion: A Treviso Dementia (TREDEM) Registry Case Report.
    J Alzheimers Dis. 2019 Jan 28. pii: JAD180715. doi: 10.3233/JAD-180715.
    PubMed     Abstract available


  920. WIEDRICK JT, Phillips JI, Lusardi TA, McFarland TJ, et al
    Validation of MicroRNA Biomarkers for Alzheimer's Disease in Human Cerebrospinal Fluid.
    J Alzheimers Dis. 2019 Jan 22. pii: JAD180539. doi: 10.3233/JAD-180539.
    PubMed     Abstract available


  921. HUDD F, Shiel A, Harris M, Bowdler P, et al
    Novel Blood Biomarkers that Correlate with Cognitive Performance and Hippocampal Volumetry: Potential for Early Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jan 21. pii: JAD180879. doi: 10.3233/JAD-180879.
    PubMed     Abstract available


  922. FOVEAU B, Correia AS, Hebert SS, Rainone S, et al
    Stem Cell-Derived Neurons as Cellular Models of Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jan 21. pii: JAD180833. doi: 10.3233/JAD-180833.
    PubMed     Abstract available


  923. RIZZO R, Bortolotti D, Gentili V, Rotola A, et al
    KIR2DS2/KIR2DL2/HLA-C1 Haplotype Is Associated with Alzheimer's Disease: Implication for the Role of Herpesvirus Infections.
    J Alzheimers Dis. 2019 Jan 21. pii: JAD180777. doi: 10.3233/JAD-180777.
    PubMed     Abstract available


  924. CUMMINGS JL, Tong G, Ballard C
    Treatment Combinations for Alzheimer's Disease: Current And Future Pharmacotherapy Options.
    J Alzheimers Dis. 2019 Jan 21. pii: JAD180766. doi: 10.3233/JAD-180766.
    PubMed     Abstract available


  925. HIROSE D, Shimizu S, Hirao K, Ogawa Y, et al
    Neuroimaging Characteristics of Frailty Status in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jan 21. pii: JAD180701. doi: 10.3233/JAD-180701.
    PubMed     Abstract available


  926. WRIGHT JW, Harding JW
    Contributions by the Brain Renin-Angiotensin System to Memory, Cognition, and Alzheimer's Disease.
    J Alzheimers Dis. 2019 Jan 14. pii: JAD181035. doi: 10.3233/JAD-181035.
    PubMed     Abstract available


  927. HUISA BN, Thomas RG, Jin S, Oltersdorf T, et al
    Memantine and Acetylcholinesterase Inhibitor Use in Alzheimer's Disease Clinical Trials: Potential for Confounding by Indication.
    J Alzheimers Dis. 2019 Jan 8. pii: JAD180684. doi: 10.3233/JAD-180684.
    PubMed     Abstract available


  928. KHOONSARI PE, Shevchenko G, Herman S, Remnestal J, et al
    Improved Differential Diagnosis of Alzheimer's Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers.
    J Alzheimers Dis. 2019 Jan 3. pii: JAD180855. doi: 10.3233/JAD-180855.
    PubMed     Abstract available


  929. YANG M, Wang Y, Liang G, Xu Z, et al
    Alzheimer's Disease Presenilin-1 Mutation Sensitizes Neurons to Impaired Autophagy Flux and Propofol Neurotoxicity: Role of Calcium Dysregulation.
    J Alzheimers Dis. 2019;67:137-147.
    PubMed     Abstract available


  930. FROLICH L, Atri A, Ballard C, Tariot PN, et al
    Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease.
    J Alzheimers Dis. 2019;67:303-313.
    PubMed     Abstract available


  931. EL BITAR F, Qadi N, Al Rajeh S, Majrashi A, et al
    Genetic Study of Alzheimer's Disease in Saudi Population.
    J Alzheimers Dis. 2019;67:231-242.
    PubMed     Abstract available


  932. WEISSBERGER GH, Gollan TH, Bondi MW, Nation DA, et al
    Neuropsychological Deficit Profiles, Vascular Risk Factors, and Neuropathological Findings in Hispanic Older Adults with Autopsy-Confirmed Alzheimer's Disease.
    J Alzheimers Dis. 2019;67:291-302.
    PubMed     Abstract available


  933. LETRA L, Matafome P, Rodrigues T, Duro D, et al
    Association between Adipokines and Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.
    J Alzheimers Dis. 2019;67:725-735.
    PubMed     Abstract available


  934. MARSHALL GA, Gatchel JR, Donovan NJ, Muniz MC, et al
    Regional Tau Correlates of Instrumental Activities of Daily Living and Apathy in Mild Cognitive Impairment and Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2019;67:757-768.
    PubMed     Abstract available


  935. CHEN YC, Chiu YJ, Lin CH, Hsu WC, et al
    Indole Compound NC009-1 Augments APOE and TRKA in Alzheimer's Disease Cell and Mouse Models for Neuroprotection and Cognitive Improvement.
    J Alzheimers Dis. 2019;67:737-756.
    PubMed     Abstract available


  936. ASHFORD JW
    Treatment of Alzheimer's Disease: Trazodone, Sleep, Serotonin, Norepinephrine, and Future Directions.
    J Alzheimers Dis. 2019;67:923-930.
    PubMed     Abstract available


  937. UNSWORTH CA, Russell K, Lovell R, Woodward M, et al
    Effect of Navigation Problems, Assessment Location, and a Practice Test on Driving Assessment Performance for People with Alzheimer's Disease.
    J Alzheimers Dis. 2019;67:1035-1043.
    PubMed     Abstract available


  938. SERRANO-POZO A, Growdon JH
    Is Alzheimer's Disease Risk Modifiable?
    J Alzheimers Dis. 2019;67:795-819.
    PubMed     Abstract available


  939. DING Y, Bao X, Lao L, Ling Y, et al
    p-Hydroxybenzyl Alcohol Prevents Memory Deficits by Increasing Neurotrophic Factors and Decreasing Inflammatory Factors in a Mice Model of Alzheimer's Disease.
    J Alzheimers Dis. 2019;67:1007-1019.
    PubMed     Abstract available


  940. GULISANO W, Maugeri D, Baltrons MA, Fa M, et al
    Role of Amyloid-beta and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.
    J Alzheimers Dis. 2019;68:415.
    PubMed    



  941. Observational Study of Clinical and Functional Progression Based on Initial Brain MRI Characteristics in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2019;68:1309.
    PubMed    



  942. Yan-Jiang Wang, M.D., Ph.D and Xian-Le Bu, M.D., Ph.D., recipients of the 2019 Alzheimer Award.
    J Alzheimers Dis. 2019;70:619-620.
    PubMed    


  943. IULITA MF, Ganesh A, Pentz R, Flores Aguilar L, et al
    Identification and Preliminary Validation of a Plasma Profile Associated with Cognitive Decline in Dementia and At-Risk Individuals: A Retrospective Cohort Analysis.
    J Alzheimers Dis. 2019;67:327-341.
    PubMed     Abstract available


  944. KASKIKALLIO A, Karrasch M, Rinne JO, Tuokkola T, et al
    Cognitive Effects of White Matter Pathology in Normal and Pathological Aging.
    J Alzheimers Dis. 2019;67:489-493.
    PubMed     Abstract available


  945. BARTON SM, Janve VA, McClure R, Anderson A, et al
    Lipopolysaccharide Induced Opening of the Blood Brain Barrier on Aging 5XFAD Mouse Model.
    J Alzheimers Dis. 2019;67:503-513.
    PubMed     Abstract available


  946. HVIDSTEN L, Engedal K, Selbaek G, Wyller TB, et al
    Quality of Life in People with Young-Onset Dementia: A Nordic Two-Year Observational Multicenter Study.
    J Alzheimers Dis. 2019;67:197-210.
    PubMed     Abstract available


  947. ZAMMIT AR, Muniz-Terrera G, Katz MJ, Hall CB, et al
    Subtypes Based on Neuropsychological Performance Predict Incident Dementia: Findings from the Rush Memory and Aging Project.
    J Alzheimers Dis. 2019;67:125-135.
    PubMed     Abstract available


  948. SCHWARZ CG, Gunter JL, Lowe VJ, Weigand S, et al
    A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR.
    J Alzheimers Dis. 2019;67:181-195.
    PubMed     Abstract available


  949. PAPPAS C, Small BJ, Andel R, Laczo J, et al
    Blood Glucose Levels May Exacerbate Executive Function Deficits in Older Adults with Cognitive Impairment.
    J Alzheimers Dis. 2019;67:81-89.
    PubMed     Abstract available


  950. RIZZO G, De Blasi R, Capozzo R, Tortelli R, et al
    Loss of Swallow Tail Sign on Susceptibility-Weighted Imaging in Dementia with Lewy Bodies.
    J Alzheimers Dis. 2019;67:61-65.
    PubMed     Abstract available


    December 2018
  951. TURCHETTA CS, Perri R, Fadda L, Caruso G, et al
    Forgetting Rate on the Recency Portion of a Word List Differentiates Mild to Moderate Alzheimer's Disease from Other Forms of Dementi.
    J Alzheimers Dis. 2018 Dec 28. pii: JAD189013. doi: 10.3233/JAD-189013.
    PubMed    


  952. OECKL P, Halbgebauer S, Anderl Straub S, Steinacker P, et al
    Glial Fibrillary Acidic Protein in Serum Is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment.
    J Alzheimers Dis. 2018 Dec 24. pii: JAD180325. doi: 10.3233/JAD-180325.
    PubMed     Abstract available


  953. GAMMAZZA AM, Restivo V, Baschi R, Bavisotto CC, et al
    Circulating Molecular Chaperones in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer's Disease: Data from the Zabut Aging Project.
    J Alzheimers Dis. 2018 Dec 20. pii: JAD180825. doi: 10.3233/JAD-180825.
    PubMed     Abstract available


  954. MENG L, He M, Xiong M, Zhang X, et al
    2',3'-Dideoxycytidine, a DNA Polymerase-beta Inhibitor, Reverses Memory Deficits in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Dec 20. pii: JAD180798. doi: 10.3233/JAD-180798.
    PubMed     Abstract available


  955. DELGADO C, Vergara RC, Martinez M, Musa G, et al
    Neuropsychiatric Symptoms in Alzheimer's Disease Are the Main Determinants of Functional Impairment in Advanced Everyday Activities.
    J Alzheimers Dis. 2018 Dec 18. pii: JAD180771. doi: 10.3233/JAD-180771.
    PubMed     Abstract available


  956. ZHOU Y, Deng J, Chu X, Zhao Y, et al
    Role of Post-Transcriptional Control of Calpain by miR-124-3p in the Development of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Dec 15. pii: JAD181053. doi: 10.3233/JAD-181053.
    PubMed     Abstract available


  957. GALLACHER J, de Reydet de Vulpillieres F, Amzal B, Angehrn Z, et al
    Challenges for Optimizing Real-World Evidence in Alzheimer's Disease: The ROADMAP Project.
    J Alzheimers Dis. 2018 Dec 15. pii: JAD180370. doi: 10.3233/JAD-180370.
    PubMed     Abstract available


  958. XU M, Zhang L, Jiang N, Zhou W, et al
    Pathological Changes in Alzheimer's Disease Analyzed Using Induced Pluripotent Stem Cell-Derived Human Microglia-Like Cells.
    J Alzheimers Dis. 2018 Dec 8. pii: JAD180722. doi: 10.3233/JAD-180722.
    PubMed     Abstract available


  959. ISHII M, Kamel H, Iadecola C
    Retinol Binding Protein 4 Levels Are Not Altered in Preclinical Alzheimer's Disease and Not Associated with Cognitive Decline or Incident Dementia.
    J Alzheimers Dis. 2018 Dec 6. pii: JAD180682. doi: 10.3233/JAD-180682.
    PubMed     Abstract available


  960. FARLOW MR, Thompson RE, Wei LJ, Tuchman AJ, et al
    A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease.
    J Alzheimers Dis. 2018 Dec 4. pii: JAD180759. doi: 10.3233/JAD-180759.
    PubMed     Abstract available


  961. TORREALBA E, Garcia-Morales P, Cejudo JC, Diaz M, et al
    In-Out-Test: A New Paradigm for Sorting the Wheat from the Chaff in Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2018 Dec 3. pii: JAD171007. doi: 10.3233/JAD-171007.
    PubMed     Abstract available


  962. DE MACEDO MEDEIROS A, Silva RH
    Sex Differences in Alzheimer's Disease: Where Do We Stand?
    J Alzheimers Dis. 2018 Dec 1. pii: JAD180213. doi: 10.3233/JAD-180213.
    PubMed     Abstract available


    November 2018
  963. ALMANSOUB HAMM, Tang H, Wu Y, Wang DQ, et al
    Tau Abnormalities and the Potential Therapy in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Nov 29. pii: JAD180868. doi: 10.3233/JAD-180868.
    PubMed     Abstract available


  964. REED MJ, Damodarasamy M, Pathan JL, Chan CK, et al
    Increased Hyaluronan and TSG-6 in Association with Neuropathologic Changes of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Nov 29. pii: JAD180797. doi: 10.3233/JAD-180797.
    PubMed     Abstract available


  965. WAN NASRI WN, Makpol S, Mazlan M, Tooyama I, et al
    Tocotrienol Rich Fraction Supplementation Modulate Brain Hippocampal Gene Expression in APPswe/PS1dE9 Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2018 Nov 28. pii: JAD180496. doi: 10.3233/JAD-180496.
    PubMed     Abstract available


  966. ROYALL DR, Palmer RF
    A delta Homolog for Dementia Case Finding with Replication in the Alzheimer's Disease Neuroimaging Initiative.
    J Alzheimers Dis. 2018 Nov 28. pii: JAD171053. doi: 10.3233/JAD-171053.
    PubMed     Abstract available


  967. JAVANSHIRI K, Landqvist Waldo M, Friberg N, Sjovall F, et al
    Atherosclerosis, Hypertension, and Diabetes in Alzheimer's Disease, Vascular dementia, and Mixed Dementia: Prevalence and Presentation.
    J Alzheimers Dis. 2018 Nov 27. pii: JAD189011. doi: 10.3233/JAD-189011.
    PubMed    


  968. ZANCO M, Placido J, Marinho V, Ferreira JV, et al
    Spatial Navigation in the Elderly with Alzheimer's Disease: A Cross-Sectional Study.
    J Alzheimers Dis. 2018 Nov 26. pii: JAD180819. doi: 10.3233/JAD-180819.
    PubMed     Abstract available


  969. LAHME L, Esser E, Mihailovic N, Schubert F, et al
    Evaluation of Ocular Perfusion in Alzheimer's Disease Using Optical Coherence Tomography Angiography.
    J Alzheimers Dis. 2018 Nov 26. pii: JAD180738. doi: 10.3233/JAD-180738.
    PubMed     Abstract available


  970. SMEDINGA M, Tromp K, Schermer MHN, Richard E, et al
    Ethical Arguments Concerning the Use of Alzheimer's Disease Biomarkers in Individuals with No or Mild Cognitive Impairment: A Systematic Review and Framework for Discussion.
    J Alzheimers Dis. 2018 Nov 26. pii: JAD180638. doi: 10.3233/JAD-180638.
    PubMed     Abstract available


  971. MENARDI A, Pascual-Leone A, Fried PJ, Santarnecchi E, et al
    The Role of Cognitive Reserve in Alzheimer's Disease and Aging: A Multi-Modal Imaging Review.
    J Alzheimers Dis. 2018 Nov 26. pii: JAD180549. doi: 10.3233/JAD-180549.
    PubMed     Abstract available


  972. YAFFE K, Barnes DE, Rosenberg D, Dublin S, et al
    Systematic Multi-Domain Alzheimer's Risk Reduction Trial (SMARRT): Study Protocol.
    J Alzheimers Dis. 2018 Nov 23. pii: JAD180634. doi: 10.3233/JAD-180634.
    PubMed     Abstract available


  973. WATT AD, Jenkins NL, McColl G, Collins S, et al
    Ethical Issues in the Treatment of Late-Stage Alzheimer's Disease.
    J Alzheimers Dis. 2018 Nov 22. pii: JAD180865. doi: 10.3233/JAD-180865.
    PubMed     Abstract available


  974. ZHANG H, Wang D, Gong P, Lin A, et al
    Formyl Peptide Receptor 2 Deficiency Improves Cognition and Attenuates Tau Hyperphosphorylation and Astrogliosis in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Nov 22. pii: JAD180823. doi: 10.3233/JAD-180823.
    PubMed     Abstract available


  975. STROBEL S, Grunblatt E, Heinsen H, Riederer P, et al
    Astrocyte-and Microglia-Specific Mitochondrial DNA Deletions Levels in Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2018 Nov 22. pii: JAD180661. doi: 10.3233/JAD-180661.
    PubMed     Abstract available


  976. SYEDA T, Sanchez-Tapia M, Pinedo-Vargas L, Granados O, et al
    Bioactive Food Abates Metabolic and Synaptic Alterations by Modulation of Gut Microbiota in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Nov 20. pii: JAD180556. doi: 10.3233/JAD-180556.
    PubMed     Abstract available


  977. LOMBARDI G, Polito C, Berti V, Bagnoli S, et al
    Contribution of Bilingualism to Cognitive Reserve of an Italian Literature Professor at High Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2018 Nov 17. pii: JAD180736. doi: 10.3233/JAD-180736.
    PubMed     Abstract available


  978. BOESPFLUG EL, Simon MJ, Leonard E, Grafe M, et al
    Targeted Assessment of Enlargement of the Perivascular Space in Alzheimer's Disease and Vascular Dementia Subtypes Implicates Astroglial Involvement Specific to Alzheimer's Disease.
    J Alzheimers Dis. 2018 Nov 17. pii: JAD180367. doi: 10.3233/JAD-180367.
    PubMed     Abstract available


  979. KOSEOGLU MM, Norambuena A, Sharlow ER, Lazo JS, et al
    Aberrant Neuronal Cell Cycle Re-Entry: The Pathological Confluence of Alzheimer's Disease and Brain Insulin Resistance, and Its Relation to Cancer.
    J Alzheimers Dis. 2018 Nov 16. pii: JAD180874. doi: 10.3233/JAD-180874.
    PubMed     Abstract available


  980. HELMAN AM, Siever M, McCarty KL, Lott IT, et al
    Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Nov 15. pii: JAD180589. doi: 10.3233/JAD-180589.
    PubMed     Abstract available


  981. CHOI H, Jeong JH, Kim YB, Jo KD, et al
    Observational Study of Clinical and Functional Progression Based on Initial Brain MRI Characteristics in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Nov 15. pii: JAD180565. doi: 10.3233/JAD-180565.
    PubMed     Abstract available


  982. OKUYA M, Matsunaga S, Ikuta T, Kishi T, et al
    Efficacy, Acceptability, and Safety of Intravenous Immunoglobulin Administration for Mild-To-Moderate Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2018 Nov 12. pii: JAD180888. doi: 10.3233/JAD-180888.
    PubMed     Abstract available


  983. SULMONT-ROSSE C, Gaillet M, Raclot C, Duclos M, et al
    Impact of Olfactory Priming on Food Intake in an Alzheimer's Disease Unit.
    J Alzheimers Dis. 2018 Nov 12. pii: JAD180465. doi: 10.3233/JAD-180465.
    PubMed     Abstract available


  984. CALDERON-GARCIDUENAS L, Mukherjee PS, Waniek K, Holzer M, et al
    Non-Phosphorylated Tau in Cerebrospinal Fluid is a Marker of Alzheimer's Disease Continuum in Young Urbanites Exposed to Air Pollution.
    J Alzheimers Dis. 2018 Nov 8. pii: JAD180853. doi: 10.3233/JAD-180853.
    PubMed     Abstract available


  985. SORIA JA, Huisa BN, Edland SD, Litvan I, et al
    Clinical-Neuropathological Correlations of Alzheimer's Disease and Related Dementias in Latino Volunteers.
    J Alzheimers Dis. 2018 Nov 8. pii: JAD180789. doi: 10.3233/JAD-180789.
    PubMed     Abstract available


  986. PORTER T, Burnham SC, Milicic L, Savage G, et al
    Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    J Alzheimers Dis. 2018 Nov 8. pii: JAD180713. doi: 10.3233/JAD-180713.
    PubMed     Abstract available


  987. JIANG H, Jayadev S, Lardelli M, Newman M, et al
    A Review of the Familial Alzheimer's Disease Locus PRESENILIN 2 and Its Relationship to PRESENILIN 1.
    J Alzheimers Dis. 2018 Nov 8. pii: JAD180656. doi: 10.3233/JAD-180656.
    PubMed     Abstract available


  988. PELOSO GM, Beiser AS, Destefano AL, Seshadri S, et al
    Genetic Interaction with Plasma Lipids on Alzheimer's Disease in the Framingham Heart Study.
    J Alzheimers Dis. 2018 Nov 5. pii: JAD180751. doi: 10.3233/JAD-180751.
    PubMed     Abstract available


  989. TANG N, Kepp KP
    Abeta42/Abeta40 Ratios of Presenilin 1 Mutations Correlate with Clinical Onset of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Nov 3. pii: JAD180829. doi: 10.3233/JAD-180829.
    PubMed     Abstract available


  990. PIRIZ A, Reyes D, Narkhede A, Guzman VA, et al
    Cerebrovascular Disease and Neurodegeneration in Alzheimer's Disease with and without a Strong Family History: A Pilot Magnetic Resonance Imaging Study in Dominican Republic.
    J Alzheimers Dis. 2018 Nov 3. pii: JAD180807. doi: 10.3233/JAD-180807.
    PubMed     Abstract available


  991. LU Z, B Harris T, J Shiroma E, Leung J, et al
    Patterns of Physical Activity and Sedentary Behavior for Older Adults with Alzheimer's Disease, Mild Cognitive Impairment, and Cognitively Normal in Hong Kong.
    J Alzheimers Dis. 2018 Nov 3. pii: JAD180805. doi: 10.3233/JAD-180805.
    PubMed     Abstract available


  992. CISTERNAS P, Zolezzi JM, Lindsay C, Rivera DS, et al
    New Insights into the Spontaneous Human Alzheimer's Disease-Like Model Octodon degus: Unraveling Amyloid-beta Peptide Aggregation and Age-Related Amyloid Pathology.
    J Alzheimers Dis. 2018 Nov 3. pii: JAD180729. doi: 10.3233/JAD-180729.
    PubMed     Abstract available


  993. EIKELBOOM WS, van Rooij JGJ, van den Berg E, Coesmans M, et al
    Neuropsychiatric Symptoms Complicating the Diagnosis of Alzheimer's Disease: A Case Report.
    J Alzheimers Dis. 2018 Nov 3. pii: JAD180700. doi: 10.3233/JAD-180700.
    PubMed     Abstract available


  994. GANT JC, Kadish I, Chen KC, Thibault O, et al
    Aging-Related Calcium Dysregulation in Rat Entorhinal Neurons Homologous with the Human Entorhinal Neurons in which Alzheimer's Disease Neurofibrillary Tangles First Appear.
    J Alzheimers Dis. 2018 Nov 3. pii: JAD180618. doi: 10.3233/JAD-180618.
    PubMed     Abstract available


  995. BANKS SJ, Zhuang X, Bayram E, Bird C, et al
    Default Mode Network Lateralization and Memory in Healthy Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2018 Nov 3. pii: JAD180541. doi: 10.3233/JAD-180541.
    PubMed     Abstract available


  996. BABULAL GM, Chen S, Williams MM, Trani JF, et al
    Depression and Alzheimer's Disease Biomarkers Predict Driving Decline.
    J Alzheimers Dis. 2018 Nov 2. pii: JAD180564. doi: 10.3233/JAD-180564.
    PubMed     Abstract available


  997. CABINIO M, Saresella M, Piancone F, LaRosa F, et al
    Association between Hippocampal Shape, Neuroinflammation, and Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Nov 1. pii: JAD180250. doi: 10.3233/JAD-180250.
    PubMed     Abstract available


  998. JARA-MORENO D, Castro-Torres RD, Ettcheto M, Auladell C, et al
    The Ethyl Acetate Extract of Leaves of Ugni molinae Turcz. Improves Neuropathological Hallmarks of Alzheimer's Disease in Female APPswe/ PS1dE9 Mice Fed with a High Fat Diet.
    J Alzheimers Dis. 2018 Nov 1. pii: JAD180174. doi: 10.3233/JAD-180174.
    PubMed     Abstract available


  999. RAMZAOUI H, Faure S, Spotorno S
    Alzheimer's Disease, Visual Search, and Instrumental Activities of Daily Living: A Review and a New Perspective on Attention and Eye Movements.
    J Alzheimers Dis. 2018 Nov 1. pii: JAD180043. doi: 10.3233/JAD-180043.
    PubMed     Abstract available


  1000. LEANDRO GS, Evangelista AF, Lobo RR, Xavier DJ, et al
    Changes in Expression Profiles Revealed by Transcriptomic Analysis in Peripheral Blood Mononuclear Cells of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2018 Nov 1. pii: JAD170205. doi: 10.3233/JAD-170205.
    PubMed     Abstract available


    October 2018
  1001. FLOREK L, Tiepolt S, Schroeter ML, Berrouschot J, et al
    Dual Time-Point [18F]Florbetaben PET Delivers Dual Biomarker Information in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2018 Oct 29. pii: JAD180522. doi: 10.3233/JAD-180522.
    PubMed     Abstract available


  1002. JIANG L, Wang J, Wang Z, Huang W, et al
    Role of the Glyoxalase System in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Oct 29. pii: JAD180413. doi: 10.3233/JAD-180413.
    PubMed     Abstract available


  1003. JOVICICH J, Babiloni C, Ferrari C, Marizzoni M, et al
    Two-Year Longitudinal Monitoring of Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Using Topographical Biomarkers Derived from Functional Magnetic Resonance Imaging and Electroencephalographic Activity.
    J Alzheimers Dis. 2018 Oct 29. pii: JAD180158. doi: 10.3233/JAD-180158.
    PubMed     Abstract available


  1004. COX KL, Cyarto EV, Ellis KA, Ames D, et al
    A Randomized Controlled Trial of Adherence to a 24-Month Home-Based Physical Activity Program and the Health Benefits for Older Adults at Risk of Alzheimer's Disease: The AIBL Active-Study.
    J Alzheimers Dis. 2018 Oct 26. pii: JAD180521. doi: 10.3233/JAD-180521.
    PubMed     Abstract available


  1005. LIGUORI C, Mercuri NB, Nuccetelli M, Izzi F, et al
    Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms.
    J Alzheimers Dis. 2018 Oct 25. pii: JAD180769. doi: 10.3233/JAD-180769.
    PubMed     Abstract available


  1006. NASOOHI S, Parveen K, Ishrat T
    Metabolic Syndrome, Brain Insulin Resistance, and Alzheimer's Disease: Thioredoxin Interacting Protein (TXNIP) and Inflammasome as Core Amplifiers.
    J Alzheimers Dis. 2018 Oct 23. pii: JAD180735. doi: 10.3233/JAD-180735.
    PubMed     Abstract available


  1007. MADRID A, Hogan KJ, Papale LA, Clark LR, et al
    DNA Hypomethylation in Blood Links B3GALT4 and ZADH2 to Alzheimer's Disease.
    J Alzheimers Dis. 2018 Oct 22. pii: JAD180592. doi: 10.3233/JAD-180592.
    PubMed     Abstract available


  1008. DI LORENZO F, Ponzo V, Motta C, Bonni S, et al
    Impaired Spike Timing Dependent Cortico-Cortical Plasticity in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2018 Oct 22. pii: JAD180503. doi: 10.3233/JAD-180503.
    PubMed     Abstract available


  1009. ZUO LJ, Guo P, Liu L, Yu SY, et al
    Analyses of Clinical Features and Investigations on Potential Mechanisms in Patients with Alzheimer's Disease and Olfactory Dysfunction.
    J Alzheimers Dis. 2018 Oct 17. pii: JAD180425. doi: 10.3233/JAD-180425.
    PubMed     Abstract available


  1010. RYAN MM, Guevremont D, Mockett BG, Abraham WC, et al
    Circulating Plasma microRNAs Are Altered with Amyloidosis in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Oct 13. pii: JAD180385. doi: 10.3233/JAD-180385.
    PubMed     Abstract available


  1011. INNES KE, Selfe TK, Brundage K, Montgomery C, et al
    Effects of Meditation and Music-Listening on Blood Biomarkers of Cellular Aging and Alzheimer's Disease in Adults with Subjective Cognitive Decline: An Exploratory Randomized Clinical Trial.
    J Alzheimers Dis. 2018 Oct 11. pii: JAD180164. doi: 10.3233/JAD-180164.
    PubMed     Abstract available


  1012. WENG YC, Hsiao IT, Huang CY, Huang KL, et al
    Progress of Brain Amyloid Deposition in Familial Alzheimer's Disease with Taiwan D678H APP Mutation.
    J Alzheimers Dis. 2018 Oct 9. pii: JAD180824. doi: 10.3233/JAD-180824.
    PubMed     Abstract available


  1013. DE MATOS MR, Ferreira C, Herukka SK, Soininen H, et al
    Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.
    J Alzheimers Dis. 2018 Oct 9. pii: JAD180512. doi: 10.3233/JAD-180512.
    PubMed     Abstract available


  1014. ELIAS A, Cummins T, Tyrrell R, Lamb F, et al
    Risk of Alzheimer's Disease in Obstructive Sleep Apnea Syndrome: Amyloid-beta and Tau Imaging.
    J Alzheimers Dis. 2018 Oct 8. pii: JAD180640. doi: 10.3233/JAD-180640.
    PubMed     Abstract available


  1015. COUSINS CC, Alosco ML, Cousins HC, Chua A, et al
    Nailfold Capillary Morphology in Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2018 Oct 6. pii: JAD180658. doi: 10.3233/JAD-180658.
    PubMed     Abstract available


  1016. BAIRD A, Brancatisano O, Gelding R, Thompson WF, et al
    Characterization of Music and Photograph Evoked Autobiographical Memories in People with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Oct 6. pii: JAD180627. doi: 10.3233/JAD-180627.
    PubMed     Abstract available


  1017. ZHANG F, Wei J, Li X, Ma C, et al
    Early Candidate Urine Biomarkers for Detecting Alzheimer's Disease Before Amyloid-beta Plaque Deposition in an APP (swe)/PSEN1dE9 Transgenic Mouse Model.
    J Alzheimers Dis. 2018 Oct 6. pii: JAD180412. doi: 10.3233/JAD-180412.
    PubMed     Abstract available


  1018. MULLER-EHRENBERG L, Riphagen JM, Verhey FRJ, Sack AT, et al
    Alzheimer's Disease Biomarkers Have Distinct Associations with Specific Hippocampal Subfield Volumes.
    J Alzheimers Dis. 2018 Oct 5. pii: JAD180676. doi: 10.3233/JAD-180676.
    PubMed     Abstract available


  1019. ABU-RUMEILEH S, Mometto N, Bartoletti-Stella A, Polischi B, et al
    Cerebrospinal Fluid Biomarkers in Patients with Frontotemporal Dementia Spectrum: A Single-Center Study.
    J Alzheimers Dis. 2018 Oct 5. pii: JAD180409. doi: 10.3233/JAD-180409.
    PubMed     Abstract available


    September 2018
  1020. STELLA TURCHETTA C, Perri R, Fadda L, Caruso G, et al
    Forgetting Rate on the Recency Portion of a Word List Differentiates Mild to Moderate Alzheimer's Disease from Other Forms of Dementi.
    J Alzheimers Dis. 2018 Sep 29. pii: JAD180690. doi: 10.3233/JAD-180690.
    PubMed     Abstract available


  1021. SONG YN, Wang P, Xu W, Li JQ, et al
    Risk Factors of Rapid Cognitive Decline in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2018 Sep 29. pii: JAD180476. doi: 10.3233/JAD-180476.
    PubMed     Abstract available


  1022. KROLAK-SALMON P, Dubois B, Sellal F, Delabrousse-Mayoux JP, et al
    France Will No More Reimburse Available Symptomatic Drugs Against Alzheimer's Disease.
    J Alzheimers Dis. 2018 Sep 28. pii: JAD180843. doi: 10.3233/JAD-180843.
    PubMed     Abstract available


  1023. LOMIGUEN C, Vidal L, Kozlowski P, Prancan A, et al
    Possible Role of Chitin-Like Proteins in the Etiology of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Sep 28. pii: JAD180326. doi: 10.3233/JAD-180326.
    PubMed     Abstract available


  1024. FRANK L, Wesson Ashford J, Bayley P, Borson S, et al
    Genetic Risk of Alzheimer's Disease: Three Wishes Now That the Genie is Out of the Bottle.
    J Alzheimers Dis. 2018 Sep 27. pii: JAD180629. doi: 10.3233/JAD-180629.
    PubMed     Abstract available


  1025. FIORINI M, Bongianni M, Donata Benedetti M, Monaco S, et al
    Reappraisal of Abeta40 and Abeta42 Peptides Measurements in Cerebrospinal Fluid of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Sep 26. pii: JAD180616. doi: 10.3233/JAD-180616.
    PubMed     Abstract available


  1026. R ZAMMIT A, B Hall C, J Katz M, Muniz-Terrera G, et al
    Class-Specific Incidence of All-Cause Dementia and Alzheimer's Disease: A Latent Class Approach.
    J Alzheimers Dis. 2018 Sep 26. pii: JAD180604. doi: 10.3233/JAD-180604.
    PubMed     Abstract available


  1027. SARYCHEVA T, Taipale H, Lavikainen P, Tiihonen J, et al
    Incidence and Prevalence of Antiepileptic Medication Use in Community-Dwelling Persons with and without Alzheimer's Disease.
    J Alzheimers Dis. 2018 Sep 26. pii: JAD180594. doi: 10.3233/JAD-180594.
    PubMed     Abstract available


  1028. GRIZZANTI J, Corrigan R, Casadesus G
    Neuroprotective Effects of Amylin Analogues on Alzheimer's Disease Pathogenesis and Cognition.
    J Alzheimers Dis. 2018 Sep 26. pii: JAD180433. doi: 10.3233/JAD-180433.
    PubMed     Abstract available


  1029. PANAGAKI T, Gengler S, Holscher C
    The Novel DA-CH3 Dual Incretin Restores Endoplasmic Reticulum Stress and Autophagy Impairments to Attenuate Alzheimer-Like Pathology and Cognitive Decrements in the APPSWE/PS1DeltaE9 Mouse Model.
    J Alzheimers Dis. 2018 Sep 25. pii: JAD180584. doi: 10.3233/JAD-180584.
    PubMed     Abstract available


  1030. MINN YK, Hye Choi S, Ju Suh Y, Hyang Jeong J, et al
    Effect of Physical Activity on the Progression of Alzheimer's Disease: The Clinical Research Center for Dementia of South Korea Study.
    J Alzheimers Dis. 2018 Sep 25. pii: JAD180333. doi: 10.3233/JAD-180333.
    PubMed     Abstract available


  1031. J DOIG A
    Positive Feedback Loops in Alzheimer's Disease: The Alzheimer's Feedback Hypothesis.
    J Alzheimers Dis. 2018 Sep 24. pii: JAD180583. doi: 10.3233/JAD-180583.
    PubMed     Abstract available


  1032. BERA G, Migliaccio R, Michelin T, Lamari F, et al
    Parietal Involvement in the Semantic Variant of Primary Progressive Aphasia with Alzheimer's Disease Cerebrospinal Fluid Profile.
    J Alzheimers Dis. 2018 Sep 24. pii: JAD180087. doi: 10.3233/JAD-180087.
    PubMed     Abstract available


  1033. AVILA-VILLANUEVA M, Maestu F, Fernandez-Blazquez MA
    Internal Consistency Over Time of Subjective Cognitive Decline: Drawing Preclinical Alzheimer's Disease Trajectories.
    J Alzheimers Dis. 2018 Sep 19. pii: JAD180307. doi: 10.3233/JAD-180307.
    PubMed     Abstract available


  1034. NAGATA T, Shinagawa S, Nakajima S, Mimura M, et al
    Association between Neuropsychiatric Improvement and Neurocognitive Change in Alzheimer's Disease: Analysis of the CATIE-AD Study.
    J Alzheimers Dis. 2018 Sep 18. pii: JAD180304. doi: 10.3233/JAD-180304.
    PubMed     Abstract available


  1035. EMMERZAAL TL, Rodenburg RJ, Tanila H, Verweij V, et al
    Age-Dependent Decrease of Mitochondrial Complex II Activity in a Familial Mouse Model for Alzheimer's Disease.
    J Alzheimers Dis. 2018 Sep 15. pii: JAD180337. doi: 10.3233/JAD-180337.
    PubMed     Abstract available


  1036. LAUGISCH O, Johnen A, Maldonado A, Ehmke B, et al
    Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Sep 11. pii: JAD180620. doi: 10.3233/JAD-180620.
    PubMed     Abstract available


  1037. EHRENBERG AJ, Suemoto CK, de Paula Franca Resende E, Petersen C, et al
    Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Sep 7. pii: JAD180688. doi: 10.3233/JAD-180688.
    PubMed     Abstract available


  1038. KOYCHEV I, Galna B, Zetterberg H, Lawson J, et al
    Abeta42/Abeta40 and Abeta42/Abeta38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2018 Sep 4. pii: JAD180622. doi: 10.3233/JAD-180622.
    PubMed     Abstract available


  1039. O'BRYANT SE, Zhang F, Johnson LA, Hall J, et al
    A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Sep 4. pii: JAD180619. doi: 10.3233/JAD-180619.
    PubMed     Abstract available


    August 2018
  1040. HUAN T, Tran T, Zheng J, Sapkota S, et al
    Metabolomics Analyses of Saliva Detect Novel Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Aug 28. pii: JAD180711. doi: 10.3233/JAD-180711.
    PubMed     Abstract available


  1041. BLOCH K, Gil-Ad I, Vanichkin A, Hornfeld SH, et al
    Intracranial Transplantation of Pancreatic Islets Attenuates Cognitive and Peripheral Metabolic Dysfunctions in a Rat Model of Sporadic Alzheimer's Disease.
    J Alzheimers Dis. 2018 Aug 28. pii: JAD180623. doi: 10.3233/JAD-180623.
    PubMed     Abstract available


  1042. HEDDERICH DM, Spiro JE, Goldhardt O, Kaesmacher J, et al
    Increasing Diagnostic Accuracy of Mild Cognitive Impairment due to Alzheimer's Disease by User-Independent, Web-Based Whole-Brain Volumetry.
    J Alzheimers Dis. 2018 Aug 27. pii: JAD180532. doi: 10.3233/JAD-180532.
    PubMed     Abstract available


  1043. WANG B, Miao L, Niu Y, Cao R, et al
    Abnormal Functional Brain Networks in Mild Cognitive Impairment and Alzheimer's Disease: A Minimum Spanning Tree Analysis.
    J Alzheimers Dis. 2018 Aug 23. pii: JAD180603. doi: 10.3233/JAD-180603.
    PubMed     Abstract available


  1044. YUMOTO S, Kakimi S, Ishikawa A
    Colocalization of Aluminum and Iron in Nuclei of Nerve Cells in Brains of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Aug 23. pii: JAD171108. doi: 10.3233/JAD-171108.
    PubMed     Abstract available


  1045. RAMANAN VK, Przybelski SA, Graff-Radford J, Castillo AM, et al
    Statins and Brain Health: Alzheimer's Disease and Cerebrovascular Disease Biomarkers in Older Adults.
    J Alzheimers Dis. 2018 Aug 22. pii: JAD180446. doi: 10.3233/JAD-180446.
    PubMed     Abstract available


  1046. YUAN H, Yang W
    Genetically Determined Serum Uric Acid and Alzheimer's Disease Risk.
    J Alzheimers Dis. 2018 Aug 21. pii: JAD180538. doi: 10.3233/JAD-180538.
    PubMed     Abstract available


  1047. HOLDEN JG, Cosnard A, Laurens B, Asselineau J, et al
    Prodromal Alzheimer's Disease Demonstrates Increased Errors at a Simple and Automated Anti-Saccade Task.
    J Alzheimers Dis. 2018 Aug 21. pii: JAD180082. doi: 10.3233/JAD-180082.
    PubMed     Abstract available


  1048. JAVANSHIRI K, Waldo ML, Friberg N, Sjovall F, et al
    Atherosclerosis, Hypertension, and Diabetes in Alzheimer's Disease, Vascular Dementia, and Mixed Dementia: Prevalence and Presentation.
    J Alzheimers Dis. 2018 Aug 20. pii: JAD180644. doi: 10.3233/JAD-180644.
    PubMed     Abstract available


  1049. BUSS SS, Padmanabhan J, Saxena S, Pascual-Leone A, et al
    Atrophy in Distributed Networks Predicts Cognition in Alzheimer's Disease and Type 2 Diabetes.
    J Alzheimers Dis. 2018 Aug 20. pii: JAD180570. doi: 10.3233/JAD-180570.
    PubMed     Abstract available


  1050. ALBANI D, Marizzoni M, Ferrari C, Fusco F, et al
    Plasma Abeta42 as Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study.
    J Alzheimers Dis. 2018 Aug 20. pii: JAD180321. doi: 10.3233/JAD-180321.
    PubMed     Abstract available


  1051. OLIVEIRA FF, Almeida SS, Chen ES, Smith MC, et al
    Lifetime Risk Factors for Functional and Cognitive Outcomes in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Aug 20. pii: JAD180303. doi: 10.3233/JAD-180303.
    PubMed     Abstract available


  1052. LIANG JW, Fang ZY, Huang Y, Liuyang ZY, et al
    Application of Weighted Gene Co-Expression Network Analysis to Explore the Key Genes in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Aug 16. pii: JAD180400. doi: 10.3233/JAD-180400.
    PubMed     Abstract available


  1053. VICENTE MC, Almeida MC, Bicego KC, Carrettiero DC, et al
    Hypercapnic and Hypoxic Respiratory Response During Wakefulness and Sleep in a Streptozotocin Model of Alzheimer's Disease in Rats.
    J Alzheimers Dis. 2018 Aug 14. pii: JAD180397. doi: 10.3233/JAD-180397.
    PubMed     Abstract available


  1054. BENVENUTTO A, Giusiano B, Koric L, Gueriot C, et al
    Imaging Biomarkers of Neurodegeneration in Alzheimer's Disease: Distinct Contributions of Cortical MRI Atrophy and FDG-PET Hypometabolism.
    J Alzheimers Dis. 2018 Aug 13. pii: JAD180292. doi: 10.3233/JAD-180292.
    PubMed     Abstract available


  1055. E BAKER J, Ying Lim Y, Jaeger J, Ames D, et al
    Episodic Memory and Learning Dysfunction Over an 18-Month Period in Preclinical and Prodromal Alzheimer's Disease.
    J Alzheimers Dis. 2018 Aug 9. pii: JAD180344. doi: 10.3233/JAD-180344.
    PubMed     Abstract available


  1056. DOMINGUEZ-PRIETO M, Velasco A, Tabernero A, Medina JM, et al
    Endocytosis and Transcytosis of Amyloid-beta Peptides by Astrocytes: A Possible Mechanism for Amyloid-beta Clearance in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Aug 7. pii: JAD180332. doi: 10.3233/JAD-180332.
    PubMed     Abstract available


  1057. BULK M, Kenkhuis B, Graaf LMV, Goeman JJ, et al
    Postmortem T2*- Weighted MRI Imaging of Cortical Iron Reflects Severity of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Aug 7. pii: JAD180317. doi: 10.3233/JAD-180317.
    PubMed     Abstract available


  1058. RITCHIE K, Carriere I, Howett D, Su L, et al
    Allocentric and Egocentric Spatial Processing in Middle-Aged Adults at High Risk of Late-Onset Alzheimer's Disease: The PREVENT Dementia Study.
    J Alzheimers Dis. 2018 Aug 4. pii: JAD180432. doi: 10.3233/JAD-180432.
    PubMed     Abstract available


  1059. DUINKERKEN EV, Farme J, Landeira-Fernandez J, Dourado MC, et al
    Medical and Research Consent Decision-Making Capacity in Patients with Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2018 Aug 3. pii: JAD180311. doi: 10.3233/JAD-180311.
    PubMed     Abstract available


  1060. ZALETEL I, Schwirtlich M, Perovic M, Jovanovic M, et al
    Early Impairments of Hippocampal Neurogenesis in 5xFAD Mouse Model of Alzheimer's Disease Are Associated with Altered Expression of SOXB Transcription Factors.
    J Alzheimers Dis. 2018 Aug 3. pii: JAD180277. doi: 10.3233/JAD-180277.
    PubMed     Abstract available


  1061. LIZIO R, Babiloni C, Percio CD, Losurdo A, et al
    Different Abnormalities of Cortical Neural Synchronization Mechanisms in Patients with Mild Cognitive Impairment due to Alzheimer's and Chronic Kidney Diseases: An EEG Study.
    J Alzheimers Dis. 2018 Aug 3. pii: JAD180245. doi: 10.3233/JAD-180245.
    PubMed     Abstract available


  1062. SCHELTENS NME, Tijms BM, Heymans MW, Rabinovici GD, et al
    Prominent Non-Memory Deficits in Alzheimer's Disease Are Associated with Faster Disease Progression.
    J Alzheimers Dis. 2018 Aug 3. pii: JAD171088. doi: 10.3233/JAD-171088.
    PubMed     Abstract available


    July 2018
  1063. KERET O, Shochat T, Steiner I, Glik A, et al
    Non-Ashkenazi Jewish Origin is Associated with Early Onset Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 30. pii: JAD180331. doi: 10.3233/JAD-180331.
    PubMed     Abstract available


  1064. ZOLOCHEVSKA O, Bjorklund N, Woltjer R, Wiktorowicz JE, et al
    Postsynaptic Proteome of Non-Demented Individuals with Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2018 Jul 30. pii: JAD180179. doi: 10.3233/JAD-180179.
    PubMed     Abstract available


  1065. SLEGERS A, Filiou RP, Montembeault M, Brambati SM, et al
    Connected Speech Features from Picture Description in Alzheimer's Disease: A Systematic Review.
    J Alzheimers Dis. 2018 Jul 30. pii: JAD170881. doi: 10.3233/JAD-170881.
    PubMed     Abstract available


  1066. KONTAXOPOULOU D, Beratis IN, Fragkiadaki S, Pavlou D, et al
    Exploring the Profile of Incidental Memory in Patients with Amnestic Mild Cognitive Impairment and Mild Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 27. pii: JAD180328. doi: 10.3233/JAD-180328.
    PubMed     Abstract available


  1067. LEE J, Cho H, Jeon S, Jin Kim H, et al
    Sex-Related Reserve Hypothesis in Alzheimer's Disease: Changes in Cortical Thickness with a Five-Year Longitudinal Follow-Up.
    J Alzheimers Dis. 2018 Jul 26. pii: JAD180049. doi: 10.3233/JAD-180049.
    PubMed     Abstract available


  1068. MANUEL GORRIZ J, Iglesias-Gonzalez E, Ramirez J
    Multivariate Approaches in Neuroimaging: Assessing the Connectome of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 21. pii: JAD180654. doi: 10.3233/JAD-180654.
    PubMed    


  1069. BOHLKEN J, Kostev K
    Relevance of Coded Prodromal Mild Cognitive Impairment in the Routine Treatment of Patients with Dementia in Germany.
    J Alzheimers Dis. 2018 Jul 21. pii: JAD180567. doi: 10.3233/JAD-180567.
    PubMed     Abstract available


  1070. GUERRIER L, Men JL, Gane A, Planton M, et al
    Involvement of the Cingulate Cortex in Anosognosia: A Multimodal Neuroimaging Study in Alzheimer's Disease Patients.
    J Alzheimers Dis. 2018 Jul 20. pii: JAD180324. doi: 10.3233/JAD-180324.
    PubMed     Abstract available


  1071. DE LA RUBIA ORTI JE, Garcia-Pardo MRIP, Drehmer E, Cantus DS, et al
    Improvement of Main Cognitive Functions in Patients with Alzheimer's Disease after Treatment with Coconut Oil Enriched Mediterranean Diet: A Pilot Study.
    J Alzheimers Dis. 2018 Jul 20. pii: JAD180184. doi: 10.3233/JAD-180184.
    PubMed     Abstract available


  1072. JIN H, Guan S, Wang R, Fang X, et al
    The Distribution of Urinary Alzheimer-Associated Neuronal Thread Protein and Its Association with Common Chronic Diseases in the General Population.
    J Alzheimers Dis. 2018 Jul 19. pii: JAD180441. doi: 10.3233/JAD-180441.
    PubMed     Abstract available


  1073. RAIKWAR SP, Thangavel R, Dubova I, Ejaz Ahmed M, et al
    Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer's Disease: Are We There Yet?
    J Alzheimers Dis. 2018 Jul 19. pii: JAD180422. doi: 10.3233/JAD-180422.
    PubMed     Abstract available


  1074. STEFFEN J, Stenzel J, Ibrahim S, Pahnke J, et al
    Short-Term Effects of Microglia-Specific Mitochondrial Dysfunction on Amyloidosis in Transgenic Models of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 19. pii: JAD180395. doi: 10.3233/JAD-180395.
    PubMed     Abstract available


  1075. MCDERMOTT B, Porter E, Hughes D, McGinley B, et al
    Gamma Band Neural Stimulation in Humans and the Promise of a New Modality to Prevent and Treat Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 19. pii: JAD180391. doi: 10.3233/JAD-180391.
    PubMed     Abstract available


  1076. SCOTT TM, Bhadelia RA, Qiao Qiu W, Folstein MF, et al
    Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer's Disease and Mild Cognitive Impairment: A Potential Target for Intervention.
    J Alzheimers Dis. 2018 Jul 18. pii: JAD180366. doi: 10.3233/JAD-180366.
    PubMed     Abstract available


  1077. AGUAYO S, Schuh CMAP, Vicente B, Aguayo LG, et al
    Association between Alzheimer's Disease and Oral and Gut Microbiota: Are Pore Forming Proteins the Missing Link?
    J Alzheimers Dis. 2018 Jul 18. pii: JAD180319. doi: 10.3233/JAD-180319.
    PubMed     Abstract available


  1078. YAO F, Hong X, Li S, Zhang Y, et al
    Urine-Based Biomarkers for Alzheimer's Disease Identified Through Coupling Computational and Experimental Methods.
    J Alzheimers Dis. 2018 Jul 18. pii: JAD180261. doi: 10.3233/JAD-180261.
    PubMed     Abstract available


  1079. SOBOL NA, Have Dall C, Hgh P, Hoffmann K, et al
    Change in Fitness and the Relation to Change in Cognition and Neuropsychiatric Symptoms After Aerobic Exercise in Patients with Mild Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 18. pii: JAD180253. doi: 10.3233/JAD-180253.
    PubMed     Abstract available


  1080. MERCORIO R, Pergoli L, Galimberti D, Favero C, et al
    PICALM Gene Methylation in Blood of Alzheimer's Disease Patients Is Associated with Cognitive Decline.
    J Alzheimers Dis. 2018 Jul 18. pii: JAD180242. doi: 10.3233/JAD-180242.
    PubMed     Abstract available


  1081. CRUZ-RIVERA YE, Perez-Morales J, Santiago YM, Gonzalez VM, et al
    A Selection of Important Genes and Their Correlated Behavior in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 18. pii: JAD170799. doi: 10.3233/JAD-170799.
    PubMed     Abstract available


  1082. WATAD A, Bragazzi NL, Tiosano S, Yavne Y, et al
    Alzheimer's Disease in Systemic Sclerosis Patients: A Nationwide Population-Based Cohort Study.
    J Alzheimers Dis. 2018 Jul 17. pii: JAD180516. doi: 10.3233/JAD-180516.
    PubMed     Abstract available


  1083. PANDAREESH MD, Chauhan V, Chauhan A
    Walnut Supplementation in the Diet Reduces Oxidative Damage and Improves Antioxidant Status in Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 17. pii: JAD180361. doi: 10.3233/JAD-180361.
    PubMed     Abstract available


  1084. ROCHA NP, Toledo A, Corgosinho LTS, Souza LC, et al
    Cerebrospinal Fluid Levels of Angiotensin-Converting Enzyme Are Associated with Amyloid-beta42 Burden in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 17. pii: JAD180282. doi: 10.3233/JAD-180282.
    PubMed     Abstract available


  1085. GUZMAN-VELEZ E, Jaimes S, Aguirre-Acevedo DC, Norton DJ, et al
    A Three-Factor Structure of Cognitive Functioning Among Carriers and Non-Carriers of Autosomal-Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 17. pii: JAD180078. doi: 10.3233/JAD-180078.
    PubMed     Abstract available


  1086. SHAO Y, Jiang H, Wei Y, Shi Y, et al
    Visualization of Focal Thinning of the Ganglion Cell- Inner Plexiform Layer in Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 17. pii: JAD180070. doi: 10.3233/JAD-180070.
    PubMed     Abstract available


  1087. PITON M, Hirtz C, Desmetz C, Milhau J, et al
    Alzheimer's Disease: Advances in Drug Development.
    J Alzheimers Dis. 2018 Jul 16. pii: JAD180145. doi: 10.3233/JAD-180145.
    PubMed     Abstract available


  1088. PADOVANI A, Benussi A, Cantoni V, Dell'Era V, et al
    Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease with Transcranial Magnetic Stimulation.
    J Alzheimers Dis. 2018 Jul 13. pii: JAD180293. doi: 10.3233/JAD-180293.
    PubMed     Abstract available


  1089. SMAILAGIC N, Lafortune L, Kelly S, Hyde C, et al
    18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy.
    J Alzheimers Dis. 2018 Jul 13. pii: JAD171125. doi: 10.3233/JAD-171125.
    PubMed     Abstract available


  1090. BRENDEL M, Sauerbeck J, Greven S, Kotz S, et al
    Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms.
    J Alzheimers Dis. 2018 Jul 13. pii: JAD170387. doi: 10.3233/JAD-170387.
    PubMed     Abstract available


  1091. CASAMITJANA A, Petrone P, Tucholka A, Falcon C, et al
    MRI-Based Screening of Preclinical Alzheimer's Disease for Prevention Clinical Trials.
    J Alzheimers Dis. 2018 Jul 12. pii: JAD180299. doi: 10.3233/JAD-180299.
    PubMed     Abstract available


  1092. NI H, Xu M, Zhan GL, Fan Y, et al
    The GWAS Risk Genes for Depression May Be Actively Involved in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 12. pii: JAD180276. doi: 10.3233/JAD-180276.
    PubMed     Abstract available


  1093. E WHITSON H, G Potter G, A Feld J, L Plassman B, et al
    Dual-Task Gait and Alzheimer's Disease Genetic Risk in Cognitively Normal Adults: A Pilot Study.
    J Alzheimers Dis. 2018 Jul 12. pii: JAD180016. doi: 10.3233/JAD-180016.
    PubMed     Abstract available


  1094. MUSAEUS CS, Engedal K, Hgh P, Jelic V, et al
    EEG Theta Power Is an Early Marker of Cognitive Decline in Dementia due to Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 6. pii: JAD180300. doi: 10.3233/JAD-180300.
    PubMed     Abstract available


  1095. KENT BA, Strittmatter SM, Nygaard H
    Sleep and EEG Power Spectral Analysis in Three Transgenic Mouse Models of Alzheimer's Disease: APP/PS1, 3xTgAD, and Tg2576.
    J Alzheimers Dis. 2018 Jul 6. pii: JAD180260. doi: 10.3233/JAD-180260.
    PubMed     Abstract available


  1096. THYGESEN C, Metaxas A, Larsen MR, Finsen B, et al
    Age-Dependent Changes in the Sarkosyl-Insoluble Proteome of APPSWE/PS1DeltaE9 Transgenic Mice Implicate Dysfunctional Mitochondria in the Pathogenesis of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 6. pii: JAD180197. doi: 10.3233/JAD-180197.
    PubMed     Abstract available


  1097. LYU J, Zhang J, Mu H, Li W, et al
    The Effects of Music Therapy on Cognition, Psychiatric Symptoms, and Activities of Daily Living in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jul 6. pii: JAD180183. doi: 10.3233/JAD-180183.
    PubMed     Abstract available


    June 2018
  1098. SAO T, Yoshino Y, Yamazaki K, Ozaki Y, et al
    TREM1 mRNA Expression in Leukocytes and Cognitive Function in Japanese Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 28. pii: JAD180418. doi: 10.3233/JAD-180418.
    PubMed     Abstract available


  1099. SAHOO A, Benjanin A, Murray ME, Tosakulwong N, et al
    TDP-43 and Alzheimer's Disease Pathologic Subtype in Non-Amnestic Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2018 Jun 28. pii: JAD180169. doi: 10.3233/JAD-180169.
    PubMed     Abstract available


  1100. R BEAM C, Kaneshiro C, Yun Jang J, A Reynolds C, et al
    Differences Between Women and Men in Incidence Rates of Dementia and Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 27. pii: JAD180141. doi: 10.3233/JAD-180141.
    PubMed     Abstract available


  1101. FEMMINELLA GD, Taylor-Davies G, Scott J, Edison P, et al
    Do Cardiometabolic Risk Factors Influence Amyloid, Tau, and Neuronal Function in APOE4 Carriers and Non-Carriers in Alzheimer's Disease Trajectory?
    J Alzheimers Dis. 2018 Jun 23. pii: JAD180365. doi: 10.3233/JAD-1803656.
    PubMed     Abstract available


  1102. RITCHIE CW, Khandker RK, Pike J, Black CM, et al
    Real-World, Multinational, Retrospective Observational Survey of the ADAS-Cog and Associations with Healthcare Resource Utilization in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 23. pii: JAD180306. doi: 10.3233/JAD-180306.
    PubMed     Abstract available


  1103. CHEN Y, Lim P, Rogers KA, Rutt BK, et al
    In Vivo MRI of Amyloid Plaques in a Cholesterol-Fed Rabbit Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 23. pii: JAD180207. doi: 10.3233/JAD-180207.
    PubMed     Abstract available


  1104. SCHARTMANN E, Schemmert S, Niemietz N, Honold D, et al
    In Vitro Potency and Preclinical Pharmacokinetic Comparison of All-D-Enantiomeric Peptides Developed for the Treatment of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 23. pii: JAD180165. doi: 10.3233/JAD-180165.
    PubMed     Abstract available


  1105. PILLAI JA, Appleby BS, Safar J, Leverenz JB, et al
    Rapidly Progressive Alzheimer's Disease in Two Distinct Autopsy Cohorts.
    J Alzheimers Dis. 2018 Jun 23. pii: JAD180155. doi: 10.3233/JAD-180155.
    PubMed     Abstract available


  1106. DERK J, Bermudez Hernandez K, Rodriguez M, He M, et al
    Diaphanous 1 (DIAPH1) is Highly Expressed in the Aged Human Medial Temporal Cortex and Upregulated in Myeloid Cells During Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 23. pii: JAD180088. doi: 10.3233/JAD-180088.
    PubMed     Abstract available


  1107. BARTOS A, Fialova L, Svarcova J
    Lower Serum Antibodies Against Tau Protein and Heavy Neurofilament in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 23. pii: JAD180039. doi: 10.3233/JAD-180039.
    PubMed     Abstract available


  1108. RUIZ E, Ramirez J, Gorriz JM, Casillas J, et al
    Alzheimer's Disease Computer-Aided Diagnosis: Histogram-Based Analysis of Regional MRI Volumes for Feature Selection and Classification.
    J Alzheimers Dis. 2018 Jun 23. pii: JAD170514. doi: 10.3233/JAD-170514.
    PubMed     Abstract available


  1109. LARSSON SC, Markus HS
    Does Treating Vascular Risk Factors Prevent Dementia and Alzheimer's Disease? A Systematic Review and Meta-Analysis.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD180288. doi: 10.3233/JAD-180288.
    PubMed     Abstract available


  1110. AKHTER H, Huang WT, van Groen T, Kuo HC, et al
    A Small Molecule Inhibitor of Plasminogen Activator Inhibitor-1 Reduces Brain Amyloid-beta Load and Improves Memory in an Animal Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD180241. doi: 10.3233/JAD-180241.
    PubMed     Abstract available


  1111. HAAPALA EA, Paananen J, Hiltunen M, Lakka TA, et al
    Associations of Genetic Susceptibility to Alzheimer's Disease with Adiposity and Cardiometabolic Risk Factors among Children in a 2-Year Follow-up Study.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD180216. doi: 10.3233/JAD-180216.
    PubMed     Abstract available


  1112. CROTEAU E, Castellano CA, Richard MA, Fortier M, et al
    Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD180202. doi: 10.3233/JAD-180202.
    PubMed     Abstract available


  1113. MARIZZONI M, Ferrari C, Jovicich J, Albani D, et al
    Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD180152. doi: 10.3233/JAD-180152.
    PubMed     Abstract available


  1114. LEOUTSAKOS JS, Yan H, Anderson WS, Asaad WF, et al
    Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD180121. doi: 10.3233/JAD-180121.
    PubMed     Abstract available


  1115. TEIPEL SJ, Metzger C, Brosseron F, Buerger K, et al
    Multicenter Resting State Functional Connectivity in Prodromal and Dementia Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD180106. doi: 10.3233/JAD-180106.
    PubMed     Abstract available


  1116. HUTTON CP, Lemon JA, Sakic B, Rollo CD, et al
    Early Intervention with a Multi-Ingredient Dietary Supplement Improves Mood and Spatial Memory in a Triple Transgenic Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD170921. doi: 10.3233/JAD-170921.
    PubMed     Abstract available


  1117. GIIL LM, Aarsland D, Hellton K, Lund A, et al
    Antibodies to Multiple Receptors are Associated with Neuropsychiatric Symptoms and Mortality in Alzheimer's Disease: A Longitudinal Study.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD170882. doi: 10.3233/JAD-170882.
    PubMed     Abstract available


  1118. CHALATSA I, Arvanitis DA, Mikropoulou EV, Giagini A, et al
    Beneficial Effects of Sideritis scardica and Cichorium spinosum against Amyloidogenic Pathway and Tau Misprocessing in Alzheimer's Disease Neuronal Cell Culture Models.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD170862. doi: 10.3233/JAD-170862.
    PubMed     Abstract available


  1119. BARNES J, Bartlett JW, Wolk DA, van der Flier WM, et al
    Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 9. pii: JAD170841. doi: 10.3233/JAD-170841.
    PubMed     Abstract available


  1120. BROOKES KJ, McConnell G, Williams K, Chaudhury S, et al
    Genotyping of the Alzheimer's Disease Genome-Wide Association Study Index Single Nucleotide Polymorphisms in the Brains for Dementia Research Cohort.
    J Alzheimers Dis. 2018 Jun 8. pii: JAD180191. doi: 10.3233/JAD-180191.
    PubMed     Abstract available


  1121. FURCILA D, DeFelipe J, Alonso-Nanclares L
    A Study of Amyloid-beta and Phosphotau in Plaques and Neurons in the Hippocampus of Alzheimer's Disease Patients.
    J Alzheimers Dis. 2018 Jun 8. pii: JAD180173. doi: 10.3233/JAD-180173.
    PubMed     Abstract available


  1122. JARVINEN H, Taipale H, Koponen M, Tanskanen A, et al
    Hospitalization after Oral Antibiotic Initiation in Finnish Community Dwellers with and without Alzheimer's Disease: Retrospective Register-Based Cohort Study.
    J Alzheimers Dis. 2018 Jun 8. pii: JAD180125. doi: 10.3233/JAD-180125.
    PubMed     Abstract available


  1123. MADSEN JB, Folke J, Pakkenberg B
    Stereological Quantification of Plaques and Tangles in Neocortex from Alzheimer's Disease Patients.
    J Alzheimers Dis. 2018 Jun 8. pii: JAD180105. doi: 10.3233/JAD-180105.
    PubMed     Abstract available


  1124. MARTINEZ-SANCHEZ F, Meilan JJG, Carro J, Ivanova O, et al
    A Prototype for the Voice Analysis Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 8. pii: JAD180037. doi: 10.3233/JAD-180037.
    PubMed     Abstract available


  1125. SCHIRINZI T, Di Lorenzo F, Sancesario GM, Di Lazzaro G, et al
    Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 8. pii: JAD171166. doi: 10.3233/JAD-171166.
    PubMed     Abstract available


  1126. SALLOWAY SP, Sperling R, Fox NC, Sabbagh MN, et al
    Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study.
    J Alzheimers Dis. 2018 Jun 8. pii: JAD171157. doi: 10.3233/JAD-171157.
    PubMed     Abstract available


  1127. KAWANISHI S, Takata K, Itezono S, Nagayama H, et al
    Bone-Marrow-Derived Microglia-Like Cells Ameliorate Brain Amyloid Pathology and Cognitive Impairment in a Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 8. pii: JAD170994. doi: 10.3233/JAD-170994.
    PubMed     Abstract available


  1128. RUIZ M, Arias A, Sanchez-Llanos E, Gil MP, et al
    Minor Hallucinations in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jun 4. pii: JAD180234. doi: 10.3233/JAD-180234.
    PubMed     Abstract available


    May 2018
  1129. LI H, Jia J, Wang W, Hou T, et al
    Honokiol Alleviates Cognitive Deficits of Alzheimer's Disease (PS1V97L) Transgenic Mice by Activating Mitochondrial SIRT3.
    J Alzheimers Dis. 2018 May 31. pii: JAD180126. doi: 10.3233/JAD-180126.
    PubMed     Abstract available


  1130. SCHMOLE AC, Lundt R, Toporowski G, Hansen JN, et al
    Cannabinoid Receptor 2-Deficiency Ameliorates Disease Symptoms in a Mouse Model with Alzheimer's Disease-Like Pathology.
    J Alzheimers Dis. 2018 May 28. pii: JAD180230. doi: 10.3233/JAD-180230.
    PubMed     Abstract available


  1131. TIEPOLT S, Schafer A, Rullmann M, Roggenhofer E, et al
    Quantitative Susceptibility Mapping of Amyloid-beta Aggregates in Alzheimer's Disease with 7T MR.
    J Alzheimers Dis. 2018 May 28. pii: JAD180118. doi: 10.3233/JAD-180118.
    PubMed     Abstract available


  1132. BARANOWSKI BJ, Hayward GC, Fajardo VA, MacPherson REK, et al
    Increased Prevalence of Obesity/Type 2 Diabetes and Lower Levels of Lithium in Rural Texas Counties May Explain Greater Alzheimer's Disease Risk.
    J Alzheimers Dis. 2018 May 28. pii: JAD171150. doi: 10.3233/JAD-171150.
    PubMed     Abstract available


  1133. POSPORELIS S, David AS, Ashkan K, Shotbolt P, et al
    Deep Brain Stimulation of the Memory Circuit: Improving Cognition in Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 26. pii: JAD180212. doi: 10.3233/JAD-180212.
    PubMed     Abstract available


  1134. TAN MS, Zhu JX, Cao XP, Yu JT, et al
    Rare Variants in PLD3 Increase Risk for Alzheimer's Disease in Han Chinese.
    J Alzheimers Dis. 2018 May 26. pii: JAD180205. doi: 10.3233/JAD-180205.
    PubMed     Abstract available


  1135. LLORENTE-OVEJERO A, Manuel I, Lombardero L, Giralt MT, et al
    Endocannabinoid and Muscarinic Signaling Crosstalk in the 3xTg-AD Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 26. pii: JAD180137. doi: 10.3233/JAD-180137.
    PubMed     Abstract available


  1136. KAMINARI A, Tsilibary EC, Tzinia A
    A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer's Disease and Type 2 Diabetes Mellitus.
    J Alzheimers Dis. 2018 May 26. pii: JAD180035. doi: 10.3233/JAD-180035.
    PubMed     Abstract available


  1137. LANE DJR, Ayton S, Bush AI
    Iron and Alzheimer's Disease: An Update on Emerging Mechanisms.
    J Alzheimers Dis. 2018 May 26. pii: JAD179944. doi: 10.3233/JAD-179944.
    PubMed     Abstract available


  1138. SIGURDSSON EM
    Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls.
    J Alzheimers Dis. 2018 May 26. pii: JAD179937. doi: 10.3233/JAD-179937.
    PubMed     Abstract available


  1139. GULISANO W, Maugeri D, Baltrons MA, Fa M, et al
    Role of Amyloid-beta and Tau Proteins in Alzheimer's Disease: Confuting the Amyloid Cascade.
    J Alzheimers Dis. 2018 May 26. pii: JAD179935. doi: 10.3233/JAD-179935.
    PubMed     Abstract available


  1140. EDISON P, Brooks DJ
    Role of Neuroinflammation in the Trajectory of Alzheimer's Disease and in vivo Quantification Using PET.
    J Alzheimers Dis. 2018 May 26. pii: JAD179929. doi: 10.3233/JAD-179929.
    PubMed     Abstract available


  1141. VOS SJB, Visser PJ
    Preclinical Alzheimer's Disease: Implications for Refinement of the Concept.
    J Alzheimers Dis. 2018 May 23. pii: JAD179943. doi: 10.3233/JAD-179943.
    PubMed     Abstract available


  1142. SCHERR M, Pasquini L, Benson G, Nuttall R, et al
    Decoupling of Local Metabolic Activity and Functional Connectivity Links to Amyloid in Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 19. pii: JAD180022. doi: 10.3233/JAD-180022.
    PubMed     Abstract available


  1143. ALOSCO ML, Sugarman MA, Besser LM, Tripodis Y, et al
    A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology.
    J Alzheimers Dis. 2018 May 19. pii: JAD180017. doi: 10.3233/JAD-180017.
    PubMed     Abstract available


  1144. ADAMS SL, Benayoun L, Tilton K, Mellott TJ, et al
    Immunohistochemical Analysis of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) Expression in the Rat and Human Hippocampus: Decline in CA3 During Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 18. pii: JAD171065. doi: 10.3233/JAD-171065.
    PubMed     Abstract available


  1145. STEENLAND K, Zhao L, John SE, Goldstein FC, et al
    A 'Framingham-like' Algorithm for Predicting 4-Year Risk of Progression to Amnestic Mild Cognitive Impairment or Alzheimer's Disease Using Multidomain Information.
    J Alzheimers Dis. 2018 May 18. pii: JAD170769. doi: 10.3233/JAD-170769.
    PubMed     Abstract available


  1146. COSTA M, Horrillo R, Ortiz AM, Perez A, et al
    Increased Albumin Oxidation in Cerebrospinal Fluid and Plasma from Alzheimer's Disease Patients.
    J Alzheimers Dis. 2018 May 16. pii: JAD180243. doi: 10.3233/JAD-180243.
    PubMed     Abstract available


  1147. BOURGIN J, Guyader N, Chauvin A, Juphard A, et al
    Early Emotional Attention is Impacted in Alzheimer's Disease: An Eye-Tracking Study.
    J Alzheimers Dis. 2018 May 16. pii: JAD180170. doi: 10.3233/JAD-180170.
    PubMed     Abstract available


  1148. MA FC, Wang HF, Cao XP, Tan CC, et al
    Meta-Analysis of the Association between Variants in ABCA7 and Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 16. pii: JAD180107. doi: 10.3233/JAD-180107.
    PubMed     Abstract available


  1149. CAI Z, Qiao PF, Wan CQ, Cai M, et al
    Role of Blood-Brain Barrier in Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 16. pii: JAD180098. doi: 10.3233/JAD-180098.
    PubMed     Abstract available


  1150. ANDRADE A, Bubu OM, Varga AW, Osorio RS, et al
    The Relationship between Obstructive Sleep Apnea and Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 16. pii: JAD179936. doi: 10.3233/JAD-179936.
    PubMed     Abstract available


  1151. MORMINO EC, Papp KV
    Amyloid Accumulation and Cognitive Decline in Clinically Normal Older Individuals: Implications for Aging and Early Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 16. pii: JAD179928. doi: 10.3233/JAD-179928.
    PubMed     Abstract available


  1152. BESSI V, Mazzeo S, Padiglioni S, Piccini C, et al
    From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study.
    J Alzheimers Dis. 2018 May 16. pii: JAD171180. doi: 10.3233/JAD-171180.
    PubMed     Abstract available


  1153. MIRON J, Picard C, Frappier J, Dea D, et al
    TLR4 Gene Expression and Pro-Inflammatory Cytokines in Alzheimer's Disease and in Response to Hippocampal Deafferentation in Rodents.
    J Alzheimers Dis. 2018 May 16. pii: JAD171160. doi: 10.3233/JAD-171160.
    PubMed     Abstract available


  1154. NIEMANTSVERDRIET E, Ribbens A, Bastin C, Benoit F, et al
    A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER).
    J Alzheimers Dis. 2018 May 16. pii: JAD171140. doi: 10.3233/JAD-171140.
    PubMed     Abstract available


  1155. PAIRE-FICOUT L, Lafont S, Conte F, Coquillat A, et al
    Naturalistic Driving Study Investigating Self-Regulation Behavior in Early Alzheimer's Disease: A Pilot Study.
    J Alzheimers Dis. 2018 May 16. pii: JAD171031. doi: 10.3233/JAD-171031.
    PubMed     Abstract available


  1156. MOUSTAFA AA, El Haj M
    Phenomenological Characteristics of Future Thinking in Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 11. pii: JAD180182. doi: 10.3233/JAD-180182.
    PubMed     Abstract available


  1157. ZHUANG ZQ, Shen LL, Li WW, Fu X, et al
    Gut Microbiome is Altered in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 11. pii: JAD180176. doi: 10.3233/JAD-180176.
    PubMed     Abstract available


  1158. QUINN J
    Lost in Translation? Finding Our Way To Effective Alzheimer's Disease Therapies.
    J Alzheimers Dis. 2018 May 11. pii: JAD179930. doi: 10.3233/JAD-179930.
    PubMed     Abstract available


  1159. ZETTERBERG H, Blennow K
    From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer's Disease.
    J Alzheimers Dis. 2018 May 11. pii: JAD179926. doi: 10.3233/JAD-179926.
    PubMed     Abstract available


  1160. ROUDIL J, Deramecourt V, Dufournet B, Dubois B, et al
    Influence of Lewy Pathology on Alzheimer's Disease Phenotype: A Retrospective Clinico-Pathological Study.
    J Alzheimers Dis. 2018 May 11. pii: JAD170914. doi: 10.3233/JAD-170914.
    PubMed     Abstract available


    April 2018
  1161. HONG YJ, Choi SH, Jeong JH, Park KW, et al
    Effectiveness of Anti-Dementia Drugs in Extremely Severe Alzheimer's Disease: A 12-Week, Multicenter, Randomized, Single-Blind Study.
    J Alzheimers Dis. 2018 Apr 28. pii: JAD180159. doi: 10.3233/JAD-180159.
    PubMed     Abstract available


  1162. MAHAMAN YAR, Huang F, Wu M, Wang Y, et al
    Moringa Oleifera Alleviates Homocysteine-Induced Alzheimer's Disease-Like Pathology and Cognitive Impairments.
    J Alzheimers Dis. 2018 Apr 28. pii: JAD180091. doi: 10.3233/JAD-180091.
    PubMed     Abstract available


  1163. GRILL JD, Hoang D, Gillen DL, Cox CG, et al
    Constructing a Local Potential Participant Registry to Improve Alzheimer's Disease Clinical Research Recruitment.
    J Alzheimers Dis. 2018 Apr 28. pii: JAD180069. doi: 10.3233/JAD-180069.
    PubMed     Abstract available


  1164. PROSERPIO P, Arnaldi D, Nobili F, Nobili L, et al
    Integrating Sleep and Alzheimer's Disease Pathophysiology: Hints for Sleep Disorders Management.
    J Alzheimers Dis. 2018 Apr 28. pii: JAD180041. doi: 10.3233/JAD-180041.
    PubMed     Abstract available


  1165. MENDEZ MF, Moheb N, Desarzant RE, Teng EH, et al
    The Progressive Acalculia Presentation of Parietal Variant Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 28. pii: JAD180024. doi: 10.3233/JAD-180024.
    PubMed     Abstract available


  1166. TYUMENTSEV MA, Stefanova NA, Muraleva NA, Rumyantseva YV, et al
    Mitochondrial Dysfunction as a Predictor and Driver of Alzheimer's Disease-Like Pathology in OXYS Rats.
    J Alzheimers Dis. 2018 Apr 27. pii: JAD180065. doi: 10.3233/JAD-180065.
    PubMed     Abstract available


  1167. LEE JH, Jahrling JB, Denner L, Dineley KT, et al
    Targeting Insulin for Alzheimer's Disease: Mechanisms, Status and Potential Directions.
    J Alzheimers Dis. 2018 Apr 27. pii: JAD179923. doi: 10.3233/JAD-179923.
    PubMed     Abstract available


  1168. HORVATH A, Szucs A, Hidasi Z, Csukly G, et al
    Prevalence, Semiology, and Risk Factors of Epilepsy in Alzheimer's Disease: An Ambulatory EEG Study.
    J Alzheimers Dis. 2018 Apr 27. pii: JAD170925. doi: 10.3233/JAD-170925.
    PubMed     Abstract available


  1169. HUANG Y, Guo B, Shi B, Gao Q, et al
    Chinese Herbal Medicine Xueshuantong Enhances Cerebral Blood Flow and Improves Neural Functions in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2018 Apr 27. pii: JAD170763. doi: 10.3233/JAD-170763.
    PubMed     Abstract available


  1170. LEE WJ, Han CE, Aganj I, Seo SW, et al
    Distinct Patterns of Rich Club Organization in Alzheimer's Disease and Subcortical Vascular Dementia: A White Matter Network Study.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD180027. doi: 10.3233/JAD-180027.
    PubMed     Abstract available


  1171. CORTES N, Andrade V, Maccioni RB
    Behavioral and Neuropsychiatric Disorders in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD180005. doi: 10.3233/JAD-180005.
    PubMed     Abstract available


  1172. SELLES MC, Oliveira MM, Ferreira ST
    Brain Inflammation Connects Cognitive and Non-Cognitive Symptoms in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD179925. doi: 10.3233/JAD-179925.
    PubMed     Abstract available


  1173. WIMO A
    The End of the Beginning of the Alzheimer's Disease Nightmare: A Devil's Advocate's View.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD179905. doi: 10.3233/JAD-179905.
    PubMed     Abstract available


  1174. ABU-RUMEILEH S, Capellari S, Parchi P
    Rapidly Progressive Alzheimer's Disease: Contributions to Clinical-Pathological Definition and Diagnosis.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD171181. doi: 10.3233/JAD-171181.
    PubMed     Abstract available


  1175. SHI Y, Fang YY, Wei YP, Jiang Q, et al
    Melatonin in Synaptic Impairments of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD171178. doi: 10.3233/JAD-171178.
    PubMed     Abstract available


  1176. MATSUOKA T, Imai A, Fujimoto H, Kato Y, et al
    Neural Correlates of Sleep Disturbance in Alzheimer's Disease: Role of the Precuneus in Sleep Disturbance.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD171169. doi: 10.3233/JAD-171169.
    PubMed     Abstract available


  1177. SEN A, Nelson TJ, Alkon DL, Hongpaisan J, et al
    Loss in PKC Epsilon Causes Downregulation of MnSOD and BDNF Expression in Neurons of Alzheimer's Disease Hippocampus.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD171008. doi: 10.3233/JAD-171008.
    PubMed     Abstract available


  1178. ALVAREZ XA, Alvarez I, Aleixandre M, Linares C, et al
    Severity-Related Increase and Cognitive Correlates of Serum VEGF Levels in Alzheimer's Disease ApoE4 Carriers.
    J Alzheimers Dis. 2018 Apr 25. pii: JAD160477. doi: 10.3233/JAD-160477.
    PubMed     Abstract available


  1179. ARISPE N, De Maio A
    Memory Loss and the Onset of Alzheimer's Disease Could Be Under the Control of Extracellular Heat Shock Proteins.
    J Alzheimers Dis. 2018 Apr 17. pii: JAD180161. doi: 10.3233/JAD-180161.
    PubMed     Abstract available


  1180. WADA M, Noda Y, Shinagawa S, Chung JK, et al
    Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.
    J Alzheimers Dis. 2018 Apr 17. pii: JAD171168. doi: 10.3233/JAD-171168.
    PubMed     Abstract available


  1181. ANDRIUTA D, Roussel M, Barbay M, Despretz-Wannepain S, et al
    Differentiating between Alzheimer's Disease and Vascular Cognitive Impairment: Is the "Memory Versus Executive Function" Contrast Still Relevant?
    J Alzheimers Dis. 2018 Apr 17. pii: JAD171097. doi: 10.3233/JAD-171097.
    PubMed     Abstract available


  1182. FANTONI ER, Chalkidou A, O' Brien JT, Farrar G, et al
    A Systematic Review and Aggregated Analysis on the Impact of Amyloid PET Brain Imaging on the Diagnosis, Diagnostic Confidence, and Management of Patients being Evaluated for Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 16. pii: JAD171093. doi: 10.3233/JAD-171093.
    PubMed     Abstract available


  1183. MAKOVAC E, Serra L, Di Domenico C, Marra C, et al
    Quantitative Magnetization Transfer of White Matter Tracts Correlates with Diffusion Tensor Imaging Indices in Predicting the Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 16. pii: JAD170995. doi: 10.3233/JAD-170995.
    PubMed     Abstract available


  1184. VOJDANI A, Vojdani E, Saidara E, Kharrazian D, et al
    Reaction of Amyloid-beta Peptide Antibody with Different Infectious Agents Involved in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 14. pii: JAD170961. doi: 10.3233/JAD-170961.
    PubMed     Abstract available


  1185. HEYMANN P, Gienger R, Hett A, Muller S, et al
    Early Detection of Alzheimer's Disease Based on the Patient's Creative Drawing Process: First Results with a Novel Neuropsychological Testing Method.
    J Alzheimers Dis. 2018 Apr 14. pii: JAD170946. doi: 10.3233/JAD-170946.
    PubMed     Abstract available


  1186. NOURIZIABARI B, Sarkar S, Tanninen SE, Dayton RD, et al
    Aberrant Cortical Event-Related Potentials During Associative Learning in Rat Models for Presymptomatic Stages of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 11. pii: JAD171033. doi: 10.3233/JAD-171033.
    PubMed     Abstract available


  1187. KUEPER JK, Speechley M, Montero-Odasso M
    The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review.
    J Alzheimers Dis. 2018 Apr 11. pii: JAD170991. doi: 10.3233/JAD-170991.
    PubMed     Abstract available


  1188. ROUCH I, Pongan E, Leveque Y, Tillmann B, et al
    Personality Modulates the Efficacy of Art Intervention on Chronic Pain in a Population of Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 11. pii: JAD170990. doi: 10.3233/JAD-170990.
    PubMed     Abstract available


  1189. MEYER PF, Savard M, Poirier J, Labonte A, et al
    Bi-Directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis.
    J Alzheimers Dis. 2018 Apr 11. pii: JAD170887. doi: 10.3233/JAD-170887.
    PubMed     Abstract available


  1190. WANG JH, Wu YJ, Tee BL, Lo RY, et al
    Medical Comorbidity in Alzheimer's Disease: A Nested Case-Control Study.
    J Alzheimers Dis. 2018 Apr 11. pii: JAD170786. doi: 10.3233/JAD-170786.
    PubMed     Abstract available


  1191. MANDAL PK, Shukla D
    Brain Metabolic, Structural, and Behavioral Pattern Learning for Early Predictive Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Apr 4. pii: JAD180063. doi: 10.3233/JAD-180063.
    PubMed     Abstract available


  1192. VAN DEN BERG E, Geerlings MI, Biessels GJ, Nederkoorn PJ, et al
    White Matter Hyperintensities and Cognition in Mild Cognitive Impairment and Alzheimer's Disease: A Domain-Specific Meta-Analysis.
    J Alzheimers Dis. 2018 Apr 4. pii: JAD170573. doi: 10.3233/JAD-170573.
    PubMed     Abstract available


    March 2018
  1193. D'AMELIO M, Serra L, Bozzali M
    Ventral Tegmental Area in Prodromal Alzheimer's Disease: Bridging the Gap between Mice and Humans.
    J Alzheimers Dis. 2018 Mar 30. pii: JAD180094. doi: 10.3233/JAD-180094.
    PubMed     Abstract available


  1194. DE LA TORRE J
    The Vascular Hypothesis of Alzheimer's Disease: A Key to Preclinical Prediction of Dementia Using Neuroimaging.
    J Alzheimers Dis. 2018 Mar 29. pii: JAD180004. doi: 10.3233/JAD-180004.
    PubMed     Abstract available


  1195. THORDARDOTTIR S, Graff C
    Findings from the Swedish Study on Familial Alzheimer's Disease Including the APP Swedish Double Mutation.
    J Alzheimers Dis. 2018 Mar 29. pii: JAD179922. doi: 10.3233/JAD-179922.
    PubMed     Abstract available


  1196. KIDDLE SJ, Voyle N, Dobson RJB
    A Blood Test for Alzheimer's Disease: Progress, Challenges, and Recommendations.
    J Alzheimers Dis. 2018 Mar 29. pii: JAD179904. doi: 10.3233/JAD-179904.
    PubMed     Abstract available


  1197. JULIAN A, Rioux-Bilan A, Ragot S, Krolak-Salmon P, et al
    Blood Inflammatory Mediators and Cognitive Decline in Alzheimer's Disease: A Two Years Longitudinal Study.
    J Alzheimers Dis. 2018 Mar 29. pii: JAD171131. doi: 10.3233/JAD-171131.
    PubMed     Abstract available


  1198. KLOPPEL S, Kotschi M, Peter J, Egger K, et al
    Separating Symptomatic Alzheimer's Disease from Depression based on Structural MRI.
    J Alzheimers Dis. 2018 Mar 29. pii: JAD170964. doi: 10.3233/JAD-170964.
    PubMed     Abstract available


  1199. FERNANDEZ G, Orozco D, Agamennoni O, Schumacher M, et al
    Visual Processing during Short-Term Memory Binding in Mild Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 29. pii: JAD170728. doi: 10.3233/JAD-170728.
    PubMed     Abstract available


  1200. RANSMAYR G, Hermann P, Sallinger K, Benke T, et al
    Caregiving and Caregiver Burden in Dementia Home Care: Results from the Prospective Dementia Registry (PRODEM) of the Austrian Alzheimer Society.
    J Alzheimers Dis. 2018 Mar 29. pii: JAD170657. doi: 10.3233/JAD-170657.
    PubMed     Abstract available


  1201. MC ARDLE R, Morris R, Hickey A, Del Din S, et al
    Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study.
    J Alzheimers Dis. 2018 Mar 28. pii: JAD171116. doi: 10.3233/JAD-171116.
    PubMed     Abstract available


  1202. JIN H, Wang R, Liu Z, Jia Q, et al
    Some Methodological Characteristics of Alzheimer-Associated Urine Neuronal Thread Protein Detected by Enzyme-Linked Immunosorbent Assay.
    J Alzheimers Dis. 2018 Mar 28. pii: JAD171109. doi: 10.3233/JAD-171109.
    PubMed     Abstract available


  1203. XIE L, Shinohara RT, Ittyerah R, Kuijf HJ, et al
    Automated Multi-Atlas Segmentation of Hippocampal and Extrahippocampal Subregions in Alzheimer's Disease at 3T and 7T: What Atlas Composition Works Best?
    J Alzheimers Dis. 2018 Mar 28. pii: JAD170932. doi: 10.3233/JAD-170932.
    PubMed     Abstract available


  1204. HOU TT, Yang HY, Wang W, Wu QQ, et al
    Sulforaphane Inhibits the Generation of Amyloid-beta Oligomer and Promotes Spatial Learning and Memory in Alzheimer's Disease (PS1V97L) Transgenic Mice.
    J Alzheimers Dis. 2018 Mar 24. pii: JAD171110. doi: 10.3233/JAD-171110.
    PubMed     Abstract available


  1205. KAMARA DM, Gangishetti U, Gearing M, Willis-Parker M, et al
    Cerebral Amyloid Angiopathy: Similarity in African-Americans and Caucasians with Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 24. pii: JAD170954. doi: 10.3233/JAD-170954.
    PubMed     Abstract available


  1206. CARDILLO GM, de-Paula VJ, Ikenaga EH, Costa LR, et al
    Chronic Lithium Treatment Increases Telomere Length in Parietal Cortex and Hippocampus of Triple-Transgenic Alzheimer's Disease Mice.
    J Alzheimers Dis. 2018 Mar 24. pii: JAD170838. doi: 10.3233/JAD-170838.
    PubMed     Abstract available


  1207. URBANOVA BS, Schwabova JP, Magerova H, Jansky P, et al
    Reduced Cerebrovascular Reserve Capacity as a Biomarker of Microangiopathy in Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2018 Mar 24. pii: JAD170815. doi: 10.3233/JAD-170815.
    PubMed     Abstract available


  1208. TEUNISSEN CE, Chiu MJ, Yang CC, Yang SY, et al
    Plasma Amyloid-beta (Abeta42) Correlates with Cerebrospinal Fluid Abeta42 in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 24. pii: JAD170784. doi: 10.3233/JAD-170784.
    PubMed     Abstract available


  1209. SCHEININ NM, Gardberg M, Roytta M, Rinne JO, et al
    Negative 11C-PIB PET Predicts Lack of Alzheimer's Disease Pathology in Postmortem Examination.
    J Alzheimers Dis. 2018 Mar 24. pii: JAD170569. doi: 10.3233/JAD-170569.
    PubMed     Abstract available


  1210. BURNS N, Watts A, Perales J, Montgomery RN, et al
    The Impact of Creative Arts in Alzheimer's Disease and Dementia Public Health Education.
    J Alzheimers Dis. 2018 Mar 23. pii: JAD180092. doi: 10.3233/JAD-180092.
    PubMed     Abstract available


  1211. GALBIATI A, Carli G, Hensley M, Ferini-Strambi L, et al
    REM Sleep Behavior Disorder and Alzheimer's Disease: Definitely No Relationship?
    J Alzheimers Dis. 2018 Mar 23. pii: JAD171164. doi: 10.3233/JAD-171164.
    PubMed     Abstract available


  1212. MARESOVA P, Dolejs J, Kuca K
    Call for a Uniform Strategy of Collecting Alzheimer's Disease Costs: A Review and Meta-Analysis.
    J Alzheimers Dis. 2018 Mar 23. pii: JAD171028. doi: 10.3233/JAD-171028.
    PubMed     Abstract available


  1213. DE MARCO M, Venneri A
    Volume and Connectivity of the Ventral Tegmental Area are Linked to Neurocognitive Signatures of Alzheimer's Disease in Humans.
    J Alzheimers Dis. 2018 Mar 23. pii: JAD171018. doi: 10.3233/JAD-171018.
    PubMed     Abstract available


  1214. AGOSTINI S, Mancuso R, Hernis A, Costa AS, et al
    HSV-1-Specific IgG Subclasses Distribution and Serum Neutralizing Activity in Alzheimer's Disease and in Mild Cognitive Impairment.
    J Alzheimers Dis. 2018 Mar 23. pii: JAD170966. doi: 10.3233/JAD-170966.
    PubMed     Abstract available


  1215. POWELL F, Tosun D, Sadeghi R, Weiner M, et al
    Preserved Structural Network Organization Mediates Pathology Spread in Alzheimer's Disease Spectrum Despite Loss of White Matter Tract Integrity.
    J Alzheimers Dis. 2018 Mar 23. pii: JAD170798. doi: 10.3233/JAD-170798.
    PubMed     Abstract available


  1216. YAN T, Wang L, Gao J, Siedlak SL, et al
    Rab10 Phosphorylation is a Prominent Pathological Feature in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD180023. doi: 10.3233/JAD-180023.
    PubMed     Abstract available


  1217. HAMPEL H, Toschi N, Babiloni C, Baldacci F, et al
    Revolution of Alzheimer Precision Neurology Passageway of Systems Biology and Neurophysiology.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179932. doi: 10.3233/JAD-179932.
    PubMed     Abstract available


  1218. GONG CX, Liu F, Iqbal K
    Multifactorial Hypothesis and Multi-Targets for Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179921. doi: 10.3233/JAD-179921.
    PubMed     Abstract available


  1219. TEIXEIRA CM, Pallas-Bazarra N, Bolos M, Terreros-Roncal J, et al
    Untold New Beginnings: Adult Hippocampal Neurogenesis and Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179918. doi: 10.3233/JAD-179918.
    PubMed     Abstract available


  1220. HERNANDEZ F, Llorens-Martin M, Bolos M, Perez M, et al
    New Beginnings in Alzheimer's Disease: The Most Prevalent Tauopathy.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179916. doi: 10.3233/JAD-179916.
    PubMed     Abstract available


  1221. GUTIERREZ A, Vitorica J
    Toward a New Concept of Alzheimer's Disease Models: A Perspective from Neuroinflammation.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179914. doi: 10.3233/JAD-179914.
    PubMed     Abstract available


  1222. MCGEER PL, McGeer E
    Conquering Alzheimer's Disease by Self Treatment.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179913. doi: 10.3233/JAD-179913.
    PubMed     Abstract available


  1223. CLARKE JR, Ribeiro FC, Frozza RL, De Felice FG, et al
    Metabolic Dysfunction in Alzheimer's Disease: From Basic Neurobiology to Clinical Approaches.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179911. doi: 10.3233/JAD-179911.
    PubMed     Abstract available


  1224. PARNETTI L, Eusebi P
    Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: An Invaluable Tool for Clinical Diagnosis and Trial Enrichment.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179910. doi: 10.3233/JAD-179910.
    PubMed     Abstract available


  1225. DRUMMOND E, Goni F, Liu S, Prelli F, et al
    Potential Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179909. doi: 10.3233/JAD-179909.
    PubMed     Abstract available


  1226. NISBET RM, Gotz J
    Amyloid-beta and Tau in Alzheimer's Disease: Novel Pathomechanisms and Non-Pharmacological Treatment Strategies.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179907. doi: 10.3233/JAD-179907.
    PubMed     Abstract available


  1227. MECOCCI P, Baroni M, Senin U, Boccardi V, et al
    Brain Aging and Late-Onset Alzheimer's Disease: A Matter of Increased Amyloid or Reduced Energy?
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179903. doi: 10.3233/JAD-179903.
    PubMed     Abstract available


  1228. CUMMINGS J, Ritter A, Zhong K
    Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD179901. doi: 10.3233/JAD-179901.
    PubMed     Abstract available


  1229. STIPHO F, Jackson R, Sabbagh MN
    Pathologically Confirmed Alzheimer's Disease in APOE varepsilon2 Homozygotes is Rare but Does Occur.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD171060. doi: 10.3233/JAD-171060.
    PubMed     Abstract available


  1230. COURTEMANCHE H, Bigot E, Pichelin M, Guyomarch B, et al
    PCSK9 Concentrations in Cerebrospinal Fluid Are Not Specifically Increased in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD170993. doi: 10.3233/JAD-170993.
    PubMed     Abstract available


  1231. BALMIK AA, Chinnathambi S
    Multi-Faceted Role of Melatonin in Neuroprotection and Amelioration of Tau Aggregates in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD170900. doi: 10.3233/JAD-170900.
    PubMed     Abstract available


  1232. HIRANO S, Shinotoh H, Shimada H, Ota T, et al
    Voxel-Based Acetylcholinesterase PET Study in Early and Late Onset Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD170749. doi: 10.3233/JAD-170749.
    PubMed     Abstract available


  1233. PENNY W, Iglesias-Fuster J, Quiroz YT, Lopera FJ, et al
    Dynamic Causal Modeling of Preclinical Autosomal-Dominant Alzheimer's Disease.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD170405. doi: 10.3233/JAD-170405.
    PubMed     Abstract available


  1234. KWAK K, Yun HJ, Park G, Lee JM, et al
    Multi-Modality Sparse Representation for Alzheimer's Disease Classification.
    J Alzheimers Dis. 2018 Mar 16. pii: JAD170338. doi: 10.3233/JAD-170338.
    PubMed     Abstract available


  1235. GAUTHIER S, Ng KP, Pascoal TA, Zhang H, et al
    Targeting Alzheimer's Disease at the Right Time and the Right Place: Validation of a Personalized Approach to Diagnosis and Treatment.
    J Alzheimers Dis. 2018 Mar 1. pii: JAD179924. doi: 10.3233/JAD-179924.
    PubMed     Abstract available


    February 2018
  1236. CHETELAT G
    Multimodal Neuroimaging in Alzheimer's Disease: Early Diagnosis, Physiopathological Mechanisms, and Impact of Lifestyle.
    J Alzheimers Dis. 2018 Feb 28. pii: JAD179920. doi: 10.3233/JAD-179920.
    PubMed     Abstract available


  1237. MARTINI AC, Forner S, Trujillo-Estrada L, Baglietto-Vargas D, et al
    Past to Future: What Animal Models Have Taught Us About Alzheimer's Disease.
    J Alzheimers Dis. 2018 Feb 28. pii: JAD179917. doi: 10.3233/JAD-179917.
    PubMed     Abstract available


  1238. STOCKBURGER C, Eckert S, Eckert GP, Friedland-Leuner K, et al
    Mitochondrial Function, Dynamics, and Permeability Transition: A Complex Love Triangle as A Possible Target for the Treatment of Brain Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2018 Feb 28. pii: JAD179915. doi: 10.3233/JAD-179915.
    PubMed     Abstract available


  1239. BUTTERFIELD DA
    Perspectives on Oxidative Stress in Alzheimer's Disease and Predictions of Future Research Emphases.
    J Alzheimers Dis. 2018 Feb 28. pii: JAD179912. doi: 10.3233/JAD-179912.
    PubMed     Abstract available


  1240. GOSZTYLA ML, Brothers HM, Robinson SR
    Alzheimer's Amyloid-beta is an Antimicrobial Peptide: A Review of the Evidence.
    J Alzheimers Dis. 2018 Feb 28. pii: JAD171133. doi: 10.3233/JAD-171133.
    PubMed     Abstract available


  1241. GHIDONI R, Squitti R, Siotto M, Benussi L, et al
    Innovative Biomarkers for Alzheimer's Disease: Focus on the Hidden Disease Biomarkers.
    J Alzheimers Dis. 2018 Feb 28. pii: JAD170953. doi: 10.3233/JAD-170953.
    PubMed     Abstract available


    January 2018
  1242. REDDY PH, Manczak M, Yin X, Reddy AP, et al
    Synergistic Protective Effects of Mitochondrial Division Inhibitor 1 and Mitochondria-Targeted Small Peptide SS31 in Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jan 30. pii: JAD170988. doi: 10.3233/JAD-170988.
    PubMed     Abstract available


  1243. SCHARRE DW, Weichart E, Nielson D, Zhang J, et al
    Deep Brain Stimulation of Frontal Lobe Networks to Treat Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jan 30. pii: JAD170082. doi: 10.3233/JAD-170082.
    PubMed     Abstract available


  1244. BOUTS MJRJ, Moller C, Hafkemeijer A, van Swieten JC, et al
    Single Subject Classification of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Anatomical, Diffusion Tensor, and Resting-State Functional Magnetic Resonance Imaging.
    J Alzheimers Dis. 2018 Jan 24. pii: JAD170893. doi: 10.3233/JAD-170893.
    PubMed     Abstract available


  1245. ZHANG Y, Guo O, Huo Y, Wang G, et al
    Amyloid-beta Induces AMPA Receptor Ubiquitination and Degradation in Primary Neurons and Human Brains of Alzheimer's Disease.
    J Alzheimers Dis. 2018 Jan 24. pii: JAD170879. doi: 10.3233/JAD-170879.
    PubMed     Abstract available


  1246. GRASSI M, Perna G, Caldirola D, Schruers K, et al
    A Clinically-Translatable Machine Learning Algorithm for the Prediction of Alzheimer's Disease Conversion in Individuals with Mild and Premild Cognitive Impairment.
    J Alzheimers Dis. 2018 Jan 17. pii: JAD170547. doi: 10.3233/JAD-170547.
    PubMed     Abstract available


  1247. ROBINSON M, Lee BY, Hanes FT
    Recent Progress in Alzheimer's Disease Research, Part 2: Genetics and Epidemiology.
    J Alzheimers Dis. 2018;61:459.
    PubMed    


  1248. CHATTERJEE P, Roy D, Rathi N
    Epigenetic Drug Repositioning for Alzheimer's Disease Based on Epigenetic Targets in Human Interactome.
    J Alzheimers Dis. 2018;61:53-65.
    PubMed     Abstract available


  1249. LAO PJ, Handen BL, Betthauser TJ, Mihaila I, et al
    Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-beta Burden in Down Syndrome.
    J Alzheimers Dis. 2018;61:631-644.
    PubMed     Abstract available


  1250. DODICH A, Cerami C, Cappa SF, Marcone A, et al
    Combined Socio-Behavioral Evaluation Improves the Differential Diagnosis Between the Behavioral Variant of Frontotemporal Dementia and Alzheimer's Disease: In Search of Neuropsychological Markers.
    J Alzheimers Dis. 2018;61:761-772.
    PubMed     Abstract available


  1251. VALECH N, Tort-Merino A, Coll-Padros N, Olives J, et al
    Executive and Language Subjective Cognitive Decline Complaints Discriminate Preclinical Alzheimer's Disease from Normal Aging.
    J Alzheimers Dis. 2018;61:689-703.
    PubMed     Abstract available


  1252. CHAI YL, Xing H, Chong JR, Francis PT, et al
    Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:793-801.
    PubMed     Abstract available


  1253. SAKSIDA T, Koprivica I, Vujicic M, Stosic-Grujicic S, et al
    Impaired IL-17 Production in Gut-Residing Immune Cells of 5xFAD Mice with Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2018;61:619-630.
    PubMed     Abstract available


  1254. WHARTON W, Goldstein FC, Tansey MG, Brown AL, et al
    Rationale and Design of the Mechanistic Potential of Antihypertensives in Preclinical Alzheimer's (HEART) Trial.
    J Alzheimers Dis. 2018;61:815-824.
    PubMed     Abstract available


  1255. JONVEAUX TR, Fescharek R
    When Art Meets Gardens: Does It Enhance the Benefits? The Nancy Hypothesis of Care for Persons with Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:885-898.
    PubMed     Abstract available


  1256. CHIZIANE E, Telemann H, Krueger M, Adler J, et al
    Free Heme and Amyloid-beta: A Fatal Liaison in Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:963-984.
    PubMed     Abstract available


  1257. TAKENOSHITA S, Terada S, Yokota O, Kutoku Y, et al
    Sally-Anne Test in Patients with Alzheimer's Disease Dementia.
    J Alzheimers Dis. 2018;61:1029-1036.
    PubMed     Abstract available


  1258. FAN Y, Luo R, Su LY, Xiang Q, et al
    Does the Genetic Feature of the Chinese Tree Shrew (Tupaia belangeri chinensis) Support Its Potential as a Viable Model for Alzheimer's Disease Research?
    J Alzheimers Dis. 2018;61:1015-1028.
    PubMed     Abstract available


  1259. ROZZINI L, Lanfranchi F, Pilotto A, Catalani S, et al
    Serum Non-Ceruloplasmin Non-Albumin Copper Elevation in Mild Cognitive Impairment and Dementia due to Alzheimer's Disease: A Case Control Study.
    J Alzheimers Dis. 2018;61:907-912.
    PubMed     Abstract available


  1260. HEMACHANDRA REDDY P, Manczak M, Yin X, Grady MC, et al
    Protective Effects of Indian Spice Curcumin Against Amyloid-beta in Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:843-866.
    PubMed     Abstract available


  1261. LIU G, Zhang Y, Wang L, Xu J, et al
    Alzheimer's Disease rs11767557 Variant Regulates EPHA1 Gene Expression Specifically in Human Whole Blood.
    J Alzheimers Dis. 2018;61:1077-1088.
    PubMed     Abstract available


  1262. SNIR JA, Suchy M, Bindseil GA, Kovacs M, et al
    An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2018;61:1241-1252.
    PubMed     Abstract available


  1263. WANG H, Stewart T, Toledo JB, Ginghina C, et al
    A Longitudinal Study of Total and Phosphorylated alpha-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment.
    J Alzheimers Dis. 2018;61:1541-1553.
    PubMed     Abstract available


  1264. SERPENTE M, Fenoglio C, Cioffi SMG, Oldoni E, et al
    Profiling of Specific Gene Expression Pathways in Peripheral Cells from Prodromal Alzheimer's Disease Patients.
    J Alzheimers Dis. 2018;61:1289-1294.
    PubMed     Abstract available


  1265. YANG CC, Chiu MJ, Chen TF, Chang HL, et al
    Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:1323-1332.
    PubMed     Abstract available


  1266. SUZUKI A, Shinozaki J, Yazawa S, Ueki Y, et al
    Establishing a New Screening System for Mild Cognitive Impairment and Alzheimer's Disease with Mental Rotation Tasks that Evaluate Visuospatial Function.
    J Alzheimers Dis. 2018;61:1653-1665.
    PubMed     Abstract available


  1267. PALEY EL, Merkulova-Rainon T, Faynboym A, Shestopalov VI, et al
    Geographical Distribution and Diversity of Gut Microbial NADH:Ubiquinone Oxidoreductase Sequence Associated with Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:1531-1540.
    PubMed     Abstract available


  1268. PORTACOLONE E, Johnson JK, Covinsky KE, Halpern J, et al
    The Effects and Meanings of Receiving a Diagnosis of Mild Cognitive Impairment or Alzheimer's Disease When One Lives Alone.
    J Alzheimers Dis. 2018;61:1517-1529.
    PubMed     Abstract available


  1269. HALLIKAINEN I, Hongisto K, Valimaki T, Hanninen T, et al
    The Progression of Neuropsychiatric Symptoms in Alzheimer's Disease During a Five-Year Follow-Up: Kuopio ALSOVA Study.
    J Alzheimers Dis. 2018;61:1367-1376.
    PubMed     Abstract available


  1270. CHE XQ, Zhao QH, Huang Y, Li X, et al
    Mutation Screening of the CHCHD2 Gene for Alzheimer's Disease and Frontotemporal Dementia in Chinese Mainland Population.
    J Alzheimers Dis. 2018;61:1283-1288.
    PubMed     Abstract available


  1271. LU J, Shu R, Zhu Y
    Dysregulation and Dislocation of SFPQ Disturbed DNA Organization in Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2018;61:1311-1321.
    PubMed     Abstract available


  1272. PEDRINOLLA A, Venturelli M, Fonte C, Munari D, et al
    Exercise Training on Locomotion in Patients with Alzheimer's Disease: A Feasibility Study.
    J Alzheimers Dis. 2018;61:1599-1609.
    PubMed     Abstract available


  1273. NAKAIZUMI K, Ouchi Y, Terada T, Yoshikawa E, et al
    In vivo Depiction of alpha7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:1355-1365.
    PubMed     Abstract available


  1274. GOMEZ-TORTOSA E, Ruggiero M, Sainz MJ, Villarejo-Galende A, et al
    SORL1 Variants in Familial Alzheimer's Disease.
    J Alzheimers Dis. 2018;61:1275-1281.
    PubMed     Abstract available


  1275. KIM J, Park S, Yoo H, Jang H, et al
    The Impact of APOE varepsilon4 in Alzheimer's Disease Differs According to Age.
    J Alzheimers Dis. 2018;61:1377-1385.
    PubMed     Abstract available


  1276. TUCHOLKA A, Grau-Rivera O, Falcon C, Rami L, et al
    Structural Connectivity Alterations Along the Alzheimer's Disease Continuum: Reproducibility Across Two Independent Samples and Correlation with Cerebrospinal Fluid Amyloid-beta and Tau.
    J Alzheimers Dis. 2018;61:1575-1587.
    PubMed     Abstract available


  1277. LIBARD S, Laurell K, Cesarini KG, Alafuzoff I, et al
    Progression of Alzheimer's Disease-Related Pathology and Cell Counts in a Patient with Idiopathic Normal Pressure Hydrocephalus.
    J Alzheimers Dis. 2018;61:1451-1462.
    PubMed     Abstract available


  1278. GUREL B, Cansev M, Sevinc C, Kelestemur S, et al
    Early Stage Alterations in CA1 Extracellular Region Proteins Indicate Dysregulation of IL6 and Iron Homeostasis in the 5XFAD Alzheimer's Disease Mouse Model.
    J Alzheimers Dis. 2018;61:1399-1410.
    PubMed     Abstract available


  1279. MAHADY L, Nadeem M, Malek-Ahmadi M, Chen K, et al
    Frontal Cortex Epigenetic Dysregulation During the Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:115-131.
    PubMed     Abstract available


  1280. REALE M, D'Angelo C, Costantini E, Di Nicola M, et al
    Expression Profiling of Cytokine, Cholinergic Markers, and Amyloid-beta Deposition in the APPSWE/PS1dE9 Mouse Model of Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2018;62:467-476.
    PubMed     Abstract available


  1281. ZHOU F, Chen S
    Effects of Gender and Other Confounding Factors on Leptin Concentrations in Alzheimer's Disease: Evidence from the Combined Analysis of 27 Case-Control Studies.
    J Alzheimers Dis. 2018;62:477-486.
    PubMed     Abstract available


  1282. IHARA M, Washida K
    Linking Atrial Fibrillation with Alzheimer's Disease: Epidemiological, Pathological, and Mechanistic Evidence.
    J Alzheimers Dis. 2018;62:61-72.
    PubMed     Abstract available


  1283. WEZYK M, Szybinska A, Wojsiat J, Szczerba M, et al
    Overactive BRCA1 Affects Presenilin 1 in Induced Pluripotent Stem Cell-Derived Neurons in Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:175-202.
    PubMed     Abstract available


  1284. XU L, Zhang W, Liu X, Zhang C, et al
    Circulatory Levels of Toxic Metals (Aluminum, Cadmium, Mercury, Lead) in Patients with Alzheimer's Disease: A Quantitative Meta-Analysis and Systematic Review.
    J Alzheimers Dis. 2018;62:361-372.
    PubMed     Abstract available


  1285. VOGELGSANG J, Wedekind D, Bouter C, Klafki HW, et al
    Reproducibility of Alzheimer's Disease Cerebrospinal Fluid-Biomarker Measurements under Clinical Routine Conditions.
    J Alzheimers Dis. 2018;62:203-212.
    PubMed     Abstract available


  1286. CORVOL A, Netter A, Campeon A, Somme D, et al
    Implementation of an Occupational Therapy Program for Alzheimer's Disease Patients in France: Patients' and Caregivers' Perspectives.
    J Alzheimers Dis. 2018;62:157-164.
    PubMed     Abstract available


  1287. MULLAN K, Cardwell CR, McGuinness B, Woodside JV, et al
    Plasma Antioxidant Status in Patients with Alzheimer's Disease and Cognitively Intact Elderly: A Meta-Analysis of Case-Control Studies.
    J Alzheimers Dis. 2018;62:305-317.
    PubMed     Abstract available


  1288. BABILONI C, Del Percio C, Lizio R, Noce G, et al
    Abnormalities of Resting State Cortical EEG Rhythms in Subjects with Mild Cognitive Impairment Due to Alzheimer's and Lewy Body Diseases.
    J Alzheimers Dis. 2018;62:247-268.
    PubMed     Abstract available


  1289. BETTCHER BM, Johnson SC, Fitch R, Casaletto KB, et al
    Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage.
    J Alzheimers Dis. 2018;62:385-397.
    PubMed     Abstract available


  1290. HAAPALINNA F, Kokki M, Jaaskelainen O, Hallikainen M, et al
    Subtle Cognitive Impairment and Alzheimer's Disease-Type Pathological Changes in Cerebrospinal Fluid are Common Among Neurologically Healthy Subjects.
    J Alzheimers Dis. 2018;62:165-174.
    PubMed     Abstract available


  1291. WATREMEZ W, Jackson J, Almari B, McLean SL, et al
    Stabilized Low-n Amyloid-beta Oligomers Induce Robust Novel Object Recognition Deficits Associated with Inflammatory, Synaptic, and GABAergic Dysfunction in the Rat.
    J Alzheimers Dis. 2018;62:213-226.
    PubMed     Abstract available


  1292. SCHWEDA M, Kogel A, Bartels C, Wiltfang J, et al
    Prediction and Early Detection of Alzheimer's Dementia: Professional Disclosure Practices and Ethical Attitudes.
    J Alzheimers Dis. 2018;62:145-155.
    PubMed     Abstract available


  1293. JESKO H, Lukiw WJ, Wilkaniec A, Cieslik M, et al
    Altered Expression of Urea Cycle Enzymes in Amyloid-beta Protein Precursor Overexpressing PC12 Cells and in Sporadic Alzheimer's Disease Brain.
    J Alzheimers Dis. 2018;62:279-291.
    PubMed     Abstract available


  1294. MALPAS CB, Saling MM, Velakoulis D, Desmond P, et al
    Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type.
    J Alzheimers Dis. 2018;62:417-427.
    PubMed     Abstract available


  1295. STITES SD
    Cognitively Healthy Individuals Want to Know Their Risk for Alzheimer's Disease: What Should We Do?
    J Alzheimers Dis. 2018;62:499-502.
    PubMed     Abstract available


  1296. DORNINGER F, Moser AB, Kou J, Wiesinger C, et al
    Alterations in the Plasma Levels of Specific Choline Phospholipids in Alzheimer's Disease Mimic Accelerated Aging.
    J Alzheimers Dis. 2018;62:841-854.
    PubMed     Abstract available


  1297. LE GUENNEC K, Tubeuf H, Hannequin D, Wallon D, et al
    Biallelic Loss of Function of SORL1 in an Early Onset Alzheimer's Disease Patient.
    J Alzheimers Dis. 2018;62:821-831.
    PubMed     Abstract available


  1298. HE XY, Isaacs C, Yang SY
    Roles of Mitochondrial 17beta-Hydroxysteroid Dehydrogenase Type 10 in Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:665-673.
    PubMed     Abstract available


  1299. TAO Q, Zhu H, Chen X, Stern RA, et al
    Pramlintide: The Effects of a Single Drug Injection on Blood Phosphatidylcholine Profile for Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:597-609.
    PubMed     Abstract available


  1300. ZADORI D, Veres G, Szalardy L, Klivenyi P, et al
    Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines.
    J Alzheimers Dis. 2018;62:523-547.
    PubMed     Abstract available


  1301. SAPKOTA S, Dixon RA
    A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEvarepsilon4 Carriers.
    J Alzheimers Dis. 2018;62:887-900.
    PubMed     Abstract available


  1302. SZABLEWSKI L
    Human Gut Microbiota in Health and Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:549-560.
    PubMed     Abstract available


  1303. WANG D, Schultz T, Novak GP, Baker S, et al
    Longitudinal Modeling of Functional Decline Associated with Pathologic Alzheimer's Disease in Older Persons without Cognitive Impairment.
    J Alzheimers Dis. 2018;62:855-865.
    PubMed     Abstract available


  1304. D'IORIO A, Garramone F, Piscopo F, Baiano C, et al
    Meta-Analysis of Personality Traits in Alzheimer's Disease: A Comparison with Healthy Subjects.
    J Alzheimers Dis. 2018;62:773-787.
    PubMed     Abstract available


  1305. CROZE ML, Zimmer L
    Ozone Atmospheric Pollution and Alzheimer's Disease: From Epidemiological Facts to Molecular Mechanisms.
    J Alzheimers Dis. 2018;62:503-522.
    PubMed     Abstract available


  1306. DEL-AGUILA JL, Fernandez MV, Schindler S, Ibanez L, et al
    Assessment of the Genetic Architecture of Alzheimer's Disease Risk in Rate of Memory Decline.
    J Alzheimers Dis. 2018;62:745-756.
    PubMed     Abstract available


  1307. ALEGRET M, Pereto M, Perez A, Valero S, et al
    The Role of Verb Fluency in the Detection of Early Cognitive Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:611-619.
    PubMed     Abstract available


  1308. MILNE R, Bunnik E, Diaz A, Richard E, et al
    Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.
    J Alzheimers Dis. 2018;62:487-498.
    PubMed     Abstract available


  1309. BURNS CM, Kaszniak AW, Chen K, Lee W, et al
    Longitudinal Changes in Serum Glucose Levels are Associated with Metabolic Changes in Alzheimer's Disease Related Brain Regions.
    J Alzheimers Dis. 2018;62:833-840.
    PubMed     Abstract available


  1310. FALSETTI L, Viticchi G, Buratti L, Grigioni F, et al
    Interactions between Atrial Fibrillation, Cardiovascular Risk Factors, and ApoE Genotype in Promoting Cognitive Decline in Patients with Alzheimer's Disease: A Prospective Cohort Study.
    J Alzheimers Dis. 2018;62:713-725.
    PubMed     Abstract available


  1311. ZHANG W, Guo Y, Li B, Zhang Q, et al
    GDF11 Rejuvenates Cerebrovascular Structure and Function in an Animal Model of Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:807-819.
    PubMed     Abstract available


  1312. D'ONOFRIO G, Panza F, Sancarlo D, Addante F, et al
    Executive Dysfunction Detected with the Frontal Assessment Battery in Alzheimer's Disease Versus Vascular Dementia.
    J Alzheimers Dis. 2018;62:699-711.
    PubMed     Abstract available


  1313. MARTINS RN, Villemagne V, Sohrabi HR, Chatterjee P, et al
    Alzheimer's Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies-Gains from AIBL and DIAN Cohort Studies.
    J Alzheimers Dis. 2018;62:965-992.
    PubMed     Abstract available


  1314. KEHOE PG
    The Coming of Age of the Angiotensin Hypothesis in Alzheimer's Disease: Progress Toward Disease Prevention and Treatment?
    J Alzheimers Dis. 2018;62:1443-1466.
    PubMed     Abstract available


  1315. MOREIRA PI
    Sweet Mitochondria: A Shortcut to Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:1391-1401.
    PubMed     Abstract available


  1316. BOADA M, Santos-Santos MA, Rodriguez-Gomez O, Alegret M, et al
    Patient Engagement: The Fundacio ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.
    J Alzheimers Dis. 2018;62:1079-1090.
    PubMed     Abstract available


  1317. BAAZAOUI N, Iqbal K
    A Novel Therapeutic Approach to Treat Alzheimer's Disease by Neurotrophic Support During the Period of Synaptic Compensation.
    J Alzheimers Dis. 2018;62:1211-1218.
    PubMed     Abstract available


  1318. DE LA MONTE SM, Tong M, Wands JR
    The 20-Year Voyage Aboard the Journal of Alzheimer's Disease: Docking at 'Type 3 Diabetes', Environmental/Exposure Factors, Pathogenic Mechanisms, and Potential Treatments.
    J Alzheimers Dis. 2018;62:1381-1390.
    PubMed     Abstract available


  1319. FORLONI G, Balducci C
    Alzheimer's Disease, Oligomers, and Inflammation.
    J Alzheimers Dis. 2018;62:1261-1276.
    PubMed     Abstract available


  1320. BLENNOW K, Zetterberg H
    The Past and the Future of Alzheimer's Disease Fluid Biomarkers.
    J Alzheimers Dis. 2018;62:1125-1140.
    PubMed     Abstract available


  1321. MECOCCI P, Boccardi V, Cecchetti R, Bastiani P, et al
    A Long Journey into Aging, Brain Aging, and Alzheimer's Disease Following the Oxidative Stress Tracks.
    J Alzheimers Dis. 2018;62:1319-1335.
    PubMed     Abstract available


  1322. FENOGLIO C, Scarpini E, Serpente M, Galimberti D, et al
    Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer's Disease and Frontotemporal Dementia.
    J Alzheimers Dis. 2018;62:913-932.
    PubMed     Abstract available


  1323. MOLINUEVO JL, Minguillon C, Rami L, Gispert JD, et al
    The Rationale Behind the New Alzheimer's Disease Conceptualization: Lessons Learned During the Last Decades.
    J Alzheimers Dis. 2018;62:1067-1077.
    PubMed     Abstract available


  1324. BJERKE M, Engelborghs S
    Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer's Disease Diagnosis.
    J Alzheimers Dis. 2018;62:1199-1209.
    PubMed     Abstract available


  1325. GRINAN-FERRE C, Corpas R, Puigoriol-Illamola D, Palomera-Avalos V, et al
    Understanding Epigenetics in the Neurodegeneration of Alzheimer's Disease: SAMP8 Mouse Model.
    J Alzheimers Dis. 2018;62:943-963.
    PubMed     Abstract available


  1326. ADLARD PA, Bush AI
    Metals and Alzheimer's Disease: How Far Have We Come in the Clinic?
    J Alzheimers Dis. 2018;62:1369-1379.
    PubMed     Abstract available


  1327. BUTTERFIELD DA, Boyd-Kimball D
    Oxidative Stress, Amyloid-beta Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:1345-1367.
    PubMed     Abstract available


  1328. SHI L, Baird AL, Westwood S, Hye A, et al
    A Decade of Blood Biomarkers for Alzheimer's Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication.
    J Alzheimers Dis. 2018;62:1181-1198.
    PubMed     Abstract available


  1329. YANG H, Hou T, Wang W, Luo Y, et al
    The Effect of Chronic Cerebral Hypoperfusion on Amyloid-beta Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).
    J Alzheimers Dis. 2018;62:1609-1621.
    PubMed     Abstract available


  1330. GU J, Jin N, Ma D, Chu D, et al
    Calpain I Activation Causes GLUT3 Proteolysis and Downregulation of O-GlcNAcylation in Alzheimer's Disease Brain.
    J Alzheimers Dis. 2018;62:1737-1746.
    PubMed     Abstract available


  1331. PIACERI I, Imperiale D, Ghidoni E, Atzori C, et al
    Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration.
    J Alzheimers Dis. 2018;62:1683-1689.
    PubMed     Abstract available


  1332. TETZLOFF KA, Graff-Radford J, Martin PR, Tosakulwong N, et al
    Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease.
    J Alzheimers Dis. 2018;62:1713-1724.
    PubMed     Abstract available



  1333. PET Tau and Amyloid-beta Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.
    J Alzheimers Dis. 2018;63:407.
    PubMed    



  1334. Patient Engagement: The Fundacio ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.
    J Alzheimers Dis. 2018;63:1207.
    PubMed    



  1335. Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study.
    J Alzheimers Dis. 2018;63:1557.
    PubMed    


  1336. SAARI T, Hallikainen I, Hanninen T, Raty H, et al
    Relationships between Cognition and Activities of Daily Living in Alzheimer's Disease During a 5-Year Follow-Up: ALSOVA Study.
    J Alzheimers Dis. 2018;64:269-279.
    PubMed     Abstract available


  1337. MANDAL PK, Shukla D
    Brain Metabolic, Structural, and Behavioral Pattern Learning for Early Predictive Diagnosis of Alzheimer's Disease.
    J Alzheimers Dis. 2018;64:669-670.
    PubMed    


  1338. NOLAN JM, Mulcahy R, Power R, Moran R, et al
    Nutritional Intervention to Prevent Alzheimer's Disease: Potential Benefits of Xanthophyll Carotenoids and Omega-3 Fatty Acids Combined.
    J Alzheimers Dis. 2018;64:367-378.
    PubMed     Abstract available


  1339. ZUSSO M, Barbierato M, Facci L, Skaper SD, et al
    Neuroepigenetics and Alzheimer's Disease: An Update.
    J Alzheimers Dis. 2018;64:671-688.
    PubMed     Abstract available


  1340. SU L, Hayes L, Soteriades S, Williams G, et al
    Hippocampal Stratum Radiatum, Lacunosum, and Moleculare Sparing in Mild Cognitive Impairment.
    J Alzheimers Dis. 2018;61:415-424.
    PubMed     Abstract available



  1341. Greg Kennedy, BSc (Hons), Recipient of the 2018 Alzheimer Award.
    J Alzheimers Dis. 2018;65:1-2.
    PubMed    


  1342. SIGURDSSON EM
    Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Progress and Potential Pitfalls.
    J Alzheimers Dis. 2018;66:855-856.
    PubMed    


  1343. CHEN DW, Wang J, Zhang LL, Wang YJ, et al
    Cerebrospinal Fluid Amyloid-beta Levels are Increased in Patients with Insomnia.
    J Alzheimers Dis. 2018;61:645-651.
    PubMed     Abstract available


  1344. LAW BM, Guest AL, Pullen MWJ, Perkinton MS, et al
    Increased Foxo3a Nuclear Translocation and Activity is an Early Neuronal Response to betagamma-Secretase-Mediated Processing of the Amyloid-beta Protein Precursor: Utility of an AbetaPP-GAL4 Reporter Assay.
    J Alzheimers Dis. 2018;61:673-688.
    PubMed     Abstract available


  1345. CAO X, Zhu M, He Y, Chu W, et al
    Increased Serum Acylated Ghrelin Levels in Patients with Mild Cognitive Impairment.
    J Alzheimers Dis. 2018;61:545-552.
    PubMed     Abstract available


  1346. YIN X, Jiang X, Wang J, Qian S, et al
    SIRT1 Deacetylates SC35 and Suppresses Its Function in Tau Exon 10 Inclusion.
    J Alzheimers Dis. 2018;61:561-570.
    PubMed     Abstract available


  1347. DING K, Tarumi T, Zhu DC, Tseng BY, et al
    Cardiorespiratory Fitness and White Matter Neuronal Fiber Integrity in Mild Cognitive Impairment.
    J Alzheimers Dis. 2018;61:729-739.
    PubMed     Abstract available


  1348. FLANAGAN ME, Larson EB, Walker RL, Keene CD, et al
    Associations between Use of Specific Analgesics and Concentrations of Amyloid-beta 42 or Phospho-Tau in Regions of Human Cerebral Cortex.
    J Alzheimers Dis. 2018;61:653-662.
    PubMed     Abstract available


  1349. SYNN A, Mothakunnel A, Kumfor F, Chen Y, et al
    Mental States in Moving Shapes: Distinct Cortical and Subcortical Contributions to Theory of Mind Impairments in Dementia.
    J Alzheimers Dis. 2018;61:521-535.
    PubMed     Abstract available


  1350. GONZALEZ-RAMIREZ M, Gavilan J, Silva-Grecchi T, Cajas-Madriaga D, et al
    A Natural Benzofuran from the Patagonic Aleurodiscus vitellinus Fungus has Potent Neuroprotective Properties on a Cellular Model of Amyloid-beta Peptide Toxicity.
    J Alzheimers Dis. 2018;61:1463-1475.
    PubMed     Abstract available


  1351. AHLEMEYER B, Halupczok S, Rodenberg-Frank E, Valerius KP, et al
    Endogenous Murine Amyloid-beta Peptide Assembles into Aggregates in the Aged C57BL/6J Mouse Suggesting These Animals as a Model to Study Pathogenesis of Amyloid-beta Plaque Formation.
    J Alzheimers Dis. 2018;61:1425-1450.
    PubMed     Abstract available


  1352. YU L, Liu Y, Jin Y, Cao X, et al
    Lentivirus-Mediated HDAC3 Inhibition Attenuates Oxidative Stress in APPswe/PS1dE9 Mice.
    J Alzheimers Dis. 2018;61:1411-1424.
    PubMed     Abstract available


  1353. CLEMENS V, Regen F, Le Bret N, Heuser I, et al
    Retinoic Acid Enhances Apolipoprotein E Synthesis in Human Macrophages.
    J Alzheimers Dis. 2018;61:1295-1300.
    PubMed     Abstract available


  1354. BEACH TG, Maarouf CL, Intorcia A, Sue LI, et al
    Antemortem-Postmortem Correlation of Florbetapir (18F) PET Amyloid Imaging with Quantitative Biochemical Measures of Abeta42 but not Abeta40.
    J Alzheimers Dis. 2018;61:1509-1516.
    PubMed     Abstract available


  1355. FERNANDO WMADB, Rainey-Smith SR, Gardener SL, Villemagne VL, et al
    Associations of Dietary Protein and Fiber Intake with Brain and Blood Amyloid-beta.
    J Alzheimers Dis. 2018;61:1589-1598.
    PubMed     Abstract available


  1356. SARACENO C, Catania M, Paterlini A, Fostinelli S, et al
    Altered Expression of Circulating Cdc42 in Frontotemporal Lobar Degeneration.
    J Alzheimers Dis. 2018;61:1477-1483.
    PubMed     Abstract available


  1357. FENG X, Zhou A, Liu Z, Li F, et al
    Validation of the Delayed Matching-to-Sample Task 48 (DMS48) in Elderly Chinese.
    J Alzheimers Dis. 2018;61:1611-1618.
    PubMed     Abstract available


  1358. SHEA TB, Remington R
    Apparent Cognitive Decline as Revealed by an Executive Function Test within a Cohort of Elderly Individuals Self-Reporting Normal Cognitive Performance.
    J Alzheimers Dis. 2018;61:913-915.
    PubMed     Abstract available


  1359. MALETTA R, Smirne N, Bernardi L, Anfossi M, et al
    Frequency of Cardiovascular Genetic Risk Factors in a Calabrian Population and Their Effects on Dementia.
    J Alzheimers Dis. 2018;61:1179-1187.
    PubMed     Abstract available


  1360. BRICI D, Gotz J, Nisbet RM
    A Novel Antibody Targeting Tau Phosphorylated at Serine 235 Detects Neurofibrillary Tangles.
    J Alzheimers Dis. 2018;61:899-905.
    PubMed     Abstract available


  1361. NIKOLAI T, Stepankova H, Kopecek M, Sulc Z, et al
    The Uniform Data Set, Czech Version: Normative Data in Older Adults from an International Perspective.
    J Alzheimers Dis. 2018;61:1233-1240.
    PubMed     Abstract available


  1362. ARNER A, Rockenstein E, Mante M, Florio J, et al
    Increased Vulnerability of the Hippocampus in Transgenic Mice Overexpressing APP and Triple Repeat Tau.
    J Alzheimers Dis. 2018;61:1201-1219.
    PubMed     Abstract available


  1363. HEINRICH J, Vidal JS, Simon A, Rigaud AS, et al
    Relationships Between Lower Olfaction and Brain White Matter Lesions in Elderly Subjects with Mild Cognitive Impairment.
    J Alzheimers Dis. 2018;61:1133-1141.
    PubMed     Abstract available


  1364. NIELSEN MS, Simonsen AH, Siersma V, Hasselbalch SG, et al
    The Diagnostic and Prognostic Value of a Dual-Tasking Paradigm in a Memory Clinic.
    J Alzheimers Dis. 2018;61:1189-1199.
    PubMed     Abstract available


  1365. LIU Z, Kameshima N, Nanjo T, Shiino A, et al
    Development of a High-Sensitivity Method for the Measurement of Human Nasal Abeta42, Tau, and Phosphorylated Tau.
    J Alzheimers Dis. 2018;62:737-744.
    PubMed     Abstract available


  1366. KATISKO K, Haapasalo A, Koivisto A, Kruger J, et al
    Low Prevalence of Cancer in Patients with Frontotemporal Lobar Degeneration.
    J Alzheimers Dis. 2018;62:789-794.
    PubMed     Abstract available


  1367. KING JL, Wong AA, Brown RE
    Age-Related Changes in the Spatial Frequency Threshold of Male and Female 3xTg-AD Mice Using OptoMotry.
    J Alzheimers Dis. 2018;62:591-596.
    PubMed     Abstract available


  1368. MARRA A, Naro A, Chillura A, Bramanti A, et al
    Evaluating Peripersonal Space through the Functional Transcranial Doppler: Are We Paving the Way for Early Detecting Mild Cognitive Impairment to Dementia Conversion?
    J Alzheimers Dis. 2018;62:133-143.
    PubMed     Abstract available


  1369. BEN BOUALLEGUE F, Mariano-Goulart D, Payoux P
    Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI.
    J Alzheimers Dis. 2018;62:399-408.
    PubMed     Abstract available


    December 2017
  1370. RAHA-CHOWDHURY R, Henderson JW, Raha AA, Stott SRW, et al
    Erythromyeloid-Derived TREM2: A Major Determinant of Alzheimer's Disease Pathology in Down Syndrome.
    J Alzheimers Dis. 2017 Dec 16. pii: JAD170814. doi: 10.3233/JAD-170814.
    PubMed     Abstract available


  1371. KONISHI K, Joober R, Poirier J, MacDonald K, et al
    Healthy versus Entorhinal Cortical Atrophy Identification in Asymptomatic APOE4 Carriers at Risk for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 16. pii: JAD170540. doi: 10.3233/JAD-170540.
    PubMed     Abstract available


  1372. BOTCHWAY BOA, Moore MK, Akinleye FO, Iyer IC, et al
    Nutrition: Review on the Possible Treatment for Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 15. pii: JAD170874. doi: 10.3233/JAD-170874.
    PubMed     Abstract available


  1373. WANG SS, Jia J, Wang Z
    Mesenchymal Stem Cell-Derived Extracellular Vesicles Suppresses iNOS Expression and Ameliorates Neural Impairment in Alzheimer's Disease Mice.
    J Alzheimers Dis. 2017 Dec 15. pii: JAD170848. doi: 10.3233/JAD-170848.
    PubMed     Abstract available


  1374. WEI EX, Oh ES, Harun A, Ehrenburg M, et al
    Vestibular Loss Predicts Poorer Spatial Cognition in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 15. pii: JAD170751. doi: 10.3233/JAD-170751.
    PubMed     Abstract available


  1375. GABRIEL AJ, Almeida MR, Ribeiro MH, Carneiro D, et al
    Influence of Butyrylcholinesterase in Progression of Mild Cognitive Impairment to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 15. pii: JAD170695. doi: 10.3233/JAD-170695.
    PubMed     Abstract available


  1376. ELDHOLM RS, Barca ML, Persson K, Knapskog AB, et al
    Progression of Alzheimer's Disease: A Longitudinal Study in Norwegian Memory Clinics.
    J Alzheimers Dis. 2017 Dec 15. pii: JAD170436. doi: 10.3233/JAD-170436.
    PubMed     Abstract available


  1377. ATANASOVA B, Mondon K, Dreyfuss L, Beaufils E, et al
    Hedonic Assessment of Odors: A Comparison of Two Sensory Scales for Use with Alzheimer's Disease Patients and Elderly Individuals.
    J Alzheimers Dis. 2017 Dec 13. pii: JAD170433. doi: 10.3233/JAD-170433.
    PubMed     Abstract available


  1378. LOVHEIM H, Olsson J, Weidung B, Johansson A, et al
    Interaction between Cytomegalovirus and Herpes Simplex Virus Type 1 Associated with the Risk of Alzheimer's Disease Development.
    J Alzheimers Dis. 2017 Dec 13. pii: JAD161305. doi: 10.3233/JAD-161305.
    PubMed     Abstract available


  1379. DI MECO A, Li JG, Pratico D
    Dissecting the Role of 5-Lipoxygenase in the Homocysteine-Induced Alzheimer's Disease Pathology.
    J Alzheimers Dis. 2017 Dec 12. pii: JAD170700. doi: 10.3233/JAD-170700.
    PubMed     Abstract available


  1380. WISCHIK CM, Schelter BO, Wischik DJ, Storey JMD, et al
    Modeling Prion-Like Processing of Tau Protein in Alzheimer's Disease for Pharmaceutical Development.
    J Alzheimers Dis. 2017 Dec 8. pii: JAD170727. doi: 10.3233/JAD-170727.
    PubMed     Abstract available


  1381. FERRARI C, Lombardi G, Polito C, Lucidi G, et al
    Alzheimer's Disease Progression: Factors Influencing Cognitive Decline.
    J Alzheimers Dis. 2017 Dec 8. pii: JAD170665. doi: 10.3233/JAD-170665.
    PubMed     Abstract available


  1382. EL HAJ M, Coello Y, Kapogiannis D, Gallouj K, et al
    Negative Prospective Memory in Alzheimer's Disease: "Do Not Perform That Action".
    J Alzheimers Dis. 2017 Dec 6. pii: JAD170807. doi: 10.3233/JAD-170807.
    PubMed     Abstract available


  1383. HARRIS R, Miners JS, Allen S, Love S, et al
    VEGFR1 and VEGFR2 in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 6. pii: JAD170745. doi: 10.3233/JAD-170745.
    PubMed     Abstract available


  1384. SINAI A, Mokrysz C, Bernal J, Bohnen I, et al
    Predictors of Age of Diagnosis and Survival of Alzheimer's Disease in Down Syndrome.
    J Alzheimers Dis. 2017 Dec 6. pii: JAD170624. doi: 10.3233/JAD-170624.
    PubMed     Abstract available


  1385. KEHOE PG, Blair PS, Howden B, Thomas DL, et al
    The Rationale and Design of the Reducing Pathology in Alzheimer's Disease through Angiotensin TaRgeting (RADAR) Trial.
    J Alzheimers Dis. 2017 Dec 6. pii: JAD170101. doi: 10.3233/JAD-170101.
    PubMed     Abstract available


  1386. TELL-MARTI G, Puig-Butille JA, Potrony M, Plana E, et al
    A Common Variant in the MC1R Gene (p.V92M) is associated with Alzheimer's Disease Risk.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-161113.
    PubMed     Abstract available


  1387. TONNIES E, Trushina E
    Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-161088.
    PubMed     Abstract available


  1388. SATHYA M, Moorthi P, Premkumar P, Kandasamy M, et al
    Resveratrol Intervenes in the Cholesterol- and Isoprenoid-Mediated Amyloidogenic Processing of AbetaPP in Familial Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-161034.
    PubMed     Abstract available


  1389. WANG H, Hong X, Wang Y
    Mitochondrial Repair Effects of Oxygen Treatment on Alzheimer's Disease Model Mice Revealed by Quantitative Proteomics.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-161010.
    PubMed     Abstract available


  1390. BASTIAN FO
    Combined Creutzfeldt-Jakob-Jacob/ Alzheimer's Disease Cases are Important in Search for Microbes in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-160999.
    PubMed     Abstract available


  1391. DASHINIMAEV EB, Artyuhov AS, Bolshakov AP, Vorotelyak EA, et al
    Neurons Derived from Induced Pluripotent Stem Cells of Patients with Down Syndrome Reproduce Early Stages of Alzheimer's Disease Type Pathology in vitro.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-160945.
    PubMed     Abstract available


  1392. VAN WAALWIJK VAN DOORN LJ, Gispert JD, Kuiperij HB, Claassen JA, et al
    Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes.
    J Alzheimers Dis. 2017 Dec 3. doi: 10.3233/JAD-160668.
    PubMed     Abstract available


  1393. SHEA TB
    While I Still Remember: 30 Years of Alzheimer's Disease Research.
    J Alzheimers Dis. 2017 Dec 2. pii: JAD170724. doi: 10.3233/JAD-170724.
    PubMed     Abstract available


  1394. TSOU HH, Hsu WC, Fuh JL, Chen SP, et al
    Alterations in Acrolein Metabolism Contribute to Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 1. pii: JAD170736. doi: 10.3233/JAD-170736.
    PubMed     Abstract available


  1395. SLACHEVSKY A, Barraza P, Hornberger M, Munoz-Neira C, et al
    Neuroanatomical Comparison of the "Word" and "Picture" Versions of the Free and Cued Selective Reminding Test in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Dec 1. pii: JAD160973. doi: 10.3233/JAD-160973.
    PubMed     Abstract available


    November 2017
  1396. THANGAVEL R, Bhagavan SM, Ramaswamy SB, Surpur S, et al
    Co-Expression of Glia Maturation Factor and Apolipoprotein E4 in Alzheimer's Disease Brain.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170777. doi: 10.3233/JAD-170777.
    PubMed     Abstract available


  1397. DI FEDE G, Giaccone G, Salmona M, Tagliavini F, et al
    Translational Research in Alzheimer's and Prion Diseases.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170770. doi: 10.3233/JAD-170770.
    PubMed     Abstract available


  1398. PEREIRA CD, Martins F, Wiltfang J, da Cruz E Silva OAB, et al
    ABC Transporters Are Key Players in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170639. doi: 10.3233/JAD-170639.
    PubMed     Abstract available


  1399. ROE CM, Babulal GM, Mishra S, Gordon BA, et al
    Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170521. doi: 10.3233/JAD-170521.
    PubMed     Abstract available


  1400. KIMURA A, Yoshikura N, Hayashi Y, Inuzuka T, et al
    Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170519. doi: 10.3233/JAD-170519.
    PubMed     Abstract available


  1401. DOECKE JD, Rembach A, Villemagne VL, Varghese S, et al
    Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.
    J Alzheimers Dis. 2017 Nov 20. pii: JAD170128. doi: 10.3233/JAD-170128.
    PubMed     Abstract available


  1402. CUBERAS-BORROS G, Roca I, Boada M, Tarraga L, et al
    Longitudinal Neuroimaging Analysis in Mild-Moderate Alzheimer's Disease Patients Treated with Plasma Exchange with 5% Human Albumin.
    J Alzheimers Dis. 2017 Nov 17. doi: 10.3233/JAD-170693.
    PubMed     Abstract available


  1403. WILCOCK GK, Gauthier S, Frisoni GB, Jia J, et al
    Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer's Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial.
    J Alzheimers Dis. 2017 Nov 17. doi: 10.3233/JAD-170560.
    PubMed     Abstract available


  1404. FREDERIKSEN KS, Gjerum L, Waldemar G, Hasselbalch SG, et al
    Effects of Physical Exercise on Alzheimer's Disease Biomarkers: A Systematic Review of Intervention Studies.
    J Alzheimers Dis. 2017 Nov 16. doi: 10.3233/JAD-170567.
    PubMed     Abstract available


  1405. SEDDIGHI S, Varma VR, An Y, Varma S, et al
    SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging.
    J Alzheimers Dis. 2017 Nov 16. doi: 10.3233/JAD-170557.
    PubMed     Abstract available


  1406. GEIJSELAERS SLC, Aalten P, Ramakers IHGB, De Deyn PP, et al
    Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 16. doi: 10.3233/JAD-170522.
    PubMed     Abstract available


  1407. MUTHUKUMARAN K, Kanwar A, Vegh C, Marginean A, et al
    Ubisol-Q10 (a Nanomicellar Water- Soluble Formulation of CoQ10) Treatment Inhibits Alzheimer-Type Behavioral and Pathological Symptoms in a Double Transgenic Mouse (TgAPEswe, PSEN1dE9) Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 16. doi: 10.3233/JAD-170275.
    PubMed     Abstract available


  1408. DOS SANTOS JPA, Vizuete A, Hansen F, Biasibetti R, et al
    Early and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 16. doi: 10.3233/JAD-170211.
    PubMed     Abstract available


  1409. LANGE C, Suppa P, Pietrzyk U, Makowski MR, et al
    Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status.
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170705.
    PubMed     Abstract available


  1410. HASEGAWA Y, Toyama K, Uekawa K, Ichijo H, et al
    Role of ASK1/p38 Cascade in a Mouse Model of Alzheimer's Disease and Brain Aging.
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170645.
    PubMed     Abstract available


  1411. HUBER CM, Yee C, May T, Dhanala A, et al
    Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy.
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170490.
    PubMed     Abstract available


  1412. GELMAN S, Palma J, Tombaugh G, Ghavami A, et al
    Differences in Synaptic Dysfunction Between rTg4510 and APP/PS1 Mouse Models of Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170457.
    PubMed     Abstract available


  1413. FAXEN-IRVING G, Falahati F, Basun H, Eriksdotter M, et al
    Does Fatty Acid Composition in Subcutaneous Adipose Tissue Differ between Patients with Alzheimer's Disease and Cohabiting Proxies?
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170359.
    PubMed     Abstract available


  1414. KIRSON NY, Andrews JS, Desai U, King SB, et al
    Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 14. doi: 10.3233/JAD-170078.
    PubMed     Abstract available


  1415. MATIAS-GUIU JA, Cabrera-Martin MN, Curiel RE, Valles-Salgado M, et al
    Comparison between FCSRT and LASSI-L to Detect Early Stage Alzheimer's Disease.
    J Alzheimers Dis. 2017 Nov 8. doi: 10.3233/JAD-170604.
    PubMed     Abstract available


  1416. VILLAMIL-ORTIZ JG, Barrera-Ocampo A, Arias-Londono JD, Villegas A, et al
    Differential Pattern of Phospholipid Profile in the Temporal Cortex from E280A-Familiar and Sporadic Alzheimer's Disease Brains.
    J Alzheimers Dis. 2017 Nov 8. doi: 10.3233/JAD-170554.
    PubMed     Abstract available


  1417. GLEASON CE, Norton D, Anderson ED, Wahoske M, et al
    Cognitive Variability Predicts Incident Alzheimer's Disease and Mild Cognitive Impairment Comparable to a Cerebrospinal Fluid Biomarker.
    J Alzheimers Dis. 2017 Nov 8. doi: 10.3233/JAD-170498.
    PubMed     Abstract available


  1418. MEDORO A, Bartollino S, Mignogna D, Passarella D, et al
    Complexity and Selectivity of gamma-Secretase Cleavage on Multiple Substrates: Consequences in Alzheimer's Disease and Cancer.
    J Alzheimers Dis. 2017 Nov 1. doi: 10.3233/JAD-170628.
    PubMed     Abstract available


  1419. NACMIAS B, Bagnoli S, Piaceri I, Sorbi S, et al
    Genetic Heterogeneity of Alzheimer's Disease: Embracing Research Partnerships.
    J Alzheimers Dis. 2017 Nov 1. doi: 10.3233/JAD-170570.
    PubMed     Abstract available


    October 2017
  1420. FAJARDO VA, Fajardo VA, LeBlanc PJ, MacPherson REK, et al
    Examining the Relationship between Trace Lithium in Drinking Water and the Rising Rates of Age-Adjusted Alzheimer's Disease Mortality in Texas.
    J Alzheimers Dis. 2017 Oct 30. doi: 10.3233/JAD-170744.